

ACCESSION NUMBER:		0001185185-14-001008
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20131231
FILED AS OF DATE:		20140416
DATE AS OF CHANGE:		20140416
FILER:
	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Mojo Organics
 Inc.
		CENTRAL INDEX KEY:			0001414953
		STANDARD INDUSTRIAL CLASSIFICATION:	CANNED
 FROZEN & PRESERVED FRUIT
 VEG & FOOD SPECIALTIES [2030]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930
	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	333-148190
		FILM NUMBER:		14767852
	BUSINESS ADDRESS:	
		STREET 1:		101 HUDSON STREET
		STREET 2:		21ST FLOOR
		CITY:			JERSEY CITY
		STATE:			NJ
		ZIP:			07302
		BUSINESS PHONE:		(201) 633-6519
	MAIL ADDRESS:	
		STREET 1:		101 HUDSON STREET
		STREET 2:		21ST FLOOR
		CITY:			JERSEY CITY
		STATE:			NJ
		ZIP:			07302
	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Mojo Ventures
 Inc.
		DATE OF NAME CHANGE:	20110518
	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Mojo Ventures
 Inc
		DATE OF NAME CHANGE:	20110506
	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Mojo Ventures
 Inc.
		DATE OF NAME CHANGE:	20110506









    










WASHINGTON
 D.C. 20549




























December 31
 2013
























MOJO Organics
 Inc.







































101 Hudson Street
 21





Jersey City
 New Jersey























Indicate by check mark if the registrant is a well-known seasoned issuer
 as defined in Rule 405 of the Securities Act.&#160;&#160;Yes&#160;



Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding past 12 months (or for such shorter period that the registrant was required to file such reports)
 and (2) has been subject to such filing requirements for the past 90 days. Yes&#160;

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site
 if any
 every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).&#160;&#160;Yes&#160;


Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein
 and will not be contained
 to the best of registrant's knowledge
 in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.&#160;

Indicate by check mark whether the registrant is a large accelerated filer
 an accelerated filer
 or a smaller reporting company. See the definitions of the &#8220;large accelerated filer
&#8221; &#8220;accelerated filer
&#8221; and &#8220;smaller reporting company&#8221; in Rule 12b-2 of the Exchange Act:











































As of June 30
 2013 (the last day of the registrant&#8217;s most recently completed second fiscal quarter)
 the aggregate market value of the registrant&#8217;s common stock (based on its reported last sale price on such date of $3.25 per share) held by non-affiliates of the registrant was $22
874
267.



On April 14
 2014
 there were 15
419
893 shares of the registrant's common stock
 par value $0.001
 issued and outstanding.




























































































































Market for Registrant&#8217;s Common Equity
 Related Stockholder Matters and Issuer

























































































Directors
 Executive Officers and Corporate Governance





























Certain Relationships and Related Transactions
 and Director Independence





























Exhibits
 Financial Statement Schedules




































This report contains forward-looking statements. Such forward-looking statements involve risks and uncertainties
 including
 among other things
 statements regarding our business strategy
 future revenues and anticipated costs and expenses. Such forward-looking statements include
 among others
 those statements using words such as &#8220;expects
&#8221; &#8220;anticipates
&#8221; &#8220;intends
&#8221; &#8220;believes&#8221; and similar language.


Although we believe that the expectations reflected in these forward-looking statements are based on reasonable assumptions
 there are a number of risks and uncertainties that could cause actual results to differ materially from such forward-looking statements.&#160;&#160;Factors that might cause or contribute to such differences include
 but are not limited to
 those discussed in the sections &#8220;Business&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.&#8221; You are cautioned not to place undue reliance on the forward-looking statements
 which speak only as of the date of this report. We undertake no obligation to publicly release any revisions to the forward-looking statements or reflect events or circumstances after the date of this document.

All references in this Annual Report on Form 10-K to &#8220;MOJO
&#8221; &#8220;MOJO Organics
&#8221; the &#8220;Company
&#8221; &#8220;we
&#8221; &#8220;us&#8221; or &#8220;our&#8221; mean MOJO Organics
 Inc.
























Headquartered in Jersey City
 New Jersey
 the Company engages in product development
 production
 marketing and distribution of CHIQUITA TROPICALS


 contain zero added sugar and no preservatives.&#160;&#160;They are naturally low sodium
 vegan
 naturally gluten free
require no refrigeration before opening and
 as a result of the way the juice is bottled
 have a longer shelf life than most other bottled juices.


We believe in safe and sustainable corporate practices. We are proud to use Rainforest Alliance Certified fruits
 which help the farmers and their families while being environmentally
 socially and economically sustainable.









100% fruit juices first became commercially available&#160;in the New York tri-state area in late July 2013 and on Amazon.com in August 2013.&#160;&#160;&#160;The Company currently produces four flavors: Banana Strawberry
 Mango
 Passion Fruit and Pineapple.








products through production facilities and services on a contract basis.&#160;&#160;The Company believes that its current production and packaging arrangements are adequate for current and near-term anticipated demand for its products.&#160;&#160;An important part of the Company&#8217;s overall strategy
 however
 will be the expansion of production capabilities and resources.


in hundreds of retail outlets. The Company also intends to sell directly to retailers
 including large chain stores.






On August 15
 2012
 the Company entered into a license agreement with Chiquita (the &#8220;License Agreement&#8221;) for the use of Chiquita&#8217;s marks in the manufacture
 sale
 promotion
 marketing
 advertising and distribution of certain fruit juice products in select containers.&#160;&#160;The License Agreement grants the Company an exclusive license in Connecticut
 New Jersey and New York and a non-exclusive license for all of the states in the United States not included in the exclusive license
 plus Costa Rica
 El Salvador
 Guatemala
 Honduras and Nicaragua.&#160;&#160;


The term of the License Agreement is for seven years from&#160;July 2013
 (the date we first invoiced customers for products sold under the License Agreement)
 subject to the Company meeting certain minimum sales volume and/or minimum royalty payments.&#160;&#160;Termination of the License Agreement could have a material and adverse impact on the Company&#8217;s business.





















The juice beverage market is highly competitive.&#160;&#160;Competitors in our market compete for brand recognition
 ingredient sourcing
 qualified personnel and product shelf space.&#160;&#160;As a developing company
 a majority of our competitors are more established and better capitalized than us.&#160;&#160;The juice beverage market is generally dominated by the largest beverage providers
 including The Coca-Cola Company and PepsiCo
 Inc.&#160;&#160;Many of our competitors enjoy significant brand recognition and consumer confidence and are able to readily secure shelf space and media attention for their products.&#160;&#160;Many of our competitors also have existing relationships with the same distribution channels and retailers through which we sell our products.&#160;&#160;&#160;We intend to compete in the market by offering consumers affordable products that taste better and possess a longer shelf life than most products in the market.





Juice products are governed by the U.S. Food and Drug Administration.&#160;&#160;As such
 it is necessary for the Company to establish
 maintain and make available for inspection records as well as to develop labels (including nutrition information) that meet legal food labeling requirements.&#160;&#160;The Company&#8217;s contracted production facilities are subject to many regulations
 including Food Facility Registration
 recordkeeping
 Good Manufacturing Practice Requirements
 reporting
 preventive controls and inspections.





As of April 14
 2014
to retail stores nationally.&#160;&#160;In certain regions of the United States
 we utilize the services of direct sales and distribution companies that sell our products in their distribution channels.&#160;&#160;This mitigates the need for a large sales and merchandising force.&#160;&#160;The Company also outsources it logistics to third-parties
 which eliminates the need for employees to perform these roles.





The Company was incorporated in the State of Delaware on August 2
 2007 under the name MOJO Shopping
 Inc. for the purpose of developing an online retail business focused on marketing merchandise to young professionals. On April 28
 2011
 the Company changed its name to MOJO Ventures
 Inc.&#160;&#160;On May 13
 2011
 the Company closed a merger with Specialty Beverage and Supplement
 Inc.
 a privately held Nevada corporation (&#8220;Specialty Beverage&#8221;)
 pursuant to which Specialty Beverage merged with and into SBSI Acquisition Corp.
 a Nevada corporation and our wholly-owned subsidiary (&#8220;SBSI&#8221;). Specialty Beverage
 incorporated in the State of Nevada on April 3
 2008
 was engaged in the development of beverage products and vitamin supplements
 such as energy drinks
 sports drinks
 wellness beverages
 ready-to-drink iced teas and vitamin enhanced children&#8217;s drinks.


The Company entered into a split-off agreement dated October 27
 2011 (&#8220;Split-Off&#8221;) with a newly organized
 wholly owned subsidiary MOJO Organics Operating Company
 Inc.
 a Delaware corporation then-known as MOJO Organics
 Inc.
 SBSI and certain stockholders of the Company (&#8220;Buyers&#8221;). &#160;In the Split-Off
 all of the issued and outstanding shares of capital stock of SBSI were assigned and transferred to the Buyers in exchange for the Buyers surrender to the Company of an aggregate of 2
330
775 shares of its common stock
 par value $0.001 per share (&#8220;Common Stock&#8221;)
 for cancellation.&#160;&#160;Such shares represented approximately 38% of the issued and outstanding shares of the Common Stock prior to the Split-Off.&#160;&#160;In the Split-Off
 SBSI assigned to the Company SBSI&#8217;s Dispensing Cap and Pinch assets (including all related intellectual property) and retained all of its other assets and all liabilities
 including its (and the Company&#8217;s former) principal office and distribution facilities in Holbrook
 New York
 as well as the Company&#8217;s other former subsidiary
 Graphic Gorilla LLC. MOJO&#8217;s management has determined that the Dispensing Cap technology and brand name Pinch do not have viable commercial value and
 as a result
 the Company has no current plans to market or use these assets.


On December 28
 2011
 we changed our name to MOJO Organics
 Inc. to better reflect our focus on the natural and organic beverage markets.


The Company effected a one-for-ten reverse stock split (&#8220;Reverse Split&#8221;) of the issued and outstanding shares of Common Stock on April 1
 2013. The number of authorized shares and the par value of our Common Stock were not changed. All share references in this report have been restated to reflect the Reverse Split.


























The Company maintains office space in Jersey City
 NJ.&#160;&#160;The Company leases the space from a third-party on a month-to-month basis at a current rate of $1
147 per month.



No legal or governmental proceedings are presently pending or
 to our knowledge
 threatened
 to which we are a party.






















5.&#160;&#160;MARKET FOR REGISTRANT&#8217;S COMMON EQUITY
 RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES





For the period from January 1
 2012 to December 31
 2013
 the following table sets forth the high and low closing bid prices by quarter
 based upon information obtained from inter-dealer quotations without retail markup
 markdown
 or commission and may not necessarily represent actual transactions:

























































































































































































































As of April 14
 2014
 there were 15
419
893 shares of Common Stock issued and outstanding held by 114 shareholders of record.




The Company has never declared any cash dividends with respect to its Common Stock. Future payment of dividends is within the discretion of the Board of Directors and will depend on earnings
 capital requirements
 financial condition and other relevant factors. Although there are no material restrictions limiting
 or that are likely to limit
 the Company&#8217;s ability to pay dividends on its Common Stock
 the Company presently intends to retain future earnings
 if any
 for use in the business and has no present intention to pay cash dividends on its Common Stock.



There were no sales of unregistered securities during the quarter ended December 31
 2013 other than the following:&#160;


On October 3
 2013
 the Company entered into two separate advisor agreements
 pursuant to which the Company agreed to issue an aggregate of 417
204 shares of Common Stock as payment for services to be rendered thereunder.&#160;&#160;As to one advisor agreement
 the Company issued 50
000 shares of Common Stock to vest six months following the issuance of such shares.&#160;&#160;As to the other advisor agreement
 the Company issued an aggregate of 367
204 shares of Common Stock
 pursuant to which agreement 200
000 of such shares were initially subject to forfeiture until certain performance objectives are met.&#160;&#160;As of December 31
 2013
 certain of the performance objectives have been met
 such that only 100
000 of such shares remain subject to forfeiture.&#160;&#160;Such shares were issued in reliance on the exemption from registration provided by Section 4(2) of the Act.



On December 4
 2013
 the Company issued an aggregate of 5
412 shares of Common Stock to a consultant of the Company as payment of consulting fees for services provided in October (2
644 shares at $2.25 per share) and November (2
768 shares at $2.15 per share).&#160;&#160;In January 2014
 the Company issued 2
520 shares of Common Stock to this consultant as payment of consulting fees for services provided in December (at $2.50 per share).&#160;&#160;Shares due in payment of such fees for each month were valued at the last sale price of the Company&#8217;s Common Stock on the last trading day of the subject month in accordance with the consultant&#8217;s agreement with the Company and vest after six months.&#160;&#160;Such shares were issued in reliance on the exemption from registration provided by Section 4(2) of the Act.


















On December 4
 2013
 the Company issued an aggregate of 15
664 shares of Common Stock to its chief executive officer as payment for amounts of the officer&#8217;s base salary due and owing under the employment agreement for the months of October (8
222 shares at $2.25 per share) and November (7
442 shares at $2.15 per share).&#160;&#160;In January 2014
 the Company issued an additional 7
400 shares of Common Stock to its chief executive officer for base salary due for December (at $2.50 per share).&#160;&#160;The shares were valued at the last sale price of the Company&#8217;s Common Stock on the last trading day of the subject month and vest after six months.&#160;&#160;Such shares were issued in reliance on the exemption from registration provided by Section 4(2) of the Act.

Also on December 4
 2013
 the Company granted an aggregate of 608
441shares of Common Stock to its chief executive officer
 directors and a special advisor under the Company&#8217;s 2012 Long-Term Equity Incentive Plan (&#8220;2012 Plan&#8221;).&#160;&#160;Such shares are subject to a Restricted Stock Agreement between each grantee and the Company
 pursuant to which such shares will vest on December 4
 2014 provided the grantee is still an employee
 director or consultant of the Company (as applicable).&#160;&#160;Such shares were issued in reliance on the exemption from registration provided by Section 4(2) of the Act.



On December 26
 2013
 the Company issued 15
000 shares of Common Stock in consideration of the extension of repayment of a promissory note.&#160;&#160;Such shares were issued in reliance on the exemption from registration provided by Section 4(2) of the Act.


In January 2014
 the Company issued 5
077 shares to one of its employees as payment in lieu of cash due to such employee for outstanding wages earned in 2013.&#160;&#160;Such shares were valued at the last sale price of the Company&#8217;s Common Stock on the last trading day of the year.&#160;&#160;Such shares were issued in reliance on the exemption from registration provided by Section 4(2) of the Act.










Our Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations (&#8220;MD&amp;A&#8221;) is provided in addition to the accompanying consolidated financial statements and notes to assist readers in understanding our results of operations
 financial condition and cash flows. MD&amp;A is organized as follows:





























Results of Operations &#8212; Analysis of our financial results comparing the year ended December 31
 2013 to 2012. Liquidity and Capital Resources &#8212; Analysis of changes in our cash flows
 and discussion of our financial condition and potential sources of liquidity.





This report includes a number of forward looking statements that reflect our current views with respect to future events and financial performance.&#160;&#160;Forward looking statements are often identified by words like: believe
 expect
 estimate
 anticipate
 intend
 project and similar expressions
 or words which
 by their nature
 refer to future events.&#160;&#160;You should not place undue certainty on these forward looking statements
 which apply only as of the date of this annual report.&#160;&#160;These forward looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from historical results or our predictions.




We have prepared our financial statements in conformity with accounting principles generally accepted in the United States
 which requires management to make significant judgments and estimates that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. We base these significant judgments and estimates on historical experience and other applicable assumptions we believe to be reasonable based upon information presently available. These estimates may change as new events occur
 as additional information is obtained and as our operating environment changes. These changes have historically been minor and have been included in the financial statements as soon as they became known. Actual results could materially differ from our estimates under different assumptions
 judgments or conditions.
















All of our significant accounting policies are discussed in Note 2
 Summary of Significant Accounting Policies
 to our financial statements
 included elsewhere in this Annual Report. We have identified the following as our critical accounting policies and estimates
 which are defined as those that are reflective of significant judgments and uncertainties
 are the most pervasive and important to the presentation of our financial condition and results of operations and could potentially result in materially different results under different assumptions
 judgments or conditions.







 &#8212; ASC Topic 718
&#8221; prescribes accounting and reporting standards for all stock-based compensation plans
 including employee stock options
 restricted stock
 employee stock purchase plans and stock appreciation rights.


ASC Topic 718 requires employee compensation expense to be recorded using the fair value method. The Company accounts for employee stock based compensation in accordance with the provisions of ASC Topic 718. For non-employee options and warrants
 the company uses the fair value method as prescribed in ASC Topic 718.

Determining the appropriate fair value of the stock-based compensation requires the input of subjective assumptions
 including the expected life of the stock-based payment and stock price volatility. The Company uses the Black-Scholes option-pricing option model to value its stock option awards which incorporate the Company&#8217;s stock price
 volatility
 U.S. risk-free rate
 dividend rate
 and estimated life.

 &#8212; Our short-term financial instruments
 including cash
 accounts payable and other liabilities
 consist primarily of instruments without extended maturities. We believe that the fair values of our current assets and current liabilities approximate their reported carrying amounts.



Recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force)
 the AICPA
 and the SEC
 did not
 or are not believed by management
 to have a material impact on the Company's present or future financial statements.





Years Ended December 31
 2013 and 2012



in June 2013 and began selling its products in late July 2013 in the New York tri-state area.&#160;&#160;Revenues from its four exotic juices for the year ended December 31
 2013 were $159
144. The Company had no revenues for the year ended December 31
 2012.



Cost of Revenues includes production costs and raw material costs.&#160;&#160;For the year ended December 31
 2013
 cost of revenues was $139
741
 or 88% of sales.



For the year ended December 31
 2013
 operating expenses were $2
791
761
 an increase of $1
193
695 or 75% over operating expenses for the year ended December 31
 2012 of $1
598
066.&#160;&#160;This increase was primarily the result of our launching commercial operations in the year ended December 31
 2013 and consisted primarily of&#160;&#160;increases in (a) advisory service fees and consulting fees
 which were paid in stock
 with the vested portion thereof having a fair market value of $964
162 for the year ended December 31
 2013 as compared to $157
500 during the year ended December 31
 2012
&#160;&#160;(b) marketing
 promotional
 licensing and related fees
 which were $381
081 for the year ended December 31
 2013 as compared to zero during the year ended December 31
 2012 and&#160;&#160;(c) salaries and related payroll fees
 which were $321
622 during the year ended December 31
 2013 as compared to $81
839 during the year ended December 31
 2012.
























During the year ended December 31
 2013
 the Company received cash proceeds of $412
134 from the sale of its Series A Preferred Stock.&#160;&#160;In addition
 cash proceeds of $448
681 were realized as a result of the Company&#8217;s private placement offering in May and June 2013.&#160;&#160;The aggregate amount realized from these two offerings was $860
815.&#160;&#160;The Company utilized the majority of these funds for the development and production of its first production runs
 as well as to promote and market the business.&#160;&#160;Additionally
 the Company used some of the funds for administrative costs
 including legal fees
 audit fees and compensation costs.


Subsequent to the year ended December 31
 2013
 the Company received additional cash proceeds of $1
835
000 from the sale of Common Stock and warrants to purchase Common Stock in concurrent private placements consummated in March 2014. See Note 10 to the Consolidated Financial Statements for additional information about this transaction.




As a result of the financing in March 2014
 the Company believes it has sufficient cash to fund the operations of the Company for the next twelve months.&#160;&#160;Our business prospects are difficult to predict
 however
Our auditors have included an explanatory paragraph in their report on our consolidated financial statements relating to the uncertainty of our business as a going concern
 due to our limited operating history and our lack of historical profitability.





































Disclosure controls and procedures include
 without limitation
 controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) is accumulated and communicated to the issuer's management
 including its principal executive and principal financial officers
 or persons performing similar functions
 as appropriate to allow timely decisions regarding required disclosure. It should be noted that the design of any system of controls is based in part upon certain assumptions about the likelihood of future events
 and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions
 regardless of how remote.



Under the supervision and with the participation of the Company&#8217;s senior management
 consisting of&#160;&#160;the Company&#8217;s principal executive and financial officer and the Company&#8217;s principal accounting officer
 the Company conducted an evaluation of the effectiveness of the design and operation of its disclosure controls and procedures
 as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act as of the end of the period covered by this report (the &#8220;Evaluation Date&#8221;). Based on this evaluation
 the Company&#8217;s principal executive and financial officer and the Company&#8217;s principal accounting officer concluded
 as of the Evaluation Date
 that the Company&#8217;s disclosure controls and procedures were effective.





The management of MOJO Organics
 Inc. is responsible for establishing and maintaining an adequate system of internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act.&#160;Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes of accounting principles generally accepted in the United States. Because of its inherent limitations
 internal control over financial reporting may not prevent or detect misstatements. Therefore
 even those systems determined to be effective can provide only reasonable assurance of achieving their control objectives. In evaluating the effectiveness of our internal control over financial reporting
. Based on this evaluation
 our officers concluded that
 during the period covered by this annual report
 our internal controls over financial reporting were operating effectively.

As previously reported
 the Company does not have an audit committee and is not currently obligated to have one. Although it remains management&#8217;s view that such a committee is an important internal control over financial reporting
 management does not believe that the lack of an audit committee could result in a material misstatement in the Company&#8217;s financial statements in the near future. Accordingly
 management has concluded that this deficiency alone does not constitute a material weakness in the Company&#8217;s internal control over financial reporting
 and has considered the foregoing in its determination that the Company&#8217;s internal controls over financial reporting and its disclosure controls and procedures were effective as of the Evaluation Date.










There was no change in our internal controls over financial reporting during the year ended December 31
 2013 that have materially affected
 or are reasonably likely to materially affect
 our internal controls over financial reporting.






















10.&#160;&#160;&#160;&#160;&#160; DIRECTORS
 EXECUTIVE OFFICERS
 AND CORPORATE GOVERNANCE

































Chief Executive Officer
 Chairman and Director



October 27
 2011























January 27
 2012



















Director
 Executive Vice President (October 1
 2012 &#8211; March 31
 2013)



May 9
 2012























March 17
 2014







 is Chairman of the Board of Directors and Chief Executive Officer of the Company.&#160;&#160;Mr. Simpson joined the Company in October 2011.&#160;&#160;He has extensive experience in the beverage industry. &#160;&#160;Mr. Simpson was Vice President and Chief Financial Officer of Coca-Cola Bottlers
 Inc. in Tashkent
 Uzbekistan from 1995 to 2000.&#160;&#160;His primary responsibilities included corporate strategy and supervision of bottling and distribution operations.&#160;&#160;His accomplishments included growing revenues from a base at $5 million to over $160 million annually.&#160;&#160;The company was awarded &#8220;Bottler of the Year&#8221; by The Coca-Cola Company for two consecutive years under his leadership based upon product quality and revenue growth.&#160;From 2009 to 2011
 Mr. Simpson was engaged in beverage projects on a consulting basis in Russia and Afghanistan.&#160;&#160;Mr. Simpson is a Certified Public Accountant and holds an MBA from Columbia University School of Business.


 has served on the Board of Directors of the Company since January 2012. Mr. Devlin has over 25 years of advertising and business development experience.&#160;&#160;Since 2002
 Mr. Devlin has been an Executive Producer and Partner of Original Films
 a well-known film and television production company.&#160;&#160;Mr. Devlin also currently serves as Senior Vice President of production and integrated programming for Arkleus Broadcasting Corp.&#160;and as a director of XA Experiential Agency. He has held various other executive and creative positions over the course of his advertising career
 including launching the introduction of Diet Coke for The Coca-Cola Company.&#160;&#160;Mr. Devlin currently serves on the board of directors of a number of private organizations
 as well as on the board of directors of two publicly traded companies: CMG Holdings and Location Based Technologies
 Inc.&#160;&#160;Mr. Devlin received a Bachelor&#8217;s degree from Bethel University.

 has served on the Board of Directors of the Company since May 2012.&#160;&#160;Mr. Seet also served as our Executive Vice President from October 2012 through March 2013.&#160; Since 1999
 Mr. Seet has served as Chairman of RXS Enterprises
 LLC. There he founded three media companies
 all backed by major private equity firms or strategic industry investors.&#160;&#160;From 1995 to 1999
 he was a principal with the Carlyle Group.&#160;&#160;From 1996 to 1999
 Mr. Seet served as an Advisory Director of Kerry Beverages Limited
 a joint venture between the Kerry Group and the Coca-Cola Company. The company operated a network of eleven bottling plants throughout China. As a Research Associate at Harvard Business School
 Mr. Seet authored two case studies examining the competitive strategies of Coke and Pepsi in China and India.&#160; He serves on the board of directors of several privately held companies.&#160;&#160;Mr. Seet received his Bachelor of Science degree from the Massachusetts Institute of Technology and his PhD in molecular genetics from Harvard University.


 joined the Board of Directors of the Company in March 2014.&#160;&#160;He is the founder and managing director of Wyatts Torch Equity Partners LP
 (&#8220;Wyatts&#8221;)
 a family business focused on public and private investments in the food and beverage industry. As General Partner and Portfolio Manager of Wyatts since 2011
 Mr. Spinner is responsible for investing the assets of the Partnership.&#160;&#160; From 2009 until Wyatts was founded in 2011
 Mr. Spinner was the managing partner of Ardent Asset Management
 a money management firm based in New York City.&#160; From 2000 to 2009
 Mr. Spinner was a portfolio manager and an equity analyst at Trellus Capital Management focusing on technology
 media and telecommunications. During his tenure at Trellus Capital Management
 assets under management expanded from $100 million to $2 billion. Prior thereto
 Mr. Spinner has also previously served as an analyst and portfolio manager at Irvine Capital and Forstmann
 Leff Associates. He began his career at Salomon Brothers Inc. in the equity trading division. Mr. Spinner received his undergraduate degree from Franklin and Marshall College and his MBA from Fordham University.


















The Company has not established any committees of the Board of Directors. Our Board of Directors may designate from among its members an executive committee and one or more other committees in the future. We do not have a nominating committee or a nominating committee charter. Further
 we do not have a policy with regard to the consideration of any director candidates recommended by security holders. To date
 no security holders have made any such recommendations. Our three directors perform all functions that would otherwise be performed by committees. Given the present size of our board it is not practical for us to have committees. If we are able to grow our business and increase our operations
 we intend to expand the size of our board and allocate responsibilities accordingly.




Currently
 we do not have a policy with regard to the consideration of any director candidates recommended by security holders. To date
 no security holders have made any such recommendations.



We have adopted a written code of ethics (the &#8220;Code of Ethics&#8221;) that applies to our principal executive officer
 principal financial officer
 principal accounting officer or controller
 and persons performing similar functions. We believe that the Code of Ethics is reasonably designed to deter wrongdoing and promote honest and ethical conduct; provide full
 fair
 accurate
 timely and understandable disclosure in public reports; comply with applicable laws; ensure prompt internal reporting of code violations; and provide accountability for adherence to the code. To request a copy of the Code of Ethics
 please make written request to our Company at 101 Hudson Street
 Floor
 Jersey City
 New Jersey 07302.



Our Common Stock is not registered pursuant to Section 12 of the Exchange Act. Accordingly
 our officers
 directors and principal shareholders are not subject to the beneficial ownership reporting requirements of Section 16(a) of the Exchange Act.















































































222
000



663
148



48
301



933
449











55
000



641
999







696
999





The Summary Compensation Table omits columns for Bonus (d)
 Non-Equity Incentive Plan Compensation (g)
 Non-Qualified Deferred Compensation Earnings (h) and All Other Compensation (i) as no such amounts were paid to the named executive officer during the fiscal years ended December 31
 2013 or 2012.












In lieu of a cash payment of $55
000 of salary earned during the first quarter of 2013
 Mr. Simpson elected to receive shares of Series A Convertible Preferred Stock (&#8220;Preferred Stock&#8221;) at a price of $4.00 per share pursuant to the terms of an Amended and Restated Securities Purchase Agreement described in Note 8 to the Consolidated Financial Statements included in this Form 10-K.&#160;&#160;Each share of Preferred Stock was convertible into a number of shares of Common Stock determined by dividing $4.00 by the conversion price of $0.40.&#160;&#160;Mr. Simpson made such election on March 29
 2013.&#160;&#160;Mr. Simpson received 13
750 shares of Preferred Stock for this election
 which were later converted into 137
500 shares of Common Stock.












In a separate private placement commenced by the Company in May 2013
 Mr. Simpson elected to convert $20
000 of unpaid salary into 50
000 shares of Common Stock
 at a price of $0.40 per share on the same terms as the other investors in the offering.











In addition to the aforementioned items
 Mr. Simpson agreed to accept shares of Common Stock in lieu of a cash payment of his base salary equal to $88
000 in 2013.&#160;&#160;Accordingly
 Mr. Simpson was issued 37
637 shares of Common Stock
 which were issued based upon the last sales price of the Common Stock on the last trading day of the month for which base salary was owed.





























In lieu of a cash payment of $55
000 of&#160;&#160;salary earned during 2012
 Mr. Simpson elected to receive shares of Preferred Stock at a price of $4.00 per share pursuant to the terms of the Amended and Restated Securities Purchase Agreement described in Note 8 to the Consolidated Financial Statements included in this Form 10-K.&#160;&#160;Each share of Preferred Stock was convertible into a number of shares of Common Stock determined by dividing $4.00 by the conversion price of $0.40.&#160;&#160;Mr. Simpson made such election on March 29
 2013.&#160;&#160;Mr. Simpson received 13
750 shares of Preferred Stock for this election
 which were later converted into 137
500 shares of Common Stock.















On December 4
 2013
 pursuant to the Company&#8217;s 2012 Plan
 the Company issued 308
441 shares of restricted Common Stock valued at the then fair market value of $2.15 per share.&#160;&#160;In accordance with the provisions of ASC Topic 718
 compensation expense of $663
148 is recorded over the vesting period of the shares.















On May 21
 2012
 the Company issued 2
365
815 shares of restricted Common Stock valued at the then fair market value of $1.40 per share.&#160;&#160;In accordance with the provisions of ASC Topic 718
 compensation expense is recorded over the vesting period of the shares.















On July 1
 2013
 the Company granted Mr. Simpson incentive stock options to purchase 100
000 shares of Common Stock pursuant to the 2012 Plan.&#160;&#160;The exercise price of the options is $2.07 per share.&#160;&#160;The options become exercisable July 1
 2014 and expire July 1
 2015.




The Company has no other plans in place and has never maintained any plans that provide for the payment of retirement benefits or benefits that will be paid primarily following retirement including
 but not limited to
 tax qualified deferred benefit plans
 supplemental executive retirement plans
 tax-qualified deferred contribution plans and nonqualified deferred contribution plans.




The Company entered into an employment agreement with Glenn Simpson on March 1
 2013 (the &#8220;Employment Agreement&#8221;). In his capacity as Chief Executive Officer and Chairman
 he is entitled to a monthly salary of not less than $18
500 and an annual bonus based upon performance goals established and approved by the Board of Directors.&#160;&#160;The Employment Agreement term ends on February 28
 2018.&#160;&#160;The Employment Agreement may be terminated prior to such date
 however
 upon Mr. Simpson&#8217;s death
 disability
 by the Company for Cause (as defined in the Employment Agreement)
 by Mr. Simpson for Good Reason (as defined in the Employment Agreement) and voluntary termination by Mr. Simpson other than for Good Reason upon 30 days&#8217; notice.&#160;&#160;Upon termination by the Company for any reason other than Cause or by Mr. Simpson for Good Reason
 Mr. Simpson will receive any accrued but unpaid salary through the date of termination and an amount equal to his salary at the time of termination payable for the remainder of the then-current term.&#160;&#160;Upon termination by reason of Mr. Simpson&#8217;s death or disability
 he will receive any accrued but unpaid salary through the date of termination and an amount equal to his salary at the time of termination payable for 1 year beginning 30 days after the date of termination.&#160;&#160;Upon termination by the Company for Cause or voluntarily by Mr. Simpson for other than Good Reason
 he will receive only accrued but unpaid salary through the date of termination.




The following table sets forth information regarding stock options held by our named executive officer at December 31
 2013.
























































100
000






July 1
 2015



2
674
256



6
685
640






 units or other rights that have not vested (#) and (j) Equity incentive plan awards: Market of payout value of unearned shares
 units or other rights that have not vested&#160;&#160;related to stock awards
 as no such awards were outstanding as of December 31














The stock options become exercisable on July 1
 2014.
















Of such shares that have not yet vested
 308
411 shares will vest on December 4
 2014.&#160;&#160;The balance of 2
365
815 shares will vest in three equal installments on January 2
 2015
 January 2
 2016 and June 30
 2016.
























None of the non-employee directors receive cash compensation for serving as such
 for serving on committees (if any) of the Board of Directors or for special assignments. Board members are not reimbursed for expenses incurred in connection with attending meetings.&#160;&#160;During the year ended December 31
 2013
 except as set forth below
 there were no arrangements that resulted in our making payments to any of our non-employee directors for any services provided to us by them as directors.





































215
000



5
314



220
314







215
000



23
668



238
668






 Column (e) Non-equity incentive plan compensation
 Column (f) Nonqualified deferred compensation earnings and Column (g) All other compensation
 as no such amounts are paid to directors during the year ended December 31













On December 4
 2013
 the Company granted Mr. Devlin and Mr. Seet 100
000 shares each of restricted Common Stock pursuant to the 2012 Plan.&#160;&#160;The fair market value on the grant date was $2.15 per share. These shares vest on December 4
 2014.















On July 1
 2013
 the Company granted Mr. Devlin and Mr. Seet stock options pursuant to the 2012 Plan in the amount of 11
000 and 49
000 shares
 respectively.&#160;&#160;On the date of grant
 the fair market value of the Common Stock of the Company was $1.80.&#160;&#160;The exercise price of the stock options was calculated at 115% of the fair market value
 or $2.07 per share.








The following table sets forth information with respect to the beneficial ownership of our Common Stock known by us as of April 14
 2014 by:



















































Except as otherwise indicated
 the persons listed below have sole voting and investment power with respect to all shares of our Common Stock owned by them
 except to the extent such power may be shared with a spouse.




















Chief Executive Officer
 Chairman and Director



3
297
665 


















439
926 


















1
437
004 


















2
456
257 

















7
630
852 

































Beneficial Ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with respect to securities. Shares of Common Stock subject to options or warrants currently exercisable or convertible

 2014 








Includes (i) 2
365
815 shares of restricted Common Stock
 which shares vest in three equal installments on January 2
 2015
 January 2
 2016 and June 30
 2016; (ii)&#160; 308
441 shares of restricted Common Stock which vest on December 4
 2014 and (iii) 200
000 shares of restricted Common Stock which vest on March 17
 2015. &#160;Does not include&#160;100
000 shares of Common Stock underlying a stock option granted pursuant to the Company&#8217;s 2012 Plan
 which option becomes exercisable in July 2014.








Includes (i) 264
925 shares of restricted Common Stock
 which shares vest in three equal installments on January 2
 2015
 January 2
 2016 and June 30
 2016; (ii)&#160; 100
000 shares of restricted Common Stock which vest on December 4
 2014 and (iii) 75
000 shares of restricted Common Stock which vest on March 17
 2015.&#160;Does not include 11
000 shares of Common Stock underlying a stock option granted pursuant to the 2012 Plan
 which option becomes exercisable in July 2014.








Includes (i) 1
165
253 shares of restricted Common Stock
 which shares vest upon achievement of performance goals; (ii) 100
000 shares of restricted Common Stock which vest on December 4
 2014 and (iii) 75
000 shares of restricted Common Stock which vest on March 17
 2015.&#160;&#160;Does not include 49
000 shares of Common Stock underlying a stock option granted pursuant to the 2012 Plan
 which option becomes exercisable in July 2014.








Includes (i) 1
648
352 shares of Common Stock held by Wyatts
 an entity of which Mr. Spinner is the general partner and portfolio manager; (ii) 75
000 shares of restricted Common Stock which vest on March 17
 2015 and (iii) 732
905 shares of Common Stock underlying currently exercisable warrants held by Wyatts.








Includes (i) 4
729
434 shares of restricted Common Stock
 subject to the vesting conditions described above and (ii) 732
905 shares of Common Stock underlying warrants
 as described above.&#160;&#160;Does not include stock options to purchase 160
000 shares of Common Stock
 as described above.







On February 22
 2013
 the 2012 Plan was adopted by the Board of Directors
 subject to stockholder approval.&#160;&#160;MOJO stockholders approved the 2012 Plan on March 29
 2013.&#160;&#160;The 2012 Plan provides the Company with the ability to issue stock options
 stock appreciation rights
 restricted stock and/or other stock-based awards for up to an aggregate of 2
050
000 shares of Common Stock.&#160;&#160;As of April 14
 2014
 (i) stock options to purchase 210
000 shares of the Company&#8217;s Common Stock and (ii) 1
073
441 shares of restricted Common Stock had been issued to directors and employees under the 2012 Plan.

13.&#160;&#160;CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
 AND DIRECTOR INDEPENDENCE

Other than as disclosed below and in this Form 10-K
 there have been no transactions
 since January 1
 2012
 or any currently proposed transaction
 in which we were or are to be a participant and the amount involved exceeds the lesser of $120
000 or 1% of the average of our total assets at year end for the last two completed fiscal years and in which any of our directors
 executive officers or beneficial holders of more than 5% of our outstanding Common Stock
 or any of their respective immediate family members
 has had or will have any direct or material indirect interest.


In 2012
 certain officers and directors of the Company advanced funds to the Company for payment of operating expenses.&#160;&#160;On May 1
 2012
 the Company issued a Note Payable to Mr. Simpson for $15
000 in connection with an advance. The note bore interest at a rate of 10% per annum
 with a maturity date of September 15
 2013. On August 17
 2012
 Mr. Seet was issued a Note Payable for $7
500
 with an interest rate of 8% per annum
 and a maturity date of September 15
 2013.&#160;&#160;Mr. Simpson and Mr. Seet exchanged their notes payable for 3
750 and 1
875 shares of Preferred Stock
 respectively.&#160;&#160;The Preferred Stock subsequently converted into shares of the Company&#8217;s Common Stock.&#160;&#160;See Note 8 to the Consolidated Financial Statements for more information about the Preferred Stock.


Prior to Peter Spinner&#8217;s appointment as a director
 Wyatts
 an affiliate of Mr. Spinner
 purchased an aggregate of 1
648
352 shares of Common Stock and five-year immediately exercisable warrants to purchase 549
451 shares of Common Stock in the Company&#8217;s concurrent private placements consummated in March 2014.&#160;&#160;Wyatts&#8217; purchases were made pursuant to subscription agreements on the same terms as other investors in the concurrent offerings.&#160;&#160;See Note 10 to the Consolidated Financial Statements included in this Form 10-K for more information about the March 2014 private placements.


















We are not currently subject to listing requirements of any national securities exchange or inter-dealer quotation system which has requirements that a majority of the board of directors be &#8220;independent&#8221; and
 as a result
 we are not at this time required to (and we do not) have our Board of Directors comprised of a majority of &#8220;Independent Directors.&#8221;

Our Board of Directors has considered the independence of its directors in reference to the definition of &#8220;independent director&#8221; established by the Nasdaq Marketplace Rule 5605(a)(2). In doing so
 the Board of Directors has reviewed all commercial and other relationships of each director in making its determination as to the independence of its directors. After such review
 the Board of Directors has determined that Mr. Devlin and Mr. Spinner qualify as independent under the requirements of the Nasdaq listing standards.







On April 25
 2013
 Friedman LLP (&#8220;Friedman&#8221;) was dismissed as the Company's independent registered public accounting firm. As of April 25
 2013
 the Company engaged Liggett
 Vogt &amp; Webb
 P.A. (&#8220;LVW&#8221;) as its new independent registered public accounting firm.


The aggregate fees billed to the Company for services rendered in connection with the years ended December 31
 2013 and 2012 are set forth in the table below:


























27
500







24
000



























































27
500







24
000













Audit fees consist of fees incurred for professional services rendered for the audit of consolidated financial statements
 for reviews of our interim consolidated financial statements included in our quarterly reports on Form 10-Q and for services that are normally provided in connection with statutory or regulatory filings or engagements.&#160;For 2013
 all audit fees were billed by LVW.&#160;&#160;&#160;For 2012
 audit fees represent fees billed from LVW and Friedman of $12
000 and $12
000
 respectively.












Audit-related fees consist of fees billed for professional services that are reasonably related to the performance of the audit or review of our consolidated financial statements
 but are not reported under &#8220;Audit fees.&#8221;












Tax fees consist of fees billed for professional services relating to tax compliance
 tax planning
 and tax advice.











































The consolidated financial statements of MOJO Organics
 Inc. are listed on the Index to Financial Statements on this annual report on Form 10-K beginning on page F-1.





































Agreement and Plan of Merger by and among Specialty Beverage and Supplement
 Inc.
 SBSI Acquisition Corp.&#160;&#160;and MOJO Ventures
 Inc. dated May 13
 2011 (1)

















Split-Off Agreement
 dated as of October 27
 2011
 by and among MOJO Ventures
 Inc.
 SBSI Acquisition Corp.
 MOJO Organics
 Inc.
 and the Buyers party thereto (2)

















Certificate of Incorporation of MOJO Shopping
 Inc. (3)

















Amendment to Certificate of Incorporation of MOJO Ventures
 Inc. (4)

















Certificate of Amendment to Certificate of Incorporation of MOJO Ventures
 Inc. (5)



































Certificate of Amendment to Certificate of Incorporation of MOJO Organics
 Inc. (9)

















Certificate of Designations
 Preferences and Rights of Series A Convertible Preferred Stock (11)

















Amended and Restated Bylaws of MOJO Ventures
 Inc. (6)

















Amendment No. 1 to Amended and Restated Bylaws of MOJO Organics
 Inc. (13)

































































































































































Commitment letter executed by each of Glenn Simpson
 Jeffrey Devlin and Richard Seet (11)




























































































&#160;Juice License Agreement between Chiquita Brands L.L.C. and MOJO Organics
 Inc. dated as of August 15
 2012 (12)



































Employment Agreement dated March 1
 2013 between MOJO Organics
 Inc. and Glenn Simpson (13) &#8224;



































Form of Restricted Stock Agreement
 dated December 4
 2014
 between MOJO Organics
 Inc. and each of Glenn Simpson
 Richard Seet
 Jeffrey Devlin and Nicholas Giannuzzi. &#8224;

















Form of Restricted Stock Agreement
 dated March 2014
 between MOJO Organics
 Inc. and each of Glenn Simpson
 Richard Seet
 Jeffrey Devlin
 Peter Spinner and Marianne Vignone. &#8224;







































































Certification of Chief Executive Officer and Chief Financial Officer
 pursuant to SEC Rules&#160;13a-14(a) and 15d-14(a)
 adopted pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002

















Certification of Chief Executive Officer and Chief Financial Officer
 pursuant to 18 U.S.C. Section&#160;1350
 adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002


































































































































** Furnished herewith.&#160;&#160;This certification is being furnished and shall not be deemed &#8220;filed&#8221; with the SEC for purposes of Section 18 of the Exchange Act
 or otherwise subject to the liability of that section
 and shall not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act
 except to the extent that the Registrant specifically incorporates it by reference.












Incorporated by reference&#160;to&#160;the Registrant&#8217;s Current Report on Form 8-K as an exhibit
 numbered as indicated above
 filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on May 18
 2011












Incorporated by reference&#160;to&#160;the Registrant&#8217;s Current Report on Form 8-K as an exhibit
 numbered as indicated above
 filed with the SEC on November 2
 2011












Incorporated by reference&#160;to&#160;the Registrant's Registration Statement on Form SB-2 as an exhibit
 numbered as indicated above
 filed with the SEC on December 19
 2007












Incorporated by reference to the Registrant&#8217;s Current Report on Form 8-K as an exhibit
 numbered as indicated above
 filed with the SEC on May 4
 2011












Incorporated by reference&#160;to&#160;the Registrant&#8217;s Current Report on Form 8-K as an exhibit
 numbered as indicated above
 filed with the SEC on January 4
 2012












Incorporated by reference to the Registrant&#8217;s Current Report on Form 8-K as an exhibit
 numbered as indicated above
 filed with the SEC on October 31
 2011













Incorporated by reference to the Registrant&#8217;s Current Report on Form 8-K as an exhibit
 numbered as indicated above
 filed with the SEC on August 12
 2011













Incorporated by reference to the Registrant&#8217;s Current Report on Form 8-K as an exhibit
 numbered as indicated above
 filed with the SEC on June 8
 2011














Incorporated by reference to the Registrant&#8217;s Current Report on Form 8-K as an exhibit
 numbered as indicated above
 filed with the SEC on April 2
 2013













Incorporated by reference to the Registrant&#8217;s Quarterly Report on Form 10-Q as an exhibit
 numbered as indicated above
 filed with the SEC on June 25
 2013













Incorporated by reference to the Registrant&#8217;s Current Report on Form 8-K as an exhibit
 numbered as indicated above
 filed with the SEC on February 1
 2013












Incorporated by reference to the Registrant&#8217;s Current Report on Form 8-K/A as an exhibit
 numbered as indicated above
 filed with the SEC on February 7
 2013












Incorporated by reference to the Registrant&#8217;s Current Report on Form 10-K as an exhibit
 numbered as indicated above
 filed with the SEC on September 24
 2013





















Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934
 as amended
 the Registrant has duly caused this report to be signed on its behalf by the undersigned
 thereunto duly authorized.






MOJO ORGANICS
 INC.






Dated:&#160; April 16
 2014











Glenn Simpson
 Chief






In accordance with the Exchange Act
 this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.



























Director
&#160;C






























April 16
 2014























April 16
 2014

























April 16
 2014














































































Consolidated Statements of Operations for the years ended December 31
 2013 and 2012









Consolidated Balance Sheets as of December 31
 2013 and 2012









Consolidated Statements of&#160;&#160;Stockholders&#8217; Deficit for the years ended December 31
 2013 and








Consolidated Statements of Cash Flows for the years ended December 31
 2013 and 2012




































MOJO Organics
 Inc.

We have audited the accompanying consolidated balance sheets of MOJO Organics
 Inc. (the &#8220;Company&#8221;) as of December 31
 2013 and 2012
 and the related consolidated statements of operations
 stockholders' deficit
 and cash flows for each of the years then ended. These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audit.

We conducted our audits in accordance with standards established by the Public Company Accounting Oversight Board (United States of America). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have
 nor were we engaged to perform
 an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances
 but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly
 we express no such opinion. An audit includes examining
 on a test basis
 evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management
 as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion
 the financial statements referred to above present fairly
 in all material respects
 the consolidated financial position of the Company as of December 31
 2013 and 2012
 and the results of its operations and its cash flows for each of the years ended December 31
 2013 and 2012
 in conformity with U.S. generally accepted accounting principles.


The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As more fully described in Note 3
 the Company has incurred substantial accumulated deficits and operating losses. These conditions raise substantial doubt about the Company&#8217;s ability to continue as a going concern. Management&#8217;s plans in regards to these matters are also discussed in Note 3. The consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that might result from the outcome of this uncertainty.














/s/ Liggett
 Vogt &amp; Webb
 P.A.







New York
 NY






April 15
 2014
























ORGANICS
 INC.

For the Years Ended December 31
 2013 and 2012

































159
144





















139
741





















19
403

































2
791
761



1
598
066







2
791
761



1
598
066

















(2
772
358



(1
598
066





























1
658



5
603







1
949











3
607



5
603

















(2
775
965



(1
603
669







































(2
775
965



(1
603
669

















158
463





















(2
934
428



(1
603
669













&#160;Net loss available to common stockholders
 basic and fully diluted

























10
485
770



6
543
566

























ORGANICS
 INC.


As of December 31
 2013 and 2012































































8
080



1
379







1
808











87
805



22
820







122
305











17
882



5
807







237
880



30
006













&#160;&#160;&#160;&#160;PROPERTY AND EQUIPMENT
 net of accumulated depreciation



4
470



2
243





























5
798



5
798

















248
148



38
047












































289
120



349
729







24
000



187
500







313
120



537
229
















































&#160;&#160;&#160;&#160;Preferred stock
 10
000
000 shares authorized at $0.001















&#160;&#160;&#160;&#160;Common stock
 190
000
000 shares authorized at $0.001



 12
631
485 and 8
551
265 shares issued and outstanding
 





12
631



8
551







13
044
119



9
838
024







(13
121
722



(10
345
757







(64
972



(499
182



















248
148



38
047
































ORGANICS
 INC


For the Years Ended December 31
 2013 and 2012


















































































































































Balance
 December 31
 2011



3
862
035



3
862



(1
143



8
573
375















(8
742
088



(165
994





















































































4
553
516



4
553







1
108
428



















1
112
981







250
000











157
250



















157
500













































(114
286







1
143



(1
029





























































































(1
603
669



(1
603
669









































Balance
 December 31
 2012



8
551
265



8
551







9
838
024















(10
345
757



(499
182





















































































42
714











100
649



















100
692



Directors and Employees
 net of forfeitures



425
253











832
714



















833
139







463
463











963
699



















964
162







1
171
705



1
172







467
510



















468
682

























































50
717



















50
717





























































197
709







790
636







790
834







1
977
085



1
977







790
806



(197
709







(790
636







1
949









































































(2
775
965



(2
775
965









































Balance
 December 31
 2013



12
631
485



12
631







13
044
119















(13
121
722



(64
972




























ORGANICS
 INC





&#160;For the Years Ended December 31
 2013 and 2012










































(2
775
965



(1
603
669


























1
442











50
717











833
139



1
112
981







100
692











964
162



157
500







1
949

































(1
808











(64
985



(22
820







(122
305











(12
075



(5
807











(5
798







100
592



183
735







(924
445



(183
334





























(3
669



(2
787







(3
669



(2
787





























74
000



187
500







412
134











448
681











934
815



187
500

















6
701



1
379

















1
379





















8
080



1
379




































7
262










































378
700











178
600











249
200




























ORGANICS
 INC.






MOJO Organics
 Inc. (&#8220;MOJO&#8221; or the &#8220;Company&#8221;) was incorporated in the State of Delaware on August 2
 2007.&#160;&#160;Headquartered in Jersey City
 NJ
 the Company engages in the product development
 production
are 100% Fruit Juices
 produced under license agreement from Chiquita Brands L.L.C. (&#8220;Chiquita&#8221;).&#160;&#160;The Company currently produces four exotic flavors: Banana Strawberry
 Mango
 Passion Fruit and Pineapple.

first became commercially available in the New York tri-state area in late July 2013
 and is currently sold in hundreds of retail outlets and on Amazon.com.


In 2012
 the accompanying consolidated financial statements include the accounts of the Company and MOJO Organics Operating Company
 Inc.
 its formerly wholly-owned subsidiary (&#8220;MOJO Operating&#8221;). All significant inter-company accounts and transactions were eliminated in consolidation.


In 2013
 the Company determined that the assets assigned to MOJO Operating
 including the Dispensing Cap technology and Pinch sweetener
 had no economic value.&#160;&#160;Further
 MOJO Operating has been dormant subsequent to the 2011 split off transaction
 through which MOJO sold a portion of its business to certain of its shareholders and was deemed to be a voided entity for regulatory purposes.&#160;&#160;MOJO Operating will no longer be considered an entity under the Company&#8217;s control for consolidation purposes.









Cash equivalents include investment instruments
 CD&#8217;s and time deposits purchased with a maturity of three months or less.



Inventories are stated at the lower of cost (first-in
 first-out method) or market. At December 31
 2013 and 2012
 inventories consisted entirely of raw materials.






Property and equipment are stated at cost.&#160;&#160;Depreciation is computed using the straight line method over the estimated useful life of the respective assets.&#160;&#160;Computer equipment is depreciated over a period of 3 -5 years.&#160;&#160;Maintenance and repairs are charged to expense when incurred.&#160;&#160;When property and equipment are retired or otherwise disposed of
 the related cost and accumulated depreciation are removed from the respective accounts and any gain or loss is credited or charged to income.&#160;&#160;At December 31
 2013 and 2012
 accumulated depreciation related to property and equipment was $1
553 and $544
 respectively.







The Company computes per share amounts in accordance with Financial Accounting Standards Board Accounting Standards Codification (&#8220;ASC&#8221;) Topic 260
&#8221;.&#160;&#160;ASC Topic 260 requires presentation of basic and diluted EPS.&#160;&#160;Basic EPS is computed by dividing the income (loss) available to common stockholders by the weighted-average number of common shares outstanding for the period.&#160;&#160;Diluted EPS is based on the weighted average number of shares of common stock and common stock equivalents outstanding during the periods. The conversion of Series A Preferred Stock and options was excluded from the computation of diluted shares outstanding for the year ended December 31
 2013.&#160;&#160;The loss for the period would have had an anti-dilutive impact on the Company&#8217;s net loss per common share.

















In accordance with ASC topic 720-15
 &#8220;
&#8221; the Company charges all costs associated with its start-up operations to income as incurred.



The Company provides for income taxes under ASC topic 740
 &#8220;
&#8221; which requires the use of an asset and liability approach in accounting for income taxes. Deferred tax assets and liabilities are recorded based on the differences between the financial statement and tax bases of assets and liabilities and the tax rates in effect when these differences are expected to reverse.


ASC 740 also requires the reduction of deferred tax assets by a valuation allowance if
 based on the weight of available evidence
 it is more likely than not that some or all of the deferred tax assets will not be realized.





ASC Topic 718
&#8221; prescribes accounting and reporting standards for all stock-based compensation plans
 including employee stock options
 restricted stock
 employee stock purchase plans and stock appreciation rights.


ASC Topic 718 requires employee compensation expense to be recorded using the fair value method. The Company&#160;accounts for employee stock based compensation in accordance with the provisions&#160;of ASC Topic 718. For non-employee options and warrants
 the company uses the fair value method as prescribed in ASC Topic 718.




The carrying amounts of financial instruments
 which include accounts payable
 accrued expenses and debt obligations approximate their fair values due to their short-term nature and/or variable interest rates. The Company&#8217;s debt obligations bear interest at rates which approximate prevailing market rates for instruments with similar characteristics and
 accordingly
 the carrying values for these instruments approximate fair value.


The Company adopted ASC Topic 820
 &#8220;
&#8221; which established a framework for measuring fair value and expands disclosure about fair value measurements.&#160;&#160;ASC Topic 820 defines fair value as the amount that would be received for an asset or paid to transfer a liability (i.e.
 an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC Topic 820 also establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC Topic 820 describes the following three levels of inputs that may be used:










Level 1 Unadjusted quoted prices in active markets that are accessible at the measurement date for identical

 unrestricted assets or liabilities;













Level 2 Quoted prices in markets that are not active
 or inputs that are observable
 either directly or indirectly
 for substantially the full term of the asset or liability;



















The Company did not have any assets or liabilities measured at fair value on a recurring basis at December 31
 2013 or 2012. The Company did not have any fair value adjustments for assets and liabilities measured at fair value on a nonrecurring basis during the periods ended December 31
 2013 or 2012.



Management does not believe that any recently issued
 but not yet effective accounting standards
 if currently adopted
 would have a material effect on the accompanying consolidated financial statements.







The Company's financial statements are prepared using GAAP applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs and allow it to continue as a going concern. For the year ended December 31
 2013
 the Company incurred a net loss from continuing operations of $2
775
965.&#160;&#160;At December 31
 2013
 the Company had a working capital deficit of $75
240 and accumulated losses of $13
121
722
 which includes accumulated losses from discontinued operations of $8
576
094.
























The Company accounts for income taxes under the assets and liability method.&#160;&#160;Deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry forwards.&#160;&#160;Deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases.&#160;&#160;Deferred tax assets are&#160;&#160;reduced by a&#160;&#160;valuation&#160;&#160;allowance&#160;&#160;when
&#160;&#160;in the opinion&#160;&#160;of&#160;&#160;management
&#160;&#160;it is more&#160;&#160;likely&#160;&#160;than not&#160;&#160;that&#160;&#160;some portion or all of the deferred&#160;&#160;tax assets will not be realized.












Year ended December 31





























State tax expense
 net of federal benefit















































Year ended December 31





















(1
099
282



(635
053







1
099
282



635
053

























As of December 31





















329
923



440
740







20
084











1
384
328



194
313







(1
734
335



(635
053

















An income tax benefit has not been recognized for operating losses generated in prior periods based on uncertainties concerning the ability to generate taxable income in future periods.&#160;&#160;At December 31
 2013
 the Company had available net operating loss carry-forwards of approximately $3
986
000 which expire in various years through the year ending December 31
 2033.&#160;&#160;Utilization of the tax loss carry-forwards are not assured
 however
 because the Company has incurred significant operating losses.&#160; As a result
 the deferred income tax asset arising from these net operating loss carry-forwards and from other temporary differences are not recorded in the accompanying Consolidated Balance Sheets.&#160;&#160;Due to the uncertainty of the Company&#8217;s realization of this benefit
 a valuation allowance was established to fully reserve such assets.





















The Company entered into an office service agreement for office space for a term of 12 months effective April 16
 2012.&#160;&#160;The base monthly office fee under that agreement was $2
899.&#160;&#160;Subsequent to April 2013
 the Company rented its office space on a month to month basis.




On August 15
 2012
 the Company entered into a license agreement (&#8220;License Agreement&#8221;) for the use of a third party&#8217;s marks in the manufacture
 sale
 promotion
 marketing
 advertising and distribution of certain fruit juice products in select containers. The License Agreement grants the Company an exclusive license in Connecticut
 New Jersey and New York and a non-exclusive license for the other states in the United States
 plus Costa Rica
 El Salvador
 Guatemala
 Honduras and Nicaragua. The term of the License Agreement is for seven years from July 2013 (the date that the Company first invoiced customers for products sold under the License Agreement)
 subject to the Company meeting certain minimum sales volume and/or minimum royalty payments. Termination of the License Agreement could have a material and adverse impact on the Company&#8217;s business. &#160;During the year ended December 31
 2013
 the accrued royalty payment due to the third party was $184
240.&#160;&#160;Future minimum royalty payments (in thousands) are $691 for 2014
 $1
265 for 2015
 $1
850 for 2016
 $2
611 for 2017 and $11
617 for 2018 to 2020.&#160;





The Company has authorized 10
000
000 shares of preferred stock (&#8220;Preferred Stock&#8221;) and 190
000
000 shares of common stock (&#8220;Common Stock&#8221;)
 each having a par value of $0.001.



On April 1
 2013
 the Company effected a one-for-ten reverse stock split of the issued and outstanding shares of Common Stock (the &#8220;Reverse Split&#8221;).&#160;The number of authorized shares and the par value of the Common Stock were not changed.&#160;&#160;The accompanying financial statements have been restated to reflect this reverse stock split.



On May 1
 2013
 the Company commenced a private placement offering of up to 1
250
000 shares of its Common Stock (the &#8220;Private Placement&#8221;) at a price of $0.40 per share pursuant to subscription agreements entered into with each investor.&#160;&#160;As of June 18
 2013
 the last date of the offering
 1
171
705 shares of Common Stock were sold
 raising an aggregate of $468
681
 which amount included $20
000 of notes outstanding.



In March 2013
 the Company approved the 2012 Long-Term Incentive Equity Plan (the &#8220;2012 Plan&#8221;)
 which provides the Company with the ability to issue stock options
 stock appreciation rights
 restricted stock and/or other stock based awards for up to an aggregate of 2
050
000 shares of Common Stock.



During the years ended December 31
 2013 and 2012
 the Company issued shares of restricted Common Stock to certain of its directors
 executive officers and employees.&#160;&#160;Unvested restricted shares are subject to forfeiture.&#160;&#160;With the exception of 1
165
251 shares which vest based upon achieving certain milestones
 the Company records compensation expense over the vesting period based upon the fair market value on the date of grant for each share
 adjusted for forfeitures.&#160;&#160;&#160;


A summary of the restricted stock issuances to directors
 executive officers and employees is as follows:




















Unvested share balance
 January 1
 2012















4
553
516











(100
000



















Unvested share balance
 December 31
 2012



4
453
516











608
441











(88
309











(183
240







Unvested share balance
 December 31
 2013



4
790
408























In connection with the issuance of restricted stock
 the Company recorded share-based compensation expense of $883
139 and $1
112
981 for the years ended December 31
 2013 and 2012
 respectively.&#160;&#160;As of December 31
 2013
 there was $4
961
202 of total unrecognized compensation cost
 net of estimated forfeitures
 related to unvested share-based compensation.&#160;&#160;That cost is expected to be recognized during the years 2014 through 2016.



On November 28
 2012
 the Company entered into an agreement with an advisor to provide strategic business advisory services and assist the Company with networking and capital formation. As compensation for these services
 the Company agreed to the issuance of 500
000 shares of Common Stock
 50% of which was issuable upon execution of the agreement and 50% of which was issuable upon the six month anniversary of the execution of the advisor agreement.&#160;&#160;Accordingly
 the Company issued 250
000 shares of Common Stock. The value of the stock issued was recorded in 2012
 resulting in an expense of $157
500.&#160;&#160;This advisory services agreement has since been terminated and the&#160;remaining 250
000 shares have not been
 and will not be
 issued.&#160;

&#160;On October 3
 2013
 the Company entered into an advisor agreement whereby the Company would receive strategic business advisory services
 distributorship advisory services
 sales and sales channel advisory services and investor relation advisory services in exchange for the issuance of 50
000 shares of restricted Common Stock.&#160;&#160;The Common Stock vests six months from the date of the agreement.&#160;&#160;In connection with this issuance
 the Company recorded $75
000 in consulting fees during the year ended December 31
 2013
 and will record an additional $75
000 in fees in 2014.


Also on October 3
 2013
 the Company entered into an agreement for strategic business advisory services
 public relations services and investor relations services.&#160;&#160;In connection with this agreement
 the Company issued 167
204 shares of restricted Common Stock and recorded consulting fees of $501
612 during 2013.&#160;&#160;The stock is fully vested. The advisor was also issued an additional 200
000 shares of restricted Common Stock
 which will vest quarterly based upon the Company reaching certain market capitalization and revenue goals.&#160;&#160;Should the Company not reach these goals
 the additional shares will be forfeited.&#160;&#160;The goals were met for the first two quarters.&#160;&#160;As a result
 100
000 of the additional 200
000 shares vested in 2013
 and the Company recorded $280
000 in consulting fees in connection with this vesting.


During the year ended December 31
 2013
 the Company issued 35
000 shares of Common Stock to two firms who provided legal services to the Company in lieu of cash.&#160;&#160;Also during 2013
 the Company entered into an agreement with a consultant whereby the Company would issue stock for services in lieu of cash.&#160;&#160;The number of shares issued is calculated monthly and based upon the last sales price of the Common Stock for the month.&#160;&#160;The number of shares issued for the year ended December 31
 2013 was 11
263.






In July 2013
 the Company granted certain directors and employees of the Company stock options pursuant to the 2012 Plan to purchase 210
000 shares of Common Stock at an exercise price of $2.07 per share
 which was 115% of the last sale price of the Common Stock on the date of grant. The options become exercisable in July 2014 and expire in July 2015. In connection with the stock option issuances
 compensation expense of&#160;$50
717 was recorded during the year ended December 31
 2013.

































Outstanding at December 31
 2012








































210
000




























































Outstanding at December 31
 2013






210
000


























Exercisable at December 31
 2013


































As of December 31
 2013
 there was $50
717&#160;of total unrecognized compensation cost related to non-vested stock options. That cost will be recognized ratably over the first two quarters of 2014.


Aggregate intrinsic value of options outstanding and exercisable at December 31
 2013 and 2012 was $90
300 and $0
 respectively.&#160;&#160;Aggregate intrinsic value represents the difference between the Company's closing stock price on the last trading day of the fiscal period
 which was&#160;$2.50 and $0.70 as of December 31
 2013 and 2012
 respectively
 and the exercise price multiplied by the number of options outstanding.
















The following table summarizes weighted-average assumptions using the Black-Scholes option-pricing model used on the date of the grants issued for the years ended December 31
 2013 and 2012:&#160;







December 31








































































































































































































On January 12
 2013
 the Company entered into an amended and restated securities purchase agreement for the offer and sale of its Series A Convertible Preferred Stock
 par value $0.001 (&#8220;Series A Preferred Stock&#8221;) at a price of $4.00 per share.&#160;&#160;In connection with the private sale of its Series A Preferred Stock
 the Company raised gross proceeds of $790
834
 including $378
700 from the conversion of promissory notes.&#160;&#160;Each share of Series A Preferred Stock was convertible into 10 shares of the Company&#8217;s Common Stock determined by dividing $4.00 by the conversion price of $0.40.


The Series A Preferred Stock includes embedded anti-dilutive provisions that meet the defined criteria of a derivative liability as described in ASC Topic 815
 &#8220;
&#8221; and therefore require bifurcation.&#160;&#160;These embedded derivatives include certain conversion features indexed to the Company's Common Stock. The accounting treatment of derivative financial instruments requires that the Company record the derivatives and related items at their fair values as of the date of issue and at fair value as of each subsequent balance sheet date.&#160;&#160;&#160;Changes in the fair value are charged to income at the end of each reporting period.

During the year ended December 31
 2013
 a total of 197
708.5 shares of the Series A Preferred Stock had been converted into 1
977
085 shares of Common Stock. As of December 31
 2013 and 2012
 there were zero shares of Series A Preferred Stock issued and outstanding.





During the year ended December 31
 2012
 various expenses of the Company
 including advances for operating purposes
 were paid for or made by officers and shareholders of the Company. As of December 31
 2012
 amounts due to related parties totaled $187
500 in notes payable. In January 2013
 the Company received an additional advance of $50
000.&#160;&#160;The notes bore interest at rates varying between 8% and 10% and were due on September 15
 2013.&#160;&#160;


The notes contained a conversion feature which allowed the holders
 at their sole discretion
 to convert some or all of the principal amount of their note outstanding into equity or debt securities issued by the Company in connection with any offering made by the Company during the period that the principal amount of the note was outstanding.&#160;&#160;The conversion terms would be identical to the offering terms.&#160;&#160;On January 31
 2013
 the balance of notes outstanding of $237
500 was converted into 59
375 shares of Series A Preferred Stock.&#160;&#160;Accrued interest of $7
261 was paid to the holders of the notes.&#160;&#160;Interest expense of $1
658 and $5
603 was charged to operations for the years ended December 31
 2013 and 2012
 respectively.


During the year ended December 31
 2013
 the Company issued 42
714 shares of Common Stock to employees in lieu of cash
 equivalent to $100
692.&#160;&#160;In addition
 accrued salary amounting to $141
200 and $20
000 was converted into 35
300 shares of Series A Preferred Stock and 50
000 shares of Common Stock as part of the Private Placement
 respectively.


In December 2013
 the Company received $24
000 in non-interest bearing
 demand loans from certain related parties.&#160;&#160;The loans were repaid in full by February 2014.



















In accordance with ASC Topic 855


 2013. In preparing these consolidated financial statements
 the Company evaluated the events and transactions that occurred through the date these consolidated financial statements were issued.&#160;


In March 2014
 the Company consummated two concurrent private placement offerings
 receiving an aggregate of $1
835
000 from accredited investors.&#160;&#160;In one of the offerings
 the Company sold an aggregate of 917
583 shares of Common Stock for $0.91 per share for a total of $835
000.&#160;&#160;For each share purchased in this offering
 investors received an immediately exercisable
 five-year warrant to purchase one share of Common Stock at a price of $0.91 per share.&#160;&#160;In the concurrent offering
 the Company sold 1
098
901 shares of Common Stock for $0.91 per share for a total of $1
000
000.&#160;&#160;The investor in the concurrent offering did not acquire warrants.


The Company issued an aggregate of 465
000 shares of Common Stock pursuant to the 2012 Plan to its employees and directors in March 2014.&#160;&#160;The shares are subject to a restricted stock agreement
 pursuant to which the shares will vest one year from the date of such agreement if the grantee is an employee or director (as applicable) of the Company at the time.&#160;&#160;As part of the compensation package for a newly appointed director
 the Company issued to an affiliate of such director warrants to purchase 183
454 shares of Common Stock
 exercisable for a period of five years from the date of issuance at a price of $0.91 per share.


The Company issued 23
272 shares of Common Stock to its chief executive officer as payment of salary due for January and February 2014 in lieu of cash.&#160;&#160;The shares were valued by the Company at the closing price of the Company&#8217;s Common Stock on the last trading day of the applicable month for which payment was due.


Also in March 2014
 the Company issued warrants to purchase 13
740 shares of Common Stock at a price of $0.91 per share as well as 82
418 shares of Common Stock for advisory services.&#160;&#160;The warrants are exercisable for five years from the date of issuance.


Finally in March 2014
 the Company entered into two agreements pursuant to which the Company will receive advisory services related to strategy
 distributorship
 sales and sales channels and investor relations.&#160;&#160;The Company granted to each advisor 100
000 shares of restricted Common Stock
 subject to forfeiture if the advisor terminates or materially breaches the agreement before the six-month anniversary thereof.&#160;&#160;The aggregate value of the advisory fees of $260
000 was calculated based upon the closing price of the Company&#8217;s Common Stock on the date of the agreement.&#160;&#160;This amount will be charged to income ratably over the six month vesting period.




























    













 day of December
 2013
 by and between Mojo Organics
 Inc.
 a Delaware corpora&#173;tion (the &#8220;Company&#8221;)
 and

WHEREAS
 on May 21
 2012
 of common stock of the Company
 $.001 par value (&#8220;Shares&#8221;);

WHEREAS
 the Company and Executive entered into a Restricted Stock Agreement
 dated as of May 21
 2012 (the &#8220;Original Agreement&#8221;)
 setting forth the terms by which the Shares are issued to the Executive and by which they vest;

WHEREAS
 the Company and Executive entered into an Amended and Restated Restricted Stock Agreement
 dated as of April 30
 2013 (&#8220;Amended Agreement&#8221;)
 revising the initial vesting period of the Shares to occur on a later date than that contained in the Original Agreement; and

WHEREAS
 potential investors in the Company have demanded that the vesting period of the Shares be modified to occur on a date later than that contained in the Amended Agreement; and

WHEREAS
 the Company and Executive desire to amend and restate the Amended Agreement in its entirety as set forth herein





The Company hereby issues to the Executive&#160;Shares on the terms and conditions set forth herein.&#160;&#160;All of the Shares shall be subject to forfeiture during the period terminating June 30
 2016 (&#8220;Restriction Period&#8221;).&#160;&#160;The Shares shall be represented by three stock certificates registered in the name of the Executive
 each of which shall represent 883
084 Shares.&#160;&#160;The certificates (collectively
 the &#8220;Restricted Share Certificates&#8221;) shall bear the legends set forth in Sections&#160;5(v) and 5(vi) of this Agreement.&#160;&#160;The Restricted Share Certificates shall be deposited by the Executive with the Company
 together with stock powers endorsed in blank
 which will permit transfer to the Company of all or any portion of the Shares represented by such certificates (the &#8220;Restricted Shares&#8221;) that shall be forfeited or shall not become vested in accordance with the terms of this Agreement.

After issuance
 the Restricted Shares shall constitute issued and outstanding shares of Common Stock for all corporate purposes unless and until forfeited in accordance with the terms hereof.&#160;&#160;The Executive shall have the right to vote such Restricted Shares
 to receive and retain all cash dividends as the Board may
 in its sole discretion
 pay on such Restricted Shares
 and to exercise all of the rights
 powers and privileges of a holder of Common Stock with respect to such Restricted Shares
 except that (a) the Executive shall not be entitled to delivery of the Restricted Share Certificates until the Restricted Shares represented by the Restricted Share Certificates vest in accordance with subparagraph (iii) below; and (b) other than cash dividends as the Board
 in its sole discretion
 distributes
 the Company will retain custody of all distributions (&#8220;Retained Distributions&#8221;) made or declared with respect to the Restricted Shares (and such Retained Distributions will be subject to the same restrictions
 terms and conditions as applicable to the Restricted Shares) until such time
 if ever
 as the Restricted Shares with respect to which such Retained Distributions shall have been distributed have become vested.





 For the avoidance of doubt
 share amounts herein have not been adjusted to account for the Company&#8217;s ten-for-one reverse stock split effected on April 1
 2013.

















On January 2
 2015
 if the Executive is still an advisor to the Company
of the Restricted Shares and the Retained Distributions with respect thereto shall become vested.&#160;&#160;On January 2
 2016
 if the Executive is still an advisor to the Company
 of the Restricted Shares and the Retained Distributions with respect thereto shall become vested.&#160;&#160;On June 30
 2016
 if the Executive is still an advisor to the Company
&#160;&#160;of the Restricted Shares and the Retained Distributions with respect thereto shall become vested. After the date that any of the Restricted Shares become vested
 upon the request of the Executive the Company shall promptly instruct its transfer agent to issue and deliver to the Executive a new certificate for the Shares that have vested
 which certificate shall not bear the legend set forth in Section 5(vi). If
 at any time prior to the vesting of the Restricted Shares in accordance with this Section 1(iii)
 the Executive&#8217;s employment with the Company is terminated
 then the Restricted Shares that have not then vested (and the Retained Distributions with respect thereto) shall be forfeited to the Company and the Executive shall not thereafter have any rights with respect to such Restricted Shares.&#160;&#160;Notwithstanding the foregoing
 if Executive&#8217;s employment with the Company is terminated at any time other than by the Company for &#8220;Cause&#8221; or by the Executive without &#8220;Good Reason&#8221; (each as defined in the Executive&#8217;s employment agreement with the Company)
 then all of the Restricted Shares shall automatically vest.

Nothing in this Agreement shall confer on the Executive any right to continue his relationship with the Company (or with any parent
 subsidiary or affiliate of the Company) or limit in any way the right of the Company (or of any parent
 subsidiary or affiliate of the Company) to terminate the Executive&#8217;s relationship with the Company (or with any parent
 subsidiary or affiliate of the Company) at any time
 with or without cause.

.&#160;&#160;The Company shall have the right to withhold from Executive that number of Shares having a Fair Market Value (as defined below) equal to the minimum amount of any federal
 state or local income and/or payroll taxes required by law to be withheld and to take such other action as the Board may deem advisable to enable the Company and Executive to satisfy obligations for the payment of withholding taxes and other tax obligations relating to the vesting of Shares.&#160;&#160;Solely for purposes of this section
 &#8220;Fair Market Value&#8221; means as of any given date: (i) if the Shares are listed on a national securities exchange or The Nasdaq Stock Market
 LLC (&#8220;Nasdaq&#8221;)
 the last sale price of the Shares in the principal trading market for the Shares on such date
 as reported by the exchange or Nasdaq
 as the case may be; (ii) if the Shares are not listed on a national securities exchange or Nasdaq
 but are traded in the over-the-counter market
 the closing bid price for the Shares on such date
 as reported by the OTC Bulletin Board or Pink Sheets
 LLC or similar publisher of such quotations; and (iii) if the fair market value of the Shares cannot be determined pursuant to clause (i) or (ii) above
 such price as the Board shall determine
 in good faith.





the Company
 by appropriate and all required action
 is duly authorized to enter into this Agreement and consummate all of the transactions contemplated hereunder; and

the Shares
 when issued and delivered by the Company to the Executive in accordance with the terms and conditions hereof
 will be duly and validly issued and fully paid and non-assessable.




















he understands that he must bear the economic risk of the invest&#173;ment in the Shares
 which cannot be sold by him unless they are registered under the Securities Act of 1933
 as amended (&#8220;Securities Act&#8221;)
 or an exemption therefrom is available thereunder and that the Company is under no obli&#173;gation to register the Shares for sale under the Securities Act;

in his position with the Company
 he has had both the opportunity to ask questions and receive answers from the officers and directors of the Company and all persons acting on its behalf concerning the terms and conditions of the offer made hereunder and to obtain any additional information to the extent the Company possesses or may possess such infor&#173;mation or can acquire it without unreasonable effort or expense;





&#8220;THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE BEEN ACQUIRED FOR INVESTMENT.&#160;&#160;THE SHARES MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
 AS AMENDED
 OR AN EXEMPTION THEREFROM UNDER SAID ACT.&#8221;




&#8220;THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE BEEN ACQUIRED PURSUANT TO A RESTRICTED STOCK AGREEMENT
 A COPY OF WHICH IS ON FILE WITH THE COMPANY
 AND MAY NOT BE TRANSFERRED
 PLEDGED OR DISPOSED OF EXCEPT IN ACCORDANCE WITH THE TERMS AND CONDITIONS THEREOF.&#8221;


.&#160;&#160;Anything in this Agreement to the contrary notwithstanding
 the Executive hereby agrees that he shall not sell
 transfer by any means or otherwise dispose of the Shares acquired by him without registration under the Securities Act
 or in the event that they are not so registered
 unless (i)&#160;an exemption from the Securities Act registra&#173;tion requirements is available thereunder
 and (ii)&#160;the Executive has furnished the Company with notice of such proposed transfer and the Company&#8217;s legal coun&#173;sel
 in its reasonable opinion
 shall deem such proposed transfer to be so exempt.&#160;&#160;Further
 the Executive agrees that he shall abide by all of the Company&#8217;s policies in effect at the time the Shares vest and thereafter
 including the Company&#8217;s Insider Trading Policy
 with respect to the ownership and trading of the Company&#8217;s securities.



.&#160;&#160;All notices
 requests
 deliveries
 payments
 demands and other communications that are required or permitted to be given under this Agreement shall be in writing and shall be either delivered personally or sent by regis&#173;tered or certified mail
 or by private courier
 return receipt requested
 postage prepaid to the Company at its principal executive office and to the Executive at his address set forth below
 or to such other address as either party shall have specified by notice in writing to the other.&#160;&#160;Notice shall be deemed duly given hereunder when delivered or mailed as provided herein.


















.&#160;&#160;This Agreement constitute the entire agreement between the parties with respect to the subject matter hereof.&#160;&#160;This Agreement may not be amended except by writing executed by the Executive and the Company.&#160;&#160;The Original Agreement is superseded in all respects by this Agreement
 and the Original Agreement is no longer of any effect.

.&#160;&#160;This Agreement shall inure to the benefit of and be binding upon the parties hereto and
 to the extent not prohibited herein
 their respective heirs
 successors
 assigns and representatives.&#160;&#160;Nothing in this Agreement
 expressed or implied
 is intended to confer on any person other than the parties hereto and as provided above
 their respective heirs
 successors
 assigns and representatives any rights
 remedies
 obligations or liabilities.



.&#160;&#160;The headings contained herein are for the sole purpose of convenience of reference
 and shall not in any way limit or affect the meaning or interpretation of any of the terms or provisions of this Agreement.



IN WITNESS WHEREOF
 the parties hereto have signed this Agreement as of the day and year first above written.




EXECUTIVE:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;MOJO ORGANICS
 INC.









































    










MOJO ORGANICS
 INC.




MOJO ORGANICS

 a Delaware corporation having an address of 101 Hudson Street
 21st Floor
 Jersey City
&#8221;)
 and
&#8221;).&#160;&#160;Each of the Company and Advisor is sometimes referred to herein as a &#8220;Party&#8221; and collectively
 the &#8220;Parties.&#8221;



.&#160;&#160;From time to time during the engagement hereunder
 Advisor shall devote such time
 interest
 and good faith effort to the performance of this Agreement as may be fair and reasonable in light of the advice required by the Company and the other work load of Advisor in his business activities outside of his service to the Company.





 shares of restricted common stock (the &#8220;Shares&#8221;)
 such Shares to be held in escrow by the Company until



.&#160;&#160;Advisor is not an employee of the Company.&#160;&#160;Advisor will not be eligible for any employee benefits.&#160;&#160;Any taxes imposed on Advisor due to activities performed hereunder will be the sole responsibility of Advisor.&#160;&#160;Advisor shall have no authority to make representations
 warranties or the like
 concerning or on behalf of the Company or bind the Company in any manner.

.&#160;&#160;The Parties acknowledge that Advisor may from time to time create intellectual property in his capacity as an advisor to the Company and as such Advisor agrees that such work product is created as a &#8220;work for hire
&#8221; is the property of the Company
 and Advisor hereby assigns all rights in and to such work product to the Company as part of services to the Company.&#160;&#160;The Parties further acknowledge and agree that during Advisor&#8217;s performance of services
 Advisor may be exposed to information relating to the Company that is not generally known by third parties
 including without limitation information regarding the Company&#8217;s business
 finances
 customers
 employees
 technology
 operations
 products
 and plans
 whether or not designated by the Company as being proprietary or confidential (collectively
 &#8220;Confidential Information&#8221;).&#160;&#160;The Company shall retain full ownership of all Confidential Information
 and nothing herein shall be construed as a license
 transfer
 or assignment of any Confidential Information to Advisor.&#160;&#160;Advisor shall use Confidential Information solely as may be strictly necessary to further Advisor&#8217;s performance of services and for no other purposes whatsoever.&#160;&#160;Advisor shall maintain the confidentiality and proprietary nature of Confidential Information using a degree of care at least as high as that degree used by Advisor for information of like sensitivity and kind in his other business dealings
 and in any event
 at least as high as that degree used by the Company for such Confidential Information.&#160;&#160;Advisor shall not disclose any Confidential Information to any third parties without the Company&#8217;s prior consent.&#160;&#160;Advisor recognizes that the Company has received and in the future will receive from third parties their confidential or proprietary information subject to a duty on the Company&#8217;s part to maintain the confidentiality of such information and to use it only for certain limited purposes.&#160;&#160;Advisor agrees that
 during the term of this Agreement and thereafter
 Advisor owes the Company and such third parties a duty to hold all such confidential or proprietary information in the strictest confidence and not to disclose it to any person or entity except as necessary in carrying out the services for the Company consistent with the Company&#8217;s agreement with such third party.&#160;&#160;Upon the termination of this Agreement
 or upon Company&#8217;s earlier request
 Advisor will deliver to the Company all of the Company&#8217;s property
 including but not limited to all electronically stored information and passwords to access such property
 or Confidential Information that Advisor may have in Advisor&#8217;s possession or control.
















.&#160;&#160;As consideration for and to induce the Company to enter into this Agreement
 Advisor hereby covenants and agrees that for a period commencing on the Effective Date and ending on the second anniversary of the date of termination of this Agreement (&#8220;Restriction Period&#8221;)
 he will not
 alone or as a partner
 joint venturer
 officer
 director
 employee
 consultant
 agent
 independent contractor or stockholder of any company or business
 or in any other capacity:

induce any person or entity that is a customer
 distributor or supplier of the Company or advise any person or entity which has a business relationship with the Company or any of its subsidiaries or affiliates to withdraw
 curtail
 qualify or cancel any business with such entity;



make any statement
 publicly or privately
 to any individual or entity
 including
 without limitation
 clients
 customers
 employees
 financial or credit institutions or news agencies
 in any case
 which could reasonably be expected to disparage
 defame
 libel or slander the Company or any of its subsidiaries
 affiliates or any of their respective employees
 officers or directors.
















.&#160;&#160;In consideration of this Agreement and for other good and valuable consideration
 the receipt of which is hereby acknowledged
 the Advisor
 on behalf of himself and his affiliates
 representatives
 agents
 trustees
 successors
 predecessors
 and assigns (collectively the &#8220;Advisor Parties&#8221;)
 hereby acknowledges that except as specifically provided by this Agreement
 the Company has no other obligations of any type or form to any of the Advisor Parties
 including under any other agreement executed prior to the Effective Date
 or to the extent any such obligations exist same are deemed hereby terminated and waived by the Advisor on his behalf and on behalf of the other Advisor Parties.&#160;&#160;Advisor
 on his behalf and behalf of each of the other Advisor Parties
 releases and discharges the Company and its officers
 directors and affiliates and their successors
 predecessors and assigns from
 any and all obligations
 debts
 liabilities
 demands
 actions
 causes of action
 suits
 covenants
 contracts
 controversies
 agreements
 promises
 sums of money owed
 accounts
 bills
 reckonings
 damages and any and all other claims
 counterclaims
 defenses
 rights of set-off
 demands and liabilities of every kind and nature and description whatsoever
 whether or not now known
 suspected or claimed
 liquidated or unliquidated
 which any of the Advisor Parties ever had
 now has or may thereafter acquire
 by reason of any matter
 cause
 event
 or thing whatsoever occurring or arising at any time on or before the Effective Date.&#160;&#160;As a condition to transfer of any of the Shares issued hereby (other than as a result of an open market sale of same)
 at the request of the Company
 the transferee shall execute and deliver to the Company a release and waiver in substance materially similar to that contained in this Section 9.&#160;&#160;The certificate evidencing the Shares shall bear a restrictive legend referencing this Agreement and the provisions of this Section 9.

.&#160;&#160;Advisor shall indemnify the Company and its officers
 managers and affiliates for any damages or losses incurred by them relating to his role with the Company or his receipt or ownership of the Shares.

.&#160;&#160;Neither Party shall transfer or assign any of its rights or delegate any of its obligations hereunder without the prior written consent of the other Party.&#160;&#160;This Agreement shall be construed in accordance with the laws of the State of New York applicable to contracts entered into and wholly to be performed therein
 without regard to that body of law pertaining to conflicts of laws.&#160;&#160;Any controversies between the Parties arising hereunder shall be adjudicated before a court of competent jurisdiction located in New York
 New York.&#160;&#160;This Agreement may be amended by the Parties solely by an instrument in writing signed on behalf of each Party.&#160;&#160;Unenforceable provisions hereof
 if any
 as applied to particular circumstances shall be reformed to the extent strictly necessary to render such provisions enforceable when applied to such particular circumstances.&#160;&#160;This Agreement constitutes the entire agreement between the Parties with respect to the subject matter hereof.&#160;&#160;This Agreement may be executed in any number of counterparts and delivered by facsimile
 each of which shall be an original but all of which together shall constitute one and the same instrument.

















 the Parties
 personally or by their duly authorized representatives
 have caused this Advisor Agreement to be executed as of the date first written above.








MOJO ORGANICS
 INC.





Glenn Simpson
 Chief Executive Officer








































    












 day of December
 2013
 by and between Mojo Organics
 Inc.
 a Delaware corpora&#173;tion (the &#8220;Company&#8221;)
 and


WHEREAS
 on December 4
 2013
 pursuant to the Company 2012 Long-Term Incentive Equity Plan (the &#8220;Plan&#8221;)
 the Company&#8217;s Board of Directors (&#8220;Board&#8221;) determined to issue to the Holder
 in consideration of&#160;&#160;
] shares of common stock of the Company
 $.001 par value (&#8220;Shares&#8221;)
 conditioned upon the Holder&#8217;s acceptance thereof upon the terms and conditions set forth in this Agreement; and


WHEREAS
 the Holder desires to acquire the Shares on the terms and conditions set forth in this Agreement;








] Shares on the terms and conditions set forth herein.&#160;&#160;All of the Shares shall be subject to forfeiture during the period terminating December 4
 2014 (&#8220;Restriction Period&#8221;).&#160;&#160;The Shares shall be represented by one stock certificate (&#8220;Restricted Stock Certificate&#8221;) registered in the name of the Holder
 which certificate shall bear the legends set forth in Sections&#160;5(v) and 5(vi) of this Agreement.&#160;&#160;The Restricted Stock Certificate shall be deposited by the Holder with the Company
 together with stock powers endorsed in blank
 which will permit transfer to the Company of all or any portion of the Shares represented by such certificates (the &#8220;Restricted Shares&#8221;) that shall be forfeited or shall not become vested in accordance with the terms of this Agreement.


(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;After issuance
 the Restricted Shares shall constitute issued and outstanding shares of Common Stock for all corporate purposes unless and until forfeited in accordance with the terms hereof.&#160;&#160;The Holder shall have the right to vote such Restricted Shares
 to receive and retain all cash dividends as the Board may
 in its sole discretion
 pay on such Restricted Shares
 and to exercise all of the rights
 powers and privileges of a holder of Common Stock with respect to such Restricted Shares
 except that (a) the Holder shall not be entitled to delivery of the Restricted Stock Certificate until the Restricted Shares represented by the Restricted Stock Certificate vest in accordance with subparagraph (iii) below; and (b) other than cash dividends as the Board
 in its sole discretion
 distributes
 the Company will retain custody of all distributions (&#8220;Retained Distributions&#8221;) made or declared with respect to the Restricted Shares (and such Retained Distributions will be subject to the same restrictions
 terms and conditions as applicable to the Restricted Shares) until such time
 if ever
 as the Restricted Shares with respect to which such Retained Distributions shall have been distributed have become vested.


(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On December 4
 2014
 if the Holder is still employed by the Company
 the Restricted Shares and the Retained Distributions with respect thereto shall become vested.&#160;&#160;After the date that any of the Restricted Shares become vested
 upon the request of the Holder the Company shall promptly instruct its transfer agent to issue and deliver to the Holder a new certificate for the Shares that have vested
 which certificate shall not bear the legend set forth in Section 5(vi). If
 at any time prior to the vesting of the Restricted Shares in accordance with this Section 1(iii)
 the Holder&#8217;s [employment/relationship] with the Company is terminated
 then the Restricted Shares that have not then vested (and the Retained Distributions with respect thereto) shall be forfeited to the Company and the Holder shall not thereafter have any rights with respect to such Restricted Shares.&#160;&#160;Notwithstanding the foregoing
 if Holder&#8217;s [employment/relationship] with the Company is terminated at any time other than by the Company for &#8220;cause&#8221; or by the Holder without &#8220;good reason&#8221; [(each as defined in the Holder&#8217;s employment agreement with the Company)]
 then all of the Restricted Shares shall automatically vest.&#160;&#160;[As used herein
 &#8220;Cause&#8221; shall mean: (a) the refusal or failure by Holder to carry out specific reasonable directions of the person Holder reports to or the Board of Directors which are of a material nature and consistent with Holder&#8217;s position or the refusal or failure by Holder to perform a reasonable material part of Holder&#8217;s duties to the Company; (b) fraud or dishonest action by Holder in his relations with the Company or any of its subsidiaries or affiliates (&#8220;dishonest &#8221; for these purposes shall mean Holder knowingly&#160;&#160;making&#160;&#160;a material misstatement or omission for Holder&#8217;s personal benefit); or (c) the conviction of Holder of a felony under federal or state law.&#160;&#160;Notwithstanding the foregoing
 no &#8220;Cause&#8221; for termination shall be deemed to exist with respect to Holder&#8217;s acts described in clause (a) above
 unless the Company shall have given written notice to Holder within a period not to exceed seven (7) calendar days of the Company&#8217;s knowledge of the initial existence of the occurrence
 specifying the &#8220;Cause&#8221; with reasonable particularity and
 within seven (7) calendar days after such notice
 Holder shall not have cured or eliminated the problem or thing giving rise to such &#8220;Cause;&#8221; provided
 however
 no more than two cure periods need be provided during any twelve-month period.&#160;&#160;As used herein
 &#8220;Good Reason&#8221; shall mean the occurrence of any of the following circumstances without Holder&#8217;s prior written consent:&#160;&#160;(a) material breach of this Agreement by the Company; (b) a failure by the Company to make any payment to Holder when due
 unless the payment is not material or is being contested by the Company
 in good faith; or (c) a liquidation
 bankruptcy or receivership of the Company. Notwithstanding the foregoing
 no &#8220;Good Reason&#8221; shall be deemed to exist with respect to the Company &#8217;s acts described in clauses (a) or (b) above
 unless Holder shall have given written notice to the Company within a period not to exceed seven (7) calendar days of Holder&#8217;s knowledge of the initial existence of the occurrence
 specifying the &#8220;Good Reason&#8221; with reasonable particularity and
 within seven (7) calendar days after such notice
 the Company shall not have cured or eliminated the problem or thing giving rise to such &#8220;Good Reason&#8221;; provided
 however
 that no more than two cure periods shall be provided during any twelve-month period.]
















(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Nothing in this Agreement shall confer on the Holder any right to continue in the employ of
 or other relationship with
 the Company (or with any parent
 subsidiary or affiliate of the Company) or limit in any way the right of the Company (or of any parent
 subsidiary or affiliate of the Company) to terminate the Holder&#8217;s [employment or other] relationship with the Company (or with any parent
 subsidiary or affiliate of the Company) at any time
 with or without cause.


.&#160;&#160;Not later than the date as of which an amount first becomes includible in the gross income of the Holder for federal income tax purposes with respect to the Shares
 the Holder shall pay to the Com&#173;pany
 or make arrangements satisfactory to the Board
 regarding the payment of
 any federal
 state and local taxes of any kind required by law to be withheld or paid with respect to such amount.&#160;&#160;In the event the Holder is no longer employed by the Company on the date any shares vest in accordance with Section 1 above
 the Company shall have the right to withhold from the Shares such a number of Shares having a Fair Market Value (as defined below) on the date of withholding equal to the minimum amount (and not any greater amount) required to be withheld for tax purposes.&#160;&#160;The obligations of the Company pursuant to this Agreement shall be conditional upon such pay&#173;ment or arrangements with the Company and the Company shall
 to the extent permitted by law
 have the right to deduct any such taxes from any payment of any kind otherwise due to the Holder from the Company.&#160;&#160;Solely for purposes of this section
 &#8220;Fair Market Value&#8221; means as of any given date: (i) if the Shares are listed on a national securities exchange or The Nasdaq Stock Market
 LLC (&#8220;Nasdaq&#8221;)
 the last sale price of the Shares in the principal trading market for the Shares on such date
 as reported by the exchange or Nasdaq
 as the case may be; (ii) if the Shares are not listed on a national securities exchange or Nasdaq
 but are traded in the over-the-counter market
 the closing bid price for the Shares on such date
 as reported by the OTC Bulletin Board or Pink Sheets
 LLC or similar publisher of such quotations; and (iii) if the fair market value of the Shares cannot be determined pursuant to clause (i) or (ii) above
 such price as the Board shall determine
 in good faith.






















(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the Company
 by appropriate and all required action
 is duly authorized to enter into this Agreement and consummate all of the transactions contemplated hereunder; and


(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the Shares
 when issued and delivered by the Company to the Holder in accordance with the terms and conditions hereof
 will be duly and validly issued and fully paid and non-assessable.








(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;he understands that he must bear the economic risk of the invest&#173;ment in the Shares
 which cannot be sold by him unless they are registered under the Securities Act of 1933
 as amended (&#8220;Securities Act&#8221;)
 or an exemption therefrom is available thereunder and that the Company is under no obli&#173;gation to register the Shares for sale under the Securities Act;


(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;in his position with the Company
 he has had both the opportunity to ask questions and receive answers from the officers and directors of the Company and all persons act&#173;ing on its behalf concerning the terms and conditions of the offer made hereunder and to obtain any additional informa&#173;tion to the extent the Company possesses or may possess such infor&#173;mation or can acquire it without unreasonable effort or expense;








&#8220;THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE BEEN ACQUIRED FOR INVESTMENT.&#160;&#160;THE SHARES MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
 AS AMENDED
 OR AN EXEMPTION THEREFROM UNDER SAID ACT.&#8221;





&#8220;THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE BEEN ACQUIRED PURSUANT TO A RESTRICTED STOCK AGREEMENT
 A COPY OF WHICH IS ON FILE WITH THE COMPANY
 AND MAY NOT BE TRANSFERRED
 PLEDGED OR DISPOSED OF EXCEPT IN ACCORDANCE WITH THE TERMS AND CONDITIONS THEREOF.&#8221;
















.&#160;&#160;Anything in this Agreement to the contrary notwithstanding
 the Holder hereby agrees that he shall not sell
 transfer by any means or otherwise dispose of the Shares acquired by him without registration under the Securities Act
 or in the event that they are not so registered
 unless (i)&#160;an exemption from the Securities Act registra&#173;tion requirements is avail&#173;able thereunder
 and (ii)&#160;the Holder has furnished the Company with notice of such proposed transfer and the Company&#8217;s legal coun&#173;sel
 in its reasonable opinion
 shall deem such proposed transfer to be so exempt.&#160;&#160;Further
 the Holder agrees that he shall abide by all of the Company&#8217;s policies in effect at the time the Shares vest and thereafter
 including the Company&#8217;s Insider Trading Policy
 with respect to the ownership and trading of the Company&#8217;s securities.





.&#160;&#160;All notices
 requests
 deliv&#173;eries
 payments
 demands and other communications that are required or permitted to be given under this Agreement shall be in writing and shall be either delivered personally or sent by regis&#173;tered or certified mail
 or by private courier
 return receipt requested
 postage prepaid to the Company at its principal executive office and to the Holder at his address set forth below
 or to such other address as either party shall have specified by notice in writing to the other.&#160;&#160;Notice shall be deemed duly given hereunder when delivered or mailed as provided herein.







.&#160;&#160;This Agree&#173;ment shall inure to the benefit of and be binding upon the parties hereto and
 to the extent not prohibited herein
 their respective heirs
 successors
 assigns and representatives.&#160;&#160;Nothing in this Agreement
 expressed or implied
 is intended to confer on any per&#173;son other than the parties hereto and as provided above
 their respective heirs
 successors
 assigns and representatives any rights
 remedies
 obligations or liabilities.





.&#160;&#160;The headings contained herein are for the sole purpose of convenience of reference
 and shall not in any way limit or affect the meaning or interpretation of any of the terms or provisions of this Agreement.



















IN WITNESS WHEREOF
 the parties hereto have signed this Agreement as of the day and year first above written.







MOJO ORGANICS
 INC.






















































    












AGREEMENT made as of the __ day of March
 2014
 by and between Mojo Organics
 Inc.
 a Delaware corpora&#173;tion (the &#8220;Company&#8221;)
 and&#160;&#160;


WHEREAS
&#160;&#160;
 pursuant to the Company 2012 Long-Term Incentive Equity Plan (the &#8220;Plan&#8221;)
 the Company&#8217;s Board of Directors (&#8220;Board&#8221;) determined to issue to the Holder
 in consideration of&#160;
&#160;shares of common stock of the Company
 $.001 par value (&#8220;Shares&#8221;)
 conditioned upon the Holder&#8217;s acceptance thereof upon the terms and conditions set forth in this Agreement; and


WHEREAS
 the Holder desires to acquire the Shares on the terms and conditions set forth in this Agreement;









 2015 (&#8220;Restriction Period&#8221;).&#160;&#160;The Shares shall be represented by one stock certificate (&#8220;Restricted Stock Certificate&#8221;) registered in the name of the Holder
 which certificate shall bear the legends set forth in Sections&#160;5(v) and 5(vi) of this Agreement.&#160;&#160;The Restricted Stock Certificate shall be deposited by the Holder with the Company
 together with stock powers endorsed in blank
 which will permit transfer to the Company of all or any portion of the Shares represented by such certificates (the &#8220;Restricted Shares&#8221;) that shall be forfeited or shall not become vested in accordance with the terms of this Agreement.


(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;After issuance
 the Restricted Shares shall constitute issued and outstanding shares of Common Stock for all corporate purposes unless and until forfeited in accordance with the terms hereof.&#160;&#160;The Holder shall have the right to vote such Restricted Shares
 to receive and retain all cash dividends as the Board may
 in its sole discretion
 pay on such Restricted Shares
 and to exercise all of the rights
 powers and privileges of a holder of Common Stock with respect to such Restricted Shares
 except that (a) the Holder shall not be entitled to delivery of the Restricted Stock Certificate until the Restricted Shares represented by the Restricted Stock Certificate vest in accordance with subparagraph (iii) below; and (b) other than cash dividends as the Board
 in its sole discretion
 distributes
 the Company will retain custody of all distributions (&#8220;Retained Distributions&#8221;) made or declared with respect to the Restricted Shares (and such Retained Distributions will be subject to the same restrictions
 terms and conditions as applicable to the Restricted Shares) until such time
 if ever
 as the Restricted Shares with respect to which such Retained Distributions shall have been distributed have become vested.



 2015
 if the Holder is still [employed by/serving as a director of] the Company
 the Restricted Shares and the Retained Distributions with respect thereto shall become vested.&#160;&#160;After the date that any of the Restricted Shares become vested
 upon the request of the Holder the Company shall promptly instruct its transfer agent to issue and deliver to the Holder a new certificate for the Shares that have vested
 which certificate shall not bear the legend set forth in Section 5(vi). If
 at any time prior to the vesting of the Restricted Shares in accordance with this Section 1(iii)
 the Holder&#8217;s [employment/relationship] with the Company is terminated
 then the Restricted Shares that have not then vested (and the Retained Distributions with respect thereto) shall be forfeited to the Company and the Holder shall not thereafter have any rights with respect to such Restricted Shares.&#160;&#160;Notwithstanding the foregoing
 if Holder&#8217;s [employment/relationship] with the Company is terminated at any time other than by the Company for &#8220;cause&#8221; or by the Holder without &#8220;good reason&#8221; [(each as defined in the Holder&#8217;s employment agreement with the Company)]
 then all of the Restricted Shares shall automatically vest.&#160;&#160;[As used herein
 &#8220;Cause&#8221; shall mean: (a) the refusal or failure by Holder to carry out specific reasonable directions of the person Holder reports to or the Board of Directors which are of a material nature and consistent with Holder&#8217;s position or the refusal or failure by Holder to perform a reasonable material part of Holder&#8217;s duties to the Company; (b) fraud or dishonest action by Holder in his relations with the Company or any of its subsidiaries or affiliates (&#8220;dishonest &#8221; for these purposes shall mean Holder knowingly&#160;&#160;making&#160;&#160;a material misstatement or omission for Holder&#8217;s personal benefit); or (c) the conviction of Holder of a felony under federal or state law.&#160;&#160;Notwithstanding the foregoing
 no &#8220;Cause&#8221; for termination shall be deemed to exist with respect to Holder&#8217;s acts described in clause (a) above
 unless the Company shall have given written notice to Holder within a period not to exceed seven (7) calendar days of the Company&#8217;s knowledge of the initial existence of the occurrence
 specifying the &#8220;Cause&#8221; with reasonable particularity and
 within seven (7) calendar days after such notice
 Holder shall not have cured or eliminated the problem or thing giving rise to such &#8220;Cause;&#8221; provided
 however
 no more than two cure periods need be provided during any twelve-month period.&#160;&#160;As used herein
 &#8220;Good Reason&#8221; shall mean the occurrence of any of the following circumstances without Holder&#8217;s prior written consent:&#160;&#160;(a) material breach of this Agreement by the Company; (b) a failure by the Company to make any payment to Holder when due
 unless the payment is not material or is being contested by the Company
 in good faith; or (c) a liquidation
 bankruptcy or receivership of the Company. Notwithstanding the foregoing
 no &#8220;Good Reason&#8221; shall be deemed to exist with respect to the Company &#8217;s acts described in clauses (a) or (b) above
 unless Holder shall have given written notice to the Company within a period not to exceed seven (7) calendar days of Holder&#8217;s knowledge of the initial existence of the occurrence
 specifying the &#8220;Good Reason&#8221; with reasonable particularity and
 within seven (7) calendar days after such notice
 the Company shall not have cured or eliminated the problem or thing giving rise to such &#8220;Good Reason&#8221;; provided
 however
 that no more than two cure periods shall be provided during any twelve-month period.]
















(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Nothing in this Agreement shall confer on the Holder any right to continue in the employ of
 or other relationship with
 the Company (or with any parent
 subsidiary or affiliate of the Company) or limit in any way the right of the Company (or of any parent
 subsidiary or affiliate of the Company) to terminate the Holder&#8217;s [employment or other] relationship with the Company (or with any parent
 subsidiary or affiliate of the Company) at any time
 with or without cause.


.&#160;&#160;Not later than the date as of which an amount first becomes includible in the gross income of the Holder for federal income tax purposes with respect to the Shares
 the Holder shall pay to the Com&#173;pany
 or make arrangements satisfactory to the Board
 regarding the payment of
 any federal
 state and local taxes of any kind required by law to be withheld or paid with respect to such amount.&#160;&#160;In the event the Holder is no longer employed by the Company on the date any shares vest in accordance with Section 1 above
 the Company shall have the right to withhold from the Shares such a number of Shares having a Fair Market Value (as defined below) on the date of withholding equal to the minimum amount (and not any greater amount) required to be withheld for tax purposes.&#160;&#160;The obligations of the Company pursuant to this Agreement shall be conditional upon such pay&#173;ment or arrangements with the Company and the Company shall
 to the extent permitted by law
 have the right to deduct any such taxes from any payment of any kind otherwise due to the Holder from the Company.&#160;&#160;Solely for purposes of this section
 &#8220;Fair Market Value&#8221; means as of any given date: (i) if the Shares are listed on a national securities exchange or The Nasdaq Stock Market
 LLC (&#8220;Nasdaq&#8221;)
 the last sale price of the Shares in the principal trading market for the Shares on such date
 as reported by the exchange or Nasdaq
 as the case may be; (ii) if the Shares are not listed on a national securities exchange or Nasdaq
 but are traded in the over-the-counter market
 the closing bid price for the Shares on such date
 as reported by the OTC Bulletin Board or Pink Sheets
 LLC or similar publisher of such quotations; and (iii) if the fair market value of the Shares cannot be determined pursuant to clause (i) or (ii) above
 such price as the Board shall determine
 in good faith.






















(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the Company
 by appropriate and all required action
 is duly authorized to enter into this Agreement and consummate all of the transactions contemplated hereunder; and


(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the Shares
 when issued and delivered by the Company to the Holder in accordance with the terms and conditions hereof
 will be duly and validly issued and fully paid and non-assessable.








(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;he understands that he must bear the economic risk of the invest&#173;ment in the Shares
 which cannot be sold by him unless they are registered under the Securities Act of 1933
 as amended (&#8220;Securities Act&#8221;)
 or an exemption therefrom is available thereunder and that the Company is under no obli&#173;gation to register the Shares for sale under the Securities Act;


(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;in his position with the Company
 he has had both the opportunity to ask questions and receive answers from the officers and directors of the Company and all persons act&#173;ing on its behalf concerning the terms and conditions of the offer made hereunder and to obtain any additional informa&#173;tion to the extent the Company possesses or may possess such infor&#173;mation or can acquire it without unreasonable effort or expense;








&#8220;THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE BEEN ACQUIRED FOR INVESTMENT.&#160;&#160;THE SHARES MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
 AS AMENDED
 OR AN EXEMPTION THEREFROM UNDER SAID ACT.&#8221;





&#8220;THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE BEEN ACQUIRED PURSUANT TO A RESTRICTED STOCK AGREEMENT
 A COPY OF WHICH IS ON FILE WITH THE COMPANY
 AND MAY NOT BE TRANSFERRED
 PLEDGED OR DISPOSED OF EXCEPT IN ACCORDANCE WITH THE TERMS AND CONDITIONS THEREOF.&#8221;
















.&#160;&#160;Anything in this Agreement to the contrary notwithstanding
 the Holder hereby agrees that he shall not sell
 transfer by any means or otherwise dispose of the Shares acquired by him without registration under the Securities Act
 or in the event that they are not so registered
 unless (i)&#160;an exemption from the Securities Act registra&#173;tion requirements is avail&#173;able thereunder
 and (ii)&#160;the Holder has furnished the Company with notice of such proposed transfer and the Company&#8217;s legal coun&#173;sel
 in its reasonable opinion
 shall deem such proposed transfer to be so exempt.&#160;&#160;Further
 the Holder agrees that he shall abide by all of the Company&#8217;s policies in effect at the time the Shares vest and thereafter
 including the Company&#8217;s Insider Trading Policy
 with respect to the ownership and trading of the Company&#8217;s securities.





.&#160;&#160;All notices
 requests
 deliv&#173;eries
 payments
 demands and other communications that are required or permitted to be given under this Agreement shall be in writing and shall be either delivered personally or sent by regis&#173;tered or certified mail
 or by private courier
 return receipt requested
 postage prepaid to the Company at its principal executive office and to the Holder at his address set forth below
 or to such other address as either party shall have specified by notice in writing to the other.&#160;&#160;Notice shall be deemed duly given hereunder when delivered or mailed as provided herein.






.&#160;&#160;This Agree&#173;ment shall inure to the benefit of and be binding upon the parties hereto and
 to the extent not prohibited herein
 their respective heirs
 successors
 assigns and representatives.&#160;&#160;Nothing in this Agreement
 expressed or implied
 is intended to confer on any per&#173;son other than the parties hereto and as provided above
 their respective heirs
 successors
 assigns and representatives any rights
 remedies
 obligations or liabilities.





.&#160;&#160;The headings contained herein are for the sole purpose of convenience of reference
 and shall not in any way limit or affect the meaning or interpretation of any of the terms or provisions of this Agreement.


















IN WITNESS WHEREOF
 the parties hereto have signed this Agreement as of the day and year first above written.








MOJO ORGANICS
 INC.




















































    






















Mojo Organics Inc.
(&#8220;Company&#8221;)
 and the Investor hereby agree as follows:

 The Company is offering (&#8220;Offering&#8221;) up to an aggregate of 1
101
036 shares (&#8220;Shares&#8221;) of the Company&#8217;s common stock (&#8220;Common Stock&#8221;) to investors executing subscription agreements from time to time in form and substance substantially identical to this Subscription Agreement.&#160;&#160;The purchase price per share to each such investor shall be $0.91.&#160;&#160;For each Share purchased in the Offering
 the investor shall receive one warrant (&#8220;Warrant&#8221;) to purchase one share of Common Stock at an exercise price of $0.91
 hereto.&#160;&#160;I (sometimes referred to herein as the &#8220;Investor&#8221;) hereby subscribe for and agree to purchase _______ Shares.&#160;&#160;The total purchase price for my Shares is $_______.&#160;&#160;&#160;Concurrently herewith
 the Company may engage in another offering of up to 1
098
902 shares of its Common Stock at a price per share of $0.91 (&#8220;Concurrent Offering&#8221;).&#160;&#160;The closing of the Concurrent Offering is not contingent upon the Closing of this Offering and the closing of this Offering is not contingent upon the closing of the Concurrent Offering.

&#160;&#160;The closing on the purchase of my Shares (and Warrants) under this subscription (the &#8220;Closing&#8221;) shall occur on the date that the Company has accepted and executed this Subscription Agreement and funds in payment therefor have been received by the Company and have cleared.&#160;&#160;The Company may hold additional Closings on additional Shares (and Warrants) in this offering to other investors from time to time.&#160;&#160;It is acknowledged that there is no minimum amount of proceeds the Company must receive for there to be a Closing.&#160;&#160;No further Closings in this Offering shall be held after February 28
 2014; provided
 however that the Company may
 in its sole discretion
 and not withstanding anything to the contrary in this Agreement
 increase the number of Shares (and the corresponding Warrants) being sold in the Offering and extend the date for further Closings.&#160;&#160;For the avoidance of doubt
 all references to &#8220;Shares&#8221; herein include any shares of Common Stock sold upon such increase in the Offering size.

 day after Closing a registration statement on Form S-1 (or such other form as permitted by the rules and regulations of the Securities and Exchange Commission (&#8220;Commission&#8221;)) registering the resale of the Investor&#8217;s Shares and the shares underlying the Warrants under the Securities Act of 1933
 as amended (&#8220;Securities Act&#8221;)
 (b) timely&#160;&#160;respond to the comments of the Commission to such registration statement and (c) have such registration statement declared effective by the Commission as soon as practicable thereafter.&#160;&#160;The Company shall use a portion of the proceeds from its sales of the Shares to fund the cost of the foregoing registration.&#160;&#160;The Investor shall timely provide the Company with any information regarding the Investor that is required for the registration statement or as otherwise reasonably requested by the Company to meet its obligations under this Section 3.

&#160;&#160;The Investor acknowledges the Company has advised Investor that it intends to amend its 2012 Long-Term Incentive Equity Plan (&#8220;Plan&#8221;) to increase the number of shares of Common Stock available for grant thereunder (excluding shares already subject to award made under the Plan) to that number of shares equal to 20% of the shares of Common Stock outstanding on a&#160;&#160;fully diluted basis and giving effect to all Shares actually sold in the Offering (including shares underlying the Warrants) and the Shares sold in the Concurrent Offering. Promptly following the end of the Offering
 the Company will convene a meeting of its stockholders to approve the above-described amendment to the Plan (&#8220;Stockholders Meeting&#8221;).&#160;&#160;Concurrently with the execution of this Subscription Agreement
 the Investor is executing the irrevocable proxy attached as 
























In the event that a Closing does not take place with respect to my subscription for any reason or if my subscription is otherwise rejected
 all cash proceeds delivered by me in accordance with the foregoing shall be returned to me as soon as practicable
 without interest
 offset or deduction
 and the Investor Proxy shall be destroyed or returned to me as I direct.

In the event my subscription is accepted and there is a Closing
 a certificate for the Shares for which I am subscribing will be delivered promptly to me along with a copy of a fully executed version of this Agreement.

.&#160;&#160;The Company has the right to reject this subscription for Shares
 in whole or in part
 for any reason and at any time prior to a Closing with respect to this subscription. The Shares subscribed for herein will not be deemed issued to or owned by me until a copy of this Subscription Agreement has been executed by me and accepted and countersigned by the Company
 and a Closing with respect to my subscription has occurred.



.&#160;&#160;I am an &#8220;accredited investor&#8221; as defined in Section 2(15) of the Securities Act
 and Rule 501 promulgated thereunder.&#160;&#160;I understand that the Shares are being issued to me without registration under the Securities Act in reliance upon the exemptions contained in Regulation D promulgated under the Securities Act (&#8220;Regulation D&#8221;) and applicable state securities laws.

.&#160;&#160;&#160;The Company has no obligation to me other than as set forth in this Agreement.&#160;&#160;I am aware that
 except for any rescission rights that may be provided under applicable laws
 I am not entitled to cancel
 terminate or revoke this Subscription Agreement or Investor Proxy and any agreements made in connection herewith will survive my death or disability.&#160;&#160;In order to induce the Company to issue and sell the Shares to me
 I represent and warrant that the information relating to me stated herein is true and complete as of the date hereof and will be true and complete as of the date on which my purchase of Shares becomes effective.


















.&#160;&#160;I have received no representation or warranty from the Company or any of its officers
 directors
 employees or agents in respect of my investment in the Company.&#160;&#160;I am not purchasing the Shares as a result of or subsequent to:&#160;&#160;(i) any advertisement
 article
 notice or other communication published in any newspaper
 magazine or similar media or broadcast over television
 radio or the Internet or (ii) any seminar or meeting whose attendees have been invited by any general solicitation or general advertising.

.&#160;&#160;I am aware that my purchase of Shares (and Warrants) is a speculative investment.&#160;&#160;I acknowledge that I can lose the entire amount of my investment in the Company.&#160;&#160;I have such knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks of an investment in the Shares and have obtained
 in my judgment
 sufficient information from the Company to evaluate the merits and risks of an investment in the Company.&#160;&#160;I have not utilized any person as my purchaser representative (as defined in Regulation D) in connection with evaluating such merits and risks and have relied solely upon my own investigation in making a decision to invest in the Company. I have been urged to seek independent advice from my professional advisors relating to the suitability of an investment in the Company in view of my overall financial needs and with respect to the legal and tax implications of such investment.&#160;&#160;I believe that the investment in the Company represented by my purchase of Shares is suitable for me based upon my investment objectives and financial needs
 and I have adequate means for providing for my current financial needs and contingencies and have no need for liquidity with respect to my investment in the Company.&#160;&#160;My investment in the Company does not constitute all
 or substantially all
 of my investment portfolio.

I have also necessary authority
 approval and consent required for my delivery of this Subscription Agreement and the Investor Proxy and to fulfill my obligations hereunder and thereunder.

.&#160;&#160;Investor understands that (i) the Shares have not been registered under the Securities Act or the securities laws of any state in reliance on specific exemptions from registration and (ii) the&#160;&#160;Shares cannot be resold
 pledged
 assigned or otherwise disposed of unless they are subsequently registered under the Securities Act and under applicable securities laws of certain states
 or an exemption from such registration is available.&#160;&#160;The certificate representing the Shares will bear a restrictive legend relating to such restrictions.&#160;&#160;In addition
 Investor understands that the Company is relying on Investor&#8217;s representations and agreements for the purpose of determining whether this transaction meets the requirements of the exemptions afforded by the Securities Act and certain state securities laws.&#160;&#160;I understand the Company and its securities are not currently registered under the Exchange Act and there can be no assurance that they will be
 and as a result
 Rule 144 may not be available to me for sales or transfers of the Shares.
















.&#160;&#160;Investor is acquiring the Shares for its own account for investment and not with a view to
 or for sale in connection with
 any subsequent distribution of the securities
 nor with any present intention of selling or otherwise disposing of all or any part of the Shares in violation of the Federal securities laws.

.&#160;&#160;The Company hereby represents and warrants to the Investor that the Company has all necessary corporate power and authority to enter into this Agreement and to consummate the transactions contemplated hereby.&#160;&#160;All corporate action necessary to be taken by the Company to authorize the execution
 delivery and performance of this Agreement and all other agreements and instruments delivered by the Company in connection with the transactions contemplated hereby has been duly and validly taken and this Agreement has&#160;&#160;been duly executed and delivered by the Company.&#160;&#160;Subject to the terms and conditions of this Agreement
 this Agreement constitutes the valid
 binding and enforceable obligation of the Company
 enforceable in accordance with its terms
 except as enforceability may be limited by (i) applicable bankruptcy
 insolvency
 reorganization
 moratorium
 fraudulent transfer or similar laws of general application now or hereafter in effect affecting the rights and remedies of creditors and by general principles of equity (regardless of whether enforcement is sought in a proceeding at law or in equity); and (ii) the applicability of the federal and state securities laws and public policy as to the enforceability of the indemnification provisions of this Agreement.&#160;&#160;The sale by the Company of the Shares does not conflict with the certificate of incorporation or bylaws of the Company or any material contract by which the Company or its property is bound
 or any federal or state laws or regulations or decree
 ruling or judgment of any United States or state court applicable to the Company or its property.&#160;&#160;The sale of the Shares will not trigger any pre-emptive or
 to the knowledge of the Company
 other rights held by any party and no governmental or regulatory consent is required for the consummation of the transactions contemplated by this Agreement.

.&#160;&#160;I hereby agree to indemnify and hold harmless the Company and its officers
 directors
 stockholders
 employees
 agents
 and attorneys against any and all losses
 claims
 demands
 liabilities
 and expenses (including reasonable legal or other expenses incurred by each such person in connection with defending or investigating any such claims or liabilities
 whether or not resulting in any liability to such person or whether incurred by the indemnified party in any action or proceeding between the indemnitor and&#160;&#160;indemnified party or between the indemnified party and any third party) to which any such indemnified party may become subject
 insofar as such losses
 claims
 demands
 liabilities and expenses (a) arise out of or are based upon any untrue statement or alleged untrue statement of a material fact made by me and contained herein
 or (b) arise out of or are based upon any breach by me of any representation
 warranty
 or agreement made by me contained herein.

.&#160;&#160;In the event any parts of this Subscription Agreement are found to be void
 the remaining provisions of this Subscription Agreement are nevertheless binding with the same effect as though the void parts were deleted.

.&#160;&#160;This Subscription Agreement
 Warrant and Investor Proxy will be deemed to have been made and delivered in New York City and will be governed as to validity
 interpretation
 construction
 effect and in all other respects by the internal law of the State of New York.&#160;&#160;Each of the Company and the Investor hereby (i) agrees that any legal suit
 action or proceeding arising out of or relating to this Subscription Agreement
 Warrant or Investor Proxy will be instituted exclusively in New York State Supreme Court
 County of New York
 or in the United States District Court for the Southern District of New York
 (ii) waives any objection to the venue of any such suit
 action or proceeding and the right to assert that such forum is not a convenient forum for such suit
 action or proceeding
 (iii) irrevocably consents to the jurisdiction of the New York State Supreme Court
 County of New York
 and the United States District Court for the Southern District of New York in any such suit
 action or proceeding
 (iv) agrees to accept and acknowledge service of any and all process that may be served in any such suit
 action or proceeding in New York State Supreme Court
 County of New York or in the United States District Court for the Southern District of New York and (v) agrees that service of process upon it mailed by certified mail to its address set forth on my signature page will be deemed in every respect effective service of process upon it in any suit
 action or proceeding.
















.&#160;&#160;This Subscription Agreement may be executed in one or more counterparts
 each of which will be deemed an original but all of which together will constitute one and the same instrument.&#160;&#160;The execution of this Subscription Agreement and Investor Proxy must be by actual signature.

.&#160;&#160;This Subscription Agreement is binding upon and inures to the benefit of the parties hereto and their respective heirs
 executors
 personal representatives
 successors and assigns.

&#160;&#160;All notices
 offers
 acceptance and any other acts under this Subscription Agreement (except payment) must be in writing
 and are sufficiently given if delivered to the addressees in person
 by overnight courier service
 or
 if mailed
 postage prepaid
 by certified mail (return receipt requested)
 and will be effective three days after being placed in the mail if mailed
 or upon receipt or refusal of receipt
 if delivered personally or by courier or confirmed telecopy
 in each case addressed to a party.&#160;&#160;All communications to me should be sent to my preferred address on the signature page hereto.&#160;&#160;All communications to the Company should be sent to Mojo Organics Inc.
 101 Hudson Street
 Floor
 Jersey City
 New Jersey 07302
 Attention: Chief Executive Officer.&#160;&#160;Each party may designate another address by notice to the other parties.

.&#160;&#160;This Subscription Agreement
 Warrant and Investor Proxy constitute the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior oral and written agreements between the parties hereto with respect to the subject matter hereof.&#160;&#160;This Subscription Agreement may not be changed
 waived
 discharged
 or terminated orally
 but rather
 only by a statement in writing signed by the party or parties against which enforcement or the change
 waiver
 discharge or termination is sought.

.&#160;&#160;Section headings herein have been inserted for reference only and will not be deemed to limit or otherwise affect
 in any matter
 or be deemed to interpret in whole or in part
 any of the terms or provisions of this Subscription Agreement.

Survival of Representations

 warranties and agreements contained herein will survive the delivery of
 and the payment for
 the Shares.








































 2014






















MOJO ORGANICS
 INC.

















































NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933
 AS AMENDED (THE &#8220;SECURITIES ACT&#8221;)
 AND
 ACCORDINGLY
 MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM
 OR IN A TRANSACTION NOT SUBJECT TO
 THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT
 THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.






MOJO ORGANICS
 INC.





&#160;&#160;&#160;&#160;
 2014



&#8221;) certifies that
 for value received
&#8221;) is entitled
 upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth
&#8221;) but not thereafter
 to subscribe for and purchase from Mojo Organics
 Inc.
&#8221;)
&#8221;) of Common Stock.&#160;&#160;The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price
 as defined in Section 2(b).

&#8221;)
 dated&#160;
 2014
 among the Company and the purchaser signatory thereto.



.&#160;&#160;Exercise of this Warrant may be made
 in whole or in part
 at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company (or such other office or agency of the Company as it may designate by notice in writing to the registered Holder at the address of the Holder appearing on the books of the Company) of a duly executed facsimile copy of the Notice of Exercise Form annexed hereto; and
 within three (3) Trading Days (as defined in Section 2(c) below) of the date said Notice of Exercise is delivered to the Company
 the Company shall have received&#160;&#160;payment of the aggregate Exercise Price of the shares thereby purchased by wire transfer or cashier&#8217;s check drawn on a United States bank.&#160;&#160;Notwithstanding anything herein to the contrary
 the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full
 in which case
 the Holder shall surrender this Warrant to the Company for cancellation within 3 Trading Days of the date the final Notice of Exercise is delivered to the Company.&#160;&#160;Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased.&#160;&#160;The Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases.&#160;&#160;The Company shall deliver any objection to any Notice of Exercise Form within two (2) Business Days of receipt of such notice.&#160;&#160;In the event of any dispute or discrepancy

 by acceptance of this Warrant
 acknowledge and agree that
 by reason of the provisions of this paragraph
 following the purchase of a portion of the Warrant Shares hereunder
 the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.
















.&#160;&#160;The exercise price per share of the Common Stock under this Warrant shall be $0.91
 subject to adjustment hereunder (the &#8220;

.&#160;&#160;This Warrant may also be exercised prior to the Termination Date by means of a &#8220;cashless exercise&#8221; in which the Holder shall be entitled to receive a certificate for the number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A)
 where:























(B) = the Exercise Price of this Warrant
 as adjusted; and




















&#8221; shall mean any day on which the Common Stock is tradable for any period on the OTC Pink marketplace
 or on the principal securities exchange or other securities market on which the Common Stock is then being traded.






.&#160;&#160;Certificates for shares purchased hereunder shall be transmitted by the Transfer Agent to the Holder by physical delivery to the address specified by the Holder in the Notice of Exercise within 3 Trading Days from the delivery to the Company of the Notice of Exercise Form
&#8221;).&#160;&#160;This Warrant shall be deemed to have been exercised on the date the Exercise Price is received by the Company.&#160;&#160;The Warrant Shares shall be deemed to have been issued
 and Holder or any other person so designated to be named therein shall be deemed to have become a holder of record of such shares for all purposes
 as of the date the Warrant has been exercised by payment to the Company of the Exercise Price (or by cashless exercise if permitted) and all taxes required to be paid by the Holder
 if any
 pursuant to Section 2(d)(v) prior to the issuance of such shares
 have been paid.

.&#160;&#160;If the Company fails to cause the Transfer Agent to transmit to the Holder a certificate or the certificates representing the Warrant Shares pursuant to Section 2(d)(i) by the second (2nd) day after the Warrant Share Delivery Date
 then
 the Holder will have the right to rescind such exercise.
















.&#160;&#160;No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant.&#160;&#160;As to any fraction of a share which Holder would otherwise be entitled to purchase upon such exercise
 the Company shall
 at its election
 either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round up to the next whole share.

Charges

 all of which taxes and expenses shall be paid by the Company
 and such certificates shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; 
 
 that in the event certificates for Warrant Shares are to be issued in a name other than the name of the Holder
 this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require
 as a condition thereto
 the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.

.&#160;&#160;The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant
 pursuant to the terms hereof.



. If the Company
 at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which
 for avoidance of doubt
 shall not include any shares of Common Stock issued by the Company upon exercise of this Warrant)
 (ii) subdivides outstanding shares of Common Stock into a larger number of shares
 (iii) combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares or (iv) issues by reclassification of shares of the Common Stock any shares of capital stock of the Company
 then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares
 if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged.&#160;&#160;Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision
 combination or re-classification.
















. If
 at any time while this Warrant is outstanding
 (i) the Company effects any merger or consolidation of the Company with or into another Person
 (ii) the Company effects any sale of all or substantially all of its assets in one or a series of related transactions
 (iii) any exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to exchange their shares for other securities
&#8221;)
 then
 upon any subsequent exercise of this Warrant
 the Holder shall have the right to receive
 for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction
 the number of shares of Common Stock of the successor or acquiring corporation or of the Company
 if it is the surviving corporation
&#8221;) receivable as a result of such merger
 consolidation or disposition of assets by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such event. For purposes of any such exercise
 the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction
 and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.&#160;&#160;If holders of Common Stock are given any choice as to the securities
 cash or property to be received in a Fundamental Transaction
 then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.&#160;&#160;To the extent necessary to effectuate the foregoing provisions
 any successor to the Company or surviving entity in such Fundamental Transaction shall issue to the Holder a new warrant consistent with the foregoing provisions and evidencing the Holder&#8217;s right to exercise such warrant into Alternate Consideration. The terms of any agreement pursuant to which a Fundamental Transaction is effected shall include terms requiring any such successor or surviving entity to comply with the provisions of this Section 3(b) and insuring that this Warrant (or any such replacement security) will be similarly adjusted upon any subsequent transaction analogous to a Fundamental Transaction. Notwithstanding anything to the contrary
 in the event of a Fundamental Transaction that is (1) an all cash transaction
 (2) a &#8220;Rule 13e-3 transaction&#8221; as defined in Rule 13e-3 under the Exchange Act
 or (3) a Fundamental Transaction involving a person or entity not traded on a national securities exchange
 the Nasdaq Global Select Market
 the Nasdaq Global Market
 or the Nasdaq Capital Market
 the Company or any successor entity shall pay at the Holder&#8217;s option
 exercisable concurrently with the consummation of the Fundamental Transaction
 an amount of cash equal to the value of this Warrant as determined in accordance with the Black Scholes Option Pricing Model obtained from the &#8220;OV&#8221; function on Bloomberg L.P. using (A) a price per share of Common Stock equal to the lesser of (x) twice the Exercise Price and (y) the VWAP of the Common Stock for the Trading Day immediately preceding the date of consummation of the applicable&#160;&#160;Fundamental Transaction
 (B) the risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the remaining term of this Warrant as of the date of consummation of the applicable Fundamental Transaction
 (C) the lesser of (x) 50% and (y) an expected volatility equal to the 100 day volatility obtained from the &#8220;HVT&#8221; function on Bloomberg L.P. determined as of the Trading Day immediately following the public announcement of the applicable Fundamental Transaction and (D) a remaining option time equal to the time between the date of the public announcement of such transaction and the Termination Date.&#160;&#160;For purposes of clarification and notwithstanding anything to the contrary in this Agreement
 in the event of any Fundamental Transaction in which the consideration is only cash
 this Warrant shall not entitle the holder to purchase any securities of the surviving entity of such Fundamental Transaction and shall only represent the right to receive what the holder would have received had this Warrant been exercised into Warrant Shares prior to the consummation of the Fundamental Transaction.

. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share
 as the case may be. For purposes of this Section 3
 the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares
 if any) issued and outstanding.


















. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3
 the Company shall promptly mail to the Holder a notice setting forth the Exercise Price after such adjustment and setting forth a brief statement of the facts requiring such adjustment. If the Company enters into a Variable Rate Transaction
 despite the prohibition thereon in the Subscription Agreement
 the Company shall be deemed to have issued Common Stock or Common Stock Equivalents at the lowest possible conversion or exercise price at which such securities may be converted or exercised.

. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock
 (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock
 (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights
 (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the Common Stock
 any consolidation or merger to which the Company is a party
 any sale or transfer of all or substantially all of the assets of the Company
 of any compulsory share exchange whereby the Common Stock is converted into other securities
 cash or property
 or (E) the Company shall authorize the voluntary or involuntary dissolution
 liquidation or winding up of the affairs of the Company
 then
 in each case
 the Company shall cause to be mailed to the Holder at its last address as it shall appear upon the Warrant Register of the Company
 at least 10 calendar days prior to the applicable record or effective date hereinafter specified
 a notice stating (x) the date on which a record is to be taken for the purpose of such dividend
 distribution
 redemption
 rights or warrants
 or if a record is not to be taken
 the date as of which the holders of the Common Stock of record to be entitled to such dividend
 distributions
 redemption
 rights or warrants are to be determined or (y) the date on which such reclassification
 consolidation
 merger
 sale
 transfer or share exchange is expected to become effective or close
 and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities
 cash or other property deliverable upon such reclassification
 consolidation
 merger
 sale
 transfer or share exchange; provided that the failure to mail such notice or any defect therein or in the mailing thereof shall not affect the validity of the corporate action required to be specified in such notice.&#160;&#160;The Holder is entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice.



.&#160;&#160;Subject to compliance with any applicable securities laws
 this Warrant and all rights hereunder (including
 without limitation
 any registration rights) are transferable
 in whole or in part
 upon surrender of this Warrant at the principal office of the Company or its designated agent
 together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer.&#160;&#160;Upon such surrender and
 if required
 such payment
 the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees
 as applicable
 and in the denomination or denominations specified in such instrument of assignment
 and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned
 and this Warrant shall promptly be cancelled.&#160;&#160;The Warrant
 if properly assigned
 may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.
















. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company
 together with a written notice specifying the names and denominations in which new Warrants are to be issued
 signed by the Holder or its agent or attorney.&#160;&#160;Subject to compliance with Section 4(a)
 as to any transfer which may be involved in such division or combination
 the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the original Issue Date and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

. The Company shall register this Warrant
&#8221;)
 in the name of the record Holder hereof from time to time.&#160;&#160;The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder
 and for all other purposes
 absent actual notice to the contrary.



.&#160;&#160;All or a portion of the outstanding Common Stock Purchase Warrants issued by the Company in the Offering (the &#8220;2014 Warrants&#8221;) may be redeemed
 at the option of the Company
 at any time while they are exercisable and prior to their expiration (so long as there is a current registration statement in effect with respect to the shares of Common Stock underlying the Warrants)
 upon the notice referred to in Section 5(b)
 at the price of $0.01 per Warrant (&#8220;Redemption Price&#8221;)
 provided that the VWAP of the Common Stock equals or exceeds $5.00 per share (subject to adjustment in accordance with Section 4 hereof)
 on any twenty Trading Days during any thirty (30) consecutive Trading Day period
 such period ending on the third business day prior to the date on which notice of redemption is given.

Date Fixed for
 and Notice of

 the Company shall fix a date for the redemption (the &#8220;Redemption Date&#8221;).&#160;&#160;Notice of redemption shall be mailed by first class mail
 postage prepaid
 by the Company not less than 30 days prior to the Redemption Date to the registered holders of the Warrants to be redeemed at their last addresses as they shall appear on the registration books.&#160;&#160;Any notice mailed in the manner herein provided shall be conclusively presumed to have been duly given whether or not the registered holder received such notice.

.&#160;&#160;The Holder hereof may exercise this Warrant
 in full or in part
 for cash (or on a &#8220;cashless basis&#8221; in accordance with Section 2 of this Agreement) at any time after notice of redemption shall have been given by the Company pursuant to Section 5(b) hereof and prior to the Redemption Date.&#160;&#160;On and after the Redemption Date
 the record holder of the Warrants shall have no further rights except to receive
 upon surrender of the Warrants
 the Redemption Price.




















Loss
 Theft

 theft
 destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares
 and in case of loss
 theft or destruction
 of indemnity or security reasonably satisfactory to it (which
 in the case of the Warrant
 shall not include the posting of any bond)
 and upon surrender and cancellation of such Warrant or stock certificate
 if mutilated
 the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation
 in lieu of such Warrant or stock certificate.

Saturdays
 Sundays
 Holidays

 then
 such action may be taken or such right may be exercised on the next succeeding Business Day.



The Company covenants that
 during the period the Warrant is outstanding
 it will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.&#160;&#160;The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of executing stock certificates to execute and issue the necessary certificates for the Warrant Shares upon the exercise of the purchase rights under this Warrant.&#160;&#160;The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation
 or of any requirements of the trading market upon which the Common Stock may be listed.&#160;&#160;The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will
 upon exercise of the purchase rights represented by this Warrant
 be duly authorized
 validly issued
 fully paid and nonassessable and free from all taxes
 liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).

Except and to the extent as waived or consented to by the Holder
 the Company shall not by any action
 including
 without limitation
 amending its certificate of incorporation or through any reorganization
 transfer of assets
 consolidation
 merger
 dissolution
 issue or sale of securities or any other voluntary action
 avoid or seek to avoid the observance or performance of any of the terms of this Warrant
 but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment.&#160;&#160;Without limiting the generality of the foregoing
 the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value
 (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations
 exemptions or consents from any public regulatory body having jurisdiction thereof
 as may be
 necessary to enable the Company to perform its obligations under this Warrant.
















Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price
 the Company shall obtain all such authorizations or exemptions thereof
 or consents thereto
 as may be necessary from any public regulatory body or bodies having jurisdiction thereof.

. All questions concerning the construction
 validity
 enforcement and interpretation of this Warrant shall be determined in accordance with the provisions of the Subscription Agreement.

.&#160;&#160;The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant
 if not registered
 will have restrictions upon resale imposed by state and federal securities laws.

.&#160;&#160;No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right or otherwise prejudice Holder&#8217;s rights
 powers or remedies
 notwithstanding the fact that all rights hereunder terminate on the Termination Date.&#160;&#160;If the Company willfully and knowingly fails to comply with any provision of this Warrant
 which results in any material damages to the Holder
 the Company shall pay to Holder such amounts as shall be sufficient to cover any costs and expenses including
 but not limited to
 reasonable attorneys&#8217; fees
 including those of appellate proceedings
 incurred by Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights
 powers or remedies hereunder.

.&#160;&#160;Any notice
 request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in accordance with the notice provisions of the Subscription Agreement.

.&#160;&#160;No provision hereof
 in the absence of any affirmative action by Holder to exercise this Warrant to purchase Warrant Shares
 and no enumeration herein of the rights or privileges of Holder
 shall give rise to any liability of Holder for the purchase price of any Common Stock or as a stockholder of the Company
 whether such liability is asserted by the Company or by creditors of the Company.

.&#160;&#160;The Holder
 in addition to being entitled to exercise all rights granted by law
 including recovery of damages
 will be entitled to specific performance of its rights under this Warrant.&#160;&#160;The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.

.&#160;&#160;Subject to applicable securities laws
 this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors of the Company and the successors and permitted assigns of Holder.&#160;&#160;The provisions of this Warrant are intended to be for the benefit of all Holders from time to time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.


















.&#160;&#160;Wherever possible
 each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law
 but if any provision of this Warrant shall be prohibited by or invalid under applicable law
 such provision shall be ineffective to the extent of such prohibition or invalidity
 without invalidating the remainder of such provisions or the remaining provisions of this Warrant.

.&#160;&#160;The headings used in this Warrant are for the convenience of reference only and shall not
 for any purpose
 be deemed a part of this Warrant.
























IN WITNESS WHEREOF
 the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.





MOJO ORGANICS
 INC.



































TO:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;MOJO ORGANICS
 INC.


The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full)
 and tenders herewith payment of the exercise price in full
 together with all applicable transfer taxes
 if any.





[&#160;&#160;] [if permitted] the cancellation of such number of Warrant Shares as is necessary
 in accordance with the formula set forth in subsection 2(c)
 to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).




















.&#160;&#160;The undersigned is an &#8220;accredited investor&#8221; as defined in Regulation D promulgated under the Securities Act of 1933
 as amended.






























(To assign the foregoing warrant
 execute








FOR VALUE RECEIVED
 [____] all of or [_______] shares of the foregoing Warrant and all rights evidenced thereby are hereby assigned to
















Dated:&#160;&#160;______________
 _______






















NOTE:&#160;&#160;The signature to this Assignment Form must correspond with the name as it appears on the face of the Warrant
 without alteration or enlargement or any change whatsoever
 and must be guaranteed by a bank or trust company.&#160;&#160;Officers of corporations and those acting in a fiduciary or other representative capacity should file proper evidence of authority to assign the foregoing Warrant.





































 shares (&#8220;Shares&#8221;) of common stock
 par value $0.001 (&#8220;Common Stock&#8221;)
 of Mojo Organics
 Inc. ( &#8220;Company&#8221;) in a private placement pursuant to the Subscription Agreement
 (&#8220;Subscription Agreement&#8221;)
 between the Company and the undersigned.&#160;&#160;Pursuant to Section 4 of the Subscription Agreement
 the Company intends to convene a special meeting of stockholders (&#8220;Meeting&#8221;) to consider an amendment (&#8220;Plan Amendment Proposal&#8221;) to the Company&#8217;s existing 2012 Long-Term Incentive Equity Plan (&#8220;Plan&#8221;) to increase the number of shares of Common Stock available for issuance under the Plan (excluding any shares already subject to award made under the Plan) to that number of shares equal to 20% of the shares of Common Stock outstanding on a fully diluted and giving effect to all shares sold in the Offering and Concurrent Offering (as each term is defined in the Subscription Agreement)
 including shares of Common Stock underlying any warrants sold therewith.&#160;&#160;The undersigned hereby represents that he/she/it has not heretofore provided any proxies or voting instructions in connection with the Shares and hereby irrevocably appoints Glenn Simpson with full power of substitution
 to vote the Shares with respect to the Plan Amendment Proposal at the Meeting and any adjournments thereof.&#160;&#160;The undersigned hereby affirms that this proxy is coupled with an interest and shall be irrevocable.
IN WITNESS WHEREOF
 the undersigned has executed this power of attorney and irrevocable proxy effective as of the date written below.







 2014




























































&#160;
 2014
 before me
 the undersigned
 personally appeared _____________________
 personally known to me or proved to me on the basis of satisfactory evidence to be the individual whose name is subscribed to the within instrument and acknowledged to me that he executed the same in his capacity
 and that by his signature on the instrument
 the individual
 or the person upon behalf of which the individual acted
 executed the instrument.


















    











NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933
 AS AMENDED (THE &#8220;SECURITIES ACT&#8221;)
 AND
 ACCORDINGLY
 MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM
 OR IN A TRANSACTION NOT SUBJECT TO
 THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT
 THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.





MOJO ORGANICS
 INC.







 2014



&#8221;) certifies that
 for value received
&#160;
&#8221;)
 is entitled
 upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth
&#8221;) but not thereafter
 to subscribe for and purchase from Mojo Organics
 Inc.
&#8221;)
&#8221;).&#160;&#160;The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price
 as defined in Section 2(b).

.&#160;&#160;Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Subscription Agreement (the &#8220;Subscription Agreement&#8221;)
 dated March 13
 2014
 among the Company and the purchaser signatory thereto.]



.&#160;&#160;Exercise of this Warrant may be made
 in whole or in part
 at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company (or such other office or agency of the Company as it may designate by notice in writing to the registered Holder at the address of the Holder appearing on the books of the Company) of a duly executed facsimile copy of the Notice of Exercise Form annexed hereto; and
 within three (3) Trading Days (as defined in Section 2(c) below) of the date said Notice of Exercise is delivered to the Company
 the Company shall have received&#160;&#160;payment of the aggregate Exercise Price of the shares thereby purchased by wire transfer or cashier&#8217;s check drawn on a United States bank.&#160;&#160;Notwithstanding anything herein to the contrary
 the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full
 in which case
 the Holder shall surrender this Warrant to the Company for cancellation within 3 Trading Days of the date the final Notice of Exercise is delivered to the Company.&#160;&#160;Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased.&#160;&#160;The Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases.&#160;&#160;The Company shall deliver any objection to any Notice of Exercise Form within two (2) Business Days of receipt of such notice.&#160;&#160;In the event of any dispute or discrepancy

 by acceptance of this Warrant
 acknowledge and agree that
 by reason of the provisions of this paragraph
 following the purchase of a portion of the Warrant Shares hereunder
 the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.
















.&#160;&#160;The exercise price per share of the Common Stock under this Warrant shall be $0.91
 subject to adjustment hereunder (the &#8220;

.&#160;&#160;This Warrant may also be exercised prior to the Termination Date by means of a &#8220;cashless exercise&#8221; in which the Holder shall be entitled to receive a certificate for the number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A)
 where:





















(B) = the Exercise Price of this Warrant
 as adjusted; and


















&#8221; shall mean any day on which the Common Stock is tradable for any period on the OTC Pink marketplace
 or on the principal securities exchange or other securities market on which the Common Stock is then being traded.




.&#160;&#160;Certificates for shares purchased hereunder shall be transmitted by the Transfer Agent to the Holder by physical delivery to the address specified by the Holder in the Notice of Exercise within 3 Trading Days from the delivery to the Company of the Notice of Exercise Form
&#8221;).&#160;&#160;This Warrant shall be deemed to have been exercised on the date the Exercise Price is received by the Company.&#160;&#160;The Warrant Shares shall be deemed to have been issued
 and Holder or any other person so designated to be named therein shall be deemed to have become a holder of record of such shares for all purposes
 as of the date the Warrant has been exercised by payment to the Company of the Exercise Price (or by cashless exercise if permitted) and all taxes required to be paid by the Holder
 if any
 pursuant to Section 2(d)(v) prior to the issuance of such shares
 have been paid.
















.&#160;&#160;If the Company fails to cause the Transfer Agent to transmit to the Holder a certificate or the certificates representing the Warrant Shares pursuant to Section 2(d)(i) by the second (2nd) day after the Warrant Share Delivery Date
 then
 the Holder will have the right to rescind such exercise.

.&#160;&#160;No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant.&#160;&#160;As to any fraction of a share which Holder would otherwise be entitled to purchase upon such exercise
 the Company shall
 at its election
 either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round up to the next whole share.

Charges

 all of which taxes and expenses shall be paid by the Company
 and such certificates shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; 
 
 that in the event certificates for Warrant Shares are to be issued in a name other than the name of the Holder
 this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require
 as a condition thereto
 the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.

.&#160;&#160;The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant
 pursuant to the terms hereof.



. If the Company
 at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which
 for avoidance of doubt
 shall not include any shares of Common Stock issued by the Company upon exercise of this Warrant)
 (ii) subdivides outstanding shares of Common Stock into a larger number of shares
 (iii) combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares or (iv) issues by reclassification of shares of the Common Stock any shares of capital stock of the Company
 then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares
 if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged.&#160;&#160;Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision
 combination or re-classification.
















. If
 at any time while this Warrant is outstanding
 (i) the Company effects any merger or consolidation of the Company with or into another Person
 (ii) the Company effects any sale of all or substantially all of its assets in one or a series of related transactions
 (iii) any exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to exchange their shares for other securities
&#8221;)
 then
 upon any subsequent exercise of this Warrant
 the Holder shall have the right to receive
 for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction
 the number of shares of Common Stock of the successor or acquiring corporation or of the Company
 if it is the surviving corporation
&#8221;) receivable as a result of such merger
 consolidation or disposition of assets by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such event. For purposes of any such exercise
 the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction
 and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.&#160;&#160;If holders of Common Stock are given any choice as to the securities
 cash or property to be received in a Fundamental Transaction
 then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.&#160;&#160;To the extent necessary to effectuate the foregoing provisions
 any successor to the Company or surviving entity in such Fundamental Transaction shall issue to the Holder a new warrant consistent with the foregoing provisions and evidencing the Holder&#8217;s right to exercise such warrant into Alternate Consideration. The terms of any agreement pursuant to which a Fundamental Transaction is effected shall include terms requiring any such successor or surviving entity to comply with the provisions of this Section 3(b) and insuring that this Warrant (or any such replacement security) will be similarly adjusted upon any subsequent transaction analogous to a Fundamental Transaction. Notwithstanding anything to the contrary
 in the event of a Fundamental Transaction that is (1) an all cash transaction
 (2) a &#8220;Rule 13e-3 transaction&#8221; as defined in Rule 13e-3 under the Exchange Act
 or (3) a Fundamental Transaction involving a person or entity not traded on a national securities exchange
 the Nasdaq Global Select Market
 the Nasdaq Global Market
 or the Nasdaq Capital Market
 the Company or any successor entity shall pay at the Holder&#8217;s option
 exercisable concurrently with the consummation of the Fundamental Transaction
 an amount of cash equal to the value of this Warrant as determined in accordance with the Black Scholes Option Pricing Model obtained from the &#8220;OV&#8221; function on Bloomberg L.P. using (A) a price per share of Common Stock equal to the lesser of (x) twice the Exercise Price and (y) the VWAP of the Common Stock for the Trading Day immediately preceding the date of consummation of the applicable&#160;&#160;Fundamental Transaction
 (B) the risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the remaining term of this Warrant as of the date of consummation of the applicable Fundamental Transaction
 (C) the lesser of (x) 50% and (y) an expected volatility equal to the 100 day volatility obtained from the &#8220;HVT&#8221; function on Bloomberg L.P. determined as of the Trading Day immediately following the public announcement of the applicable Fundamental Transaction and (D) a remaining option time equal to the time between the date of the public announcement of such transaction and the Termination Date.&#160;&#160;For purposes of clarification and notwithstanding anything to the contrary in this Agreement
 in the event of any Fundamental Transaction in which the consideration is only cash
 this Warrant shall not entitle the holder to purchase any securities of the surviving entity of such Fundamental Transaction and shall only represent the right to receive what the holder would have received had this Warrant been exercised into Warrant Shares prior to the consummation of the Fundamental Transaction.
















. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share
 as the case may be. For purposes of this Section 3
 the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares
 if any) issued and outstanding.



. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3
 the Company shall promptly mail to the Holder a notice setting forth the Exercise Price after such adjustment and setting forth a brief statement of the facts requiring such adjustment. If the Company enters into a Variable Rate Transaction
 the Company shall be deemed to have issued Common Stock or Common Stock Equivalents at the lowest possible conversion or exercise price at which such securities may be converted or exercised.
















. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock
 (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock
 (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights
 (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the Common Stock
 any consolidation or merger to which the Company is a party
 any sale or transfer of all or substantially all of the assets of the Company
 of any compulsory share exchange whereby the Common Stock is converted into other securities
 cash or property
 or (E) the Company shall authorize the voluntary or involuntary dissolution
 liquidation or winding up of the affairs of the Company
 then
 in each case
 the Company shall cause to be mailed to the Holder at its last address as it shall appear upon the Warrant Register of the Company
 at least 10 calendar days prior to the applicable record or effective date hereinafter specified
 a notice stating (x) the date on which a record is to be taken for the purpose of such dividend
 distribution
 redemption
 rights or warrants
 or if a record is not to be taken
 the date as of which the holders of the Common Stock of record to be entitled to such dividend
 distributions
 redemption
 rights or warrants are to be determined or (y) the date on which such reclassification
 consolidation
 merger
 sale
 transfer or share exchange is expected to become effective or close
 and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities
 cash or other property deliverable upon such reclassification
 consolidation
 merger
 sale
 transfer or share exchange; provided that the failure to mail such notice or any defect therein or in the mailing thereof shall not affect the validity of the corporate action required to be specified in such notice.&#160;&#160;The Holder is entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice.



.&#160;&#160;Subject to compliance with any applicable securities laws
 this Warrant and all rights hereunder (including
 without limitation
 any registration rights) are transferable
 in whole or in part
 upon surrender of this Warrant at the principal office of the Company or its designated agent
 together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer.&#160;&#160;Upon such surrender and
 if required
 such payment
 the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees
 as applicable
 and in the denomination or denominations specified in such instrument of assignment
 and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned
 and this Warrant shall promptly be cancelled.&#160;&#160;The Warrant
 if properly assigned
 may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.
















. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company
 together with a written notice specifying the names and denominations in which new Warrants are to be issued
 signed by the Holder or its agent or attorney.&#160;&#160;Subject to compliance with Section 4(a)
 as to any transfer which may be involved in such division or combination
 the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the original Issue Date and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

. The Company shall register this Warrant
&#8221;)
 in the name of the record Holder hereof from time to time.&#160;&#160;The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder
 and for all other purposes
 absent actual notice to the contrary.



&#8221;) may be redeemed
 at the option of the Company
 at any time while they are exercisable and prior to their expiration (so long as there is a current registration statement in effect with respect to the shares of Common Stock underlying the Warrants)
 upon the notice referred to in Section 5(b)
&#8221;)
 provided that the VWAP of the Common Stock equals or exceeds $5.00 per share (subject to adjustment in accordance with Section 4 hereof)
 on any twenty Trading Days during any thirty (30) consecutive Trading Day period
 such period ending on the third business day prior to the date on which notice of redemption is given.

Date Fixed for
 and Notice of

&#8221;).&#160;&#160;Notice of redemption shall be mailed by first class mail
 postage prepaid
 by the Company not less than 30 days prior to the Redemption Date to the registered holders of the Warrants to be redeemed at their last addresses as they shall appear on the registration books.&#160;&#160;Any notice mailed in the manner herein provided shall be conclusively presumed to have been duly given whether or not the registered holder received such notice.

.&#160;&#160;The Holder hereof may exercise this Warrant
 in full or in part
 for cash (or on a &#8220;cashless basis&#8221; in accordance with Section 2 of this Agreement) at any time after notice of redemption shall have been given by the Company pursuant to Section 5(b) hereof and prior to the Redemption Date.&#160;&#160;On and after the Redemption Date
 the record holder of the Warrants shall have no further rights except to receive
 upon surrender of the Warrants
 the Redemption Price.




















Loss
 Theft

 theft
 destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares
 and in case of loss
 theft or destruction
 of indemnity or security reasonably satisfactory to it (which
 in the case of the Warrant
 shall not include the posting of any bond)
 and upon surrender and cancellation of such Warrant or stock certificate
 if mutilated
 the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation
 in lieu of such Warrant or stock certificate.

Saturdays
 Sundays
 Holidays

 then
 such action may be taken or such right may be exercised on the next succeeding Business Day.



The Company covenants that
 during the period the Warrant is outstanding
 it will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.&#160;&#160;The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of executing stock certificates to execute and issue the necessary certificates for the Warrant Shares upon the exercise of the purchase rights under this Warrant.&#160;&#160;The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation
 or of any requirements of the trading market upon which the Common Stock may be listed.&#160;&#160;The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will
 upon exercise of the purchase rights represented by this Warrant
 be duly authorized
 validly issued
 fully paid and nonassessable and free from all taxes
 liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).

Except and to the extent as waived or consented to by the Holder
 the Company shall not by any action
 including
 without limitation
 amending its certificate of incorporation or through any reorganization
 transfer of assets
 consolidation
 merger
 dissolution
 issue or sale of securities or any other voluntary action
 avoid or seek to avoid the observance or performance of any of the terms of this Warrant
 but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment.&#160;&#160;Without limiting the generality of the foregoing
 the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value
 (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations
 exemptions or consents from any public regulatory body having jurisdiction thereof
 as may be
 necessary to enable the Company to perform its obligations under this Warrant.
















Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price
 the Company shall obtain all such authorizations or exemptions thereof
 or consents thereto
 as may be necessary from any public regulatory body or bodies having jurisdiction thereof.

. All questions concerning the construction
 validity
 enforcement and interpretation of this Warrant shall be governed by and construed and enforced in accordance with the internal laws of the State of New York
 without regard to the principles of conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations
 enforcement and defense of the transactions contemplated by this Warrant (whether brought against a party hereto or their respective affiliates
 directors
 officers
 shareholders
 partners
 members
 employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York
 Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein
 and hereby irrevocably waives
 and agrees not to assert in any suit
 action or proceeding
 any claim that it is not personally subject to the jurisdiction of any such court
 that such suit
 action or proceeding is improper or is an inconvenient venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit
 action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If either party shall commence an action
 suit or proceeding to enforce any provisions of this Warrant
 the prevailing party in such action
 suit or proceeding shall be reimbursed by the other party for their reasonable attorneys&#8217; fees and other costs and expenses incurred with the investigation
 preparation and prosecution of such action or proceeding.
















.&#160;&#160;The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant
 if not registered
 will have restrictions upon resale imposed by state and federal securities laws.

.&#160;&#160;No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right or otherwise prejudice Holder&#8217;s rights
 powers or remedies
 notwithstanding the fact that all rights hereunder terminate on the Termination Date.&#160;&#160;If the Company willfully and knowingly fails to comply with any provision of this Warrant
 which results in any material damages to the Holder
 the Company shall pay to Holder such amounts as shall be sufficient to cover any costs and expenses including
 but not limited to
 reasonable attorneys&#8217; fees
 including those of appellate proceedings
 incurred by Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights
 powers or remedies hereunder.

.&#160;&#160;Any notice
 request or other document required or permitted to be given or delivered to the Holder by the Company shall be in writing and shall be either delivered personally or sent by registered or certified mail
 or by private courier to the parties at their respective addresses set forth herein
 or to such other address as either shall have specified by notice in writing to the other.&#160;&#160;Notice shall be deemed duly given hereunder when delivered or mailed as provided herein..

.&#160;&#160;No provision hereof
 in the absence of any affirmative action by Holder to exercise this Warrant to purchase Warrant Shares
 and no enumeration herein of the rights or privileges of Holder
 shall give rise to any liability of Holder for the purchase price of any Common Stock or as a stockholder of the Company
 whether such liability is asserted by the Company or by creditors of the Company.

.&#160;&#160;The Holder
 in addition to being entitled to exercise all rights granted by law
 including recovery of damages
 will be entitled to specific performance of its rights under this Warrant.&#160;&#160;The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.

.&#160;&#160;Subject to applicable securities laws
 this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors of the Company and the successors and permitted assigns of Holder.&#160;&#160;The provisions of this Warrant are intended to be for the benefit of all Holders from time to time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.


















.&#160;&#160;Wherever possible
 each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law
 but if any provision of this Warrant shall be prohibited by or invalid under applicable law
 such provision shall be ineffective to the extent of such prohibition or invalidity
 without invalidating the remainder of such provisions or the remaining provisions of this Warrant.

.&#160;&#160;The headings used in this Warrant are for the convenience of reference only and shall not
 for any purpose
 be deemed a part of this Warrant.




























IN WITNESS WHEREOF
 the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.





MOJO ORGANICS
 INC.

































TO:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;MOJO ORGANICS
 INC.


The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full)
 and tenders herewith payment of the exercise price in full
 together with all applicable transfer taxes
 if any.





[ &#160;] [if permitted] the cancellation of such number of Warrant Shares as is necessary
 in accordance with the formula set forth in subsection 2(c)
 to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).


















.&#160;&#160;The undersigned is an &#8220;accredited investor&#8221; as defined in Regulation D promulgated under the Securities Act of 1933
 as amended.







Signature of Authorized Signatory of Investing Entity


























(To assign the foregoing warrant
 execute








FOR VALUE RECEIVED
 [____] all of or [_______] shares of the foregoing Warrant and all rights evidenced thereby are hereby assigned to
















Dated:&#160;&#160;______________
 _______



















NOTE:&#160;&#160;The signature to this Assignment Form must correspond with the name as it appears on the face of the Warrant
 without alteration or enlargement or any change whatsoever
 and must be guaranteed by a bank or trust company.&#160;&#160;Officers of corporations and those acting in a fiduciary or other representative capacity should file proper evidence of authority to assign the foregoing Warrant.




























    




















Mojo Organics Inc.
(&#8220;Company&#8221;)
 and the Investor hereby agree as follows:

 The Company is offering (&#8220;Offering&#8221;) up to an aggregate of 1
098
902 shares (&#8220;Shares&#8221;) of the Company&#8217;s common stock (&#8220;Common Stock&#8221;) to investors executing subscription agreements from time to time in form and substance substantially identical to this Subscription Agreement.&#160;&#160;The purchase price per share to each such investor shall be $0.91.&#160;&#160;I (sometimes referred to herein as the &#8220;Investor&#8221;) hereby subscribe for and agree to purchase _____________ Shares.&#160;&#160;The total purchase price for my Shares is $_____________.&#160;&#160;&#160;Concurrently herewith
 the Company may engage in another offering (the &#8220;Concurrent Offering&#8221;) of up to 1
101
036 shares of Common Stock
 in which investors will also receive for each share purchased one warrant to purchase one share of Common Stock at an exercise price of $0.91
 such warrants exercisable immediately

&#160;&#160;The closing on the purchase of my Shares under this subscription (the &#8220;Closing&#8221;) shall occur on the date that the Company has accepted and executed this Subscription Agreement and funds in payment therefor have been received by the Company and have cleared.&#160;&#160;The Company may hold additional Closings on additional Shares in this offering to other investors from time to time.&#160;&#160;It is acknowledged that there is no minimum amount of proceeds the Company must receive for there to be a Closing.&#160;&#160;No further Closings in this Offering shall be held after February 28
 2014; provided
 however that the Company may
 in its sole discretion
 and not withstanding anything to the contrary in this Agreement
 increase the number of Shares being sold in the Offering and extend the date for further Closings.&#160;&#160;For the avoidance of doubt
 all references to &#8220;Shares&#8221; herein include any shares of Common Stock sold upon such increase in the Offering size.

 day after Closing a registration statement on Form S-1 (or such other form as permitted by the rules and regulations of the Securities and Exchange Commission (&#8220;Commission&#8221;) registering the resale of the Investor&#8217;s Shares under the Securities Act of 1933
 as amended (&#8220;Securities Act&#8221;)
 (b) timely&#160;&#160;respond to the comments of the Commission to such registration statement and (c) have such registration statement declared effective by the Commission as soon as practicable thereafter.&#160;&#160;The Company shall use a portion of the proceeds from its sales of the Shares to fund the cost of the foregoing registration.&#160;&#160;The Investor shall timely provide the Company with any information regarding the Investor that is required for the registration statement or as otherwise reasonably requested by the Company to meet its obligations under this Section 3.

&#160;&#160;The Investor acknowledges the Company has advised Investor that it intends to amend its 2012 Long-Term Incentive Equity Plan (&#8220;Plan&#8221;) to increase the number of shares of Common Stock available for grant thereunder (excluding shares already subject to award made under the Plan) to that number of shares equal to 20% of the shares of Common Stock outstanding on a&#160;&#160;fully diluted basis and giving effect to all Shares actually sold in the Offering and the shares of Common Stock (including shares of Common Stock underlying the warrants) sold in the Concurrent Offering. Promptly following the end of the Offering
 the Company will convene a meeting of its stockholders to approve the above-described amendment to the Plan (&#8220;Stockholders Meeting&#8221;).&#160;&#160;Concurrently with the execution of this Subscription Agreement
 the Investor is executing the irrevocable proxy attached as 
























In the event that a Closing does not take place with respect to my subscription for any reason or if my subscription is otherwise rejected
 all cash proceeds delivered by me in accordance with the foregoing shall be returned to me as soon as practicable
 without interest
 offset or deduction
 and the Investor Proxy shall be destroyed or returned to me as I direct.

In the event my subscription is accepted and there is a Closing
 a certificate for the Shares for which I am subscribing will be delivered promptly to me along with a copy of a fully executed version of this Agreement.

.&#160;&#160;The Company has the right to reject this subscription for Shares
 in whole or in part
 for any reason and at any time prior to a Closing with respect to this subscription. The Shares subscribed for herein will not be deemed issued to or owned by me until a copy of this Subscription Agreement has been executed by me and accepted and countersigned by the Company
 and a Closing with respect to my subscription has occurred.



.&#160;&#160;I am an &#8220;accredited investor&#8221; as defined in Section 2(15) of the Securities Act
 and Rule 501 promulgated thereunder.&#160;&#160;I understand that the Shares are being issued to me without registration under the Securities Act in reliance upon the exemptions contained in Regulation D promulgated under the Securities Act (&#8220;Regulation D&#8221;) and applicable state securities laws.

.&#160;&#160;&#160;The Company has no obligation to me other than as set forth in this Agreement.&#160;&#160;I am aware that
 except for any rescission rights that may be provided under applicable laws
 I am not entitled to cancel
 terminate or revoke this Subscription Agreement or Investor Proxy and any agreements made in connection herewith will survive my death or disability.&#160;&#160;In order to induce the Company to issue and sell the Shares to me
 I represent and warrant that the information relating to me stated herein is true and complete as of the date hereof and will be true and complete as of the date on which my purchase of Shares becomes effective.


















.&#160;&#160;I have received no representation or warranty from the Company or any of its officers
 directors
 employees or agents in respect of my investment in the Company.&#160;&#160;I am not purchasing the Shares as a result of or subsequent to:&#160;&#160;(i) any advertisement
 article
 notice or other communication published in any newspaper
 magazine or similar media or broadcast over television
 radio or the Internet or (ii) any seminar or meeting whose attendees have been invited by any general solicitation or general advertising.

.&#160;&#160;I am aware that my purchase of Shares is a speculative investment.&#160;&#160;I acknowledge that I can lose the entire amount of my investment in the Company.&#160;&#160;I have such knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks of an investment in the Shares and have obtained
 in my judgment
 sufficient information from the Company to evaluate the merits and risks of an investment in the Company.&#160;&#160;I have not utilized any person as my purchaser representative (as defined in Regulation D) in connection with evaluating such merits and risks and have relied solely upon my own investigation in making a decision to invest in the Company. I have been urged to seek independent advice from my professional advisors relating to the suitability of an investment in the Company in view of my overall financial needs and with respect to the legal and tax implications of such investment.&#160;&#160;I believe that the investment in the Company represented by my purchase of Shares is suitable for me based upon my investment objectives and financial needs
 and I have adequate means for providing for my current financial needs and contingencies and have no need for liquidity with respect to my investment in the Company.&#160;&#160;My investment in the Company does not constitute all
 or substantially all
 of my investment portfolio.

I have also necessary authority
 approval and consent required for my delivery of this Subscription Agreement and the Investor Proxy and to fulfill my obligations hereunder and thereunder.

.&#160;&#160;Investor understands that (i) the Shares have not been registered under the Securities Act or the securities laws of any state in reliance on specific exemptions from registration and (ii) the&#160;&#160;Shares cannot be resold
 pledged
 assigned or otherwise disposed of unless they are subsequently registered under the Securities Act and under applicable securities laws of certain states
 or an exemption from such registration is available.&#160;&#160;The certificate representing the Shares will bear a restrictive legend relating to such restrictions.&#160;&#160;In addition
 Investor understands that the Company is relying on Investor&#8217;s representations and agreements for the purpose of determining whether this transaction meets the requirements of the exemptions afforded by the Securities Act and certain state securities laws.&#160;&#160;I understand the Company and its securities are not currently registered under the Exchange Act and there can be no assurance that they will be
 and as a result
 Rule 144 may not be available to me for sales or transfers of the Shares.

.&#160;&#160;Investor is acquiring the Shares for its own account for investment and not with a view to
 or for sale in connection with
 any subsequent distribution of the securities
 nor with any present intention of selling or otherwise disposing of all or any part of the Shares in violation of the Federal securities laws.

.&#160;&#160;The Company hereby represents and warrants to the Investor that the Company has all necessary corporate power and authority to enter into this Agreement and to consummate the transactions contemplated hereby.&#160;&#160;All corporate action necessary to be taken by the Company to authorize the execution
 delivery and performance of this Agreement and all other agreements and instruments delivered by the Company in connection with the transactions contemplated hereby has been duly and validly taken and this Agreement has&#160;&#160;been duly executed and delivered by the Company.&#160;&#160;Subject to the terms and conditions of this Agreement
 this Agreement constitutes the valid
 binding and enforceable obligation of the Company
 enforceable in accordance with its terms
 except as enforceability may be limited by (i) applicable bankruptcy
 insolvency
 reorganization
 moratorium
 fraudulent transfer or similar laws of general application now or hereafter in effect affecting the rights and remedies of creditors and by general principles of equity (regardless of whether enforcement is sought in a proceeding at law or in equity); and (ii) the applicability of the federal and state securities laws and public policy as to the enforceability of the indemnification provisions of this Agreement.&#160;&#160;The sale by the Company of the Shares does not conflict with the certificate of incorporation or bylaws of the Company or any material contract by which the Company or its property is bound
 or any federal or state laws or regulations or decree
 ruling or judgment of any United States or state court applicable to the Company or its property.&#160;&#160;The sale of the Shares will not trigger any pre-emptive or
 to the knowledge of the Company
 other rights held by any party and no governmental or regulatory consent is required for the consummation of the transactions contemplated by this Agreement.
















.&#160;&#160;I hereby agree to indemnify and hold harmless the Company and its officers
 directors
 stockholders
 employees
 agents
 and attorneys against any and all losses
 claims
 demands
 liabilities
 and expenses (including reasonable legal or other expenses incurred by each such person in connection with defending or investigating any such claims or liabilities
 whether or not resulting in any liability to such person or whether incurred by the indemnified party in any action or proceeding between the indemnitor and&#160;&#160;indemnified party or between the indemnified party and any third party) to which any such indemnified party may become subject
 insofar as such losses
 claims
 demands
 liabilities and expenses (a) arise out of or are based upon any untrue statement or alleged untrue statement of a material fact made by me and contained herein
 or (b) arise out of or are based upon any breach by me of any representation
 warranty
 or agreement made by me contained herein.

.&#160;&#160;In the event any parts of this Subscription Agreement are found to be void
 the remaining provisions of this Subscription Agreement are nevertheless binding with the same effect as though the void parts were deleted.

.&#160;&#160;This Subscription Agreement and Investor Proxy will be deemed to have been made and delivered in New York City and will be governed as to validity
 interpretation
 construction
 effect and in all other respects by the internal law of the State of New York.&#160;&#160;Each of the Company and the Investor hereby (i) agrees that any legal suit
 action or proceeding arising out of or relating to this Subscription Agreement or Investor Proxy will be instituted exclusively in New York State Supreme Court
 County of New York
 or in the United States District Court for the Southern District of New York
 (ii) waives any objection to the venue of any such suit
 action or proceeding and the right to assert that such forum is not a convenient forum for such suit
 action or proceeding
 (iii) irrevocably consents to the jurisdiction of the New York State Supreme Court
 County of New York
 and the United States District Court for the Southern District of New York in any such suit
 action or proceeding
 (iv) agrees to accept and acknowledge service of any and all process that may be served in any such suit
 action or proceeding in New York State Supreme Court
 County of New York or in the United States District Court for the Southern District of New York and (v) agrees that service of process upon it mailed by certified mail to its address set forth on my signature page will be deemed in every respect effective service of process upon it in any suit
 action or proceeding.

.&#160;&#160;This Subscription Agreement may be executed in one or more counterparts
 each of which will be deemed an original but all of which together will constitute one and the same instrument.&#160;&#160;The execution of this Subscription Agreement and Investor Proxy must be by actual signature.
















.&#160;&#160;This Subscription Agreement is binding upon and inures to the benefit of the parties hereto and their respective heirs
 executors
 personal representatives
 successors and assigns.

&#160;&#160;All notices
 offers
 acceptance and any other acts under this Subscription Agreement (except payment) must be in writing
 and are sufficiently given if delivered to the addressees in person
 by overnight courier service
 or
 if mailed
 postage prepaid
 by certified mail (return receipt requested)
 and will be effective three days after being placed in the mail if mailed
 or upon receipt or refusal of receipt
 if delivered personally or by courier or confirmed telecopy
 in each case addressed to a party.&#160;&#160;All communications to me should be sent to my preferred address on the signature page hereto.&#160;&#160;All communications to the Company should be sent to Mojo Organics Inc.
 101 Hudson Street
 Floor
 Jersey City
 New Jersey 07302
 Attention: Chief Executive Officer.&#160;&#160;Each party may designate another address by notice to the other parties.

.&#160;&#160;This Subscription Agreement and Investor Proxy constitute the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior oral and written agreements between the parties hereto with respect to the subject matter hereof.&#160;&#160;This Subscription Agreement may not be changed
 waived
 discharged
 or terminated orally
 but rather
 only by a statement in writing signed by the party or parties against which enforcement or the change
 waiver
 discharge or termination is sought.

.&#160;&#160;Section headings herein have been inserted for reference only and will not be deemed to limit or otherwise affect
 in any matter
 or be deemed to interpret in whole or in part
 any of the terms or provisions of this Subscription Agreement.

Survival of Representations

 warranties and agreements contained herein will survive the delivery of
 and the payment for
 the Shares.







































 2014




























MOJO ORGANICS
 INC.






















































shares (&#8220;Shares&#8221;) of common stock
 par value $0.001 (&#8220;Common Stock&#8221;)
 of Mojo Organics
 Inc. ( &#8220;Company&#8221;) in a private placement pursuant to the Subscription Agreement
 &#160;(&#8220;Subscription Agreement&#8221;)
 between the Company and the undersigned.&#160;&#160;Pursuant to Section 4 of the Subscription Agreement
 the Company intends to convene a special meeting of stockholders (&#8220;Meeting&#8221;) to consider an amendment (&#8220;Plan Amendment Proposal&#8221;) to the Company&#8217;s existing 2012 Long-Term Incentive Equity Plan (&#8220;Plan&#8221;) to increase the number of shares of Common Stock available for issuance under the Plan (excluding any shares already subject to award made under the Plan) to that number of shares equal to 20% of the shares of Common Stock outstanding on a fully diluted and giving effect to all shares sold in the Offering and Concurrent Offering (as each term is defined in the Subscription Agreement)
 including shares of Common Stock underlying any warrants sold therewith.&#160;&#160;The undersigned hereby represents that he/she/it has not heretofore provided any proxies or voting instructions in connection with the Shares and hereby irrevocably appoints Glenn Simpson with full power of substitution
 to vote the Shares with respect to the Plan Amendment Proposal at the Meeting and any adjournments thereof.&#160;&#160;The undersigned hereby affirms that this proxy is coupled with an interest and shall be irrevocable.
IN WITNESS WHEREOF
 the undersigned has executed this power of attorney and irrevocable proxy effective as of the date written below.




 
 2014























































































































 2014
 before me
 the undersigned
 personally appeared _____________________
 personally known to me or proved to me on the basis of satisfactory evidence to be the individual whose name is subscribed to the within instrument and acknowledged to me that he executed the same in his capacity
 and that by his signature on the instrument
 the individual
 or the person upon behalf of which the individual acted
 executed the instrument.






























    









UNDER THE SECURITIES EXCHANGE ACT OF 1934
 AS AMENDED





I
 Glenn Simpson
 certify that:


1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;I have reviewed this annual report on Form 10-K of Mojo Organics
 Inc.;


2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge
 this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made
 in light of the circumstances under which such statements were made
 not misleading with respect to the period covered by this report;


3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge
 the financial statements
 and other financial information included in this report
 fairly present in all material respects the financial condition
 results of operations and cash flows of the issuer as of
 and for
 the periods presented in this report;





(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures
 or caused such disclosure controls and procedures to be designed under my supervision
 to ensure that material information relating to the issuer is made known to me by others within those entities
 particularly during the period in which this report is being prepared;


(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Designed such internal control over financial reporting
 or caused such internal control over financial reporting to be designed under our supervision
 to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Evaluated the effectiveness of the issuer's disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures
 as of the end of the period covered by this report based on such evaluation; and


(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Disclosed in this report any change in the issuer's internal control over financial reporting that occurred during the issuer's most recent fiscal quarter (the issuer's fourth fiscal quarter in the case of an annual report) that has materially affected
 or is reasonably likely to materially affect
 the issuer's internal control over financial reporting; and


5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;I have disclosed
 based on my most recent evaluation of internal control over financial reporting
 to the issuer's auditors and the audit committee of the issuer's board of directors (or persons performing the equivalent functions):


(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the issuer's ability to record
 process
 summarize and report financial information; and


(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Any fraud
 whether or not material
 that involves management or other employees who have a significant role in the issuer's internal control over financial reporting.


Date: April 16
 2014








































    
















In connection with the Annual Report of Mojo Organics
 Inc. (the &#8220;Company&#8221;) on Form 10-K for the year ended December 31
 2013 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;)
 each of the undersigned
 in the capacities and on the dates indicated below
 hereby certifies pursuant to 18 U.S.C. Section 1350
 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
 that:





2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The information contained in the Report fairly presents
 in all material respects
 the financial condition and results of operation of the Company.


Date: April 16
 2014















































      


      
      




      


      
      




      


      




      


      




      

        



      




      

        



      




      

        
        



      




      

        



      




      


      




      

        



      
      




      

        
        



      
      




      

        



      
      




      

        



      
      




      

        



      




      

        
        



      




      

        



      




      

        



      
      




      

        
        



      
      




      

        



      
      




      

        
        



      
      




      

        



      
      




      

        



      




      

        
        



      




      

        



      




      

        
        



      
      




      

        
        



      
      




      

        



      
      




      

        



      
      




      


      




      


      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      




      

        



      
      




      

        



      




      

        



      




      

        



      




      

        



      
      




      

        



      
      




      

        



      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      




      

        



      




      

        



      
      




      

        



      
      




      

        



      




      

        



      




      

        



      
      




      

        



      
      




      

        



      




      

        



      




      

        



      
      




      

        



      




      

        



      




      

        



      




      

        



      




      

        



      
      




      

        



      
      




      

        



      




      

        



      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      
      




      

        



      




      

        



      




      

        



      
      




      

        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      
      




      

        



      
      




      

        
        



      
      




      

        
        



      
      




      

        
        



      




      

        
        



      
      




      

        
        



      




      

        
        



      
      




      

        
        



      
      




      

        
        



      




      

        
        



      
      




      

        
        



      
      




      

        
        



      




      

        
        



      
      



    




        


        




    


    

  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  


  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  


  
  
  
  
  
  
  
  
  
  
  
  
  

      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;NOTE 1 &amp;#8211; BUSINESS AND BASIS OF PRESENTATION&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Overview&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;MOJO Organics
 Inc. (&amp;#8220;MOJO&amp;#8221; or the &amp;#8220;Company&amp;#8221;) was incorporated in the State of Delaware on August 2
 2007.&amp;#160;&amp;#160;Headquartered in Jersey City
 NJ
 the Company engages in the product development
 production

 produced under license agreement from Chiquita Brands L.L.C. (&amp;#8220;Chiquita&amp;#8221;).&amp;#160;&amp;#160;The Company currently produces four exotic flavors: Banana Strawberry
 Mango
 Passion Fruit and Pineapple.&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;

 and is currently sold in hundreds of retail outlets and on Amazon.com.&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Basis of Presentation&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;In 2012
 the accompanying consolidated financial statements include the accounts of the Company and MOJO Organics Operating Company
 Inc.
 its formerly wholly-owned subsidiary (&amp;#8220;MOJO Operating&amp;#8221;). All significant inter-company accounts and transactions were eliminated in consolidation.&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;In 2013
 the Company determined that the assets assigned to MOJO Operating
 including the Dispensing Cap technology and Pinch sweetener
 had no economic value.&amp;#160;&amp;#160;Further
 MOJO Operating has been dormant subsequent to the 2011 split off transaction
 through which MOJO sold a portion of its business to certain of its shareholders and was deemed to be a voided entity for regulatory purposes.&amp;#160;&amp;#160;MOJO Operating will no longer be considered an entity under the Company&amp;#8217;s control for consolidation purposes.&lt;/font&gt;


      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;NOTE 2 &amp;#8211; SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Use of Estimates&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;The consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States (&quot;GAAP&quot;). Management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Cash and Cash Equivalents&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Cash equivalents include investment instruments
 CD&amp;#8217;s and time deposits purchased with a maturity of three months or less.&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Inventories&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Inventories are stated at the lower of cost (first-in
 first-out method) or market. At December 31
 2013 and 2012
 inventories consisted entirely of raw materials.&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Supplier Deposits&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Supplier Deposits consist of prepaid inventory for which the Company has not yet taken delivery.&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Property and Equipment and Depreciation&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Property and equipment are stated at cost.&amp;#160;&amp;#160;Depreciation is computed using the straight line method over the estimated useful life of the respective assets.&amp;#160;&amp;#160;Computer equipment is depreciated over a period of 3 -5 years.&amp;#160;&amp;#160;Maintenance and repairs are charged to expense when incurred.&amp;#160;&amp;#160;When property and equipment are retired or otherwise disposed of
 the related cost and accumulated depreciation are removed from the respective accounts and any gain or loss is credited or charged to income.&amp;#160;&amp;#160;At December 31
 2013 and 2012
 accumulated depreciation related to property and equipment was $1
553 and $544
 respectively.&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Revenue Recognition&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Revenues from sales of products are recognized at the time of delivery when title and risk of loss passes to the customer.&amp;#160;&amp;#160;Recognition of revenue also requires reasonable assurance of collection of sales proceeds.&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Net Loss Per Common Share&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;The Company computes per share amounts in accordance with Financial Accounting Standards Board Accounting Standards Codification (&amp;#8220;ASC&amp;#8221;) Topic 260
 &amp;#8220;&lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline&quot;&gt;Earnings per Share&lt;/font&gt;&amp;#8221;.&amp;#160;&amp;#160;ASC Topic 260 requires presentation of basic and diluted EPS.&amp;#160;&amp;#160;Basic EPS is computed by dividing the income (loss) available to common stockholders by the weighted-average number of common shares outstanding for the period.&amp;#160;&amp;#160;Diluted EPS is based on the weighted average number of shares of common stock and common stock equivalents outstanding during the periods. The conversion of Series A Preferred Stock and options was excluded from the computation of diluted shares outstanding for the year ended December 31
 2013.&amp;#160;&amp;#160;The loss for the period would have had an anti-dilutive impact on the Company&amp;#8217;s net loss per
      common share.&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block&quot;&gt;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Start-Up Costs&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;In accordance with ASC topic 720-15
 &amp;#8220;&lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline&quot;&gt;Start-Up Costs&lt;/font&gt;
&amp;#8221; the Company charges all costs associated with its start-up operations to income as incurred.&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Income Taxes&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;The Company provides for income taxes under ASC topic 740
 &amp;#8220;&lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline&quot;&gt;Income Taxes&lt;/font&gt;
&amp;#8221; which requires the use of an asset and liability approach in accounting for income taxes. Deferred tax assets and liabilities are recorded based on the differences between the financial statement and tax bases of assets and liabilities and the tax rates in effect when these differences are expected to reverse.&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;ASC 740 also requires the reduction of deferred tax assets by a valuation allowance if
 based on the weight of available evidence
 it is more likely than not that some or all of the deferred tax assets will not be realized.&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Tax returns for the years from 2009 to 2013 are subject to examination by tax authorities.&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Stock-Based Compensation&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;ASC Topic 718
 &amp;#8220;&lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline&quot;&gt;Accounting for Stock-Based Compensation&lt;/font&gt;&amp;#8221; prescribes accounting and reporting standards for all stock-based compensation plans
 including employee stock options
 restricted stock
 employee stock purchase plans and stock appreciation rights.&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;ASC Topic 718 requires employee compensation expense to be recorded using the fair value method. The Company&amp;#160;accounts for employee stock based compensation in accordance with the provisions&amp;#160;of ASC Topic 718. For non-employee options and warrants
 the company uses the fair value method as prescribed in ASC Topic 718.&lt;/font&gt;&lt;br /&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Fair value of financial instruments&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;The carrying amounts of financial instruments
 which include accounts payable
 accrued expenses and debt obligations approximate their fair values due to their short-term nature and/or variable interest rates. The Company&amp;#8217;s debt obligations bear interest at rates which approximate prevailing market rates for instruments with similar characteristics and
 accordingly
 the carrying values for these instruments approximate fair value.&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;The Company adopted ASC Topic 820
 &amp;#8220;&lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline&quot;&gt;Fair Value Measurement&lt;/font&gt;
&amp;#8221; which established a framework for measuring fair value and expands disclosure about fair value measurements.&amp;#160;&amp;#160;ASC Topic 820 defines fair value as the amount that would be received for an asset or paid to transfer a liability (i.e.
 an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC Topic 820 also establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC Topic 820 describes the following three levels of inputs that may be used:&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;100%&quot; style=&quot;FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;
        &lt;tr&gt;
          &lt;td valign=&quot;top&quot; width=&quot;3%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;3%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: symbol
 serif; FONT-SIZE: 10pt&quot;&gt;&amp;#183;&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;77%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Level 1 Unadjusted quoted prices in active markets that are accessible at the measurement date for identical

 unrestricted assets or liabilities;&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;100%&quot; style=&quot;FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;
        &lt;tr&gt;
          &lt;td valign=&quot;top&quot; width=&quot;3%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;3%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: symbol
 serif; FONT-SIZE: 10pt&quot;&gt;&amp;#183;&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;77%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Level 2 Quoted prices in markets that are not active
 or inputs that are observable
 either directly or indirectly
 for substantially the full term of the asset or liability;&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;100%&quot; style=&quot;FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;
        &lt;tr&gt;
          &lt;td valign=&quot;top&quot; width=&quot;3%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;3%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: symbol
 serif; FONT-SIZE: 10pt&quot;&gt;&amp;#183;&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;77%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Level 3 Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity).&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;The Company did not have any assets or liabilities measured at fair value on a recurring basis at December 31
 2013 or 2012. The Company did not have any fair value adjustments for assets and liabilities measured at fair value on a nonrecurring basis during the periods ended December 31
 2013 or 2012.&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;New Accounting Pronouncements&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Management does not believe that any recently issued
 but not yet effective accounting standards
 if currently adopted
 would have a material effect on the accompanying consolidated financial statements.&lt;/font&gt;&lt;br /&gt;


    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;


    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Cash equivalents include investment instruments


    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Inventories are stated at the lower of cost (first-in
 first-out method) or market. At December 31
 2013 and 2012


    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;


    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Property and equipment are stated at cost.&amp;#160;&amp;#160;Depreciation is computed using the straight line method over the estimated useful life of the respective assets.&amp;#160;&amp;#160;Computer equipment is depreciated over a period of 3 -5 years.&amp;#160;&amp;#160;Maintenance and repairs are charged to expense when incurred.&amp;#160;&amp;#160;When property and equipment are retired or otherwise disposed of
 the related cost and accumulated depreciation are removed from the respective accounts and any gain or loss is credited or charged to income.&amp;#160;&amp;#160;At December 31
 2013 and 2012
 accumulated depreciation related to property and equipment was $1
553 and $544

  
  
  
  

    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;


    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;The Company computes per share amounts in accordance with Financial Accounting Standards Board Accounting Standards Codification (&amp;#8220;ASC&amp;#8221;) Topic 260
 &amp;#8220;&lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline&quot;&gt;Earnings per Share&lt;/font&gt;&amp;#8221;.&amp;#160;&amp;#160;ASC Topic 260 requires presentation of basic and diluted EPS.&amp;#160;&amp;#160;Basic EPS is computed by dividing the income (loss) available to common stockholders by the weighted-average number of common shares outstanding for the period.&amp;#160;&amp;#160;Diluted EPS is based on the weighted average number of shares of common stock and common stock equivalents outstanding during the periods. The conversion of Series A Preferred Stock and options was excluded from the computation of diluted shares outstanding for the year ended December 31
 2013.&amp;#160;&amp;#160;The loss for the period would have had an anti-dilutive impact on the Company&amp;#8217;s net loss per


    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;In accordance with ASC topic 720-15
 &amp;#8220;&lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline&quot;&gt;Start-Up Costs&lt;/font&gt;


    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;The Company provides for income taxes under ASC topic 740
 &amp;#8220;&lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline&quot;&gt;Income Taxes&lt;/font&gt;
&amp;#8221; which requires the use of an asset and liability approach in accounting for income taxes. Deferred tax assets and liabilities are recorded based on the differences between the financial statement and tax bases of assets and liabilities and the tax rates in effect when these differences are expected to reverse.&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;ASC 740 also requires the reduction of deferred tax assets by a valuation allowance if
 based on the weight of available evidence
 it is more likely than not that some or all of the deferred tax assets will not be realized.&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;


    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;ASC Topic 718
 &amp;#8220;&lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline&quot;&gt;Accounting for Stock-Based Compensation&lt;/font&gt;&amp;#8221; prescribes accounting and reporting standards for all stock-based compensation plans
 including employee stock options
 restricted stock
 employee stock purchase plans and stock appreciation rights.&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;ASC Topic 718 requires employee compensation expense to be recorded using the fair value method. The Company&amp;#160;accounts for employee stock based compensation in accordance with the provisions&amp;#160;of ASC Topic 718. For non-employee options and warrants


    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;The carrying amounts of financial instruments
 which include accounts payable
 accrued expenses and debt obligations approximate their fair values due to their short-term nature and/or variable interest rates. The Company&amp;#8217;s debt obligations bear interest at rates which approximate prevailing market rates for instruments with similar characteristics and
 accordingly
 the carrying values for these instruments approximate fair value.&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;The Company adopted ASC Topic 820
 &amp;#8220;&lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline&quot;&gt;Fair Value Measurement&lt;/font&gt;
&amp;#8221; which established a framework for measuring fair value and expands disclosure about fair value measurements.&amp;#160;&amp;#160;ASC Topic 820 defines fair value as the amount that would be received for an asset or paid to transfer a liability (i.e.
 an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC Topic 820 also establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC Topic 820 describes the following three levels of inputs that may be used:&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;100%&quot; style=&quot;FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;
        &lt;tr&gt;
          &lt;td valign=&quot;top&quot; width=&quot;3%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;3%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: symbol
 serif; FONT-SIZE: 10pt&quot;&gt;&amp;#183;&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;77%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Level 1 Unadjusted quoted prices in active markets that are accessible at the measurement date for identical

 unrestricted assets or liabilities;&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;100%&quot; style=&quot;FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;
        &lt;tr&gt;
          &lt;td valign=&quot;top&quot; width=&quot;3%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;3%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: symbol
 serif; FONT-SIZE: 10pt&quot;&gt;&amp;#183;&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;77%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Level 2 Quoted prices in markets that are not active
 or inputs that are observable
 either directly or indirectly
 for substantially the full term of the asset or liability;&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;100%&quot; style=&quot;FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;
        &lt;tr&gt;
          &lt;td valign=&quot;top&quot; width=&quot;3%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;3%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: symbol
 serif; FONT-SIZE: 10pt&quot;&gt;&amp;#183;&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;77%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Level 3 Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity).&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;The Company did not have any assets or liabilities measured at fair value on a recurring basis at December 31
 2013 or 2012. The Company did not have any fair value adjustments for assets and liabilities measured at fair value on a nonrecurring basis during the periods ended December 31


    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Management does not believe that any recently issued
 but not yet effective accounting standards
 if currently adopted


      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;NOTE 3 - GOING CONCERN&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;The Company&apos;s financial statements are prepared using GAAP applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs and allow it to continue as a going concern. For the year ended December 31
 2013
 the Company incurred a net loss from continuing operations of $2
775
965.&amp;#160;&amp;#160;At December 31
 2013
 the Company had a working capital deficit of $75
240 and accumulated losses of $13
121
722
 which includes accumulated losses from discontinued operations of $8
576
094.&lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman&quot;&gt;&amp;#160;&lt;/font&gt;&lt;/font&gt;
      &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;The ability of the Company to continue as a going concern is dependent upon its ability to successfully obtain and retain customers in order to achieve profitable operations. The accompanying consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.&lt;/font&gt;

  
  

      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;NOTE 4 &amp;#8211; INCOME TAX&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;The Company accounts for income taxes under the assets and liability method.&amp;#160;&amp;#160;Deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry forwards.&amp;#160;&amp;#160;Deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases.&amp;#160;&amp;#160;Deferred tax assets are&amp;#160;&amp;#160;reduced by a&amp;#160;&amp;#160;valuation&amp;#160;&amp;#160;allowance&amp;#160;&amp;#160;when
&amp;#160;&amp;#160;in the opinion&amp;#160;&amp;#160;of&amp;#160;&amp;#160;management
&amp;#160;&amp;#160;it is more&amp;#160;&amp;#160;likely&amp;#160;&amp;#160;than not&amp;#160;&amp;#160;that&amp;#160;&amp;#160;some portion or all of the deferred&amp;#160;&amp;#160;tax assets will not be realized.&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;The reconciliation of income taxes at the statutory rate of 34% to the provision for income taxes recorded in the Consolidated Statements of Operations is as follows:&lt;/font&gt;&lt;br /&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;75%&quot; style=&quot;FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;
          &lt;tr&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td colspan=&quot;6&quot; valign=&quot;bottom&quot; width=&quot;26%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;Year ended December 31
&lt;/font&gt;
              &lt;/div&gt;
            &lt;/td&gt;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;2013&lt;/font&gt;
              &lt;/div&gt;
            &lt;/td&gt;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;2012&lt;/font&gt;
              &lt;/div&gt;
            &lt;/td&gt;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style=&quot;background-color: #CCEEFF;&quot;&gt;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;47%&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Tax benefit at federal statutory rate&lt;/font&gt;
              &lt;/div&gt;
            &lt;/td&gt;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;34.0&lt;/font&gt;
            &lt;/td&gt;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;
            &lt;/td&gt;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;34.0&lt;/font&gt;
            &lt;/td&gt;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;
            &lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr&gt;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;47%&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;State tax expense
 net of federal benefit&lt;/font&gt;
              &lt;/div&gt;
            &lt;/td&gt;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;5.6&lt;/font&gt;
            &lt;/td&gt;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;5.6&lt;/font&gt;
            &lt;/td&gt;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style=&quot;background-color: #CCEEFF;&quot;&gt;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;47%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Change in valuation allowance&lt;/font&gt;
              &lt;/div&gt;
            &lt;/td&gt;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(39.6&lt;/font&gt;
            &lt;/td&gt;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;
            &lt;/td&gt;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(39.6&lt;/font&gt;
            &lt;/td&gt;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;
            &lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr&gt;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;47%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Effective tax rate&lt;/font&gt;
              &lt;/div&gt;
            &lt;/td&gt;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
            &lt;/td&gt;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
            &lt;/td&gt;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
          &lt;/tr&gt;
        &lt;/table&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;The reported provision for income tax differs from the amount computed by applying the statutory income tax rates to the loss before income tax as follows:&lt;/font&gt;
      &lt;/div&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;75%&quot; style=&quot;FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;
        &lt;tr&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td colspan=&quot;6&quot; valign=&quot;bottom&quot; width=&quot;26%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;Year ended December 31
&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;12%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;2013&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;12%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;2012&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style=&quot;background-color: #CCEEFF;&quot;&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;47%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Income tax expense at statutory rate&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align=&quot;right&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(1
099
282&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;
          &lt;/td&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(635
053&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;47%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Valuation allowance&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1
099
282&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;635
053&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style=&quot;background-color: #CCEEFF;&quot;&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;47%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Income tax expense&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Net deferred tax assets consist of the following components:&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;75%&quot; style=&quot;FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;
        &lt;tr&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td colspan=&quot;6&quot; valign=&quot;bottom&quot; width=&quot;26%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;As of December 31
&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;2013&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;2012&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style=&quot;background-color: #CCEEFF;&quot;&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;47%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Restricted Common Stock issued to directors and employees&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align=&quot;right&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;329
923&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td align=&quot;right&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;440
740&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;47%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Share-based compensation &amp;#8211; stock options&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align=&quot;right&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;20
084&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style=&quot;background-color: #CCEEFF;&quot;&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;47%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Net operating loss carryover&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align=&quot;right&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1
384
328&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;194
313&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;47%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Valuation allowance&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align=&quot;right&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(1
734
335&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;
          &lt;/td&gt;
          &lt;td align=&quot;right&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(635
053&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style=&quot;background-color: #CCEEFF;&quot;&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;47%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Net deferred tax asset&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;An income tax benefit has not been recognized for operating losses generated in prior periods based on uncertainties concerning the ability to generate taxable income in future periods.&amp;#160;&amp;#160;At December 31
 2013
 the Company had available net operating loss carry-forwards of approximately $3
986
000 which expire in various years through the year ending December 31
 2033.&amp;#160;&amp;#160;Utilization of the tax loss carry-forwards are not assured
 however
 because the Company has incurred significant operating losses.&amp;#160; As a result
 the deferred income tax asset arising from these net operating loss carry-forwards and from other temporary differences are not recorded in the accompanying Consolidated Balance Sheets.&amp;#160;&amp;#160;Due to the uncertainty of the Company&amp;#8217;s realization of this benefit
 a valuation allowance was established to fully reserve such assets.&lt;/font&gt;&lt;br /&gt;

  
  

    &lt;br /&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;75%&quot; style=&quot;FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;
          &lt;tr&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td colspan=&quot;6&quot; valign=&quot;bottom&quot; width=&quot;26%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;Year ended December 31
&lt;/font&gt;
              &lt;/div&gt;
            &lt;/td&gt;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;2013&lt;/font&gt;
              &lt;/div&gt;
            &lt;/td&gt;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;2012&lt;/font&gt;
              &lt;/div&gt;
            &lt;/td&gt;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style=&quot;background-color: #CCEEFF;&quot;&gt;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;47%&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Tax benefit at federal statutory rate&lt;/font&gt;
              &lt;/div&gt;
            &lt;/td&gt;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;34.0&lt;/font&gt;
            &lt;/td&gt;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;
            &lt;/td&gt;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;34.0&lt;/font&gt;
            &lt;/td&gt;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;
            &lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr&gt;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;47%&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;State tax expense
 net of federal benefit&lt;/font&gt;
              &lt;/div&gt;
            &lt;/td&gt;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;5.6&lt;/font&gt;
            &lt;/td&gt;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;5.6&lt;/font&gt;
            &lt;/td&gt;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style=&quot;background-color: #CCEEFF;&quot;&gt;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;47%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Change in valuation allowance&lt;/font&gt;
              &lt;/div&gt;
            &lt;/td&gt;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(39.6&lt;/font&gt;
            &lt;/td&gt;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;
            &lt;/td&gt;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(39.6&lt;/font&gt;
            &lt;/td&gt;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;
            &lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr&gt;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;47%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Effective tax rate&lt;/font&gt;
              &lt;/div&gt;
            &lt;/td&gt;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
            &lt;/td&gt;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
            &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
            &lt;/td&gt;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
            &lt;/td&gt;
          &lt;/tr&gt;
        &lt;/table&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;75%&quot; style=&quot;FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;
        &lt;tr&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td colspan=&quot;6&quot; valign=&quot;bottom&quot; width=&quot;26%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;Year ended December 31
&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;12%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;2013&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;12%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;2012&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style=&quot;background-color: #CCEEFF;&quot;&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;47%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Income tax expense at statutory rate&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align=&quot;right&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(1
099
282&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;
          &lt;/td&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(635
053&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;47%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Valuation allowance&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1
099
282&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;635
053&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style=&quot;background-color: #CCEEFF;&quot;&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;47%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Income tax expense&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;

  
  
  
  
  
  
  
  
  
  
  
  


    &lt;br /&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;75%&quot; style=&quot;FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;
        &lt;tr&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td colspan=&quot;6&quot; valign=&quot;bottom&quot; width=&quot;26%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;As of December 31
&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;2013&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;2012&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style=&quot;background-color: #CCEEFF;&quot;&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;47%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Restricted Common Stock issued to directors and employees&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align=&quot;right&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;329
923&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td align=&quot;right&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;440
740&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;47%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Share-based compensation &amp;#8211; stock options&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align=&quot;right&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;20
084&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style=&quot;background-color: #CCEEFF;&quot;&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;47%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Net operating loss carryover&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align=&quot;right&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1
384
328&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;194
313&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;47%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Valuation allowance&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align=&quot;right&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(1
734
335&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;
          &lt;/td&gt;
          &lt;td align=&quot;right&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(635
053&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style=&quot;background-color: #CCEEFF;&quot;&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;47%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Net deferred tax asset&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;

  
  
  
  
  
  
  
  
  
  

      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;NOTE 5 &amp;#8211; COMMITMENTS AND CONTINGENCIES&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Lease Commitment&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;The Company entered into an office service agreement for office space for a term of 12 months effective April 16
 2012.&amp;#160;&amp;#160;The base monthly office fee under that agreement was $2
899.&amp;#160;&amp;#160;Subsequent to April 2013
 the Company rented its office space on a month to month basis.&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Licensing Agreement&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
        &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;On August 15
 2012
 the Company entered into a license agreement (&amp;#8220;License Agreement&amp;#8221;) for the use of a third party&amp;#8217;s marks in the manufacture
 sale
 promotion
 marketing
 advertising and distribution of certain fruit juice products in select containers. The License Agreement grants the Company an exclusive license in Connecticut
 New Jersey and New York and a non-exclusive license for the other states in the United States
 plus Costa Rica
 El Salvador
 Guatemala
 Honduras and Nicaragua. The term of the License Agreement is for seven years from July 2013 (the date that the Company first invoiced customers for products sold under the License Agreement)
 subject to the Company meeting certain minimum sales volume and/or minimum royalty payments. Termination of the License Agreement could have a material and adverse impact on the Company&amp;#8217;s business. &amp;#160;During the year ended
        December 31
 2013
 the accrued royalty payment due to the third party was $184
240.&amp;#160;&amp;#160;Future minimum royalty payments (in thousands) are $691 for 2014
 $1
265 for 2015
 $1
850 for 2016
 $2
611 for 2017 and $11
617 for 2018 to 2020.&amp;#160;&lt;/font&gt;

  
  


  
  
  
  
  
  
  

      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;NOTE 6 &amp;#8211; STOCKHOLDERS&amp;#8217; DEFICIT&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;The Company has authorized 10
000
000 shares of preferred stock (&amp;#8220;Preferred Stock&amp;#8221;) and 190
000
000 shares of common stock (&amp;#8220;Common Stock&amp;#8221;)
 each having a par value of $0.001.&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 7.7pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline&quot;&gt;Stock Splits&lt;/font&gt;&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;On April 1
 2013
 the Company effected a one-for-ten reverse stock split of the issued and outstanding shares of Common Stock (the &amp;#8220;Reverse Split&amp;#8221;).&amp;#160;The number of authorized shares and the par value of the Common Stock were not changed.&amp;#160;&amp;#160;The accompanying financial statements have been restated to reflect this reverse stock split.&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Private Placement Offering&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;On May 1
 2013
 the Company commenced a private placement offering of up to 1
250
000 shares of its Common Stock (the &amp;#8220;Private Placement&amp;#8221;) at a price of $0.40 per share pursuant to subscription agreements entered into with each investor.&amp;#160;&amp;#160;As of June 18
 2013
 the last date of the offering
 1
171
705 shares of Common Stock were sold
 raising an aggregate of $468
681
 which amount included $20
000 of notes outstanding.&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Stock Incentive Plans&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;In March 2013
 the Company approved the 2012 Long-Term Incentive Equity Plan (the &amp;#8220;2012 Plan&amp;#8221;)
 which provides the Company with the ability to issue stock options
 stock appreciation rights
 restricted stock and/or other stock based awards for up to an aggregate of 2
050
000 shares of Common Stock.&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Restricted Stock Compensation&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;During the years ended December 31
 2013 and 2012
 the Company issued shares of restricted Common Stock to certain of its directors
 executive officers and employees.&amp;#160;&amp;#160;Unvested restricted shares are subject to forfeiture.&amp;#160;&amp;#160;With the exception of 1
165
251 shares which vest based upon achieving certain milestones
 the Company records compensation expense over the vesting period based upon the fair market value on the date of grant for each share
 adjusted for forfeitures.&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;A summary of the restricted stock issuances to directors
 executive officers and employees is as follows:&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;75%&quot; style=&quot;FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;
        &lt;tr&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block&quot;&gt;
              &amp;#160;
            &lt;/div&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;Number of Shares&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;Weighted Average&lt;/font&gt;
            &lt;/div&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;Grant Date Fair Value&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style=&quot;background-color: #CCEEFF;&quot;&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Unvested share balance
 January 1
 2012&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&amp;#160;&amp;#160;Granted&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align=&quot;right&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;4
553
516&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1.35&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style=&quot;background-color: #CCEEFF;&quot;&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&amp;#160;&amp;#160;Vested&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align=&quot;right&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(100
000&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1.30&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&amp;#160;&amp;#160;Forfeited&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style=&quot;background-color: #CCEEFF;&quot;&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Unvested share balance
 December 31
 2012&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align=&quot;right&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;4
453
516&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1.35&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&amp;#160;&amp;#160;Granted&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align=&quot;right&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;608
441&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2.15&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style=&quot;background-color: #CCEEFF;&quot;&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&amp;#160;&amp;#160;Vested&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align=&quot;right&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(88
309&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1.40&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&amp;#160;&amp;#160;Forfeited&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align=&quot;right&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(183
240&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1.40&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style=&quot;background-color: #CCEEFF;&quot;&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Unvested share balance
 December 31
 2013&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align=&quot;right&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;4
790
408&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1.45&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;In connection with the issuance of restricted stock
 the Company recorded share-based compensation expense of $883
139 and $1
112
981 for the years ended December 31
 2013 and 2012
 respectively.&amp;#160;&amp;#160;As of December 31
 2013
 there was $4
961
202 of total unrecognized compensation cost
 net of estimated forfeitures
 related to unvested share-based compensation.&amp;#160;&amp;#160;That cost is expected to be recognized during the years 2014 through 2016.&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Advisory Services&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;On November 28
 2012
 the Company entered into an agreement with an advisor to provide strategic business advisory services and assist the Company with networking and capital formation. As compensation for these services
 the Company agreed to the issuance of 500
000 shares of Common Stock
 50% of which was issuable upon execution of the agreement and 50% of which was issuable upon the six month anniversary of the execution of the advisor agreement.&amp;#160;&amp;#160;Accordingly
 the Company issued 250
000 shares of Common Stock. The value of the stock issued was recorded in 2012
 resulting in an expense of $157
500.&amp;#160;&amp;#160;This advisory services agreement has since been terminated and the&amp;#160;remaining 250
000 shares have not been
 and will not be
 issued.&amp;#160;&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;On October 3
 2013
 the Company entered into an advisor agreement whereby the Company would receive strategic business advisory services
 distributorship advisory services
 sales and sales channel advisory services and investor relation advisory services in exchange for the issuance of 50
000 shares of restricted Common Stock.&amp;#160;&amp;#160;The Common Stock vests six months from the date of the agreement.&amp;#160;&amp;#160;In connection with this issuance
 the Company recorded $75
000 in consulting fees during the year ended December 31
 2013
 and will record an additional $75
000 in fees in 2014.&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Also on October 3
 2013
 the Company entered into an agreement for strategic business advisory services
 public relations services and investor relations services.&amp;#160;&amp;#160;In connection with this agreement
 the Company issued 167
204 shares of restricted Common Stock and recorded consulting fees of $501
612 during 2013.&amp;#160;&amp;#160;The stock is fully vested. The advisor was also issued an additional 200
000 shares of restricted Common Stock
 which will vest quarterly based upon the Company reaching certain market capitalization and revenue goals.&amp;#160;&amp;#160;Should the Company not reach these goals
 the additional shares will be forfeited.&amp;#160;&amp;#160;The goals were met for the first two quarters.&amp;#160;&amp;#160;As a result
 100
000 of the additional 200
000 shares vested in 2013
 and the Company recorded $280
000 in consulting fees in connection with this vesting.&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;During the year ended December 31
 2013
 the Company issued 35
000 shares of Common Stock to two firms who provided legal services to the Company in lieu of cash.&amp;#160;&amp;#160;Also during 2013
 the Company entered into an agreement with a consultant whereby the Company would issue stock for services in lieu of cash.&amp;#160;&amp;#160;The number of shares issued is calculated monthly and based upon the last sales price of the Common Stock for the month.&amp;#160;&amp;#160;The number of shares issued for the year ended December 31
 2013 was 11
263.&lt;/font&gt;

  
  
  
  
  
  
  
  
  
  
  
  

000 shares of Common Stock

  
  

000 shares have not been
 and will not be

  
  
  
  
  
  
  
  
  
  
  
  

 executive officers and employees is as follows:&lt;br /&gt;
    &lt;br /&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;75%&quot; style=&quot;FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;
        &lt;tr&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block&quot;&gt;
              &amp;#160;
            &lt;/div&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;Number of Shares&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;Weighted Average&lt;/font&gt;
            &lt;/div&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;Grant Date Fair Value&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style=&quot;background-color: #CCEEFF;&quot;&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Unvested share balance
 January 1
 2012&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&amp;#160;&amp;#160;Granted&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align=&quot;right&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;4
553
516&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1.35&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style=&quot;background-color: #CCEEFF;&quot;&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&amp;#160;&amp;#160;Vested&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align=&quot;right&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(100
000&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1.30&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&amp;#160;&amp;#160;Forfeited&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style=&quot;background-color: #CCEEFF;&quot;&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Unvested share balance
 December 31
 2012&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align=&quot;right&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;4
453
516&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1.35&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&amp;#160;&amp;#160;Granted&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align=&quot;right&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;608
441&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2.15&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style=&quot;background-color: #CCEEFF;&quot;&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&amp;#160;&amp;#160;Vested&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align=&quot;right&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(88
309&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1.40&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&amp;#160;&amp;#160;Forfeited&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align=&quot;right&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(183
240&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1.40&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style=&quot;background-color: #CCEEFF;&quot;&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;justify&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Unvested share balance
 December 31
 2013&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align=&quot;right&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;4
790
408&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1.45&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;

  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  

      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;&lt;font style=&quot;DISPLAY: inline; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&lt;font style=&quot;DISPLAY: inline; FONT-WEIGHT: bold&quot;&gt;NOTE&amp;#160;7 &amp;#8211; STOCK OPTIONS&lt;/font&gt;&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Stock Incentive Plans&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;In July 2013
 the Company granted certain directors and employees of the Company stock options pursuant to the 2012 Plan to purchase 210
000 shares of Common Stock at an exercise price of $2.07 per share
 which was 115% of the last sale price of the Common Stock on the date of grant. The options become exercisable in July 2014 and expire in July 2015. In connection with the stock option issuances
 compensation expense of&amp;#160;$50
717 was recorded during the year ended December 31
 2013.&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;The following table summarizes stock option activity under the Plans:&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;75%&quot; style=&quot;FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;
        &lt;tr&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;33%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;Number&amp;#160;of&lt;/font&gt;
            &lt;/div&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;shares&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;Weighted-&lt;/font&gt;
            &lt;/div&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;average&lt;/font&gt;
            &lt;/div&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;exercise&lt;/font&gt;
            &lt;/div&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;price&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;Weighted-average&lt;/font&gt;
            &lt;/div&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;remaining&lt;/font&gt;
            &lt;/div&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;contractual&amp;#160;term&lt;/font&gt;
            &lt;/div&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;(in&amp;#160;years)&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style=&quot;background-color: #CCEEFF;&quot;&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;33%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Outstanding at December 31
 2012&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;11%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;33%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Granted&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;11%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;right&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;210
000&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;11%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;right&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2.07&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;11%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style=&quot;background-color: #CCEEFF;&quot;&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;33%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Forfeited&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;11%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;11%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;11%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;33%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Outstanding at December 31
 2013&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;right&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;210
000&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;right&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2.07&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;11%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;right&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;0.75&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style=&quot;background-color: #CCEEFF;&quot;&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;33%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Exercisable at December 31
 2013&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;11%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;11%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;11%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;As of December 31
 2013
 there was $50
717&amp;#160;of total unrecognized compensation cost related to non-vested stock options. That cost will be recognized ratably over the first two quarters of 2014.&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Aggregate intrinsic value of options outstanding and exercisable at December 31
 2013 and 2012 was $90
300 and $0
 respectively.&amp;#160;&amp;#160;Aggregate intrinsic value represents the difference between the Company&apos;s closing stock price on the last trading day of the fiscal period
 which was&amp;#160;$2.50 and $0.70 as of December 31
 2013 and 2012
 respectively
 and the exercise price multiplied by the number of options outstanding.&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;The following table summarizes weighted-average assumptions using the Black-Scholes option-pricing model used on the date of the grants issued for the years ended December 31
 2013 and 2012:&amp;#160;&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;75%&quot; style=&quot;FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;
        &lt;tr&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;47%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td colspan=&quot;6&quot; valign=&quot;bottom&quot; width=&quot;26%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;December 31
&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;47%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;2013&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;2012&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style=&quot;background-color: #CCEEFF;&quot;&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Volatility&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;right&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;81&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;right&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Expected term (years)&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;right&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;right&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style=&quot;background-color: #CCEEFF;&quot;&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Risk-free interest rate&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;right&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;0.15&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;right&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Dividend yield&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;right&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;0&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;right&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;The exercise price grant dates in relation to the market price during 2013 and 2012 are as follows:&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;75%&quot; style=&quot;FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;
        &lt;tr&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;47%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;2013&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;2012&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style=&quot;background-color: #CCEEFF;&quot;&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Exercise price lower than market price&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style=&quot;background-color: #CCEEFF;&quot;&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Exercise price equal to market price&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style=&quot;background-color: #CCEEFF;&quot;&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Exercise price exceeded market price&lt;/font&gt;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2.07&lt;/font&gt;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;

  
  
  
  
  
  
  
  
  
  
  
  

    &lt;br /&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;75%&quot; style=&quot;FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;
        &lt;tr&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;33%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;Number&amp;#160;of&lt;/font&gt;
            &lt;/div&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;shares&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;Weighted-&lt;/font&gt;
            &lt;/div&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;average&lt;/font&gt;
            &lt;/div&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;exercise&lt;/font&gt;
            &lt;/div&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;price&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;Weighted-average&lt;/font&gt;
            &lt;/div&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;remaining&lt;/font&gt;
            &lt;/div&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;contractual&amp;#160;term&lt;/font&gt;
            &lt;/div&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;(in&amp;#160;years)&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align=&quot;left&quot; valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style=&quot;background-color: #CCEEFF;&quot;&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;33%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Outstanding at December 31
 2012&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;11%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;33%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Granted&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;11%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;right&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;210
000&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;11%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;right&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2.07&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;11%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style=&quot;background-color: #CCEEFF;&quot;&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;33%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Forfeited&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;11%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;11%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;11%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;33%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Outstanding at December 31
 2013&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;right&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;210
000&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;11%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;right&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2.07&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;11%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;right&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;0.75&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style=&quot;background-color: #CCEEFF;&quot;&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;33%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Exercisable at December 31
 2013&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;11%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;11%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;11%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;top&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;

  
  
  
  
  
  
  
  
  
  
  

 2013 and 2012:&lt;br /&gt;
    &lt;br /&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;75%&quot; style=&quot;FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;
        &lt;tr&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;47%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td colspan=&quot;6&quot; valign=&quot;bottom&quot; width=&quot;26%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;December 31
&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;47%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;2013&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;2012&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style=&quot;background-color: #CCEEFF;&quot;&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Volatility&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;right&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;81&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;right&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Expected term (years)&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;right&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;right&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style=&quot;background-color: #CCEEFF;&quot;&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Risk-free interest rate&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;right&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;0.15&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;right&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Dividend yield&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;right&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;0&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;right&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;

  
  
  
  
  
  
  
  

    &lt;br /&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;75%&quot; style=&quot;FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;
        &lt;tr&gt;
          &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;47%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;2013&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;center&quot;&gt;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;2012&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style=&quot;background-color: #CCEEFF;&quot;&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Exercise price lower than market price&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style=&quot;background-color: #CCEEFF;&quot;&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot;&gt;
            &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
              &lt;div style=&quot;TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Exercise price equal to market price&lt;/font&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style=&quot;background-color: #CCEEFF;&quot;&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;47%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Exercise price exceeded market price&lt;/font&gt;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2.07&lt;/font&gt;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
          &lt;td valign=&quot;bottom&quot; width=&quot;11%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;
          &lt;/td&gt;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;
          &lt;/td&gt;
        &lt;/tr&gt;





  


      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;NOTE 8 &amp;#8211; SERIES A CONVERTIBLE PREFERRED STOCK&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;On January 12
 2013
 the Company entered into an amended and restated securities purchase agreement for the offer and sale of its Series A Convertible Preferred Stock
 par value $0.001 (&amp;#8220;Series A Preferred Stock&amp;#8221;) at a price of $4.00 per share.&amp;#160;&amp;#160;In connection with the private sale of its Series A Preferred Stock
 the Company raised gross proceeds of $790
834
 including $378
700 from the conversion of promissory notes.&amp;#160;&amp;#160;Each share of Series A Preferred Stock was convertible into 10 shares of the Company&amp;#8217;s Common Stock determined by dividing $4.00 by the conversion price of $0.40.&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;The Series A Preferred Stock includes embedded anti-dilutive provisions that meet the defined criteria of a derivative liability as described in ASC Topic 815
 &amp;#8220;&lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline&quot;&gt;Derivatives and Hedging&lt;/font&gt;
&amp;#8221; and therefore require bifurcation.&amp;#160;&amp;#160;These embedded derivatives include certain conversion features indexed to the Company&apos;s Common Stock. The accounting treatment of derivative financial instruments requires that the Company record the derivatives and related items at their fair values as of the date of issue and at fair value as of each subsequent balance sheet date.&amp;#160;&amp;#160;&amp;#160;Changes in the fair value are charged to income at the end of each reporting period.&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;During the year ended December 31
 2013
 a total of 197
708.5 shares of the Series A Preferred Stock had been converted into 1
977
085 shares of Common Stock. As of December 31
 2013 and 2012
 there were zero shares of Series A Preferred Stock issued and outstanding.&lt;/font&gt;

  
  
  
  
  
  
  
  
  
  
  

      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;NOTE 9 &amp;#8211; RELATED PARTY TRANSACTIONS&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;During the year ended December 31
 2012
 various expenses of the Company
 including advances for operating purposes
 were paid for or made by officers and shareholders of the Company. As of December 31
 2012
 amounts due to related parties totaled $187
500 in notes payable. In January 2013
 the Company received an additional advance of $50
000.&amp;#160;&amp;#160;The notes bore interest at rates varying between 8% and 10% and were due on September 15
 2013.&amp;#160;&amp;#160;&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;The notes contained a conversion feature which allowed the holders
 at their sole discretion
 to convert some or all of the principal amount of their note outstanding into equity or debt securities issued by the Company in connection with any offering made by the Company during the period that the principal amount of the note was outstanding.&amp;#160;&amp;#160;The conversion terms would be identical to the offering terms.&amp;#160;&amp;#160;On January 31
 2013
 the balance of notes outstanding of $237
500 was converted into 59
375 shares of Series A Preferred Stock.&amp;#160;&amp;#160;Accrued interest of $7
261 was paid to the holders of the notes.&amp;#160;&amp;#160;Interest expense of $1
658 and $5
603 was charged to operations for the years ended December 31
 2013 and 2012
 respectively.&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;During the year ended December 31
 2013
 the Company issued 42
714 shares of Common Stock to employees in lieu of cash
 equivalent to $100
692.&amp;#160;&amp;#160;In addition
 accrued salary amounting to $141
200 and $20
000 was converted into 35
300 shares of Series A Preferred Stock and 50
000 shares of Common Stock as part of the Private Placement
 respectively.&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;In December 2013
 the Company received $24
000 in non-interest bearing
 demand loans from certain related parties.&amp;#160;&amp;#160;The loans were repaid in full by February 2014.&lt;/font&gt;

  
  
  
  
  

 at their sole discretion

  
  
  
  
  
  
  
  
  
  
  

      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;NOTE 10 &amp;#8211; SUBSEQUENT EVENTS&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;In accordance with ASC Topic 855
 &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline&quot;&gt;&amp;#8220;Subsequent Events
&amp;#8221;&lt;/font&gt; the Company evaluates events and transactions that occur after the balance sheet date for potential recognition in the consolidated financial statements. The effects of all subsequent events that provide additional evidence of conditions that existed at the balance sheet date are recognized in the consolidated financial statements as of December 31
 2013. In preparing these consolidated financial statements
 the Company evaluated the events and transactions that occurred through the date these consolidated financial statements were issued.&amp;#160;&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;In March 2014
 the Company consummated two concurrent private placement offerings
 receiving an aggregate of $1
835
000 from accredited investors.&amp;#160;&amp;#160;In one of the offerings
 the Company sold an aggregate of 917
583 shares of Common Stock for $0.91 per share for a total of $835
000.&amp;#160;&amp;#160;For each share purchased in this offering
 investors received an immediately exercisable
 five-year warrant to purchase one share of Common Stock at a price of $0.91 per share.&amp;#160;&amp;#160;In the concurrent offering
 the Company sold 1
098
901 shares of Common Stock for $0.91 per share for a total of $1
000
000.&amp;#160;&amp;#160;The investor in the concurrent offering did not acquire warrants.&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;The Company issued an aggregate of 465
000 shares of Common Stock pursuant to the 2012 Plan to its employees and directors in March 2014.&amp;#160;&amp;#160;The shares are subject to a restricted stock agreement
 pursuant to which the shares will vest one year from the date of such agreement if the grantee is an employee or director (as applicable) of the Company at the time.&amp;#160;&amp;#160;As part of the compensation package for a newly appointed director
 the Company issued to an affiliate of such director warrants to purchase 183
454 shares of Common Stock
 exercisable for a period of five years from the date of issuance at a price of $0.91 per share.&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;The Company issued 23
272 shares of Common Stock to its chief executive officer as payment of salary due for January and February 2014 in lieu of cash.&amp;#160;&amp;#160;The shares were valued by the Company at the closing price of the Company&amp;#8217;s Common Stock on the last trading day of the applicable month for which payment was due.&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Also in March 2014
 the Company issued warrants to purchase 13
740 shares of Common Stock at a price of $0.91 per share as well as 82
418 shares of Common Stock for advisory services.&amp;#160;&amp;#160;The warrants are exercisable for five years from the date of issuance.&lt;/font&gt;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Finally in March 2014
 the Company entered into two agreements pursuant to which the Company will receive advisory services related to strategy
 distributorship
 sales and sales channels and investor relations.&amp;#160;&amp;#160;The Company granted to each advisor 100
000 shares of restricted Common Stock
 subject to forfeiture if the advisor terminates or materially breaches the agreement before the six-month anniversary thereof.&amp;#160;&amp;#160;The aggregate value of the advisory fees of $260
000 was calculated based upon the closing price of the Company&amp;#8217;s Common Stock on the date of the agreement.&amp;#160;&amp;#160;This amount will be charged to income ratably over the six month vesting period.&lt;/font&gt;

  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  

000 shares of restricted Common Stock

  
  





















        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        




        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        





        
        
        


        
        
        
        



 Stock Options

        
        
        



 Stock Options

        
        
        



 Stock Options

        
        
        


        
        
        
        


        
        
        
        


        
        
        
        


        
        
        
        















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































    


    


    


    


    

    


    


    


    


    

    


    


    


    


    


    


    


    


    






    


    


    

    


    


    


    





    


    


    






    

    


    


    


    

    


    

    


    


    


    


    


    

    



 10
000




 190
000
000 shares authorized at $0.001 par value
 12
631
485 and 8
551
265 shares issued and outstanding



    


    


    


    


























    


    


    

    

    


    

    


    

    










    


    


    


    

    


    

    


    

    


    

    


    


    


    


    


    


    


    


    


    


    

    


    

    


    


    


    


    

    


    

    


    

    


    


    


    


    


    


    


    


    

    


    


    


    

    


    


    


    


    


    

    

    


    

    


    


    


    

    


    


    


    






    


    


    

    


    

    


    


    


    


    


    


    










    


    


    


    


    


    














    



 Plant and Equipment






























    

    


    


    






    



 Stock Options




 Stock Options



 Stock Options



    

    


    






    


    


    


    

    


    

    


    


    


    


    


    









    










    

    


    

    


    


    


    


    


    


    



 Stock Options



 Stock Options



    



 Stock Options




 Stock Options











    


    


    


    





















 Stock Options



 Stock Options



    


    


    


    



 Stock Options



 Stock Options




 Shares Authorized under Stock Option Plans




 Stock Options




 Stock Options



    

    


    


    


    



 Plant and Equipment




 Depletion and Amortization
 Property
 Plant


    


    

    


    

    

    


 at Federal Statutory Income Tax Rate



    






    


    


    


    



 Rent Expense







    


    



 Future Minimum Payments Due


















    


 personal
 or intellectual.  Almost always


    

    

    

    

    


    


    


    


    


    


















    






 Shares


    


 Original Debt










    



 Nonvested Awards







 Shares



 Value
















 Shares
 Restricted Stock Award



 Equity Instruments Other than Options




 Value
 Restricted Stock Award




    







    

    

    

    


    


    


 Options
 Grants in Period



 Options
 Grants in Period














    



 Nonvested Awards
 Compensation Not yet Recognized




 Nonvested Awards
 Compensation Cost Not yet Recognized




 Options
 Outstanding



    

    

    


    


    










 Converted Instrument


























    










    


    


 Related Parties



    



 Interest Rate
 Stated Percentage Rate Range




 Interest Rate
 Stated Percentage Rate Range








 Convertible



 Original Debt




 Converted Instrument


    






 Shares



 Value



    


    


    


    


 Value















 Shares






    

    

    


    


    


    


    


    


    


    


    


    






    


    


    


    


    


    


    


    


    


    


    


    


    


    


    


    


    


    


    

    

    


    

    

    


    

    

    


    

    

    


    

    

    


    

    

    


    

    

    


    

    

    


    


 Distribution



 Distribution



    

    

    


    

    

    


    

    

    


    

    

    


    

    

    


    

    

    


    

    

    


    

    

    


    

    

    


    

    

    


    

    

    


    

    

    


    

    

    


    

    

    


    

    

    


    

    

    


    

    

    


    

    

    


    








    

    

    


    


 Public Relations Service



 Public Relations Service



    

    

    


    


 Distributorship



 Distributorship



    

    

    


    

    

    


    

    

    


    

    

    


    

    

    


    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    




    


 Nonvested Awards



 Stock Options


    


 Equity Instruments Other than Options
 Vested in Period










 Convertible



 Stock Options






 Options
 Grants in Period


    





 Plant and Equipment


    














 Shares
 Share-based Compensation









 Plant









 Equity Instruments Other than Options
 Nonvested









    

    


    

    


 Interest Rate
 Stated Percentage Rate Range



 Options
 Exercisable


    




    





 Equity Instruments Other than Options
 Nonvested


    


 Options
 Forfeitures in Period



 Shares



    











 Equity Instruments Other than Options
 Grants in Period



    


    


 Equity Instruments Other than Options
 Forfeitures



 Shares


    


    


    




    


 Options
 Exercisable






 Depletion and Amortization
 Property
 Plant


    

    





 Interest Rate
 Stated Percentage Rate Range








    


 Converted Instrument






    


    

    


 Shares



 Options
 Outstanding





    


 Options
 Outstanding


    


 Value
 Restricted Stock Award


    

    


 Plant and Equipment



    


 Nonvested Awards
 Compensation Not yet Recognized






 Options
 Outstanding





    




    


 Shares
 Restricted Stock Award



 Related Parties



    





    

    


 Equity Instruments Other than Options








    







    


 Equity Instruments Other than Options


    

    

    


 Shares



    








 Rent Expense





    











    


 Value



    


    













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































begin 644 Financial_Report.xlsx
M4$L#!!0`!@`(````(0`=?[]DX`$``+H6```3``@6T-O;G1E;G1?5'EP97-=
M+GAM;"B!`(HH``````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M``````````````````````````````````````#
F-UNVC`8AL\G[1XBGT[$
MV-FZMB+T8#^'&]+8!;CQ!XE(;



MK`6*68OW
FM

M'\GF0_
\_0\``/__`P!02P
$%``&``@````A`+55
/U````3`(```L``)?

M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````

%'*86C1DQFH9=R4Y3V&OQY0+3S5P6H(!WL'
MJC[Z//FRMS1-;W@OYGUBETZ


ZYLIIS)(9860TQE*-M#D%W^$S9


M2P
$%``&``@````A`



LZZRWY+(P=PI7U9]HE/.Y3
6D3-=+430[
MD4KDO

:)2I^H]#\L
MI-L.:Z@I[AF1&?R%S)C3EJB*@H*V%$:)#S:
'E@0^HR!%TY@Y+&`070+
]*2

P^4KY_K6UI4P?XQNDT2*9^F.R
P`H2K(3J

M1XBJ[`M@?ASXV$1KXJ
#'0]71R+'2$*,*[3^_1E-6#@RZ1I7(H
MPACHCJITRF(DNSH23XD4+-@E&/GSSC^7P7H#G<IRACHVCI1#3#:EHO!?MI@


=U3



!2&

MY[QVG
G-BVB9Z8TEVV!XC!`6NI+'F[+-#O7_=70Q1H0]J2-+)E!7IE&MU

M*


B'880=ZV/
(CS`X

MK/2AM']!





9KYDOBL99EF<Y%N%QS:XA
V*]]BV#UK_0


MW#C9W+Z4A?-




MQ@TBS93P`AR`=Z=DNC0@(N2E^3RR5.4QFLW=:.'/

='97JD6E*Y0'J7CY
MUX!P2V5(@I8$/EL2/'?#(%HL1[!XQJ-&X`-19+L1_.A`U8!-61-=@W@-S%K9

M=SHN_1VD$^6-5A;UD'7KMR;&WTSP=MF9E/,:'
@+MS/IQ%':^Q;#!A#W
.



M][O?+E3/I]C48-NF'6^#B1J;`?;A];;AQ13#&FP;/J?1)-I@!L7JR=]KJ^$`
M:[!MTTZMP;PO=C7%L`;;AI==$(U8@QD4BZ%X^VI/0V18=7/JTGH8V=9;T(B2

O37Q1K:?&6O#


MU0
GHZ'Q<$W`25
#(=IKVW^\



M


$WLI]!4_3

A
M(0FZ-8-N&B?0:`;``2!D7JL-
%`$QF08PJ-$8(

M)FK*&GIS
C?(AL_[HFM
T.73F5!L




UC+U8E:74A6-Z?2'9-P$FZ^











'




M!



M8B


M_:
\=2QLV;=C48

M]OFYND0[;H:$.Z;EUY?SATUQ/$.(I_R0US^:H-[DN+G[\GPJRO3I`//^KL)T

S!IGY39;N4]JKLDFGNS


MS


FK.:

M%4$K8220(9FM`/:!F\@
:E;MA`L8XZP1DUX`RD4B4O!&'(+:.;S8A7'B3@


M@R3G4GB9HE9_.5#P!\G;SYF=/,Q=&80IPM]G[_]&C5OTKWYF-$9HQ*]I#]W
M9ID$XUAC1K89-==&OIMA39EGG0U;04QRN482C-(4HHE7*
F;E8X#!?Q0DPC


=MMA'ZB4(00RSA4L=R*


M)Z=+PCF%JYBN'??ZLCE[=8I:V@N)G)S

XYREU4UUXLQ8
B*IZ%



M:
HG2N#_JXFU/LHYA?GT\%E


8Y]*IQ3N
[`^K&YCSP!:Q1A
_*G8AH)





AP1!*84/F?-2_-T.+'6EIEB2ZA0BU.$0E%E$[6[[JHPPI






M%F.G*$
H07-K1.Z/0Y%1R]46?69-(OS&43Q



UTMZ#_\#``#__P
`4$L#!!0`!@`(````(0`;\VOR
MM@
``/@



3
H\T7
J]HTK)




TJ_)'@+%CN]U4]5!?Z75L)WT3'3W\3I
T_W!PWEGD!&
C.$14)?@8Z6BUD.)D


M=


MAA47%YF(8P.1-(08A





OFB1ADO[?Q7=$-L%[JNEB+L4.
MP:6!
U5/S14
9^!L
HM?S0Q2



'-ZPE-T)09).C
MOR-TFL02PF:Q

8E&U*N!

MT=L1LA8:)IY]K.$#QV^!!Z(*R'T86%F\_&3N?@+``#__P,`4$L#!!0`!@`(
M````(01-(^7+@
``

M;)26VV^;

EGSW)V[X+1:Y@PJP-@M08O$OO,7:]^SW=6R^@/HWMY]MV2)=]_





/X8:GO!?UI]R



M`/__`P!02P




I_;*=CLG^V^ZPKP7:&<%617FQ]R


@/ZPWKD19=)F*3_=_$=41?@



/V$=;\/5A6/
6:W**UT_2U


ROH5=W




M)*2)0JJ&JENE59JF?5P[8()5P

MI?/



@HV;CA#IU24


M^K]0(48TN467F

D-W[)'*':^54[(<+'UW#B\9:<X%9J!%T_;6K=#0S]O+`LYO#!J2[X(X
M%T*?!MCNNA/A^B\```#__P
`4$L#!!0`!@`(````(0`@EA9%^P
``+8.```9

S+GAM;)R776^K.!&[U?:_XX+^!`


:M$Q8FI6'C?GW7Z]/@6EP$9=IG+.2;LQ/RLUOVY]_6I]9


\=9


#.EJ##-2_M
MI0U.VW6:P0HP[$9-]QOSF:PB$ICV=MT$Z)^
GGGOM\&/[/QKG:4_LI)M%/

MI@+P.D8(6Y_Q=M0O*A&%,PLH7R!GAW;#.5+!HJW*M$(8$(]4DP6M[=.K@0


MX`XP'VXH!);R/S!QEO;N^+[ZOH:--?10N7MK;U;4C5X+YKI.-==:6WELZ\9/


M)GE
D%_1!:T/-*)YSHV$G?`(
(


M6JFJNNTSQF
;!1B+P7'R[WN'BS$S;`C.0Q*8P^'
N1_#W7Q[+POCC=4BYU5D

#R;



LTK$QG6
M]1P.?CCD&7OFV:5D58

U'


3&3@*-$O'
MDTP9+T``_#;*7*8&.)*^MW^O^;XY1:;K+[W`=@G`C1T3S4LN*4TCNXB&E_\A




BB-PQ
PWKD6K^4;OE84ET&&F$FX2

M6GKOX)U_B.D$AE0+?])Q3/80(MOQ0-T7JK!Y*ZJTQA6WC)&)JES?UDHY4=8G
M;)

M?2T?DPZANZH:IQT*
VMT?#I0K;_&!#'X/;1P0I=21\
D*F;:0.V(D$(II-87

?S)X<
M^3&NW8]A8FO'&ZM?@('IG![9GVE]SMA%.P`E/8R@(C5.'+A1<//[=BRXPV



J&\[FU67H%\E
MNXC!SY8X\LN?3;G[5M8
L@WG)$]@R_FCE'[=R5_!P\[HZ8?N!/YIK!W;YT^G
M]CN__
7*P[&%XPY@1W)CR]WK/1


MF8XFQ6L;8O=HGO[B%5AE]/8C5U].1LN$R]*KLL:%.QL.I04&U#^-2SFR5!
Q:ZQGPW5*8_H!5C@'2XH-
M+*-L4I2H1%'JC;A0<#-5T1PF*3:8(B-5*%%,41P;S9`-UX/8[1_7#E!.L,GV
M(,4&E5$S*4J0BGJ`U9]05W/94.Y
.:NV]*X$IU+&K('MG[;ON1#!E_?25CR
M*$$^WX]

W$V)CC?/\]&O
MA^X5CDP?-9BV($J
4\_(A^LZF+3?R=5&T*PU





MYJ(OY@WFJH$9H#`O
??U*/TD\_TK(C(C(TE*LMN]]P#=+I&
C
.*=?C7(2*_

L[_

'93\,P@'Z0_'^;]Y]GV9BO;VMC<3G]LWTV?
M9YL[]N-.^N-W\S%/;BQ^LIPL1%LTV9_:E\5LVNO/_EO:[=/T[_4B_QZJ$<@
MP&GO-D];/7TS^=





LR&54U9




AZQZ@Y8MALW-XX*XW'`0A:`SN^#?8
MT791L.!T]/.+L_.CB^Z/6?OT

Q'ILN8QC3O


T.CXY/#DZZ
:Y3?3V
IT'=?/%38TE(Z8S


D`-?ZG6J#._+/K3X9WX


.!B8

M3NL1CZZ`.T!RQ




MNOYX1G0
[/$6

/R\T0

M$S



M9Q=OVMV3L]





MOT\7_.;LN[



:O$/F1:Q




M3;

%1Z
HAAU8WQ



M!

M9LA


JC!$Q#?-;%\FA4V2X1Q0)
`WG4TAYLF
M

$?&Q
ZCWUYL82A2EOQJC!5[3%QBG\
H:]V080W%1[W
[6Q]%YI1NN`,#R8-,VSA77&V!7Z4
MSV1
/7TVJD9+[Q83.B


M$NQ4/QU0VRO
;LL1NF]W#LR=[D[N0+5;+RAKY5LW6V:I_YWSG^&7E-7^1:B7
K=#E'
K@=]\:5U

MOE\_XU--IQ*JM

L7S

XKR.
M







03QUNCBC)#M



J12L\

MGV



TI5_BW1+)N1V$-^&3(@5EB3-@ULI_OE=H4R6]M9MK@



/^$]YP4Y




\.'^*


M5)UM;FVV]K:H_'([[?T1B-!\PA8@&.?6`!LE2^!TY]Z+UL;+'9:0\KPXU)VI

KT4^G1R6[$1T2$)FXM@PUR


M59F%8M[E^F=)^Q5ZR$]Y47+IR%6


MOJ:F2OB!)&MC\%C;2=\F
Z`GM[.+AH?G%GUM`%0
$L\T#@$_IBI)J[$@@=:D
M.
V-01J3W,MSV*U2#IXJJ?/):C3AS(PJP_^RW]X=4\.9\Q1D#?3*[T7_*M

'B1X6LX6LVB(=



OS

JO#
Z-@KDXB&O;K9?[P$[N./%AR@]W%$YIJ8IL*S[G$G&A



MYF0V#Z#`-5
L)V@QAKV?F@(X]H#5%Q+T60B
_/I2:U8#R#73%DYPN_N4'%`J

Y=

Q*






M!*JPBG0L^M7.C4`5'F5`VF07Q



M%^@0D&ON`$GF^Q9QRVMKG)EWOARWTIIZV-+4TJ5=T6A7F!0:O?3::+_+H_
MIHT[PL[EU6='1&_9R%

JS`(.R7\O8^=?\;5K';2K
.
?Y0L5O/E
I`.0OL



M8XI.-(!8&@L#[QB:9`*^G;NZ40?W=+/53(



O7*69V7DF.-]8W32&XMZLRJN[TXV!A&?WT1.?,FK?50!\#`I%I.=E)X
MV*QC#$`@XK=+D#I=:B-RLE6-(YERC_Q;1J)1!XSULT#@*^SARBWB+BU^Y

=LXI]\=R0S4





P3!8?R7_U5!!@L=V.AM(4WJ1A'

O8P\J0FY'P













M71('+K#




0GX*.C#
K!C

9EE(JI*T_Z\R=
:VN/

MB-QIJO3[$!EJ%Y27+LX5O3Y4^#M*_/GXPQTJ_+(99V6#H@Z:.?/[%Q^+MV








#R:.KY/4L
M*IH^]_%S#X.\U'S?03-+30*F&FTFJ'@F1K.IK7WDQS[15YY!2K`8&=EJ4/





M+'/C.;5B=4$P-ZC+:$LGZT@RAE




@KO`I^]O
MN(\8XBJW:W;49@`J*#




M!W-O[Z/`H]`^V45#UH(:Z=Z`Y%\XP^!+@&P/PX6Z[&0TFN5_^2H&RA8VPL7P

SL=`$Z2










M

ZLOD

M

WID6MH



MIWQI:-&RMV5N
=GLD!%CT,#AA9M?)MFO-O7@Q+G5:\Y4NZ-7E_WLP5&)E7

0:\T(1&5],VTW&KTT;VFEDO3P^MJ&[4_;P&N4.6(XE=MIC.
MFG[

MS%



?ASX4WK`!



+BR_`8?VGKOO9[V`4I&F.LQ_:S2


MT_S#+.L2Z\-3?#





I-M
MWAY3O$CNT/


N^7E28\_5AVM



MR^I#S-_H*.8J*M1
-Y?DG<U(G=3F<0('%N




MDT.'-LEV
.XN0




FLYB59B8QN:BX0SI6^9$!-O3//L*1]A
M!=9D?5






RWS;1C
U!\:$A0`/S-V





(H2RII'T&RDD&U

MY&O@(G#@;-D1\)OSH
48R)T`=!;ZI]#^W[S`.LGN\?%X__P7````__\#`%!+

MXL@1_AXI_\'R)M&=E%G`F`'FACDMS#A9:3
YW4Z42+DH
F!F?.
78IO=X4[Y
M[ZEJOU4/V&Y#0^]*N=$M8.BJIYZJKNXNM^WK[U]\3_OD1+$;!A.]][:K:TZP


MVB?;@R



MV[@YU4PWGUS!%-;M




MA7_GB)


M




D@9
5
M-]=+UWX


4)0V)'A(AL_2$];O

UC/X+Q_
^XGC\CU4Q




M.2:WDE-Y0BNKTB_HK['2XM+O4323?`N!7M(
'VH`'*6R*L6J2C'$[=#32@K@

M`!'03BB)ZB\;='



$



M@Z

M9AV
DE9+EG.B8SO8VLV(S@E/*)XH(!AXY$X:CW.?=#A2_85G&
6C?9J=YE06


MT=N0;X6RP=%L`HC5OLT6N[X7]G;C-!YEKU1OS




M!

MG@)YQ(3OAWJ/!1GV?7%&1W:B_SK


6S-H




%S&U8FUA7=_\TG7I@O%TS?`4P2AG

NUNM5&M

M.69EN`YQ


54&2KI3
MJ2
:_UW99A3JMN7PKFRWO6W8Q

7R%O6N0K^K
MT-Y;7Z%7Y?+%U^5%*88JK1L2VVN;SCM:V7A/*&
#-6?DIC2]MX0-:-R'0;W.
M'#I)?A!+0GC4F0P


S6KZ1$0;?7
M85;30IV96\V(9HJBPRU769O8G
O!Y+EJ
)A;$SH;!/T06+D)QW[-&LX[F)&Q





MIH@8A.



`U!!7?4YK\@A_J_S3E+PZ0U

M]U`(H6ZJ25H&#.YD_+GO:0:-`MWD%//-J63YWFMSX)_N?&PR@U)N'38-36;_
M7
2\/5CLJG:]69[MO45%]
2BS:IG60'

M@L;)#MI@TJ2L:=/625LMVZPON-/-^9XPMI;L+/X^I['SYLQEY^3B11H[M;!C
M:SNVTM3@V9


$%``&``@````A`$XQQ62A!@``
B4``!D```!X





M9H??LVL*T0:?J`
O1?&-HL&!-L'!VN!HMW'@SU(YI

K*4^

F/KB`Y$E
8/W1D?-H@TMD
M'UH98_(5:6S

1AB%5


.X'Q)C#^!:8P(03F&C(S!\AY*R+/4!JRC-624V


MMTNLPI39HX2-$@Y*NCAH82/$@%*A@1R0C.M(5@FMPL2F]5R)Z=$181%M\=


-9D::V$K.SV
M`:*O5VM=6'$\]0^2@0H$:)$)
XSZ&^X1G]C!LZ4XS1@C\PPE;)1P&+%N
M/--G:\$/5_ZSA^K[*!&@1(@2D8S@[*)E
E($!M7<5KDW3F'2WB(A(]+!(A$B$M$4H3WC9;/'U_:*NZ

!CH0X$DD1WC]:9(O^
MX94S8;4Y[Y^X^V\AJ7]



MKXTC#HZX..+AB-\B['J
N;$4*M


IV1'8K
MH)UZ*&+C*@Z.N#CBX8B/(T&+
(=7ABFN`B&N$7$:!MT

)D





M'/%PQ



E52=7=




JM?Z2&EC

M-D985+?$8/M]EM)GEKX5M&PP2$7SI`'^]3$[U9=H17I+N*I7M].WU)6G#$
M-LNSYE
$M:TB7?PXE*Q*MCG
^X-


M


9IS^TC_M$80(*
M=9EPM7PH23,C/@AP'0+3:*I2B!$S[6!%;$Q(12.$.1^CGS0R@8A6I&F4:`R
MB!$3BO1Z4]=UU?N;[GT2S8(.0$([\W]!/D@G:`F48R80!`DLRCL$!EL$'`








M#
]%S;?F-B/Y1@-1\AWUBK'K


:_3WH#XU-RH#^3ZI5M973


M:&5E='



S+6(^81=:PC='5A6Q@


MUM].):OB0PZYW\DL3EKM^L*2+[*D8IP=Q03D/&G4SKSR5AXH[39I!@FP[$Y%
MCUOWF:PCLG2]W:8NT(^

M



D&A+14N#/

MGKIZ$G




M5#B$HR)V@5KAJ36*;
:*
(3(/*@*,\N!:U.=$_SG#L)N^+!C\`8Z.YV)]GF
MB-E]`6?2WRBO\?5*2NYD]

M4XD_`?C(F&@O\`S;_0FQ^P\``/__`P!02P

C


@X5

WNZ9IA`HV'C1U#I160$`
-L1+!Q
MFED;W62^F(RS<^O7-U0<N^L8*I@6U95&E&YMP
G`N?^;C\+[R)[_$?W-S`C

M/!#G4IKNPKZ\_=_;^B\```#__P
`4$L#!!0`!@`(````(0`DCDT]^@(``'P(



-4Q9253
MKRTILJHD?
QK+LBV!-TO[I0D1^YV

M)@?
_1CC]1'K




JQY


M*[`3XAZA7W





AG8P`W`AA!X^
/+Q[\WF'P``
M`/__`P!02P

M971S+W-H965T

MUXI


CM]TMTN=90YOI=O0I


M^O0A^E:$4FBRET_LYFY



G-'OE`V`:V]/I*N7).D-^G5`9(!R8$4
M0$H@%9#:)HY(E-!^A4CLAA8C==

MKHD5`$!2(!F0'$@!I`12`:EMX@R4*IDS!LK6[D`5\28Y\E9Y;]1/
I`
2`ZD

%GW^.S^O5
MET5+&8K&









MGZ
THF^6[3GPHBK35K&[]8*^^B;




O8C3U3DM/DM


JXKC3B6#.WZ3^\J:4A%E;TI.8LH?!`T'GHGBM;=Q!Z`TS$
MRH1!*LB4YYE&.L2Z:.0J^4S:69'6/JKF*SADNQ


M48FH0E0[R-62W_WKND_?;

]!_1+


\];\B&
M`--NFPMPX
J.-\RO(_2JRC$9+?MO13\)
9W2-3J=








MM5RVB_O??VPWH^_UH5TWNX=Q


((N_9A_'X\[N^FTW;U7F^7[:39USM$

N7KFB[F:8W-^5TNUSOQG:$N\
E8S2OK^M5736KCVV]




M9I`G
\K#&`L



M?
L9+_HD7U91A-$IA]`QR9R.0V9];RX44E&$?384O5P*D\P_VR&WI*&2\D9(

^F*#
P-Q

Z==F



MQA$O)^#\DQ)P$&^B7(K29P51*








MD.!FS5LTD=Q:NT+;




M\^WN51_G-


BGEURA?=M#E(#+E#%LCB!029=:)-VD%CS<L<?LL*LV+%0


MB@E7/]-BVKP+!P5Y%AJJ&
04*X53^\O*:2)=%7=L#]D#-^;TQL)#Z!=R&19W


HCS'63Y


R@*1



M1Q]C$2B-

``


M5JJJ7IY-XA!KDSBRS;+[]YVQ24@(+/R&1\SIRY.+.X?\LS[Y4K+601$MKK



M+20#(!:Q24



MLN+H8(3':DJ


-J2KA#5GU[/3VL
MRL
)0KP4^Z+YV09U9H?5XY?ML:RRESW
^X?PLM4Y=OOA(ORA6%5E76Z:.81;






6;I
M)4+U$
($%)K.1(

AT;AJ\=&#BG2AQ1`=.



MBFPC-B'9T(D8]P$LPZ;1:.J'@S

45$*E3]
M'E+9A97U!MQ=GGQ:1V:!

+NS\6C0[/4E6
!<@PZC-`N<$XT\N=U&AJ


MGY`W^42+IJ()Q1W

X3RXFYF@M@3K.OW

MB4*?N))P!%D3;H-0GG?9B1JQD\'O=&8O#^U$P0'T



7CNVDAAM6X&E=+K??HLJRA)+


+Q^9I_MZV'ZOELMF\

M[C956F\^#]6Q12.G:K]NP?_F???1]-8.FUO
'=:G[Y\?BTU]^``3+[O]KOW5

S!]VFU/=U*_M`YA;HJ/39XZ6T1(L

@3L1L$^%2=!02N?
2![*+

MHC.R!'W/(D.DCT6^/-MZ+24LM92S3XH;TPL)O9#B!?!G4(5HFUU`R/GU&Q!
M+Y2C]KSP2R\_?DD_#0'4V=G(^LL&SXQ(GX72$[HVWIS

M)64GHB21*D9D4-(39-HE2)C$9(F

M3D1&L@#&B*`





M^=O%Q+1_+*:@NTLL$!K4M'VR0R4*






=*P1-3S*;8X$
NN#Z#OR06D@1QN`TE2)*4Q;)
M^1L5/%(:$4U4FY1%YN#L:+JI$ZUB!:&:0@1DLTI4NTE+S83K!YX@97[&&\EY
JJ9@``,+1*`F48L+L<H.MN_<IT&:=]N
M%)$^D<9U;NZF++ZN#M9LK%F&2=+<$1%RM64.\!A$5(5MA$(48]V0HJXZWD
MFB\+<3%&V1N5QAOILI(B4F7+A1&D]!$QB!58K-(RB
9C^0\4B@$!W]A!X$7

AX
M
SF/%-J=%@).9$'3#+F4H?@'=


`4$L#!!0`!@`(````(0`*

M
!2&[R?M/UB^+Y\!FBBD:JBZ55JE:=K'M6

6`6






MKZ=#*:!YXX$$(?3LRL&;[&J]\```#__P
`4$L#!!0`!@`(````(0!27^9P

M[[=JWX'B_@`VAB14DE



\?XK?+




C=V-PHCOEJ
M?#4F3[?7#QL:@99]L*L?;X9WR4+-)L/Q[74KT'\W]?L^^/]@_]R\E[O-PS\V

:

)$HM_T*D;0;6HQT
MF4Z`='H9J62-CJG4F70J`2F``ED`J(!*)PE2B[,M4ZG]^N;2BK5LQW#N







M^6?_$E&.J$`D$)6(*D02D6*(CSFN&T^




`/:&2-H]4
BB*ON@.EA1C[9
O
MR'4.^8@I'*+T&2@..EE?M(*]51*E@=+ZHOORTMF._HK27]%*Q[?KRK7WQ)VN

M^PK=RP^Y5\P]C[Z^0COY*^EQBO6V15&`QO6VM:)GG]
@MXAP*'^;HRRSCK

'XO/#^9%6Y.'`6H1#U#(

K?-H)2ZM%8M6TY'E2.O+YLB+JTDVB;*M<)['&FZT1[
Z]@Y








V;S$T'S(ZYMO7NJE_7+







M971S+W-H965T


MB&0-U:!?U;Q7![0VOP2NI?)QVU_EHNT!8L
;KE\
*/':/+VO.B'II@'?S]&$


WNUV?+9
5

.E$/KP@+?1\]A]1\``/__`P!0
M2P

M965T

=36UNSN-2%.0C7@


MLX$`(TH/`F9ASX8#CE^AM'[XW$TGMX/?L(VZJ8!8]Q[(@`(\3P$K(A!1$%
M

M(@IBA(*4@HRG(*EA04%*PH6!O`
A-&C-S#+-(^R2-N2E*P71LY*;KS6VS
M%C+&@;FF26#/#@F:D,901B)&8D821E)&,D9R1I:,%(RL&%F;Q/(6QC[S5BR`
M7YP(A`S,)5!-8^1H/+.M7*@@T^W1F'1)T`0U?C,2,1(SDC2
I(QDC.R9*1@
M9
7(VB26WVMY7=W#HOHVE8T8Z'(M)D2`D91B)&8D821E)&
D9R1I:
%(RL
M&%F;Q#(
-A!?
$Q$VX9)
M9S:)-VXL#%4
3.9-]KK3L9V]41.$?1$SH821

MIM




ML2?`@GK4A!Q%DVF]?G2=8;PQ\[:F)=*.$I1-JF&\7[3#9]
I/5W0V]N?F'


M.'&9W?.7%B-QH*)#2R(RM

CQIO-X-'+S0*C8'_?9/MH
M0LX#@8[&3?D*.(HYBCA*.4HXRCG:
E1P=&*H[6%[%$#_6;9?V7#(
+)AD$A
7(%&SKD_!3I`%2.N4S4:H+UFOCD&[C
QV`RKDE8ULF
M3FW
LJ_O[(4













##'%\\7N$W










TI;GO(?^




\W


NH#7CY
[1!-$@;

*(#M

M!Q$09#&NIU!!M@JR4Y!(06(%210D59,1X2!PD;S'P:*HL6!8L2RV$`QXKA
M;Y68G8)$&'&'0\105F.%)R$(5




.*(:MBB
M&N$81+N\Q8B-SWAH*]X1!+8()JLIC3W01;;ZV*#


M
NB#.-$A210




M:3$E7-`BWJ$507'*E!7189NWXB#H3]5(?'R'Y4%['


@XL^)'

.3Y</E2\=CSXP$W1H7@U?J:'\O?\_98
M73KM7!Y@DN;#N;[%[][X2T\N3D]-#^_5

MG6UVH
.X'171\KC\^&&_^]:CJ88]?Z5!-7





MB!-T0(@,9`$2`HD`Y(#*840H@-9#&)4(PBA8AF-I@AI,K&M47KBS*D=12
M$V\2#+UX/!F=XA%(#0!D@+)@.1`B`ED`I(#:1QB9!792!W_
!V9I+%1DY



M
E4EEAOQ&CG*1


M1/G+F2YC*[7TTJ_3WAI:V$Z)J$)4&V2&\)#F
SE?-**.&%4A30YGN^U]4V+K
MQNLWY9D.BD1`3;WI9&$JNJ


MB&I$C4!24I797BI3H2%I`:Y(0DH@'%B!)$*:(
48ZH0%0BJA#5B!J!I'ZT
MM1;Z_?(QN[H/1#.OD%8C&:VWWK9R82J2E8W64T5&


48ZH0%0BJA#5B!J!
MI'Y^




M$5W:EX-B]J6C:WCE'Q\F;/!&?('G#-O/V=



8)+9XVHJ.ANP^
M12
:
F8CYNUM8N.&#+A.PIXM2AE9SYFM^+
MWJEI]ERPF]:SE$GMX]TP\V5Z

AD!#UMFI^








J:6/'JT/?:O_464




73C$$KK/
M/%/W#K&$KC7/U*7EKI(QE73U)=T5I9*NIZ:+C%32U0[=X9ZINY;8#EWEGJDK


$%``&``@````A`)0'OR/```Z0``!D```!X;]W








F_SN

M;1S8A5TDS8@XG4FG#D
BAL0
V3`D84C*D
Q$+)$@MS&1/-A1']Q)@@8V([CI

1A2,J0S$0LG2`-6SKUES!,+,*Z
ME0,7L5+(O-M/:X:$#(D8$C-DPY$(2E#





^1ZRZ.MM&@RV9;^D=3GR+85.@44
7)I^A2AB_09<O%*




;(F3598?4Y0BMH&LP
M=B0M(&CU5E:2W0M:F7E0+HC

M23[SII


MM5961H$


CM
M&EW4(7W:6V.]^?S.D!:H9$/+&[]

M@0A%RLKW5?
\69!V



/K!+^Q\@/XL:P'GP;PVQ+'PUD`/[GTX/
@ZA
PF0?P

M:&5E='






K^L1F:[\
M5TA=7&


M9-;P6F6+&9]@/E+0
@B0X081#&?0EIZ?25O0`&DHJN'2#;237+K/3)21X6

MMJ$+;4P`=2I[95`A^DS-AGH






M9Q

@P
LNR-9GI!-$-\%
^*M5Z9`?SG;J]Z[HTJQ_RIY]ITW


M#(*AK+WD(W_9\5IEBYGU
(L.
3`(D.D&$0P]&$@'?D=LI2UH@C3

MX%1=:#N,UET=3Y$8-B[?D;!F8XNAJKOSQ*AU(V8C;@H([70UJS;6;0^??Y

M@;0ONEV#'HH=@B-#06XW7N%,LT)YN[%23,+3T20T)#2[
SEO``Z`F_/PS(




M5GMYIJ%LHP8*4;C=_?=SLO(:D=E@V'YIMT]$1IV
C(R3=?'#;]_VN\'7YM1M
MV\/C
!E-AH/FL&XWV\/+X_`___[TZVPXZ



7T\OX^YX:E:;

_AWK]MC9Z+M




M1E;?^I_OV\WY]7&8E:-B.LD2N`\^-]WYTU:&'`[6;]VYW?]/.24ZE`J2ZB#X
MJ8
37'U^-R/0X_;Z8]5BGH,RI6Y]73
MPZE]'Z!,,<GNN))%GRP0V*12T;#)_5%ND5099FC/`ZQOYV#@7Q]2E+RX?Q
M5RSB6OM4H4]/6KC(5=

`9?2QHY_PFD911)VERN



RF[]

Y4M4PGL@HOER\?


MESF=K7S,K,2!*)\F6KT?-$R;]3AU,J)8Y9E[#Q5&:^+)1A*CAN&5'VLKE[




M


C3$LL7O
M




M2P%+W\02PE+&1TSA:5?3CXFGR\$[A+ZRR+;C%6./LOA`XB(=CJ@+?(*,Y
MQRS(#LZI,0NR@T-BS((


X(P&N[E88G.-
=J



M


QW#9
M'2+X$KLLNLED#XSX5R`:S0?J
5J.J

M[Y/^3'Q2?\BB?CFW1YR$\

M
#W]!0``__\#`%!+`P04``8`````$`MD.4.#$!``!``@``$0`(`61O8U!R

M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````G)%!3\
@&(;O)OZ'AGL+=
MB2
L2-3NYQ


K`RE9INZW1\VJ1WZ`L1&&5:%H+
M-3I`0'-^?55)QV3KX=&W#GS4$+)$LH%)5Z-=C(YA'.0.C`A%:M@4;EIO1$Q'

L
&HE`BGP$YFXDH@&IY(AT'[[I`4IB:,`C0'3@N+O;@1O
MPI\7^N2B:70\N#33H'O)5O(4CNU]T&.QZ[JBF_0:R9_BU^7#4S]JKNUQ5Q(0


M`2B@``$`````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````G%;?;YLP$'Z?
MM/\AXGTEZ8^MJP@3(;1%:X!AIUN?3BXX#1JU$7:C9G_]#E!;TN%TVU.
[_ON



MTYBENRBR6BJYTJ/@




E4QD'
@?Q?D;/3L[1[JHC^YT1\MG-JS\*BF`8P


^4(+N(P

M@Y1`\&T9TALS_%
'ASBA81P1

_POA-MM



9/A#



``)`-```9`````````````````*P4``!X

M(0`;\VORM@
``/@



M4$L!`BT`%``&``@````A`!5Y36`?`P``5@H``!D`````````````````I3$`



M=#


BYX;6Q02P$+0`4``8````
&PO=&AE;64O=&AE;64Q+GAM;%!+`0(M`!0`!@`(````(0!.,<5DH08`
M`#(E```9``````````````````*3``!X;]W;W)K<VAE971S+W-H965T
S4N







)```9







M='


M;%!+`0(M`!0`!@`(````(0`G?\#PGPH``$HQ```9`````````````````#'K





/`P`+`#FP``8BL!````
`
end











    
  
      

          

        

      










        
        
        


Preferred Stock
 Par or Stated Value Per Share (in Dollars per share)
        
        


Conversion of Stock
 Shares Issued

977
085
        



          

        
        


        
        
        


Debt Conversion
 Converted Instrument
 Amount (in Dollars)

700
        



          

        
        


        
        
        


Preferred Stock
 Par or Stated Value Per Share (in Dollars per share)
        
        


Shares Issued
 Price Per Share (in Dollars per share)
        
        


Proceeds from Issuance of Private Placement
 Gross (in Dollars)

834
        


Convertible Preferred Stock
 Shares Issued upon Conversion
        
        


Convertible Preferred Stock
 Terms of Conversion
        
        


Conversion of Stock
 Shares Converted

708.5
        


Preferred Stock
 Shares Outstanding
        
        


Preferred Stock
 Shares Issued
        
        




        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 exercise (or conversion) price or rates
 dates relevant to conversion timing and events relevant to conversion. Describe also any beneficial conversion features. where convertible preferred stock with a nondetachable conversion feature is in-the-money at commitment date. For contingently convertible preferred stock
 discuss the circumstances of the contingency
 including the events or changes in circumstance that would cause the contingency to be met and any of the significant features necessary to understand the conversion rights and the timing of those rights. Include also an events or changes in circumstance
 if any
 that could adjust or change the contingency
 conversion price
 or number of shares
 including significant terms of those changes.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 repurchased
 and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    


















/* Updated 2009-11-04 */
/* v2.2.0.24 */
/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}
..report table.authRefData a {
	display: block;
	font-weight: bold;
}
..report table.authRefData p {
	margin-top: 0px;
}
..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}
..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}
..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}
..report table.authRefData table{
	font-size: 1em;
}
/* Report Styles */
..pl a
 .pl a:visited {
	color: black;
	text-decoration: none;
}
/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica
 Arial
 san-serif;
	margin-bottom: 2em;
}
..report hr {
	border: 1px solid #acf;
}
/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}
..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica
 Arial
 san-serif;
	text-align: left;
}
..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	word-wrap: break-word;
}
..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}
..report td.pl div.a {
	width: 200px;
}
..report td.pl a:hover {
	background-color: #ffc;
}
/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}
/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}
/* Even rows... */
..report .re
 .report .reu {
	background-color: #def;
}
..report .reu td {
	border-bottom: 1px solid black;
}
/* Odd rows... */
..report .ro
 .report .rou {
	background-color: white;
}
..report .rou td {
	border-bottom: 1px solid black;
}
..report .rou table td
 .report .reu table td {
	border-bottom: 0px solid black;
}
/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}
/* styles for numeric types */
..report .num
 .report .nump {
	text-align: right;
	white-space: nowrap;
}
..report .nump {
	padding-left: 2em;
}
..report .nump {
	padding: 0px 0.4em 0px 2em;
}
/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}
..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}
..report .text .more {
	display: none;
}
..report .text .note {
	font-style: italic;
	font-weight: bold;
}
..report .text .small {
	width: 10em;
}
..report sup {
	font-style: italic;
}
..report .outerFootnotes {
	font-size: 1em;
}











    
  
      

          











        
        
        


        

923

740


        

084
        


        

384
328

313


        

734
335)

053)


        
        
        




        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

 net of deferred tax liability attributable to taxable temporary differences.
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    





















    
  
      

          

        

      






        
        


        
        
      
    

 2013
 the Company incurred a net loss from continuing operations of $2
775
965.&#160;&#160;At December 31
 2013
 the Company had a working capital deficit of $75
240 and accumulated losses of $13
121
722
 which includes accumulated losses from discontinued operations of $8
576
094.
      
        
      




        
          

        
          
            
                
              
                
              

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    








        
          

        
          
            

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    

                  
                    
                    


















begin 644 Financial_Report.xls
M[[N_34E-12U697)S:6]N.B`Q+C`-E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O
M;VL-D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y
M/2(M+2TM/5].97AT4&%R=%\R9&-D
S@X9E]D.6$T7S1B8C!?8C9A
U\W-3DU
M



M@T*+2TM+2TM/5].97AT4&%R=%\R9&-D,S@X9E]D.6$T7S1B8C!?8C9A,U\W
M-3DU,61E8C1B8CD-D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO
F1C
M9#





M.F]F9FEC93IO9F9I8V4B('AM;&YS.G@]
T0B=7)N.G-C:&5M87


N
M;W)G+U12+U)%0RUH=&UL-#`B/@T*/&AE860^#0H\;65T82!N86UE/3-$(D5X

T1&:6QE+4QI


M7U-T871E;65N='-?;V9?3W!E/]X.DYA;64^#0H@(`@/'@Z5V]R:W-H965T

&-E;%=O<FMS:&5E=#X-B`@(#QX.D5X8V5L5V]R:W-H965T/@T*


M7T)A;&%N8V5?4VAE971S7U!A/]X.DYA;64^#0H@(`@/'@Z5V]R:W-H965T

&-E;%=O<FMS:&5E=#X-B`@(#QX.D5X8V5L5V]R:W-H965T/@T*



M=&5D7U-T871E;65N='-?;V9?0V%S/]X.DYA;64^#0H@(`@/'@Z5V]R:W-H



M/@T*(`@(#QX.DYA;64^3D]415\Q7T)54TE.15-37T%.1%]05-)4U]/1E]0

T0B5V]R


#I.86UE/DY/

M:&5E=#X-B`@(#QX.D5X8V5L5V]R:W-H965T/@T*(`@(#QX.DYA;64^3D]4
M15\W7U-43T-+7T]05$E/3E


M971S+U-H965T


M#0H@(`@/'@Z3F%M93Y.3U1%7S$P7U-50E-%455%3E1?159%3E13/]X.DYA



&-E;%=O<FMS:&5E=#X-B`@(#QX.D5X8V5L5V]R:W-H965T/@T*
M(`@(#QX.DYA;64^3D]415\T7TE.0T]-15]405A?5&%B;&5S/]X.DYA;64^

M1$524U]%455)5%E?5&%B/]X.DYA;64^#0H@(`@/'@Z5V]R:W-H965T4V]U

&-E;%=O<FMS:&5E=#X-B`@(#QX.D5X8V5L5V]R:W-H965T/@T*(`@
M(#QX.DYA;64^3D]415\W7U-43T-+7T]05$E/3E-?5&%B;&5S/]X.DYA;64^

M3T9?4TE'3DE&24-!3E1?

&-E;%=O<FMS:&5E=#X-B`@
#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1)7;W)K<VAE971S
M+U-H965T
C(N:'1M;(O/@T*(`@/]X.D5X8V5L5V]R:W-H965T/@T*(`@














T0B5V]R


O4VAE970R.2YH=&UL(B\^
&-E;%=O<FMS:&5E

#I.86UE/DY/5$5?


M:6QS7U

M



O4VAE970S
M





M3F%M93Y.3U1%7S$P7U-50E-%455%3E1?159%3E137T1E=&$\+W@Z3F%M93X-

T0B5V]R





F1C9#
X.&9?9#EA

O4VAE970P
2YH


M87-C
M:6DB#0H-CQH=&UL/@T*(`\:&5A9#X-B`@(`\345402!H='1P+65Q=6EV






T0Q(')O=W-P86X]


T0Q

M;'-P86X]

#$S/&)R/CPO=&@^#0H@

MB`@(`@(`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,P@
C`Q


]




T1T;W`^16YT:71Y(%)E



T1T;W`^1&]C=6UE;G0@5'EP93PO=&0^#0H@





3(M



]
T1P

]
M





BPX-S0L



]


'0^)S`P,#$T,30Y-3,\<W!A;CX\+W-P86X^/]T9#X-B`@(`@




]
T1T97AT





]
'0^)U-M86QL97(@4F5P;W)T



]
T1P


T1T;W`^1&]C
M=6UE;G0@4&5R:6]D($5N9!$871E/]T9#X-B`@(`@(`@/'1D(&-L87-S
M/3-$=&5X=#Y$96,@,S$L#0H)3(P
3




]

]

#$S



]

\+W1D/@T*(`@(`@


]


S@X9E]D.6$T7S1B8C!?8C9A
U\W
M-3DU



]
T1T:#Y$96
N
M(#

M8RX@
S$L(#(P









#




]





]


]


@9G)O




2PU.3@L



]


]
M

]
T1N=6UP

M1&YU;7`^-2PV
#


@;VX@8VAA;F=E(&EN(&9A:7(@=F%L=64@;V8@


T1T;W`^5&]T86P@3W1H97(@17AP96YS97
\+W1D/@T*


]
T1R;SX-



T1T;W`^4')O=FES


M86QI9VX]




]


M

@879A:6QA8FQE('1O(&-O;6UO;B!S=&]C:VAO;&1E


BPY
S0L-#(X

2PV
#

]
T1P

]
T1N=6T^




M1&YU;7`^-BPU-#

M/5].97AT4&%R=%\R9&-D
S@X9E]D.6$T7S1B8C!?8C9A
U\W-3DU
61E8C1B




M/]T:#X-B`@(`@(`@/'1H(&-L87-S/3-$=&@^1&5C+B`S
2P@
C`Q
SQB

#$R




]

]



]



3(R+#


]
T1R;SX-

]
T1N=6UP/C$W+#@X
M


M9VX]


]




]
T1R;SX-B`@(`@

M455)4$U%3E0L(&YE=!O9B!A8V-U;75L871E9!D97!R96-I871I;VX\+W1D


]
T1R



]
T1P



($%34T544SPO

]
T1N=6UP/C
X+#`T-SQS

]



]

]
M
T1N=6UP/C(X.2PQ





]
T1N=6UP/C
Q
RPQ



C(Y/'-P86X^


]






M
#`L

]


M8VLL(#$Y

2!P
M87(@=F%L=64L(#$R+#8S
2PT.#4@86YD(#@L-34Q+#(V-2!S:&%R97
@:7-S




]
T1N=6UP





]




G($1%1DE#250\+W1D/@T*

]
T1N=6UP/B0@
S@L
#0W/'-P


S@X
M9E]D.6$T7S1B8C!?8C9A
U\W-3DU



M87-C:6DB#0H-CQH=&UL/@T*(`\



M4F5M;W9E(%1H:7


M
T0Q(')O=W-P86X]



#$S/&)R

]
T1R93X-

]
T1N=6UP/B0@



#`L

3`L
#`P+#`P


]





#$\



#`L

3DP+#`P

]
M


3(L-C

T1T;W`^0V]M;6]N('-T;V-K

]
M
T1N=6UP/C$R+#8S




%]B-F$S






]




]
M






T1T;W`^0F%L
M86YC92!A=!$96,N(#,Q+`R
#$Q/]T9#X-B`@(`@(`@/'1D(&-L87-S


]


]
T1P

N(#
Q

]
T1T



]

M9F5I='5R97

]
T1N=6UP
M/C$L


]
T1N=6UP/C$L
3$R+#DX


]
T1P;!V86QI9VX],T1T;W`^1&ER96-T;W)S(&%N9!%;7!L;WEE
M97



]







]






]




T1T;W`^4F5V97)S86P@




]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P



]

I/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$;G5M
M/B@Q
30L


]


]
M


]



]


M8V4@870@1&5C+B`S
2P@
C`Q



S@L





M86QA;F-E(AI;B!3:&%R97,I(&%T($1E8RX@,S$L(#(P,3(\+W1D/@T*(`@

]



]



]


]






T1T;W`^16UP;&]Y965S(&EN(&QI


]






]
T1N=6UP/C@S
BPW





M97

C4L
C4S/'-P


]
T1T97AT





]


38R




]




]


]
T1N=6UP/C$L




]








]





]




]


]


]









]
T1N=6UP/C$Y-RPW

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


]

]
T1T97AT








]
T1T97AT




]



]




^

M(&%T($1E8RX@
S$L(#(P
3


]
T1N=6UP/B0@
3
L




RPQ



]

N(#
Q+`R,#$S/]T

]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


M871I;VXZ(&9I;&4Z+R\O0SHO
F1C9#
X.&9?9#EA-%\T8F(P7V(V83-?-S4Y

O4VAE970P-BYH=&UL#0I#;VYT96YT+51R





M;W0@4F5M;W9E(%1H:7


M86X]
T0Q(')O=W-P86X]

M;65N='


]
T1T:#Y$96
N(#
Q+`R,#$S/&)R/CPO=&@^#0H@(`@

S$L(#(P
3(\8G(^/]T:#X-B`@



]

M/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$;G5M/B0@*#$L-C`S+#8V.2D\








CQS


T1T



]






T1T;W`^4W1O8VL@:7-S=65D



]
T1R93X-B`@(`@



M86YG97

]






]

BPX








M;W5N='


3`P+#4Y


]
T1R974^

M/'1D(&-L87-S/3-$;G5M/B@Y










]
T1N=6T^*#


M97-T:6YG(&%C=&EV:71I97


]

]
M



]










]


M

M97




]

]
T1N=6UP/C8L-S`Q/'-P86X^

2PS-SD\


@870@8F5G:6YN:6YG(&]F('!E


]
T1N=6UP/C@L




($1)4T-



]

]
M




]
T1P




]



]


]
M




]









]



]
T1T97AT





;V-A=&EO;CH@9FEL93HO+R]#.B\R
M9&-D
S@X9E]D.6$T7S1B8C!?8C9A
U\W-3DU
61E8C1B8CDO5V]R:W-H965T


M(&AT='`M97%U:78]

]


T0Q(')O=W-P86X]
T0R/CQS

]
T1T



T1T;W`^



T1T;W`^3W)G86YI

M86YC:6%L(%-T871E;65N='



2`F(S@R
3$[($)54TE.15-3($%.
M1!05-)4R!/1B!04D5314Y4051)3TX\+V9O;G0^(`@(`-B`@(`\+V1I


1494.B`P


T0G

M63H@8FQO8VL[($U!4D=)3BU

'!T

N(@F(S@R,C`[34]*3R8C.#(R,3L@;W(@
M=&AE(8C.#(R
#M#;VUP86YY)B
X

M92!#;VUP86YY(&5N9V%G97


M25%5251!(%123U!)0T%

05DZ(&EN;&EN
M93L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q
M

@3Y,+D,N(@F
M(S@R

C$[*2XF(S$V
#LF(S$V






M

M4$Q!63H@8FQO8VL[($U!4D=)3BU

M







M86YY(&%N9!-3TI/($]R9V%N:6-S($]P97)A=&EN9R!#;VUP86YY+!);F
N

M
#M-3TI/($]P97)A=&EN9R8C.#(R


M;6EN871E9!I;B!C;VYS;VQI9&%T:6]N+CPO9F]N=#X@(`-B`@(`\+V1I


1494.B`P




M;V=Y(&%N9!0:6YC:!S=V5E=&5N97(L(&AA9!N;R!E8V]N;VUI8R!V86QU
M92XF(S$V,#LF(S$V,#M&=7)T:&5R+!-3TI/($]P97)A=&EN9R!H87
@8F5E






N)B
Q-C`[)B


M=&AE($-O;7!A;GDF(S@R




S@X9E]D
M.6$T7S1B8C!?8C9A
U\W-3DU



M87-C:6DB#0H-CQH=&UL/@T*(`\:&5A

M

M;W9E(%1H:7



]

]




]

24=..B!J=7-T:69Y.R!415A4+4E.1$5.
M5#H@
'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2

M05DZ(&EN;&EN93L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].
M5U325I%.B`Q

M

M+4%
24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@
'!T.R!$25-03$%9.B!B






@870@=&AE(&1A=&4@;V8@=&AE(&9I;F%N



M=R!2;VUA;CL@1D].5U325I%.B`Q,'!T)SY#87-H(&%N9!#87-H($5Q=6EV






05DZ(&)L;V-K.R!-05)'24XM3$5&
M5#H@




S$L(#(P
3
@86YD
M(#(P


M+4%
24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@
'!T.R!$25-03$%9.B!B


T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E
63H@5&EM97



M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
'!T.R!-05)'24XM4DE'2%0Z(#!P

M:6
[($1)4U!
05DZ(&EN;&EN93L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;CL@1D].5U325I%.B`Q

M(&%N9!$97!R96-I871I;VX\+V9O;G0^(`-B`@(`\+V1I=CX\8G(O/CQD


M(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU

M3BU224=(5#H@


#LF(S$V
#M$97!R96-I871I;VX@:7



M96X@:6YC=7)R960N)B
Q-C`[)B



@86YD

@:7



M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
'!T.R!-05)'24XM4DE'2%0Z(#!P

M:6
[($1)4U!
05DZ(&EN;&EN93L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;CL@1D].5U325I%.B`Q

M97



M63H@:6YL:6YE.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&3TY4


05DZ(&)L;V-K.R!-
M05)'24XM3$5&5#H@




#L\9F]N=!S='EL93TS1=&3TY4+5-4
M64Q%.B!I=&%L:6
[($1)4U!




@86YD(&1I;'5T960@15!3
M+B8C
38P.R8C








M('EE87(@96YD960@1&5C96UB97(@
S$L(#(P
3
N)B
Q-C`[)B
Q-C`[5&AE

@9F]R('1H92!P97)I;V0@=V]U;&0@:&%V92!H860@86X@86YT:2UD
M:6QU=&EV92!I;7!A8W0@;VX@=&AE($-O;7!A;GDF(S@R




05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M

@=&]P:6

13H@:71A;&EC.R!$25-03$%9.B!I;FQI;F4G



@:6YC=7)R960N/]F;VYT/B`@(`-


[($1)4U!
05DZ(&EN;&EN93L@
M1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q
'!T
M)SY);F-O;64@5&%X97
\+V9O;G0^(`@(`-B`@(`\+V1I=CX\8G(O/CQD



M13H@


T0G



M($U!4D=)3BU

'!T)R!A;&EG;CTS



T1J=7-T:69Y/B`@

T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E
63H@5&EM97



[($1)4U!
05DZ
M(&EN;&EN93L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U3
M25I%.B`Q

M=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU

M24=(5#H@



M=!S='EL93TS1=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE






T1J=7-T:69Y/B`@


M=')U;65N='

T1J=7-T:69Y

T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E
63H@5&EM97




N(%1H92!#;VUP86YY)B
X
M
C$W.W

@9F]R('1H97-E

T1J=7-T:69Y/B`@(`T*(`@(`@/&9O;G0@

T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@5&EM97
@



C$[('=H:6-H(&5S=&%B;&ES:&5D(&$@


M
38P.R8C
38P.T%30R!4;W!I8R`X




M='

C`@86QS

M=6ER97

M86)L92!I;G!U='


@5&]P
M:6

M9B!I;G!U='
@=&AA=!M87D@8F4@=7-E9#H\+V9O;G0^(`-B`@(`\+V1I

T0P
M('=I9'1H/3-$

M(`-B`@(`@(`@(`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$,R4^(`@






M(`@(`@(`@(#QT9!V86QI9VX]
T1T;W`@=VED=&@]



@;W(@;&EA8FEL:71I97


T0P('=I9'1H/3-$
M


M(`@(#QT9!V86QI9VX]
T1T;W`@=VED=&@]

T1T;W`@=VED=&@]
T0S)3X@(`@(`T*(`@(`@(`@(`@
M/&1I=B!S='EL93TS1=415A4+4E.1$5.5#H@
'!T.R!$25-03$%9.B!B;&]C


T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E

'!T)SXF(S$X
SL\+V9O;G0^(`@(`T*(`@(`@(`@


05DZ(&)L;V-K
M.R!-05)'24XM3$5&5#H@


M($9/3E0M4TE:13H@



T0P('=I9'1H/3-$

T1T;W`@=VED
M=&@]

T1T;W`@=VED=&@]
T0S
M)3X@(`@(`T*(`@(`@(`@(`@/&1I=B!S='EL93TS1=415A4+4E.1$5.
M5#H@
'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2


T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E

'!T)SXF(S$X
SL\



05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
'!T.R!-05)'

M(`@(`\9F]N=!S='EL93TS1=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-








@870@1&5C96UB97(@
S$L(#(P
3
@;W(@
C`Q
BX@5&AE($-O

#$S(&]R(#(P


05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
'!T.R!-05)'

13H@:71A;&EC.R!$25-03$%9.B!I;FQI

M









;V-A=&EO;CH@
M9FEL93HO+R]#.B\R9&-D
S@X9E]D.6$T7S1B8C!?8C9A
U\W-3DU
61E8C1B



]


T0Q(')O
M=W-P86X]

]







]

'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.



3!P=#L@

M1$5.5#H@
'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@

T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
M63H@5&EM97

M86YY)W
@9FEN86YC:6%L('-T871E;65N='








@86YD(&%L;&]W(&ET('1O(&-O

M($1E8V5M8F5R(#


3
L

BP@=VAI8V@@
M:6YC;'5D97

M(&]P97)A=&EO;G


M($1)4U!
05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
'!T.R!-05)'24XM4DE'

T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&3TY4


M='


@

@=6YA


F1C9#
X.&9?

O4VAE970Q
M








3(@36]N=&AS($5N9&5D/]T
M:#X-B`@(`@(#PO='(^#0H@(`@(`\='(^#0H@(`@(`@(#QT:!C;&%S

S$L(#(P
3


]
T1T




05DZ(&EN;&EN93L@1D].5U&04U)
M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q
'!T.R!&3TY4+5=%

3L@24Y#3TU%(%1!6#PO9F]N=#X@


05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
'!T.R!-05)'24XM

#LF(S$V


N)B
Q-C`[)B
Q-C`[1&5F97)R960@=&%X(&QI86)I;&ET
2!D:69F

M96YC97

@

38P.R8C

M)B
Q-C`[)B
Q-C`[;V8F(S$V
#LF(S$V

38P.R8C
38P.W1H870F(S$V
#LF(S$V


M='


05DZ
M(&)L;V-K.R!-05)'24XM3$5&5#H@

@:7
@87
@9F]L;&]W

M861D:6YG/3-$

M5%1/33H@

M;CL@1D].5U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*(`@(`@(`@


05DZ(&EN;&EN
M93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
M

05DZ(&)L
M;V-K.R!-05)'24XM3$5&5#H@




T1B;W1T;VT@=VED=&@]
M
T0Q)2!S='EL93TS1=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/
M33H@,G!X)SX@(`T*(`@(`@(`@(`@(`\9F]N=!S='EL93TS1=$25-0

M3E0M4TE:13H@

M=&0^(`@(`T*(`@(`@(`@(#PO='(^(`-B`@(`@(`@(`\='(^(`T*
M(`@(`@(`@(`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#0W)2!S
M='EL93TS1=0041$24Y'+4)/5%1/33H@
G!X)SX@(`@#0H@(`@(`@(`@

6QE
M/3-$)T1)4U!
05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5U325I%.B`Q



05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
'!T.R!-05)'


C`Q
SPO9F]N=#X@#0H@(`@(`@(`@(`@(#PO
M9&EV/B`@#0H@(`@(`@(`@(`\+W1D/B`@(`-B`@(`@(`@(`@(#QT
M9!N;W=R87`]
T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
24@

T0G5$585U!3$E'3CH@;&5F=#L@4$%$1$E.1RU3U143TTZ(#)P

M(`-B`@(`@(`@(`@(#PO=&0^(`@(`T*(`@(`@(`@(`@/'1D('9A


38P.SPO
M9F]N=#X@(`@(`T*(`@(`@(`@(`@/]T9#X@(`@#0H@(`@(`@(`@


3!P=#L@1D].5U714E'
M2%0Z(&)O;&0G/C(P,3(\+V9O;G0^(`T*(`@(`@(`@(`@(`\+V1I=CX@
M(`T*(`@(`@(`@(`@/]T9#X@(`@#0H@(`@(`@(`@(`\=&0@;F]W



05DZ(&EN;&EN
M93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
M

M)SX@#0H@(`@(`@(`@(`\=&0@86QI9VX]
T1L969T('9A;&EG;CTS1&)O

M3BU

'!T)R!A;&EG;CTS1&QE9G0^




M)T1)4U!
05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5U325I%.B`Q
'!T)SXF(S$V
#L\+V9O;G0^(`T*(`@(`@(`@
M(`@/]T9#X@(`@#0H@(`@(`@(`@(`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$


S0N


T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E
63H@=&EM97


24=..B!L969T)SX@(`@(`T*(`@(`@(`@
M(`@(`\9F]N=!S='EL93TS1=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-


M+4%


M+4%

M)T1)4U!
05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5U325I%.B`Q
'!T)SXE/]F;VYT/B`@#0H@(`@(`@(`@(`\
M+W1D/B`@(`-B`@(`@(`@(`\+W1R/B`@#0H@(`@(`@(`@/'1R/B`-
MB`@(`@(`@(`@(#QT9!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M


05DZ(&EN;&EN
M93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
M
'!T)SY3=&%T92!T87@@97AP96YS92P@;F5T(&]F(&9E9&5R86P@8F5N969I
M=#PO9F]N=#X@(`@#0H@(`@(`@(`@(`@(#PO9&EV/B`@#0H@(`@(`@
M(`@(`\+W1D/B`@(`-B`@(`@(`@(`@(#QT9!A;&EG;CTS1&QE9G0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^(`@#0H@(`@(`@(`@(`@

05DZ(&EN;&EN93L@1D].5U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V
#L\+V9O
M;G0^(`T*(`@(`@(`@(`@/]T9#X@(`@#0H@(`@(`@(`@(`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$




05DZ(&EN;&EN93L@
M1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T
M)SXU+C8\+V9O;G0^(`@(`T*(`@(`@(`@(`@/]T9#X@(`@#0H@(`@

T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E
63H@=&EM97

M
38P.SPO9F]N=#X@#0H@(`@(`@(`@(`\+W1D/B`@(`-B`@(`@(`@
M(`@(#QT9!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M



T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E
63H@=&EM97

38P
M.SPO9F]N=#X@#0H@(`@(`@(`@(`\+W1D/B`@(`-B`@(`@(`@(`@
M(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q

T0G5$58

M;VUA;CL@1D].5U325I%.B`Q,'!T)SXU+C8\+V9O;G0^(`@(`T*(`@(`@




T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#0W)2!S='EL93TS1=0041$24Y'+4)/5%1/33H@,G!X)SX@(`T*(`@

M4U!
05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
'!T.R!-05)'24XM4DE'2%0Z


T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@







M4TE:13H@


M(&YE=R!R;VUA;CL@1D].5U325I%.B`Q,'!T)SXI/]F;VYT/B`@#0H@(`@
M(`@(`@(`\+W1D/B`@(`-B`@(`@(`@(`@(#QT9!A;&EG;CTS1&QE
M9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

T0G4$%$1$E.


Q-C`[/]F;VYT/B`-B`@(`@(`@
M(`@(#PO=&0^(`@(`T*(`@(`@(`@(`@/'1D('9A;&EG;CTS1&)O='1O


T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@
M=&EM97

38P.SPO9F]N
M=#X@#0H@(`@(`@(`@(`\+W1D/B`@(`-B`@(`@(`@(`@(#QT9!V
M86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q

T0G0D]21$52+4)/
M5%1/33H@8FQA8VL@
G!X('-O;&ED.R!415A4+4%


Y+C8\+V9O;G0^(`T*(`@(`@(`@(`@/]T9#X@(`@#0H@



M/3-$)T1)4U!
05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5U325I%.B`Q
'!T)SXI/]F;VYT/B`@#0H@(`@(`@(`@
M(`\+W1D/B`@(`-B`@(`@(`@(`\+W1R/B`@#0H@(`@(`@(`@/'1R
M/B`-B`@(`@(`@(`@(#QT9!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T





T1B;W1T;VT@=VED=&@]


05DZ(&EN;&EN93L@1D].5U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V
#L\
M+V9O;G0^(`T*(`@(`@(`@(`@/]T9#X@(`@#0H@(`@(`@(`@(`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$


M)SX@(`@(`T*(`@(`@(`@(`@(`\9F]N=!S='EL93TS1=$25-03$%9

M4TE:13H@

M=R!R;VUA;CL@1D].5U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*(`@

M
T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O

38P.SPO9F]N=#X@#0H@(`@(`@
M(`@(`\+W1D/B`@(`-B`@(`@(`@(`@(#QT9!V86QI9VX]
T1B;W1T
M;VT@=VED=&@]
T0Q)2!S='EL93TS1=3U)$15(M0D]45$]-.B!B;&%C:R`T


T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
M63H@=&EM97

38P.SPO
M9F]N=#X@#0H@(`@(`@(`@(`\+W1D/B`@(`-B`@(`@(`@(`@(#QT
M9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q

T0G0D]21$52

05DZ
M(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U3
M25I%.B`Q
'!T)SXM/]F;VYT/B`@#0H@(`@(`@(`@(`\+W1D/B`@(`-


M;&4]
T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W


M9F]N=!S='EL93TS1=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4


6EN9R!T:&4@<W1A='5T;W)Y(&EN8V]M


@8F5F;W)E(&EN8V]M92!T87@@87
@

M(&-E;&QP861D:6YG/3-$

6QE
M/3-$)T1)4U!
05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V
#L\+V9O;G0^(`@(`T*(`@


M
T1B;W1T;VT@=VED=&@]

T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@
G!X('-O;&ED)SX@(`@(`T*(`@(`@(`@(`@/&1I=B!S='EL
M93TS1=415A4+4E.1$5.5#H@
'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.


05DZ(&EN
M;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%
M.B`Q





M14E'2%0Z(&)O;&0G/B8C
38P.SPO9F]N=#X@(`-B`@(`@(`@(`\+W1D
M/B`@#0H@(`@(`@(#PO='(^(`@(`-B`@(`@(`@/'1R/B`@(`-B`@


05DZ(&EN;&EN93L@
M1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T
M)SXF(S$V
#L\+V9O;G0^(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@(`@
M(`@(`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^(`@#0H@(`@
M(`@(`@(`\9F]N=!S='EL93TS1=$25-03$%9.B!I;FQI;F4[($9/3E0M

3!P=#L@1D].
M5U714E'2%0Z(&)O;&0G/B8C,38P.SPO9F]N=#X@(`-B`@(`@(`@(`\


T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P

#$S/]F;VYT/B`@(`-B`@(`@


T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E
63H@=&EM97

M5T5)1TA4.B!B;VQD)SXF(S$V

05DZ(&EN
M;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%
M.B`Q


M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
3(E/B`-B`@(`@(`@(`@(#QD



M3E0M4TE:13H@

24=..B!L969T)SX@

38P.SPO9F]N=#X@(`-B`@
M(`@(`@(`\+W1D/B`@#0H@(`@(`@(#PO='(^(`@(`-B`@(`@(`@

M#0H@(`@(`@(`@/'1D(&%L:6=N/3-$;&5F=!V86QI9VX]
T1B;W1T;VT@
M=VED=&@]

1494.B`P



M('=I9'1H/3-$

M1D].5U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`@(`T*(`@(`@(`@
M(#PO=&0^(`-B`@(`@(`@(`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$



T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&

M05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5U325I%.B`Q
'!T)SXI/]F;VYT/B`@(`@#0H@(`@(`@(`@/]T9#X@
M(`T*(`@(`@(`@(#QT9!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$

T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&

38P.SPO9F]N=#X@(`@#0H@(`@(`@(`@
M/]T9#X@(`T*(`@(`@(`@(#QT9!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1=415A4+4%
24=..B!L969T)SX@(`-B`@(`@(`@

M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q,'!T)SXD/]F;VYT



24=..B!L969T



M86QI9VX]

M;VUA;CL@1D].5U325I%.B`Q,'!T)SY686QU871I;VX@86QL;W=A;F-E/]F
M;VYT/B`@(`@#0H@(`@(`@(`@(`\+V1I=CX@(`@(`T*(`@(`@(`@
M(#PO=&0^(`-B`@(`@(`@(`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$



T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E
63H@=&EM97

38P
M.SPO9F]N=#X@(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT


M



T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&

#DY+#(X
CPO9F]N=#X@(`-B`@(`@(`@

24=..B!L
M969T.R!0041$24Y'+4)/5%1/33H@

M9VX]
T1B;W1T;VT@=VED=&@]

Q-C`[/]F;VYT/B`@(`-B`@(`@(`@(`\+W1D

M;VUA;CL@1D].5U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`@(`T*(`@
M(`@(`@(#PO=&0^(`-B`@(`@(`@(`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$

U+#`U
SPO9F]N
M=#X@#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT9!N;W=R87`]
M
T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

T0G


T0G8F%C:V=R;W5N

M
T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#0W)2!S='EL93TS1=0
M041$24Y'+4)/5%1/33H@-'!X)SX@(`@(`T*(`@(`@(`@(`@/&1I=B!S

M(`@(`@(`@(#PO9&EV/B`@(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@
M(`@(`@(#QT9!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$



T1B;W1T;VT@=VED=&@]
T0Q)2!S='EL93TS1=3U)$

24=..B!L969T
M)SX@#0H@(`@(`@(`@(`\9F]N=!S='EL93TS1=$25-03$%9.B!I;FQI

M

M(`@(`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$






05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V
6QE/3-$
M)T1)4U!
05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5U325I%.B`Q
'!T)SXF(S$V

M(`@(`@(`\+W1D/B`@#0H@(`@(`@(`@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$Q)2!S='EL93TS1=3U)$15(M0D]45$]-.B!B;&%C:R`T








05DZ(&)L;V-K.R!-05)'24XM
M3$5&5#H@

05DZ(&EN;&EN93L@1D].
M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q
'!T)SY.




T1B;W1T;VT@=VED=&@]

T0G4$%$

M;VUA;CL@1D].5U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`@(`T*(`@
M(`@(`@(#PO=&0^(`-B`@(`@(`@(`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$



T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E
63H@=&EM97

M($9/3E0M5T5)1TA4.B!B;VQD)SXF(S$V


@;V8@1&5C96UB97(@
S$L

M9VX]
T1B;W1T;VT@=VED=&@]
T0Q)2!S='EL93TS1=415A4+4%,24=..B!L
M969T.R!0041$24Y'+4)/5%1/33H@,G!X)SX@(`@(`T*(`@(`@(`@(`@

T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@
M=&EM97

M.B!B;VQD)SXF(S$V

M(`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#0W)2!S='EL93TS1=0
M041$24Y'+4)/5%1/33H@

M;&4]
T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W

38P.SPO9F]N=#X@(`@#0H@
M(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT9!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1=0041$24Y'+4)/5%1/33H@
G!X)SX@
M#0H@(`@(`@(`@(`\9F]N=!S='EL93TS1=$25-03$%9.B!I;FQI;F4[

3!P
M=#L@1D].5U714E'2%0Z(&)O;&0G/B8C,38P.SPO9F]N=#X@(`-B`@(`@


05DZ(&)L;V-K.R!-05)'
M24XM3$5&5#H@

M(`@(`@(`@(#QT9!N;W=R87`]
T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$



Q


B!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q

M
T0G0D]21$52+4)/5%1/33H@8FQA8VL@
G!X('-O;&ED)SX@(`@(`T*(`@
M(`@(`@(`@/&1I=B!S='EL93TS1=415A4+4E.1$5.5#H@
'!T.R!$25-0
M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P


05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5U325I%.B`Q


M(`@(`\9F]N=!S='EL93TS1=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-

3!P=#L@1D].5U7
M14E'2%0Z(&)O;&0G/B8C,38P.SPO9F]N=#X@(`-B`@(`@(`@(`\+W1D




T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@
M=&EM97



Q-C`[/]F;VYT/B`@(`-


05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXS
CDL.3(S/]F;VYT/B`-B`@





05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V

M#0H@(`@(`@(`@(`\9F]N=!S='EL93TS1=$25-03$%9.B!I;FQI;F4[

3!P







X

M;VYS/]F;VYT/B`-B`@(`@(`@(`@(#PO9&EV/B`@(`@#0H@(`@(`@
M(`@/]T9#X@(`T*(`@(`@(`@(#QT9!A;&EG;CTS1')I9VAT('9A;&EG





T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P

38P.SPO9F]N=#X@(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@

C`L
#@T/]F;VYT/B`@
M(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT9!N;W=R87`]
M
T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

T0G

M(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT9!V86QI9VX]
T1B;W1T
M;VT@=VED=&@]

M;CL@1D].5U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`@(`T*(`@(`@
M(`@(#PO=&0^(`-B`@(`@(`@(`\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$



Q
M-C`[/]F;VYT/B`@(`-B`@(`@(`@(`\+W1D/B`@#0H@(`@(`@(`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$Q)2!S='EL93TS1=415A4
M+4%



T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&3TY4





M;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@#0H@
M(`@(`@(`@(`\9F]N=!S='EL93TS1=$25-03$%9.B!I;FQI;F4[($9/



M
T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O

38P.SPO9F]N=#X@(`@#0H@(`@

2PS.#0L
S(X/]F;VYT/B`@(`T*(`@(`@(`@(#PO=&0^(`-B`@
6QE/3-$)T1)4U!
05DZ(&EN;&EN93L@1D].
M5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF
M(S$V
#L\+V9O;G0^(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@(`@(`@
M(`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^(`@#0H@(`@(`@
M(`@(`\9F]N=!S='EL93TS1=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-




T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&

38P.SPO9F]N=#X@(`@#0H@(`@(`@(`@


3DT
M+#
Q
SPO9F]N=#X@#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT
M9!N;W=R87`]
T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
24@






M(`@(#QT9!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS


Q

MB`@(`@(`@(`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
3$E('-T

T+#
S-3PO9F]N=#X@(`@#0H@(`@


05DZ(&EN;&EN93L@1D].5U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXI/]F;VYT
M/B`@(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT9!A;&EG




M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@(`@(`@(`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$



24=..B!L969T.R!0041$24Y'
M+4)/5%1/33H@

M(`\+W1D/B`@#0H@(`@(`@(#PO='(^(`@(`-B`@(`@(`@/'1R('-T

T1B;W1T;VT@=VED=&@]
M




T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@

M87-S970\+V9O;G0^(`@#0H@(`@(`@(`@(`\+V1I=CX@(`@(`T*(`@
M(`@(`@(#PO=&0^(`-B`@(`@(`@(`\=&0@86QI9VX]
T1L969T('9A


M1D].5U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`@(`T*(`@(`@(`@
M(#PO=&0^(`-B`@(`@(`@(`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$

T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L

M;&4]
T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W


M(`@(`@(`@(`\9F]N=!S='EL93TS1=$25-03$%9.B!I;FQI;F4[($9/


Q-C`[




T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&3TY4+5-)


T1B;W1T;VT@
M=VED=&@]

M
T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O

38P.SPO9F]N=#X@(`@#0H@(`@

'!T.R!$25-0
M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P

T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N



M)#
L.3@V+#`P


2P@
C`S
RXF(S$V
#LF
M(S$V


M9'




M+R\O0SHO
F1C9#
X.&9?9#EA-%\T8F(P7V(V83-?-S4Y-3%D96(T8F(Y+U=O

O4VAE970Q
2YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D



T1T97AT

M:7

]


]
T1T:#Y$96
N
M(#



]
T1P


]


05DZ(&)L;V-K.R!-05)'24XM3$5&
M5#H@


T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@5&EM97
@

M)SY.3U1%(#4@)B
X
C$Q.R!#3TU-251-14Y44R!!3D0@0T].5$E.1T5.0TE%

13H@:71A;&EC

M86X[($9/3E0M4TE:13H@


05DZ(&)L;V-K.R!-
M05)'24XM3$5&5#H@



C`Q
BXF(S$V
#LF(S$V
#M4:&4@8F%S92!M;VYT
M:&QY(&]F9FEC92!F964@=6YD97(@=&AA=!A9W)E96UE;G0@=V%S(0R+#@Y
M.2XF(S$V
#LF(S$V

3
L('1H92!#



M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
'!T.R!-05)'24XM4DE'2%0Z(#!P

05DZ(&EN;&EN
M93L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q
M

34L(#(P
3(L('1H92!#;VUP86YY(&5N=&5R960@

M86EN97)S+B!4:&4@3&EC96YS92!!9W)E96UE;G0@9W)A;G1S('1H92!#;VUP






M;VX@=&AE($-O;7!A;GDF(S@R

Q-C`[1'5R:6YG
M('1H92!Y96%R(&5N9&5D(`-B`@(`@(`@1&5C96UB97(@
S$L(#(P
3
L

#LF(S$V


2PR-C4@9F]R(#(P
34L(0Q+#@U,!F;W(@
C`Q-BP@)#(L


F1C9#
X.&9?9#EA-%\T
M8F(P7V(V83-?-S4Y-3%D96(T8F(Y#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE
M.B\O+T
Z+S)D8V0S.#AF7V0Y831?-&)B




^+RH@1&\@3F]T(%)E;6]V92!4

$5-13X-B`@(`@(#QT

]






]
T1R;SX-

]


05DZ
M(&)L;V-K.R!-05)'24XM3$5&5#H@

T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E
63H@5&EM97

M($9/3E0M5T5)1TA4.B!B;VQD)SY.3U1%(#8@)B
X
C$Q.R!35$]#2TA/3$1%
M4E
F(S@R

M05DZ(&EN;&EN93L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].
M5U325I%.B`Q

@875T:&]R:7IE9`Q,PP
M
#`L


M(&-O;6UO;B!S=&]C:R`H)B
X
C(P.T-O;6UO;B!3=&]C:R8C.#(R



05DZ(&EN;&EN93L@1D].5U&04U)3%DZ
M(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V
#L\9F]N
M=!S='EL93TS1=&3TY4+5-464Q%.B!I=&%L:6
[($1)4U!
05DZ(&EN;&EN



05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
'!T

M86X[($9/3E0M4TE:13H@

3LI
M+B8C
38P.U1H92!N=6UB97(@;V8@875T:&]R:7IE9!S:&%R97,@86YD('1H
M92!P87(@=F%L=64@;V8@=&AE($-O;6UO;B!3=&]C:R!W97)E(&YO=!C:&%N
M9V5D+B8C
38P.R8C

M871E;65N='




05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
'!T.R!-05)'

M+5-464Q%.B!I=&%L:6
[($1)4U!
05DZ(&EN;&EN93L@1D].5U&04U)3%DZ
M(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q




05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
'!T.R!-05)'


M3E0M4TE:13H@

M(#$L
C4P+#`P
!S:&%R97,@;V8@:71S($-O;6UO;B!3=&]C:R`H=&AE(8C
M.#(R

C`Q



@;V8@0V]M;6]N(%-T;V-K

M('=H:6-H(&%M;W5N=!I;F-L=61E9`D
C`L
#`P(&]F(&YO=&5S(&]U='-T


M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
'!T.R!-05)'24XM4DE'2%0Z(#!P

M:6
[($1)4U!
05DZ(&EN;&EN93L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;CL@1D].5U325I%.B`Q
'!T)SY3=&]C:R!);F-E;G1I=F4@4&QA;G
\




05DZ(&)L;V-K.R!-
M05)'24XM3$5&5#H@

[($1)4U!
05DZ
M(&EN;&EN93L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U3
M25I%.B`Q


24=.
M.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@
'!T.R!$25-03$%9.B!B;&]C:SL@

T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
M63H@5&EM97


@96YD960@1&5C96UB97(@
S$L(#(P
3
@86YD(#(P
3(L('1H

M4W1O8VL@=&\@8V5R=&%I;B!O9B!I='





N)B
Q-C`[)B
Q
M-C`[)B


M86YC97


T0P('=I

M86X[($9/3E0M4TE:13H@

M(`@(`@(`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#0W)2!S='EL
M93TS1=0041$24Y'+4)/5%1/33H@
G!X)SX@(`T*(`@(`@(`@(`@/&9O

T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM
M97

38P.SPO9F]N=#X@
M(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT9!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1=0041$24Y'+4)/5%1/33H@
M
G!X)SX@#0H@(`@(`@(`@(`\9F]N=!S='EL93TS1=$25-03$%9.B!I

M13H@
3!P=#L@1D].5U714E'2%0Z(&)O;&0G/B8C,38P.SPO9F]N=#X@(`-


05DZ(&)L;V-K
M)SX@(`@(`T*(`@(`@(`@(`@(`F(S$V
#L@(`@(`T*(`@(`@(`@

T0G5$58

M(`@(`@(`@(`\9F]N=!S='EL93TS1=$25-03$%9.B!I;FQI;F4[($9/

3!P=#L@


T1B;W1T;VT@
M=VED=&@]

M
T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O

M
#L\+V9O;G0^(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT
M9!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1=0041$24Y'
M+4)/5%1/33H@
G!X)SX@#0H@(`@(`@(`@(`\9F]N=!S='EL93TS1=$

M($9/3E0M4TE:13H@

M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
'!T.R!-05)'24XM4DE'2%0Z(#!P


05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
'!T.R!-05)'24XM


24=..B!L969T.R!0041$24Y'+4)/5%1/
M33H@


T1B;W1T;VT@=VED
M=&@]



M4$Q!63H@8FQO8VL[($U!4D=)3BU

M


M86QA;F-E+!*86YU87)Y(#$L(#(P,3(\+V9O;G0^(`@(`-B`@(`@(`@
M(`@(#PO9&EV/B`@(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@
M(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q)2!S='EL93TS1=0041$
M24Y'+4)/5%1/33H@,G!X)SX@#0H@(`@(`@(`@(`\9F]N=!S='EL93TS

Q-C`[/]F;VYT/B`@(`-B`@(`@

M;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@(`@(`@(`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$




M13H@





M;CL@1D].5U325I%.B`Q,'!T)SXM/]F;VYT/B`@(`@#0H@(`@(`@(`@



05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V
#L\+V9O;G0^

M(`@(`@(`\='(^(`@(`T*(`@(`@(`@(#QT9!V86QI9VX]
T1B;W1T
M;VT@=VED=&@]
T0T-R4^(`@(`T*(`@(`@(`@(`@/&1I=B!S='EL93TS
M1=415A4+4E.1$5.5#H@
'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%


T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&3TY4+5-)6D4Z

38P.R8C
38P.R8C
38P.T=R86YT960\+V9O;G0^(`@#0H@
M(`@(`@(`@(`\+V1I=CX@(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@
M(`@(`@(`\=&0@86QI9VX]

M9#X@(`T*(`@(`@(`@(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q
M)2!S='EL93TS1=415A4+4%,24=..B!L969T)SX@(`-B`@(`@(`@(`@

05DZ(&EN;&EN93L@1D].5U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V
#L\+V9O

T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&


24=..B!L

Q-C`[/]F;VYT/B`@(`-B`@(`@(`@(`\+W1D

M(`@(`@(`@(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q)2!S='EL
M93TS1=415A4+4%,24=..B!L969T)SX@(`-B`@(`@(`@(`@(#QF;VYT

05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V

T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&3TY4+5-)



T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E
63H@=&EM97

M/B8C




M4U!
05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5U325I%.B`Q
'!T)SXF(S$V
#L\+V9O;G0^(`@(`T*(`@(`@(`@

M(`@(`\9F]N=!S='EL93TS1=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-



M)T1)4U!
05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5U325I%.B`Q
'!T)SXH
3`P+#`P
#PO9F]N=#X@(`T*(`@(`@




05DZ(&EN;&EN
M93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
M
'!T)SXF(S$V
#L\+V9O;G0^(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@





05DZ(&EN
M;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%
M.B`Q
'!T)SXQ+C
P/]F;VYT/B`@(`T*(`@(`@(`@(#PO=&0^(`-B`@
6QE/3-$)T1)4U!
05DZ(&EN;&EN93L@1D].
M5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF
M(S$V
#L\+V9O;G0^(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@(`@(`@

M86QI9VX]
T1B;W1T;VT@=VED=&@]


1494.B`P


M(`@(`@(`@(#PO9&EV/B`@(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@
M(`@(`@(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q)2!S='EL93TS
M1=0041$24Y'+4)/5%1/33H@,G!X)SX@#0H@(`@(`@(`@(`\9F]N=!S

Q-C`[/]F;VYT/B`@(`-



M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@(`@(`@(`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$



M3E0M4TE:13H@

6QE/3-$)T1)4U!
05DZ(&EN;&EN93L@1D].5U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V
#L\


T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P

38P.SPO9F]N=#X@(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@




05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V




M9VX]
T1J=7-T:69Y/B`@(`T*(`@(`@(`@(`@(`\9F]N=!S='EL93TS

M1&5C96UB97(@
S$L(#(P
3(\+V9O;G0^(`-B`@(`@(`@(`@(#PO9&EV
M/B`@(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT9!A;&EG




M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@(`@(`@(`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$






Q-C`[/]F;VYT/B`@(`-B`@
M(`@(`@(`\+W1D/B`@#0H@(`@(`@(`@/'1D(&%L:6=N/3-$;&5F=!V
M86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q)2!S='EL93TS1=0041$24Y'+4)/
M5%1/33H@,G!X)SX@(`@#0H@(`@(`@(`@(`\9F]N=!S='EL93TS1=$

M($9/3E0M4TE:13H@

M(`\+W1D/B`@#0H@(`@(`@(`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T



05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXD/]F;VYT/B`@(`@#0H@
M(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT9!V86QI9VX]
T1B;W1T
M;VT@=VED=&@]
T0Q

T0G0D]21$52+4)/5%1/33H@8FQA8VL@
M
G!X('-O;&ED.R!415A4+4%


05DZ(&EN;&EN93L@1D].5U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXQ+C

M#0H@(`@(`@(`@(`\9F]N=!S='EL93TS1=$25-03$%9.B!I;FQI;F4[

3!P



M/3-$)T1)4U!
05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V
#LF(S$V
#LF(S$V

M=&5D/]F;VYT/B`@(`T*(`@(`@(`@(`@/]D:78^(`@(`-B`@(`@


05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V


M



05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXV


M15A4+4%
24=..B!L969T)SX@(`@#0H@(`@(`@(`@(`\9F]N=!S='EL


M(`@/]T9#X@(`T*(`@(`@(`@(#QT9!V86QI9VX]
T1B;W1T;VT@=VED
M=&@]
T0Q)2!S='EL93TS1=415A4+4%,24=..B!L969T)SX@(`-B`@(`@

05DZ(&EN;&EN93L@1D].5U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V
M

M
T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O



T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&3TY4


M(#QT9!V86QI9VX],T1B;W1T;VT@=VED=&@],T0T-R4^(`@(`T*(`@(`@



05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V


M



05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXH.#@L


M15A4+4%
24=..B!L969T)SX@(`@#0H@(`@(`@(`@(`\9F]N=!S='EL


M3E0M4TE:13H@


T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
M63H@=&EM97

38P.SPO


2XT

24=..B!L969T

Q-C`[/]F;VYT/B`@(`-B`@(`@(`@(`\+W1D/B`@
M#0H@(`@(`@(#PO='(^(`@(`-B`@(`@(`@/'1R/B`@(`-B`@(`@



05DZ(&)L;V-K.R!-05)'
M24XM3$5&5#H@


M4TE:13H@

M/B`@(`@#0H@(`@(`@(`@(`\+V1I=CX@(`@(`T*(`@(`@(`@(#PO
M=&0^(`-B`@(`@(`@(`\=&0@86QI9VX]
T1R:6=H=!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1=0041$24Y'+4)/5%1/33H@
G!X

M(`T*(`@(`@(`@(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q)2!S

M04Q)1TXZ(&QE9G0G/B`@(`@#0H@(`@(`@(`@(`\9F]N=!S='EL93TS

Q-C`[/]F;VYT/B`@(`-B`@(`@

M/B`@#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT9!N;W=R87`]
M
T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

T0G

M(#QT9!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1=0041$
M24Y'+4)/5%1/33H@

M86X[($9/3E0M4TE:13H@




05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V
#L\+V9O;G0^




T1B;W1T;VT@=VED=&@]
T0Q)2!S

T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&3TY4+5-)




T0G


05DZ(&EN;&EN
M93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
M

2P@
C`Q
M
SPO9F]N=#X@(`T*(`@(`@(`@(`@/]D:78^(`@(`-B`@(`@(`@

M/3-$8F]T=&]M('=I9'1H/3-$


M05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5U325I%.B`Q
'!T)SXF(S$V
#L\+V9O;G0^(`@(`T*(`@(`@(`@(#PO

M;&4]
T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W



#@\


05DZ(&EN
M;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%
M.B`Q
'!T)SXF(S$V


05DZ(&EN;&EN93L@
M1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T
M)SXF(S$V

T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&3TY4


T1N;W=R87`@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$




M4D=)3BU

'!T)SX@(`T*(`@(`@

T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@
M5&EM97




RPQ

2P@
C`Q
R!A;F0@
C`Q

M96QY+B8C
38P.R8C
38P.T%S(&]F($1E8V5M8F5R(#
Q+`R,#$S+!T:&5R
M92!W87
@)#0L.38Q+#(P

L(')E

M
38P.R8C

65A<G
@
C`Q-!T:')O=6=H(#(P,38N/]F;VYT


M63H@:6YL:6YE.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&3TY4



05DZ(&)L;V-K.R!-05)'24XM
M3$5&5#H@

M=!S='EL93TS1=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE





#`P('-H87)E


M96YS92!O9B`D
34W+#4P



@:&%V92!N;W0@


24=..B!J
M=7-T:69Y.R!415A4+4E.1$5.5#H@
'!T.R!$25-03$%9.B!B;&]C:SL@34%2


T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@
M5&EM97

38P.T]N($]C
M=&]B97(@
RP@
C`Q

@86YD('-A

@86YD(&EN=F5S=&]R(')E

M:7-S=6%N8V4@;V8@-3`L

M;B!3=&]C:RXF(S$V
#LF(S$V




S$L(#(P
3

T0G

M63H@8FQO8VL[($U!4D=)3BU

'!T






B!D

C`Q
RXF(S$V
#LF(S$V

@9G5L;'D@=F5S



38P.R8C

#LF(S$V
#M4:&4@9V]A;'
@=V5R

#`@;V8@=&AE(&%D9&ET:6]N86P@
C`P+#`P
M


@:6X@8V]N;F5C=&EO
M;B!W:71H('1H:7

24=..B!J=7-T:69Y.R!415A4+4E.1$5.
M5#H@
'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2

T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&

@


@=&\@=&AE($-O;7!A;GD@:6X@;&EE=2!O9B!C87-H+B8C
M
38P.R8C

3
L('1H92!#;VUP86YY(&5N=&5R

@
M:6X@;&EE=2!O9B!C87-H+B8C
38P.R8C


S$L(#(P
3
@
M=V%S(#$Q+#(V

F1C9#
X.&9?9#EA
M-%\T8F(P7V(V83-?-S4Y-3%D96(T8F(Y#0I#;VYT96YT+4QO8V%T:6]N.B!F
M:6QE.B\O+T
Z+S)D8V0S.#AF7V0Y831?-&)B


3


^+RH@1&\@3F]T(%)E;6]V


$5-13X-B`@(`@

M


#$S/&)R



]






T0G1$E34$Q!63H@:6YL:6YE.R!&

38P.SPO9F]N=#X\9F]N=!S='EL93TS1=$
M25-03$%9.B!I;FQI;F4[($9/3E0M5T5)1TA4.B!B;VQD)SY.3U1%)B
Q-C`[
M-R`F(S@R
3$[(%-43T-+($]05$E/3E
\+V9O;G0^/]F;VYT/B`@(`T*(`@

13H@:71A;&EC.R!$25-03$%9.B!I;FQI;F4[

3!P


M/3-$)T1)4U!
05DZ(&EN;&EN93L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;CL@1D].5U325I%.B`Q
'!T)SY);B!*=6QY(#(P
3
L('1H92!#;VUP



M

C$P+#`P


M:&4@0V]M;6]N(%-T;V-K(&]N('1H92!D871E(&]F(&=R86YT+B!4:&4@;W!T


6QE/3-$)T1)
M4U!
05DZ(&EN;&EN93L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@
M1D].5U325I%.B`Q

M97


M25I%.B`Q
'!T.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N)SX@#0H@


M;CL@1D].5U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`@(`T*(`@(`@
M(`@(#PO=&0^(`-B`@(`@(`@(`\=&0@86QI9VX]
T1L969T('9A;&EG


M9'1H/3-$


M3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU

M($U!4D=)3BU224=(5#H@


38P.V]F/]F;VYT/B`@(`T*(`@

M


M

MB`@(`@(`@(`\=&0@86QI9VX]

M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@(`@(`@(`\
M=&0@86QI9VX]

M(&YE=R!R;VUA;CL@1D].5U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`@

M1#(@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$


M8VL[($U!4D=)3BU

'!T)R!A;&EG

M+3PO9F]N=#X@(`@#0H@(`@(`@(`@(`\+V1I=CX@(`@(`T*(`@(`@


Q

M1$E34$Q!63H@8FQO8VL[($U!4D=)3BU

M5#H@

M;&0G/B8C
38P.V5X97)C:7-E/]F;VYT/B`@(`T*(`@(`@(`@(`@/]D


M(`@(`\9F]N=!S='EL93TS1=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-

3!P=#L@1D].5U7
M14E'2%0Z(&)O;&0G/B8C,38P.W!R:6-E/]F;VYT/B`@(`@#0H@(`@(`@
M(`@(`\+V1I=CX@(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@(`@(`@
M(`\=&0@86QI9VX]

M;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@(`@(`@(`\=&0@86QI9VX]
M

M;CL@1D].5U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`@(`T*(`@(`@

M/3-$8F]T=&]M('=I9'1H/3-$
!S;VQI9<^(`@(`-B`@(`@(`@(`@(#QD:78@<W1Y
M;&4],T0G5$585U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)
M3BU

'!T)R!A;&EG;CTS1&-E;G1E


M8VL[($U!4D=)3BU

'!T)R!A;&EG

38P.W)E
M;6%I;FEN9SPO9F]N=#X@(`@#0H@(`@(`@(`@(`\+V1I=CX@(`@(`T*


Q-C`[8V]N=')A8W1U86PF(S$V
#MT97)M/]F;VYT/B`@(`@#0H@
M(`@(`@(`@(`\+V1I=CX@(`@(`T*(`@(`@(`@(`@/&1I=B!S='EL
M93TS1=415A4+4E.1$5.5#H@
'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.


05DZ(&EN
M;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%
M.B`Q

M:6=N/3-$=&]P('=I9'1H/3-$


T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&3TY4+5-)




T0G


05DZ(&)L;V-K
M.R!-05)'24XM3$5&5#H@

T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&

Q+`R
M,#$R/]F;VYT/B`@(`@#0H@(`@(`@(`@(`@(#PO9&EV/B`@#0H@(`@
M(`@(`@(`\+V1I=CX@(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@(`@
M(`@(`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$

T0G4$%$





T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&3TY4



05DZ(&)L
M;V-K.R!-05)'24XM3$5&5#H@





T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@

38P.SPO9F]N=#X@(`@
M#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT9!V86QI9VX],T1T
M;W`@=VED=&@],T0Q)2!S='EL93TS1=0041$24Y'+4)/5%1/33H@
G!X)SX@


T0G
M0D]21$52+4)/5%1/33H@8FQA8VL@



T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E
63H@=&EM97

M;G0^(`@(`T*(`@(`@(`@(`@(`\+V1I=CX@(`T*(`@(`@(`@(`@
M/]D:78^(`@(`-B`@(`@(`@(`\+W1D/B`@#0H@(`@(`@(`@/'1D


05DZ(&)L;V-K.R!-
M05)'24XM3$5&5#H@

M(`@(`@(`@/&1I=B!S='EL93TS1=415A4+4%
24=..B!R:6=H=#L@5$58

M9F]N=!S='EL93TS1=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T


M#0H@(`@(`@(`@(`@(#PO9&EV/B`@#0H@(`@(`@(`@(`\+V1I=CX@



M13H@

M
T1T;W`@=VED=&@]

05DZ(&EN
M;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%
M.B`Q
'!T)SXF(S$V




M15A4+4E.1$5.5#H@
'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z

M('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q,'!T)SXM/]F;VYT/B`@
M(`-B`@(`@(`@(`@(`@/]D:78^(`-B`@(`@(`@(`@(#PO9&EV
M/B`@(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT9!V86QI
M9VX],T1T;W`@=VED=&@],T0Q)2!S='EL93TS1=0041$24Y'+4)/5%1/33H@
M

M(`@(`@(#QT9!V86QI9VX],T1B;W1T;VT@=VED=&@],T0S,R4^(`@(`T*

M3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU

M($U!4D=)3BU224=(5#H@
'!T)R!A;&EG;CTS1&QE9G0^(`-B`@(`@(`@

M;G1E9#PO9F]N=#X@(`@(`T*(`@(`@(`@(`@(`\+V1I=CX@(`T*(`@
M(`@(`@(`@/]D:78^(`@(`-B`@(`@(`@(`\+W1D/B`@#0H@(`@






M;VYT/B`@(`-B`@(`@(`@(`\+W1D/B`@#0H@(`@(`@(`@/'1D('9A


#`\+V9O;G0^(`@(`-
MB`@(`@(`@(`@(`@/]D:78^(`-B`@(`@(`@(`@(#PO9&EV/B`@
M(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT9!V86QI9VX]
M
T1T;W`@=VED=&@]

M(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT9!V86QI9VX]
T1T;W`@
M=VED=&@]

M(`@/]T9#X@(`T*(`@(`@(`@(#QT9!V86QI9VX]
T1T;W`@=VED=&@]
M
T0Q)3X@(`@(`T*(`@(`@(`@(`@/&1I=B!S='EL93TS1=415A4+4E.
M1$5.5#H@
'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@

M;&4]


M13H@

M#0H@(`@(`@(`@(`\+V1I=CX@(`@(`T*(`@(`@(`@(#PO=&0^(`-
MB`@(`@(`@(`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$,3$E/B`-B`@

M4$Q!63H@8FQO8VL[($U!4D=)3BU

M

T1R:6=H=#X@(`-B`@(`@(`@

BXP
M-SPO9F]N=#X@(`T*(`@(`@(`@(`@(`\+V1I=CX@(`T*(`@(`@(`@








05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
'!T



M($9/3E0M4TE:13H@

M(#PO9&EV/B`@#0H@(`@(`@(`@(`\+V1I=CX@(`@(`T*(`@(`@(`@

T0G

M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
S
E/B`@(`-B`@(`@(`@

M8FQO8VL[($U!4D=)3BU

'!T)SX@


M/]D:78^(`@(`-B`@(`@(`@(`\+W1D/B`@#0H@(`@(`@(`@/'1D

M9F]N=!S='EL93TS1=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T


M/B`@(`-B`@(`@(`@(`\+W1D/B`@#0H@(`@(`@(`@/'1D('9A;&EG




M=B!S='EL93TS1=415A4+4%,24=..B!R:6=H=#L@5$585U)3D1%3E0Z(#!P
M=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU

M24=(5#H@
'!T)SX@(`-B`@(`@(`@(`@(`@(`\9F]N=!S='EL93TS

M(`@(#PO9&EV/B`@#0H@(`@(`@(`@(`\+V1I=CX@(`@(`T*(`@(`@
M(`@(#PO=&0^(`-B`@(`@(`@(`\=&0@=F%L:6=N/3-$=&]P('=I9'1H
M/3-$

M05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5U325I%.B`Q
'!T)SXF(S$V
#L\+V9O;G0^(`@(`T*(`@(`@(`@(#PO

MB`@(`@(`@(`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$
24^(`@(`-



05DZ(&)L;V-K
M.R!-05)'24XM3$5&5#H@


3!P


M8FQO8VL[($U!4D=)3BU

'!T)SX@


05DZ(&EN;&EN93L@1D].5U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXM/]F
M;VYT/B`@(`-B`@(`@(`@(`@(`@/]D:78^(`-B`@(`@(`@(`@
M(#PO9&EV/B`@(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT
M9!V86QI9VX]
T1T;W`@=VED=&@]

M9VX]
T1T;W`@=VED=&@]

M#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT9!V86QI9VX]
T1T
M;W`@=VED=&@]

T1T;W`@=VED
M=&@]
T0Q

M4U!
05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
'!T.R!-05)'24XM4DE'2%0Z



Q-C`[/]F;VYT/B`@(`-B`@(`@(`@(`\+W1D/B`@
M#0H@(`@(`@(#PO='(^(`@(`-B`@(`@(`@/'1R/B`@(`-B`@(`@
M(`@(`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
S



05DZ(&)L;V-K.R!-05)'
M24XM3$5&5#H@

'!T.R!$25-03$%9


M;VUA;CL@1D].5U325I%.B`Q,'!T)SY/=71S=&%N9&EN9R!A=!$96-E;6)E

2P@
C`Q
SPO9F]N=#X@(`@(`T*(`@(`@(`@(`@(`\+V1I=CX@

M
T1T;W`@=VED=&@]
T0Q)2!S='EL93TS1=3U)$15(M0D]45$]-.B!B;&%C

M;CL@1D].5U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`@(`T*(`@(`@
M(`@(#PO=&0^(`-B`@(`@(`@(`\=&0@=F%L:6=N/3-$=&]P('=I9'1H
M/3-$


M3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU

M4D=)3BU224=(5#H@

T1R:6=H=#X@

C$P+#`P
#PO9F]N=#X@(`@(`T*(`@(`@(`@(`@(`\


M86QI9VX]
T1T;W`@=VED=&@]

M05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5U325I%.B`Q
'!T)SXF(S$V
#L\+V9O;G0^(`@(`T*(`@(`@(`@(#PO


M($1)4U!
05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
'!T.R!-05)'24XM4DE'

M+4E.1$5.5#H@
'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P




M1$E34$Q!63H@8FQO8VL[($U!4D=)3BU

M5#H@

M;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q,'!T)SXR+C`W/]F;VYT/B`@
M#0H@(`@(`@(`@(`@(#PO9&EV/B`@#0H@(`@(`@(`@(`\+V1I=CX@



M13H@

M
T1T;W`@=VED=&@]

05DZ(&EN
M;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%
M.B`Q
'!T)SXF(S$V




M4U!
05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
'!T.R!-05)'24XM4DE'2%0Z

M=!S='EL93TS1=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE




T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&3TY4+5-)6D4Z




M1$E34$Q!63H@8FQO8VL[($U!4D=)3BU

M5#H@

M1&5C96UB97(@
S$L(#(P
3
\+V9O;G0^(`@(`-B`@(`@(`@(`@(`@
M/]D:78^(`-B`@(`@(`@(`@(#PO9&EV/B`@(`@#0H@(`@(`@(`@
M/]T9#X@(`T*(`@(`@(`@(#QT9!V86QI9VX]
T1T;W`@=VED=&@]
T0Q

M(`T*(`@(`@(`@(#QT9!V86QI9VX]
T1T;W`@=VED=&@]

T1T;W`@=VED=&@]
T0Q
24^(`T*(`@(`@


05DZ(&)L;V-K.R!-05)'
M24XM3$5&5#H@






M;&4]
T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W


M='EL93TS1=415A4+4%,24=..B!R:6=H=#L@5$585U)3D1%3E0Z(#!P=#L@
M1$E34$Q!63H@8FQO8VL[($U!4D=)3BU

M5#H@

M

05DZ
M(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U3
M25I%.B`Q
'!T)SXF(S$V
#L\+V9O;G0^(`@(`T*(`@(`@(`@(#PO=&0^
M(`-B`@(`@(`@(`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$,24^(`@


05DZ(&EN;&EN93L@1D].
M5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF
M(S$V
#L\+V9O;G0^(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@(`@(`@

M8VL[($U!4D=)3BU

'!T)SX@(`T*

05DZ(&EN;&EN93L@1D].5U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXM/]F;VYT
M/B`@(`-B`@(`@(`@(`@(`@/]D:78^(`-B`@(`@(`@(`@(#PO
M9&EV/B`@(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT9!V
M86QI9VX]
T1T;W`@=VED=&@]


@;V8@1&5C96UB
M97(@
S$L(#(P
3

Q-C`[;V8@=&]T86P@



M(#(P


M4U!
05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
'!T.R!-05)'24XM4DE'2%0Z


M

M(S$V
#LF(S$V

M='




2P@
C`Q
R!A;F0@
C`Q



24=..B!J=7-T
M:69Y.R!415A4+4E.1$5.5#H@
'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.


T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@5&EM
M97







M3TY4+49!34E
63H@=&EM97

M($9/3E0M4TE:13H@



M=!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1=0041$24Y'
M+4)/5%1/33H@
G!X)SX@(`@#0H@(`@(`@(`@(`\9F]N=!S='EL93TS

Q-C`[/]F;VYT/B`@(`-B`@(`@


05DZ(&)L;V-K.R!-05)'
M24XM3$5&5#H@

T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&3TY4+5-)6D4Z


M(`@/'1D(&%L:6=N/3-$;&5F=!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0T



05DZ(&EN;&EN93L@1D].5U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V
M


05DZ(&EN;&EN93L@1D].5U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V
#L\+V9O
!S;VQI9<^(`@(`-B`@(`@



3!P=#L@1D].5U714E'2%0Z(&)O;&0G/C(P
M,3,\+V9O;G0^(`@(`T*(`@(`@(`@(`@/]D:78^(`@(`-B`@(`@
M(`@(`\+W1D/B`@#0H@(`@(`@(`@/'1D(&%L:6=N/3-$;&5F=!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1=0041$24Y'+4)/5%1/
M33H@

Q-C`[/]F;VYT/B`@(`-B`@(`@(`@(`\
M+W1D/B`@#0H@(`@(`@(`@/'1D(&%L:6=N/3-$;&5F=!V86QI9VX]
T1B
M;W1T;VT@=VED=&@]
T0Q)2!S='EL93TS1=0041$24Y'+4)/5%1/33H@,G!X
M)SX@(`@#0H@(`@(`@(`@(`\9F]N=!S='EL93TS1=$25-03$%9.B!I

M13H@

T0R('9A;&EG;CTS1&)O='1O;2!W



T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E
63H@=&EM97

M3E0M5T5)1TA4.B!B;VQD)SXR
#$R/]F;VYT/B`@(`-B`@(`@(`@(`@
M(#PO9&EV/B`@(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT


T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@
M=&EM97

38P.SPO9F]N


M4D=)3BU

'!T)R!A;&EG;CTS1&QE

M05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5U325I%.B`Q
'!T)SXF(S$V
#L\+V9O;G0^(`@(`T*(`@(`@(`@(#PO
M=&0^(`-B`@(`@(`@(`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24^(`@#0H@(`@(`@(`@(`\9F]N=!S='EL93TS1=$25-03$%9.B!I

M13H@





05DZ(&EN;&EN93L@1D].5U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXE/]F
M;VYT/B`@(`-B`@(`@(`@(`@(`@/]D:78^(`-B`@(`@(`@(`@
M(#PO9&EV/B`@(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT
M9!V86QI9VX]
T1B;W1T;VT@=VED=&@]

M('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@(`@(`@(`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$

Q-C`[/]F;VYT/B`@
M(`-B`@(`@(`@(`\+W1D/B`@#0H@(`@(`@(`@/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$Q)3X@(`@#0H@(`@(`@(`@(`\9&EV('-T

05DZ(&)L;V-K.R!-05)'
M24XM3$5&5#H@

'!T.R!$25-03$%9


M;&4]
T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W

M(`@(`@(`\+W1D/B`@#0H@(`@(`@(`@/'1D('9A;&EG;CTS1&)O='1O

T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N



05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
'!T.R!-05)'

'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%



M(`@/]T9#X@(`T*(`@(`@(`@(#QT9!V86QI9VX]
T1B;W1T;VT@=VED
M=&@]

M5U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`@(`T*(`@(`@(`@(#PO
M=&0^(`-B`@(`@(`@(`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M

M3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU

M4D=)3BU224=(5#H@

T1R:6=H=#X@

3PO9F]N=#X@(`@#0H@(`@(`@(`@(`@(#PO9&EV/B`@
M#0H@(`@(`@(`@(`\+V1I=CX@(`@(`T*(`@(`@(`@(#PO=&0^(`-
MB`@(`@(`@(`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

Q-C`[/]F;VYT/B`@(`-B`@(`@(`@(`\+W1D/B`@#0H@(`@
M(`@(`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@(`T*(`@

T1B;W1T;VT@=VED=&@]
T0Q)3X@(`-B`@(`@(`@

M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@(`@(`@(`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

M8VL[($U!4D=)3BU

'!T)SX@(`T*


M/3-$8F]T=&]M('=I9'1H/3-$
24^(`@#0H@(`@(`@(`@(`\9F]N=!S

Q-C`[/]F;VYT/B`@(`-
MB`@(`@(`@(`\+W1D/B`@#0H@(`@(`@(#PO='(^(`@(`-B`@(`@

M(`@#0H@(`@(`@(`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#0W


05DZ(&EN;&EN
M93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
M

M(`@(`@(#PO9&EV/B`@#0H@(`@(`@(`@(`\+V1I=CX@(`@(`T*(`@
M(`@(`@(#PO=&0^(`-B`@(`@(`@(`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24^(`@#0H@(`@(`@(`@(`\9F]N=!S='EL93TS1=$

M($9/3E0M4TE:13H@

M(`\+W1D/B`@#0H@(`@(`@(`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T

T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&3TY4



'!T)R!A;&EG;CTS1')I9VAT/B`@

M#0H@(`@(`@(`@(`\+V1I=CX@(`@(`T*(`@(`@(`@(#PO=&0^(`-
MB`@(`@(`@(`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^(`@

M($1)4U!
05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
'!T.R!-05)'24XM4DE'

M+4E.1$5.5#H@
'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P



05DZ(&EN;&EN93L@1D].5U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V
#L\
M+V9O;G0^(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@(`@(`@(`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^(`@#0H@(`@(`@(`@(`\
M9F]N=!S='EL93TS1=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T


M/B`@(`-B`@(`@(`@(`\+W1D/B`@#0H@(`@(`@(`@/'1D('9A;&EG





05DZ(&EN
M;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%
M.B`Q
'!T)SY$:79I9&5N9!Y:65L9#PO9F]N=#X@(`T*(`@(`@(`@(`@
M(`\+V1I=CX@(`T*(`@(`@(`@(`@/]D:78^(`@(`-B`@(`@(`@
M(`\+W1D/B`@#0H@(`@(`@(`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T

T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&3TY4


05DZ(&EN
M;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%
M.B`Q
'!T)SXF(S$V



05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M


3!P

M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
'!T.R!-05)'24XM4DE'2%0Z(#!P

M5#H@
'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2


M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q,'!T)SXE/]F;VYT
M/B`@(`-B`@(`@(`@(`@(`@/]D:78^(`-B`@(`@(`@(`@(#PO
M9&EV/B`@(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT9!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`-B`@(`@(`@(`@(#QF

05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V
#L\+V9O;G0^







M
3
@86YD(#(P
3(@87)E(&%S(&9O;&QO=W

M(`T*(`@(`@(`@(#QT9!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M


Q-C`[/]F;VYT/B`@(`-B`@(`@(`@(`\+W1D/B`@#0H@
6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S

!S;VQI9<^



3!P=#L@1D].5U714E'
M2%0Z(&)O;&0G/C(P,3,\+V9O;G0^(`@(`T*(`@(`@(`@(`@/]D:78^
M(`@(`-B`@(`@(`@(`\+W1D/B`@#0H@(`@(`@(`@/'1D(&YO=W)A

24=..B!L969T.R!0041$24Y'+4)/5%1/33H@

T1B;W1T;VT@
M=VED=&@]

38P.SPO9F]N=#X@(`-B`@(`@(`@
M(`\+W1D/B`@#0H@(`@(`@(`@/'1D(&-O;'-P86X]
T0R('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$R)2!S='EL93TS1=3U)$15(M0D]45$]-.B!B

T1C96YT97(^

T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&3TY4+5-)6D4Z

#$R/]F;VYT/B`@(`-B`@
M(`@(`@(`@(#PO9&EV/B`@(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@
6QE/3-$
M)T1)4U!
05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5U325I%.B`Q




1494


M

M(`@(`@(`@(#PO9&EV/B`@(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@
M(`@(`@(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q)3X@(`-B`@


T0G5$58


Q-C`[/]F;VYT/B`@(`-B`@(`@
M(`@(`\+W1D/B`@#0H@(`@(`@(`@/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$Q)2!S='EL93TS1=415A4+4%


T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
M63H@=&EM97

38P.SPO
M9F]N=#X@(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT9!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`-B`@(`@(`@(`@(#QF

05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V
#L\+V9O;G0^



M13H@



05DZ(&EN;&EN93L@1D].5U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXM/]F;VYT/B`@
M(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT9!N;W=R87`]
M
T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

T0G

M(`@(`@(`@/]T9#X@(`T*(`@(`@(`\+W1R/B`@(`@#0H@(`@(`@


Q-C`[/]F;VYT/B`@(`-B`@(`@(`@(`\

M(`T*(`@(`@(`@(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q)2!S
M='EL93TS1=415A4+4%,24=..B!L969T)SX@(`-B`@(`@(`@(`@(#QF

05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V
#L\+V9O;G0^

T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&3TY4


T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&3TY4+5-)6D4Z

38P.SPO9F]N=#X@(`@#0H@(`@(`@(`@/]T9#X@(`T*
M(`@(`@(`@(#QT9!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`-

05DZ(&EN;&EN93L@
M1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T
M)SXF(S$V



M(`@(`@(`\+W1D/B`@#0H@(`@(`@(`@/'1D('9A;&EG;CTS1&)O='1O

05DZ(&EN;&EN
M93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
M
'!T)SXF(S$V
#L\+V9O;G0^(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@
6QE/3-$)T1)4U!
05DZ(&EN;&EN93L@1D].
M5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF
M(S$V
#L\+V9O;G0^(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@(`@(`@


M;&4]


05DZ
M(&)L;V-K.R!-05)'24XM3$5&5#H@

M
T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O


M/B`@#0H@(`@(`@(`@(`\+V1I=CX@(`@(`T*(`@(`@(`@(#PO=&0^
M(`-B`@(`@(`@(`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^
M(`@#0H@(`@(`@(`@(`\9F]N=!S='EL93TS1=$25-03$%9.B!I;FQI

M

M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*(`@(`@(`@(`@/&9O;G0@

T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@



6QE/3-$)T1)4U!
05DZ(&EN;&EN93L@1D].
M5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF
M(S$V
#L\+V9O;G0^(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@(`@(`@
M(`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^(`@#0H@(`@(`@
M(`@(`\9F]N=!S='EL93TS1=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-




T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&

38P.SPO9F]N=#X@(`@#0H@(`@(`@(`@




05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V
#L\+V9O;G0^

M(`@(`@(`\='(^(`@(`T*(`@(`@(`@(#QT9!V86QI9VX]
T1B;W1T
M;VT@=VED=&@]

T1B;W1T;VT@
M=VED=&@]

M1D].5U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`@(`T*(`@(`@(`@
M(#PO=&0^(`-B`@(`@(`@(`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$


Q-C`[
M/]F;VYT/B`@(`-B`@(`@(`@(`\+W1D/B`@#0H@(`@(`@(`@/'1D
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$Q)2!S='EL93TS1=415A4+4%

M;CL@1D].5U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`@(`T*(`@(`@



M5U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`@(`T*(`@(`@(`@(#PO
M=&0^(`-B`@(`@(`@(`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M

Q-C`[/]F;VYT/B`@(`-B`@(`@(`@(`\+W1D/B`@

M
T1B;W1T;VT@=VED=&@]
T0Q



M4TE:13H@

24=..B!L969T)SX@

Q-C`[/]F;VYT/B`@(`-B`@(`@(`@(`\+W1D/B`@#0H@


Q-C`[/&9O;G0@

T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@


M(#PO=&0^(`-B`@(`@(`@(`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24^(`@#0H@(`@(`@(`@(`\9F]N=!S='EL93TS1=$25-03$%9

M4TE:13H@



T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@
M=&EM97

24=..B!R:6=H

M
BXP-SPO9F]N=#X\+V9O;G0^(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@
6QE/3-$)T1)4U!
05DZ(&EN;&EN93L@1D].
M5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF
M(S$V
#L\+V9O;G0^(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@(`@(`@
M(`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^(`@#0H@(`@(`@
M(`@(`\9F]N=!S='EL93TS1=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-




T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&

38P.SPO9F]N=#X@(`@#0H@(`@(`@(`@




05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V
#L\+V9O;G0^



F1C9#
X.&9?9#EA-%\T8F(P7V(V83-?-S4Y-3%D
M96(T8F(Y#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T
Z+S)D8V0S.#AF
M7V0Y831?-&)B

M



^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\




S$L(#(P
M
3




T1T;W`^




24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@
'!T.R!$
M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4

T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z

3(L(#(P
3
L('1H92!#;VUP86YY(&5N=&5R




M86QU92`D
XP,#$@*8C.#(R
#M397)I97

M(S@R

#LF
M(S$V

M='

S0L(&EN8VQU9&EN9R`D






M;VUP86YY)B
X
C$W.W
@0V]M;6]N(%-T;V-K(&1E=&5R;6EN960@8GD@9&EV



T0G5$58

M8FQO8VL[($U!4D=)3BU

'!T)SX@









05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
'!T.R!-05)'


M3E0M4TE:13H@



@;V8@
M1&5C96UB97(@
S$L(#(P
3
@86YD(#(P

M:&%R97

;V-A=&EO
M;CH@9FEL93HO+R]#.B\R9&-D
S@X9E]D.6$T7S1B8C!?8C9A
U\W-3DU
61E



]

T0Q
M(')O=W-P86X]

M4D%.4T%#5$E/3E


]

@6T%B


M

]



05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
'!T.R!-05)'


2P@
C`Q




M960@)#$X-RPU
#`@:6X@;F]T97

#$S

M;V8@)#4P+#`P



05DZ(&)L;V-K
M.R!-05)'24XM3$5&5#H@

M(`@(`\9F]N=!S='EL93TS1=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-



M('-E8W5R:71I97
@:7-S=65D(&)Y('1H92!#;VUP86YY(&EN(&-O;FYE8W1I


#LF(S$V
#M4:&4@8V]N=F5R




M+#(V
2!W87

M
R!W87

05DZ(&EN;&EN93L@1D].
M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q
'!T)SY$

S$L(#(P
3
L('1H92!#


2PR
#`@86YD(0R,PP
#`@=V%S(&-O;G9E


M(%-T;V-K(&%N9`U,PP


M+4%
24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@
'!T.R!$25-03$%9.B!B


T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E
63H@5&EM97

M($1E8V5M8F5R(#(P
3
L('1H92!#;VUP86YY(')E8V5I=F5D(0R-PP
#`@

38P.R8C




F1C9#
X.&9?9#EA-%\T8F(P7V(V83-?-S4Y-3%D
M96(T8F(Y#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T
Z+S)D8V0S.#AF
M7V0Y831?-&)B

M



^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\






]

M='

M86QI9VX]

M9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=B!S='EL93TS1=4
M15A4+4%
24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@
'!T.R!$25-03$%9


T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E
63H@5&EM97

M($9/3E0M5T5)1TA4.B!B;VQD)SY.3U1%(#$P(8C.#(Q,3L@4U54T51545.

24=..B!J=7-T:69Y.R!415A4+4E.1$5.5#H@
'!T.R!$
M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4

T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z

M=!S='EL93TS1=&3TY4+5-464Q%.B!I=&%L:6
[($1)4U!
05DZ(&EN;&EN

X



M8VEA;!S=&%T96UE;G1S(&%S(&]F($1E8V5M8F5R(#,Q+`R
#$S+B!);B!P



M4U!
05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
'!T.R!-05)'24XM4DE'2%0Z


M


#`@9G)O;2!A8V-R

#LF(S$V
#M);B!O;F4@;V8@=&AE(&]F



#`N)B
Q-C`[)B
Q-C`[1F]R(&5A



M9`Q+#`Y.PY


#`N)B
Q-C`[)B
Q
M-C`[5&AE(&EN=F5S=&]R(&EN('1H92!C;VYC=7)R96YT(&]F9F5R:6YG(&1I



M3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU

M($U!4D=)3BU224=(5#H@


C`Q

@86YD(&1I






05DZ(&)L;V-K
M.R!-05)'24XM3$5&5#H@

M(`@(`\9F]N=!S='EL93TS1=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-


M;&4]

M1$E34$Q!63H@8FQO8VL[($U!4D=)3BU

M5#H@




T0G5$58

M8FQO8VL[($U!4D=)3BU

'!T)SX@



@;W(@;6%T97)I86QL

M(&%N;FEV97)S87)Y('1H97)E;V8N)B
Q-C`[)B
Q-C`[5&AE(&%G9W)E9V%T

C8P+#`P


M871I;VXZ(&9I;&4Z+R\O0SHO
F1C9#
X.&9?9#EA-%\T8F(P7V(V83-?-S4Y

O4VAE970Q-RYH=&UL#0I#;VYT96YT+51R





M;W0@4F5M;W9E(%1H:7


M86X]
T0Q(')O=W-P86X]



3(@36]N=&AS($5N

S$L(#(P
3







05DZ(&EN;&EN93L@1D].5U&04U)
M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q
'!T)SY4:&4@8V]N



@

M9FEN86YC:6%L('-T871E;65N='

@8V]U;&0@9&EF9F5R(&9R;VT@=&AO


M:79A;&5N='






]
T1P;!V86QI9VX],T1T;W`^26YV96YT;W)Y+!0
'0^)SQD:78@<W1Y;&4],T0G5$585U!3$E'3CH@:G5S=&EF



M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
'!T.R!-05)'24XM4DE'2%0Z(#!P


3!P

M1&5C96UB97(@
S$L(#(P
3
@86YD(#(P
3(L(&EN=F5N=&]R:65S(&-O;G-I


]

]


05DZ(&)L
M;V-K.R!-05)'24XM3$5&5#H@

13H@:71A;&EC.R!$25-03$%9.B!I;FQI

M

24=..B!J=7-T:69Y.R!415A4
M+4E.1$5.5#H@
'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P

M
T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O


]
M







2PU-3






'!T)SX\9F]N=!S='EL93TS1=&
M3TY4+5-464Q%.B!I=&%L:6
[($1)4U!
05DZ(&EN;&EN93L@1D].5U&04U)
M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q
'!T)SY2979E;G5E
6QE/3-$)T1)4U!
05DZ(&EN
M;&EN93L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%
M.B`Q




38P
M.R8C





T0G1D].

@


M=&EN9R!3=&%N9&%R9'

@0V]D
M:69I8V%T:6]N(@F(S@R,C`[05-#)B,X,C(Q.RD@5&]P:6,@,C8P+`F(S@R
M


#LF(S$V

@:7
@
M8F%S960@;VX@=&AE('=E:6=H=&5D(&%V97)A9V4@;G5M8F5R(&]F('-H87)E


N(%1H92!C;VYV97)S

M:&%R97

M(#


]

'0^)SQD:78@<W1Y;&4],T0G5$585U)3D1%3E0Z(#!P=#L@1$E34$Q!

M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@5&EM97
@3F5W(%)O;6%N





#L\9F]N=!S='EL93TS1=&3TY4
M+5-464Q%.B!I=&%L:6
[($1)4U!

M='


'0^)SQD:78@<W1Y;&4]

13H@:71A;&EC.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9


T1J=7-T:69Y/B`@

T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E
63H@5&EM97


@=6YD97(@05-#




@;V8@87-S



T1J=7-T:69Y/B`@

T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E
63H@5&EM97





05DZ(&EN;&EN93L@1D].5U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q

M;W(@=&AE('EE87)S(&9R;VT@
C`P.2!T;R`R
#$S(&%R92!S=6)J96-T('1O



M1$5.5#H@
'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@

[($1)4U!
05DZ(&EN;&EN93L@1D].
M5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5U325I%.B`Q
'!T)SY3
M=&]C:RU87-E9!#;VUP96YS871I;VX\+V9O;G0^(`@(`T*(`@(#PO9&EV
6QE/3-$)T1)
M4U!
05DZ(&EN;&EN93L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@
M1D].5U325I%.B`Q
'!T)SY!4T
@5&]P:6

13H@:71A;&EC.R!$25-03$%9.B!I;FQI;F4G

M=#XF(S@R







6QE/3-$
M)T1)4U!
05DZ(&EN;&EN93L@1D].5U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;CL@1D].5U325I%.B`Q
'!T)SY!4T
@5&]P:6



38P.V]F($%3
M0R!4;W!I8R`W


L('1H92!C;VUP86YY('5S97
@=&AE(&9A:7(@=F%L=64@;65T:&]D



]
M

M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
'!T.R!-05)'24XM4DE'2%0Z(#!P




M13H@




M3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU

M($U!4D=)3BU224=(5#H@




M

3L@=VAI8V@@97-T86)L


M=F%L=64@87




M
'!T.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N)SX@(`T*(`@(`@
M(`\='(^(`@(`T*(`@(`@(`@(#QT9!V86QI9VX]
T1T;W`@=VED=&@]
M

M9#X@(`T*(`@(`@(`@(#QT9!V86QI9VX]
T1T;W`@=VED=&@]
T0S)3X@
M(`@(`T*(`@(`@(`@(`@/&1I=B!S='EL93TS1=415A4+4E.1$5.5#H@
M
'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.

T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E

'!T)SXF(S$X
SL\+V9O
M;G0^(`@(`T*(`@(`@(`@(`@/]D:78^(`@(`-B`@(`@(`@(`\



05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
'!T.R!-05)'24XM




@=&AA


M=VED=&@]
T0Q






E/B`@(`@#0H@(`@

T1J=7-T:69Y/B`@(`T*(`@(`@(`@(`@(`\9F]N=!S

M(`@(`@(`@(`\+V1I=CX@(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@

M63H@8FQO8VL[($U!4D=)3BU

'!T


@

M/3-$

'!T.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N






05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M


M/B8C
3@S.SPO9F]N=#X@(`@#0H@(`@(`@(`@(`\+V1I=CX@(`@(`T*
M(`@(`@(`@(#PO=&0^(`-B`@(`@(`@(`\=&0@=F%L:6=N/3-$=&]P

T0G5$58


05DZ(&EN;&EN93L@
M1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T
M)SY

M+W1D/B`@#0H@(`@(`@(#PO='(^(`@(`-B`@(`@(#PO=&%B;&4^/&)R

05DZ(&)L
M;V-K.R!-05)'24XM3$5&5#H@

2P@
C`Q

#$R

M=7-T;65N='




@96YD960@1&5C96UB97(@
S$L(#(P
3
@;W(@
C`Q
BX\



]

M($1)4U!
05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
'!T.R!-05)'24XM4DE'




M13H@




M
S@X9E]D.6$T7S1B8C!?8C9A
U\W-3DU






M;W0@4F5M;W9E(%1H:7


]




]


]
M




05DZ(&EN
M;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%
M.B`Q
'!T)SXF(S$V
#L\+V9O;G0^(`T*(`@(`@(`@(`@/]T9#X@(`@
M#0H@(`@(`@(`@(`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
24@




Q-C`[/]F;VYT/B`@(`@#0H@(`@(`@(`@(`\

M
T1B;W1T;VT@=VED=&@]

T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@

T1C96YT97(^

05DZ
M(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U3
M25I%.B`Q


2P\+V9O;G0^(`@(`-B`@(`@(`@(`@(`@/]D:78^(`-
MB`@(`@(`@(`@(#PO=&0^(`@(`T*(`@(`@(`@(`@/'1D(&YO=W)A

24=..B!L969T.R!0041$24Y'+4)/5%1/33H@
G!X)SX@(`T*

Q-C`[/]F;VYT/B`-B`@(`@(`@(`@(#PO=&0^(`@(`T*(`@
M(`@(`@(#PO='(^(`-B`@(`@(`@(`\='(^(`T*(`@(`@(`@(`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#0W)2!S='EL93TS1=0041$
M24Y'+4)/5%1/33H@,G!X)SX@(`@#0H@(`@(`@(`@(`@(#QF;VYT('-T

05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V
#L\+V9O;G0^(`T*(`@
M(`@(`@(`@/]T9#X@(`@#0H@(`@(`@(`@(`\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$

6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U3
M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9<^)B
Q-C`[/]F;VYT/B`@
M(`@#0H@(`@(`@(`@(`\+W1D/B`@(`-B`@(`@(`@(`@(#QT9!C

B!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q

M
T0G0D]21$52+4)/5%1/33H@8FQA8VL@
G!X('-O;&ED)SX@(`T*(`@(`@

T1C96YT97(^(`@(`T*(`@(`@(`@(`@(`@(#QF;VYT

05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T.R!&3TY4+5=%24=(5#H@8F]L


T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E
63H@=&EM97

M3E0M5T5)1TA4.B!B;VQD)SXF(S$V


M
3!P=#L@1D].5U714E'2%0Z(&)O;&0G/B8C,38P.SPO9F]N=#X@(`@(`T*

M;CTS1#(@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$


M(`@/&1I=B!S='EL93TS1=415A4+4E.1$5.5#H@
'!T.R!$25-03$%9.B!B

M:6=N/3-$8V5N=&5R/B`@(`-B`@(`@(`@(`@(`@(`\9F]N=!S='EL

M
3(\+V9O;G0^(`T*(`@(`@(`@(`@(`\+V1I=CX@(`T*(`@(`@(`@



Q-C`[/]F;VYT/B`@(`@#0H@(`@(`@(`@(`\
M+W1D/B`@(`-B`@(`@(`@(`\+W1R/B`@#0H@(`@(`@(`@/'1R('-T




T1L969T('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E/B`@(`T*(`@(`@(`@(`@(`\9F]N=!S='EL

Q-C`[/]F;VYT/B`-B`@(`@
M(`@(`@(#PO=&0^(`@(`T*(`@(`@(`@(`@/'1D('9A;&EG;CTS1&)O






MB`@(`@(`@(`@(#PO=&0^(`@(`T*(`@(`@(`@(`@/'1D(&%L:6=N
M/3-$;&5F=!V86QI9VX]
T1B;W1T;VT@=VED=&@]

T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E
63H@=&EM97

M
38P.SPO9F]N=#X@#0H@(`@(`@(`@(`\+W1D/B`@(`-B`@(`@(`@
M(`@(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q)2!S='EL93TS1=4
M15A4+4%,24=..B!L969T)SX@(`@(`T*(`@(`@(`@(`@(`\9F]N=!S

Q-C`[/]F;VYT/B`-B`@
M(`@(`@(`@(#PO=&0^(`@(`T*(`@(`@(`@(`@/'1D('9A;&EG;CTS

T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&3TY4+5-)

T+C`\+V9O;G0^(`@(`-B`@(`@(`@(`@(#PO=&0^

M
T1B;W1T;VT@=VED=&@]

M(`@(`@(`\+W1R/B`@#0H@(`@(`@(`@/'1R/B`-B`@(`@(`@(`@

M5#H@
'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2


M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q,'!T)SY3=&%T92!T
M87@@97AP96YS92P@;F5T(&]F(&9E9&5R86P@8F5N969I=#PO9F]N=#X@(`@
M#0H@(`@(`@(`@(`@(#PO9&EV/B`@#0H@(`@(`@(`@(`\+W1D/B`@
M(`-B`@(`@(`@(`@(#QT9!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$



T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&3TY4+5-)6D4Z

38P.SPO9F]N=#X@#0H@(`@(`@(`@(`\+W1D/B`@(`-
MB`@(`@(`@(`@(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q
24@


M('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q,'!T)SXU+C8\+V9O;G0^
M(`@(`T*(`@(`@(`@(`@/]T9#X@(`@#0H@(`@(`@(`@(`\=&0@

6QE/3-$)T1)4U!
05DZ(&EN;&EN93L@1D].
M5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF
M(S$V
#L\+V9O;G0^(`T*(`@(`@(`@(`@/]T9#X@(`@#0H@(`@(`@
M(`@(`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

T0G


05DZ
M(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U3
M25I%.B`Q
'!T)SXU+C8\+V9O;G0^(`@(`T*(`@(`@(`@(`@/]T9#X@

T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&3TY4+5-)6D4Z




M

M:6=N/3-$8F]T=&]M('=I9'1H/3-$


Q-C`[/]F;VYT/B`-B`@(`@(`@(`@(#PO
M=&0^(`@(`T*(`@(`@(`@(`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T



T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@

38P.SPO9F]N=#X@#0H@
M(`@(`@(`@(`\+W1D/B`@(`-B`@(`@(`@(`@(#QT9!V86QI9VX]
M
T1B;W1T;VT@=VED=&@]
T0Q

T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@
G!X('-O;&ED.R!415A4+4%

M*#
Y+C8\+V9O;G0^(`T*(`@(`@(`@(`@/]T9#X@(`@#0H@(`@(`@



M4U!
05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5U325I%.B`Q



M13H@

M(`@(`\9F]N=!S='EL93TS1=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-


M63H@8FQO8VL[($U!4D=)3BU

'!T
M)R!A;&EG;CTS1&QE9G0^(`-B`@(`@(`@(`@(`@(`\9F]N=!S='EL

M;VYT/B`-B`@(`@(`@(`@(`@/]D:78^(`-B`@(`@(`@(`@(#PO
M=&0^(`@(`T*(`@(`@(`@(`@/'1D(&%L:6=N/3-$;&5F=!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1=0041$24Y'+4)/5%1/33H@

05DZ
M(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U3
M25I%.B`Q
'!T)SXF(S$V
#L\+V9O;G0^(`T*(`@(`@(`@(`@/]T9#X@
M(`@#0H@(`@(`@(`@(`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M

T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@

M=R!R;VUA;CL@1D].5U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`T*(`@





M05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5U325I%.B`Q
'!T)SXF(S$V
#L\+V9O;G0^(`T*(`@(`@(`@(`@/]T
M9#X@(`@#0H@(`@(`@(`@(`\=&0@86QI9VX]
T1L969T('9A;&EG;CTS




T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M

T0G5$585U!3$E'3CH@;&5F=#L@4$%$1$E.1RU3U143TTZ

M8FQE(&-E;&QP861D:6YG/3-$







M;&4]


M13H@
3!P=#L@1D].5U714E'2%0Z(&)O;&0G/EEE87(@96YD960@1&5C96UB
M97(@,S$L/]F;VYT/B`@(`T*(`@(`@(`@(`@/]D:78^(`@(`-B`@


M24=..B!L969T.R!0041$24Y'+4)/5%1/33H@


Q-C`[/]F;VYT/B`@(`-B`@(`@(`@(`\+W1D/B`@#0H@(`@
M(`@(`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@(`T*(`@

B!V86QI9VX]
T1B
M;W1T;VT@=VED=&@]
T0Q
B4^(`T*(`@(`@(`@(`@/&1I=B!S='EL93TS

C`Q
SPO9F]N=#X@(`@#0H@(`@
M(`@(`@(`\+V1I=CX@(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@(`@



Q-C`[/]F;VYT/B`@(`T*(`@(`@(`@(#PO
M=&0^(`-B`@(`@(`@(`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24^(`@#0H@(`@(`@(`@(`\9F]N=!S='EL93TS1=$25-03$%9.B!I

M13H@
3!P=#L@1D].5U714E'2%0Z(&)O;&0G/B8C,38P.SPO9F]N=#X@(`-

M

T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&


T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&3TY4+5-)6D4Z





M4U!
05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5U325I%.B`Q
'!T)SXH
2PP.3DL
C@R/]F;VYT/B`@(`-B`@(`@

M86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q)2!S='EL93TS1=415A4+4%,24=.
M.B!L969T)SX@(`@#0H@(`@(`@(`@(`\9F]N=!S='EL93TS1=$25-0

M3E0M4TE:13H@

T1L969T('9A;&EG;CTS1&)O='1O

M4U!
05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5U325I%.B`Q
'!T)SXF(S$V
#L\+V9O;G0^(`@(`T*(`@(`@(`@

M(`@(`\9F]N=!S='EL93TS1=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-


M:6=N/3-$8F]T=&]M('=I9'1H/3-$


T1N;W=R87`@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$


M(`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#0W
M)2!S='EL93TS1=0041$24Y'+4)/5%1/33H@
G!X)SX@(`@(`T*(`@(`@
M(`@(`@/&1I=B!S='EL93TS1=415A4+4E.1$5.5#H@
'!T.R!$25-03$%9




M(`\+W1D/B`@#0H@(`@(`@(`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T


05DZ(&EN;&EN93L@1D].5U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V
M

T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&3TY4+5-)6D4Z


M1D].5U325I%.B`Q,'!T)SXQ+#`Y.2PR.#(\+V9O;G0^(`@#0H@(`@(`@
M(`@/]T9#X@(`T*(`@(`@(`@(#QT9!N;W=R87`]
T1N;W=R87`@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$


M('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@(`@(`@(`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$


T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&3TY4




M(`@(`@(`\+W1D/B`@#0H@(`@(`@(`@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$Q)2!S='EL93TS1=3U)$15(M0D]45$]-.B!B;&%C:R`R


T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@
M=&EM97

\+V9O





M4D=)3BU

'!T)R!A;&EG;CTS1&QE

M(`@(`@(`@(`\+V1I=CX@(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@
6QE/3-$)T1)4U!
05DZ(&EN;&EN93L@1D].
M5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF
M(S$V
#L\+V9O;G0^(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@(`@(`@


M(`@(`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$Q)2!S='EL93TS

24=.


M3E0M4TE:13H@




Q-C`[/]F;VYT/B`@(`-
MB`@(`@(`@(`\+W1D/B`@#0H@(`@(`@(`@/'1D(&%L:6=N/3-$;&5F
M=!V86QI9VX]
T1B;W1T;VT@=VED=&@]

M86X[($9/3E0M4TE:13H@


M;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`-B`@(`@(`@(`@(#QF;VYT

05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXD/]F;VYT/B`@(`@#0H@
M(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT9!V86QI9VX]
T1B;W1T
M;VT@=VED=&@]
T0Q

T0G0D]21$52+4)/5%1/33H@8FQA8VL@






]





63H@=&EM97
@;F5W(')O;6%N.R!&3TY4+5-)6D4Z



Q-C`[/]F;VYT/B`@(`-B`@(`@


Q-C`[/]F;VYT/B`@(`T*(`@(`@(`@


M


M
3!P=#L@1D].5U714E'2%0Z(&)O;&0G/D%S(&]F($1E8V5M8F5R(#,Q+#PO
M9F]N=#X@(`-B`@(`@(`@(`@(#PO9&EV/B`@(`@#0H@(`@(`@(`@



05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T.R!&3TY4+5=%24=(5#H@

6QE
M/3-$)T1)4U!
05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V
#L\+V9O;G0^(`@(`T*(`@


B!V86QI9VX]
M
T1B;W1T;VT@=VED=&@]
T0Q

T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@
G!X('-O;&ED)SX@(`@(`T*(`@(`@(`@(`@/&1I=B!S='EL
M93TS1=415A4+4E.1$5.5#H@
'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.


05DZ(&EN
M;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%
M.B`Q

M(`@(`@(`@(`\+V1I=CX@(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@

M86X[($9/3E0M4TE:13H@
6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@

!S;VQI9<^(`@(`-B`@(`@




24=.
M.B!L969T.R!0041$24Y'+4)/5%1/33H@
G!X)SX@(`@(`T*(`@(`@(`@



M($1)4U!
05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
'!T.R!-05)'24XM4DE'


05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q


M(#PO=&0^(`-B`@(`@(`@(`\=&0@86QI9VX],T1R:6=H=!V86QI9VX]
M
T1B;W1T;VT@=VED=&@]

M;&4]
T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W

38P.SPO9F]N=#X@(`@#0H@
M(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT9!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1=415A4+4%



S(Y+#DR
SPO9F]N=#X@#0H@(`@
M(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT9!N;W=R87`]
T1N;W=R87`@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$





M(`@(`@(`\+W1D/B`@#0H@(`@(`@(`@/'1D('9A;&EG;CTS1&)O='1O


T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E
63H@=&EM97

M/B0\+V9O;G0^(`@(`-B`@(`@(`@(`\+W1D/B`@#0H@(`@(`@(`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$Q)2!S='EL93TS1=415A4
M+4%

M;VUA;CL@1D].5U325I%.B`Q,'!T)SXT-#`L-S0P/]F;VYT/B`-B`@(`@

M86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q)2!S='EL93TS1=415A4+4%,24=.
M.B!L969T)SX@(`@#0H@(`@(`@(`@(`\9F]N=!S='EL93TS1=$25-0

M3E0M4TE:13H@

M+4E.1$5.5#H@
'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P

M(`@(`@(`@(`\9F]N=!S='EL93TS1=$25-03$%9.B!I;FQI;F4[($9/




M(#PO=&0^(`-B`@(`@(`@(`\=&0@86QI9VX],T1R:6=H=!V86QI9VX]
M
T1B;W1T;VT@=VED=&@]

M;&4]
T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W

38P.SPO9F]N=#X@(`@#0H@
M(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT9!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1=415A4+4%

M(`@(`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$





M;VUA;CL@1D].5U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`@(`T*(`@
M(`@(`@(#PO=&0^(`-B`@(`@(`@(`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$


T1B;W1T;VT@=VED=&@]
T0Q


M86X[($9/3E0M4TE:13H@



T0G

M=&0@86QI9VX]
T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#0W)3X@


M9VX]
T1R:6=H=!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*(`@

T1B;W1T;VT@=VED=&@]

M)T1)4U!
05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5U325I%.B`Q
'!T)SXF(S$V


T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E
63H@=&EM97

M/C$L
S@T+#
R.#PO9F]N=#X@(`-B`@(`@(`@(`\+W1D/B`@#0H@(`@

24=..B!L969T)SX@(`@#0H@(`@

Q
M-C`[/]F;VYT/B`@(`-B`@(`@(`@(`\+W1D/B`@#0H@(`@(`@(`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@(`T*(`@(`@(`@

M86QI9VX]
T1B;W1T;VT@=VED=&@]

M05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5U325I%.B`Q
'!T)SXF(S$V
#L\+V9O;G0^(`@(`T*(`@(`@(`@(#PO


T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E
63H@=&EM97


05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V
#L\+V9O;G0^

M(`@(`@(`\='(^(`@(`T*(`@(`@(`@(#QT9!A;&EG;CTS1&QE9G0@



T1R:6=H=!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!S='EL93TS1=0041$24Y'+4)/5%1/33H@

T1B;W1T;VT@=VED=&@]
T0Q)2!S='EL93TS1=3U)$15(M


Q-C`[/]F;VYT/B`@(`-B`@(`@(`@(`\+W1D/B`@#0H@




M
T1R:6=H=!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1=0
M041$24Y'+4)/5%1/33H@

M#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT9!V86QI9VX]
T1B
M;W1T;VT@=VED=&@]
T0Q)2!S='EL93TS1=3U)$15(M0D]45$]-.B!B;&%C

Q-C`[

T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$

T0G5$585U!3$E'3CH@;&5F=#L@4$%$1$E.1RU

M;CL@1D].5U325I%.B`Q,'!T)SXI/]F;VYT/B`@(`@#0H@(`@(`@(`@

M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
'!T.R!-05)'24XM4DE'2%0Z(#!P


05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SY.970@9&5F97)R960@=&%X(&%S

M(`@(`\+W1D/B`@#0H@(`@(`@(`@/'1D(&%L:6=N/3-$;&5F=!V86QI
M9VX]
T1B;W1T;VT@=VED=&@]
T0Q)2!S='EL93TS1=0041$24Y'+4)/5%1/
M33H@-'!X)SX@(`@#0H@(`@(`@(`@(`\9F]N=!S='EL93TS1=$25-0

M3E0M4TE:13H@



M/3-$)T1)4U!
05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5U325I%.B`Q
'!T)SXD/]F;VYT/B`@(`@#0H@(`@(`@
M(`@/]T9#X@(`T*(`@(`@(`@(#QT9!V86QI9VX]
T1B;W1T;VT@=VED
M=&@]
T0Q

T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O


M+4%
24=..B!L969T.R!0041$24Y'+4)/5%1/33H@-'!X)SX@(`@(`T*(`@

24@



M86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q)2!S='EL93TS1=3U)$15(M0D]4

24=..B!L969T)SX@#0H@
M(`@(`@(`@(`\9F]N=!S='EL93TS1=$25-03$%9.B!I;FQI;F4[($9/


M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$



6QE/3-$
M)T1)4U!
05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5U325I%.B`Q
'!T)SXF(S$V


M;V-A=&EO;CH@9FEL93HO+R]#.B\R9&-D
S@X9E]D.6$T7S1B8C!?8C9A
U\W
M-3DU

T1#;VYT96YT+51Y

]
T13:&]W+FIS/B\J($1O


M86X]
T0Q(')O=W-P86X]

3(@36]N=&AS($5N9&5D
M/]T:#X-B`@(`@(#PO='(^#0H@(`@(`\='(^#0H@(`@(`@(#QT:!C

S$L(#(P
3





M56YI='


L(&5X96-U=&EV92!O

Z/&)R(\^(`-


M/3-$

63H@=&EM97
@

3!P=#L@



Q
6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA

Q-C`[

T0G5$585U)3D1%3E0Z(#!P=#L@1$E3
M4$Q!63H@8FQO8VLG/B`@(`@#0H@(`@(`@(`@(`@(8C,38P.R`@(`@
M#0H@(`@(`@(`@(`\+V1I=CX@(`@(`T*(`@(`@(`@(`@/&1I=B!S
M='EL93TS1=415A4+4E.1$5.5#H@
'!T.R!$25-03$%9.B!B;&]C:SL@34%2


05DZ
M(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U3
M25I%.B`Q



M(&)O;&0G/B8C



05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T.R!&3TY4+5=%24=(5#H@8F]L


M
!S;VQI9<^
M(`@(`-B`@(`@(`@(`@(#QD:78@<W1Y;&4],T0G5$585U)3D1%3E0Z
M(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU

M3BU224=(5#H@



1494.B`P


M=#X@#0H@(`@(`@(`@(`\+V1I=CX@(`@(`T*(`@(`@(`@(#PO=&0^


3!P=#L@1D].5U714E'2%0Z(&)O;&0G
M/B8C,38P.SPO9F]N=#X@(`-B`@(`@(`@(`\+W1D/B`@#0H@(`@(`@

M1&)O='1O;2!W:61T:#TS1#0W)2!S='EL93TS1=0041$24Y'+4)/5%1/33H@
M,G!X)SX@(`T*(`@(`@(`@(`@/&1I=B!S='EL93TS1=415A4+4E.1$5.
M5#H@
'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2


T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E
63H@=&EM97


2P@
C`Q
CPO9F]N=#X@(`@
M(`T*(`@(`@(`@(`@/]D:78^(`@(`-B`@(`@(`@(`\+W1D/B`@
6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@(`@(`@(`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$

T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@
G!X('-O;&ED.R!415A4+4%
24=..B!L969T)SX@(`@(`T*(`@

T1B;W1T;VT@=VED=&@]
T0Q

T0G0D]2
M1$52+4)/5%1/33H@8FQA8VL@
G!X('-O;&ED.R!415A4+4%
24=..B!R:6=H

05DZ(&EN
M;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%
M.B`Q
'!T)SXM/]F;VYT/B`@(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@
M(`@(`@(#QT9!N;W=R87`]
T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$

T0G5$585U!3$E'3CH@;&5F=#L@4$%$1$E.1RU

M;CL@1D].5U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`@(`T*(`@(`@
M(`@(#PO=&0^(`-B`@(`@(`@(`\=&0@86QI9VX]
T1L969T('9A;&EG


M5U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`@(`T*(`@(`@(`@(#PO
M=&0^(`-B`@(`@(`@(`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M

T0G0D]21$52+4)/5%1/33H@8FQA8VL@
G!X('-O;&ED.R!4
M15A4+4%




T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM
M97


T1B;W1T;VT@=VED=&@]

T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E
63H@=&EM97

M
38P.SPO9F]N=#X@(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`\


05DZ(&)L;V-K
M.R!-05)'24XM3$5&5#H@


M($9/3E0M4TE:13H@

M/]T9#X@(`T*(`@(`@(`@(#QT9!A;&EG;CTS1')I9VAT('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E/B`@#0H@(`@(`@(`@(`\9F]N=!S='EL


M(`@(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q

T0G



6QE
M/3-$)T1)4U!
05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V
#L\+V9O;G0^(`@(`T*(`@
M(`@(`@(#PO=&0^(`-B`@(`@(`@(`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24^(`@#0H@(`@(`@(`@(`\9F]N=!S='EL93TS1=$

M($9/3E0M4TE:13H@

M(`\+W1D/B`@#0H@(`@(`@(`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T


T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E
63H@=&EM97

38P
M.SPO9F]N=#X@(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT



2XS-3PO9F]N=#X@(`-B`@(`@(`@

24=..B!L

Q-C`[/]F;VYT/B`@(`-B`@(`@(`@(`\+W1D


M86QI9VX]
T1J=7-T:69Y/B`@(`T*(`@(`@(`@(`@(`\9F]N=!S='EL

Q-C`[)B
Q-C`[)B
Q-C`[5F5S
M=&5D/]F;VYT/B`@#0H@(`@(`@(`@(`\+V1I=CX@(`@(`T*(`@(`@
M(`@(#PO=&0^(`-B`@(`@(`@(`\=&0@86QI9VX]

M#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT9!V86QI9VX]
T1B
M;W1T;VT@=VED=&@]

05DZ(&EN;&EN
M93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
M
'!T)SXF(S$V
#L\+V9O;G0^(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@


T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM
M97

#`L

M;&4]
T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W


T1B;W1T;VT@=VED=&@]
M

05DZ(&EN;&EN93L@1D].5U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V
#L\

T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N

S`\+V9O;G0^(`@#0H@(`@(`@(`@


T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&3TY4+5-)


G!X)SX@(`T*(`@(`@(`@(`@/&1I=B!S

6QE/3-$)T1)4U!
05DZ(&EN;&EN93L@1D].5U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V
#L\


T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P

38P.SPO9F]N=#X@(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@




05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V

T1B;W1T;VT@=VED=&@]
T0Q)2!S='EL93TS


Q-C`[/]F;VYT/B`@(`-B`@(`@(`@(`\

24=.
M.B!L969T.R!0041$24Y'+4)/5%1/33H@
G!X)SX@(`@(`T*(`@(`@(`@

T1B;W1T;VT@
M=VED=&@]


M1$E34$Q!63H@8FQO8VL[($U!4D=)3BU

M5#H@




M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@(`@(`@(`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@
G!X('-O;&ED.R!415A4+4%
24=..B!L969T)SX@

M(`@(`@(`@(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q

M;&4]
T0G0D]21$52+4)/5%1/33H@8FQA8VL@
G!X('-O;&ED.R!415A4+4%

M4U!
05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5U325I%.B`Q
'!T)SXT+#0U
RPU



05DZ(&EN;&EN93L@1D].5U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V
#L\+V9O


05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V


T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E
63H@=&EM97


T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M

T0G5$585U!3$E'3CH@;&5F=#L@4$%$1$E.1RU3U143TTZ



M(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@(`@(`@(`\=&0@86QI9VX]
M,T1R:6=H=!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q)3X@(`T*(`@(`@

T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E
63H@=&EM97

38P
M.SPO9F]N=#X@(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT
M9!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1=415A4+4%

M1D].5U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`@(`T*(`@(`@(`@
M(#PO=&0^(`-B`@(`@(`@(`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$




M('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@(`@(`@(`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$


M(`@(`@(`@(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q

M;&4]

M9F]N=!S='EL93TS1=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T


T1B;W1T;VT@=VED=&@]



M(`@(`@(`\+W1D/B`@#0H@(`@(`@(#PO='(^(`@(`-B`@(`@(`@



05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
'!T.R!-05)'24XM



M(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@(`@(`@(`\=&0@86QI9VX]
M,T1R:6=H=!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q)3X@(`T*(`@(`@

T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E
63H@=&EM97

38P
M.SPO9F]N=#X@(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT
M9!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1=415A4+4%

M1D].5U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`@(`T*(`@(`@(`@
M(#PO=&0^(`-B`@(`@(`@(`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$


#D\+V9O;G0^(`T*(`@(`@(`@(#PO=&0^(`-B`@(`@(`@(`\


M('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q,'!T)SXI/]F;VYT/B`@
M(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT9!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)3X@(`-B`@(`@(`@(`@(#QF;VYT('-T

05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V

M#0H@(`@(`@(`@(`\9F]N=!S='EL93TS1=$25-03$%9.B!I;FQI;F4[

3!P

M(`@(`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$Q)2!S='EL93TS


05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
6QE/3-$
M)T1)4U!
05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5U325I%.B`Q
'!T)SXF(S$V

T1B;W1T;VT@=VED=&@]
T0T



M8FQO8VL[($U!4D=)3BU

'!T)R!A

M;VUA;CL@1D].5U325I%.B`Q,'!T)SXF(S$V,#LF(S$V,#LF(S$V,#M&;W)F
M96ET960\+V9O;G0^(`@(`-B`@(`@(`@(`@(#PO9&EV/B`@(`@#0H@
M(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT9!A;&EG;CTS1')I9VAT



Q-C`[/]F;VYT/B`@(`-B`@(`@

M;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@(`@(`@(`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$


M
RPR-#`\+V9O;G0^(`-B`@(`@(`@(`\+W1D/B`@#0H@(`@(`@(`@

24=..B!L969T.R!0041$24Y'+4)/5%1/33H@
M



05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V
#L\+V9O;G0^

T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E
63H@=&EM97

M
38P.SPO9F]N=#X@(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@




Q-C`[/]F;VYT/B`@(`-B`@(`@

M93TS1=0041$24Y'+4)/5%1/33H@,G!X)SX@(`T*(`@(`@(`@(`@/&1I
M=B!S='EL93TS1=415A4+4E.1$5.5#H@
'!T.R!$25-03$%9.B!B;&]C:SL@


T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&

M8F5R(#
Q+`R,#$S/]F;VYT/B`@#0H@(`@(`@(`@(`\+V1I=CX@(`@
M(`T*(`@(`@(`@(#PO=&0^(`-B`@(`@(`@(`\=&0@86QI9VX],T1R
M:6=H=!V86QI9VX]
T1B;W1T;VT@=VED=&@]

M;&4]
T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W




M;VYT/B`@(`-B`@(`@(`@(`\+W1D/B`@#0H@(`@(`@(`@/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$Q)2!S='EL93TS1=3U)$15(M0D]4


T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E
63H@=&EM97

M/C0L-SDP+#0P.#PO9F]N=#X@(`-B`@(`@(`@(`\+W1D/B`@#0H@(`@

24=..B!L969T.R!0041$24Y'+4)/
M5%1/33H@

M(`@/]T9#X@(`T*(`@(`@(`@(#QT9!A;&EG;CTS1&QE9G0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$


M9#X@(`T*(`@(`@(`@(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q

M6%0M04Q)1TXZ(&QE9G0G/B`@(`@#0H@(`@(`@(`@(`\9F]N=!S='EL

M=!S='EL93TS1=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE



T1B;W1T;VT@=VED=&@]

T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E
63H@=&EM97

M
38P.SPO9F]N=#X@(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`\

F1C9#
X.&9?9#EA-%\T8F(P7V(V83-?
M-S4Y-3%D96(T8F(Y#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T
Z+S)D
M8V0S.#AF7V0Y831?-&)B

M+U-H965T

M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-B`@/&AE860^#0H@(`@/$U%5$$@


^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE





]
T1T:#Y$96
N(#



L(%-H87)E+6)A



]




63H@=&EM97
@;F5W(')O;6%N



M


T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
M63H@=&EM97

38P.SPO


M3G5M8F5R)B



M;&EG;CTS1&QE9G0@=F%L:6=N/3-$=&]P('=I9'1H/3-$

T0G

M;&4]
T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W




B!V86QI9VX]
T1B;W1T
M;VT@=VED=&@]
T0Q

T0G0D]21$52+4)/5%1/33H@8FQA8VL@
M
G!X('-O;&ED)SX@(`@(`T*(`@(`@(`@(`@/&1I=B!S='EL93TS1=4
M15A4+4E.1$5.5#H@
'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z


05DZ(&EN;&EN93L@
M1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T



05DZ(&)L;V-K.R!-05)'24XM
M3$5&5#H@

M/B`@#0H@(`@(`@(`@(`\+V1I=CX@(`@(`T*(`@(`@(`@(`@/&1I
M=B!S='EL93TS1=415A4+4E.1$5.5#H@
'!T.R!$25-03$%9.B!B;&]C:SL@


M05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5U325I%.B`Q

'!T.R!$25-03$%9


M/3-$)T1)4U!
05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5U325I%.B`Q

M#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT9!A;&EG;CTS1&QE
M9G0@=F%L:6=N/3-$=&]P('=I9'1H/3-$


T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&

38P.SPO9F]N=#X@(`@#0H@(`@(`@(`@

B!V86QI9VX]
T1B;W1T;VT@=VED=&@]
M
T0Q

T0G0D]21$52+4)/5%1/33H@8FQA8VL@
G!X('-O;&ED
M)SX@(`@(`T*(`@(`@(`@(`@/&1I=B!S='EL93TS1=415A4+4E.1$5.
M5#H@
'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2

05DZ(&EN;&EN93L@1D].5U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T.R!&3TY4+5=%


T1C

T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&3TY4




05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
'!T.R!-05)'


M(`@(`@(`@(`@/]D:78^(`@(`-B`@(`@(`@(`\+W1D/B`@#0H@
M(`@(`@(`@/'1D(&%L:6=N/3-$;&5F=!V86QI9VX],T1T;W`@=VED=&@]
M,T0Q)2!S='EL93TS1=0041$24Y'+4)/5%1/33H@
G!X)SX@#0H@(`@(`@
M(`@(`\9F]N=!S='EL93TS1=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-


M(-#0T5%1D8[)SX@(`@#0H@(`@(`@(`@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#,S)2!S='EL93TS1=0041$24Y'+4)/5%1/33H@
G!X)SX@

1494.B`P



S$L(#(P
3(\+V9O;G0^(`@(`-
MB`@(`@(`@(`@(`@/]D:78^(`-B`@(`@(`@(`@(#PO9&EV/B`@
M(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT9!V86QI9VX]
M
T1T;W`@=VED=&@]

05DZ(&EN
M;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%
M.B`Q
'!T)SXF(S$V





05DZ(&)L;V-K
M.R!-05)'24XM3$5&5#H@

24=..B!R:6=H=#L@






M4TE:13H@

M9VX]
T1T;W`@=VED=&@]
T0Q)2!S='EL93TS1=3U)$15(M0D]45$]-.B!B


'!T)SX@(`T*(`@(`@(`@(`@


M9'1H/3-$


M3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU

M($U!4D=)3BU224=(5#H@

M4U!
05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5U325I%.B`Q
'!T)SXM/]F;VYT/B`@(`-B`@(`@(`@(`@(`@
M/]D:78^(`-B`@(`@(`@(`@(#PO9&EV/B`@(`@#0H@(`@(`@(`@
M/]T9#X@(`T*(`@(`@(`@(#QT9!V86QI9VX]
T1T;W`@=VED=&@]
T0Q

05DZ(&EN;&EN93L@1D].5U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V
#L\



M3E0M4TE:13H@


M86QI9VX]
T1T;W`@=VED=&@]
T0Q


M+4E.1$5.5#H@
'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P



T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N


M;CTS1&)O='1O;2!W:61T:#TS1#


05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5U325I%.B`Q

M#0H@(`@(`@(`@(`@(#PO9&EV/B`@#0H@(`@(`@(`@(`\+V1I=CX@

M=R!R;VUA;CL@1D].5U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`@(`T*
M(`@(`@(`@(#PO=&0^(`-B`@(`@(`@(`\=&0@=F%L:6=N/3-$=&]P
M('=I9'1H/3-$

M)T1)4U!
05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5U325I%.B`Q
'!T)SXF(S$V

M3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU

M4D=)3BU224=(5#H@

T1R:6=H=#X@

C$P+#`P
#PO9F]N=#X@(`@(`T*(`@(`@(`@(`@(`\


M13H@

M#0H@(`@(`@(`@(`\9F]N=!S='EL93TS1=$25-03$%9.B!I;FQI;F4[

3!P


M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
'!T.R!-05)'24XM4DE'2%0Z(#!P

M5#H@
'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2


M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q,'!T)SXD/]F;VYT
M/B`@(`-B`@(`@(`@(`@(`@/]D:78^(`-B`@(`@(`@(`@(#PO
M9&EV/B`@(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT9!V
M86QI9VX],T1T;W`@=VED=&@],T0Q,24^(`T*(`@(`@(`@(`@/&1I=B!S
M='EL93TS1=415A4+4E.1$5.5#H@
'!T.R!$25-03$%9.B!B;&]C:SL@34%2




05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXR+C`W/]F;VYT/B`@#0H@(`@
M(`@(`@(`@(#PO9&EV/B`@#0H@(`@(`@(`@(`\+V1I=CX@(`@(`T*
M(`@(`@(`@(#PO=&0^(`-B`@(`@(`@(`\=&0@=F%L:6=N/3-$=&]P
M('=I9'1H/3-$

M)T1)4U!
05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5U325I%.B`Q
'!T)SXF(S$V

M5U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`@(`T*(`@(`@(`@(#PO
M=&0^(`-B`@(`@(`@(`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$
24^

05DZ(&EN
M;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%
M.B`Q
'!T)SXF(S$V
#L\+V9O;G0^(`@(`T*(`@(`@(`@(#PO=&0^(`-
MB`@(`@(`@(`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$,3$E/B`-B`@

M4$Q!63H@8FQO8VL[($U!4D=)3BU

M


05DZ(&EN;&EN93L@
M1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T
M)SXM/]F;VYT/B`@(`-B`@(`@(`@(`@(`@/]D:78^(`-B`@(`@
M(`@(`@(#PO9&EV/B`@(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@
M(`@(#QT9!V86QI9VX]
T1T;W`@=VED=&@]

T1B;W1T
M;VT@=VED=&@]
T0S
R4^(`@(`T*(`@(`@(`@(`@/&1I=B!S='EL93TS
M1=415A4+4E.1$5.5#H@
'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%




M($9/3E0M4TE:13H@

M(`@(`@(#PO9&EV/B`@#0H@(`@(`@(`@(`\+V1I=CX@(`@(`T*(`@

M1D].5U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`@(`T*(`@(`@(`@
M(#PO=&0^(`-B`@(`@(`@(`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$
M

05DZ
M(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U3
M25I%.B`Q
'!T)SXF(S$V
#L\+V9O;G0^(`@(`T*(`@(`@(`@(#PO=&0^

M1$E34$Q!63H@8FQO8VL[($U!4D=)3BU

M5#H@

05DZ(&EN;&EN
M93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
M
'!T)SXM/]F;VYT/B`@(`-B`@(`@(`@(`@(`@/]D:78^(`-B`@
M(`@(`@(`@(#PO9&EV/B`@(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@
M(`@(`@(#QT9!V86QI9VX]
T1T;W`@=VED=&@]
T0Q)3X@(`@(`T*(`@

T1T;W`@=VED=&@]
T0Q)3X@(`@(`T*(`@(`@(`@

M86QI9VX]
T1T;W`@=VED=&@]
T0Q)3X@(`@(`T*(`@(`@(`@(`@/&1I
M=B!S='EL93TS1=415A4+4E.1$5.5#H@
'!T.R!$25-03$%9.B!B;&]C:SL@

T0G5$585U!3$E'3CH@;&5F=#L@5$58
M5U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU
1494.B`P


M;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q,'!T)SXD/]F;VYT/B`@(`-
MB`@(`@(`@(`@(`@/]D:78^(`-B`@(`@(`@(`@(#PO9&EV/B`@
M(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT9!V86QI9VX]
M,T1T;W`@=VED=&@],T0Q,24^(`T*(`@(`@(`@(`@/&1I=B!S='EL93TS
M1=415A4+4E.1$5.5#H@
'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%



M;&4]
T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W



M($9/3E0M4TE:13H@



M4TE:13H@


M


M4D=)3BU


M+3PO9F]N=#X@(`@#0H@(`@(`@(`@(`@(#PO9&EV/B`@#0H@(`@(`@
M(`@(`\+V1I=CX@(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@(`@(`@
M(`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$

05DZ(&EN;&EN93L@1D].5U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V
#L\

M
T1B;W1T;VT@=VED=&@]
T0S


M3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU

M4D=)3BU224=(5#H@

T1L969T/B`@

#$S/]F;VYT
M/B`@(`@#0H@(`@(`@(`@(`@(#PO9&EV/B`@#0H@(`@(`@(`@(`\



M3E0M4TE:13H@

T1T;W`@=VED=&@]
T0Q

T0G
M0D]21$52+4)/5%1/33H@8FQA8VL@
G!X('-O;&ED)SX@(`@(`T*(`@(`@
M(`@(`@/&1I=B!S='EL93TS1=415A4+4E.1$5.5#H@
'!T.R!$25-03$%9



05DZ(&EN;&EN93L@1D].5U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXR
3`L
#`P
M/]F;VYT/B`@(`@#0H@(`@(`@(`@(`@(#PO9&EV/B`@#0H@(`@(`@
M(`@(`\+V1I=CX@(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@(`@(`@

M86X[($9/3E0M4TE:13H@


T1T;W`@=VED=&@]
T0Q)2!S='EL93TS1=3U)$15(M

M($U!4D=)3BU






T1T;W`@=VED=&@]
T0Q

05DZ(&EN;&EN93L@1D].5U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V
#L\



M3E0M4TE:13H@


M86QI9VX]
T1T;W`@=VED=&@]
T0Q


M+4E.1$5.5#H@
'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P



M05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5U325I%.B`Q

24@




M0T5%1D8[)SX@(`@#0H@(`@(`@(`@/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#


M05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5U325I%.B`Q


Q-C`[



05DZ(&)L;V-K.R!-05)'24XM
M3$5&5#H@

M(`@/&1I=B!S='EL93TS1=415A4+4%



M;CL@1D].5U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`@(`T*(`@(`@
M(`@(#PO=&0^(`-B`@(`@(`@(`\=&0@=F%L:6=N/3-$=&]P('=I9'1H
M/3-$

M05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5U325I%.B`Q
'!T)SXF(S$V
#L\+V9O;G0^(`@(`T*(`@(`@(`@(#PO

M(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU

M3BU224=(5#H@


MB`@(`@(`@(`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$


M1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@
'!T.R!$25-03$%9.B!B;&]C:SL@

M(`@(`@(#PO9&EV/B`@(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@
M(`@(#QT9!V86QI9VX],T1T;W`@=VED=&@],T0Q)3X@(`@(`T*(`@(`@

T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E
63H@=&EM97

38P
M.SPO9F]N=#X@(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT
M9!V86QI9VX],T1T;W`@=VED=&@],T0Q)3X@(`@(`T*(`@(`@(`@(`@

T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@
M=&EM97

38P.SPO9F]N
M=#X@(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT9!V86QI
M9VX],T1T;W`@=VED=&@],T0Q)3X@(`@(`T*(`@(`@(`@(`@/&9O;G0@

T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@

38P.SPO9F]N=#X@(`@
M#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT9!V86QI9VX],T1T
M;W`@=VED=&@],T0Q,24^(`T*(`@(`@(`@(`@/&1I=B!S='EL93TS1=4
M15A4+4E.1$5.5#H@
'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z



M
T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O



M3E0M4TE:13H@



M8VM=/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG5&AE(&9O;&QO

M=&EO;G



M;W(@=&AE('EE87)S(&5N9&5D($1E8V5M8F5R(#
Q+`R,#$S(&%N9`R
#$R

M25I%.B`Q
'!T.R!&3TY4+49!34E
63H@=&EM97



M(`@(`@(`\+W1D/B`@#0H@(`@(`@(`@/'1D(&%L:6=N/3-$;&5F=!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1=0041$24Y'+4)/
M5%1/33H@



05DZ(&)L;V-K.R!-05)'24XM
M3$5&5#H@


T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P

38P.SPO9F]N=#X@(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@

T1B;W1T;VT@=VED=&@]
T0T-R4@


05DZ(&EN;&EN93L@1D].5U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V
#L\


05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V
#L\+V9O;G0^


M86X[($9/3E0M4TE:13H@
3!P=#L@1D].5U714E'2%0Z(&)O;&0G/C(P,3,\
M+V9O;G0^(`@(`T*(`@(`@(`@(`@/]D:78^(`@(`-B`@(`@(`@
M(`\+W1D/B`@#0H@(`@(`@(`@/'1D(&%L:6=N/3-$;&5F=!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1=0041$24Y'+4)/5%1/33H@
M

Q-C`[/]F;VYT/B`@(`-B`@(`@(`@(`\+W1D
M/B`@#0H@(`@(`@(`@/'1D(&%L:6=N/3-$;&5F=!V86QI9VX]
T1B;W1T
M;VT@=VED=&@]
T0Q)2!S='EL93TS1=0041$24Y'+4)/5%1/33H@,G!X)SX@
M(`@#0H@(`@(`@(`@(`\9F]N=!S='EL93TS1=$25-03$%9.B!I;FQI

M

T0R('9A;&EG;CTS1&)O='1O;2!W:61T


T1C96YT97(^(`-B`@(`@(`@

T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E
63H@=&EM97

M5T5)1TA4.B!B;VQD)SXR
#$R/]F;VYT/B`@(`-B`@(`@(`@(`@(#PO


T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM
M97

38P.SPO9F]N=#X@


M3BU

'!T)R!A;&EG;CTS1&QE9G0^

M/]D:78^(`-B`@(`@(`@(`@(#PO9&EV/B`@(`@#0H@(`@(`@(`@

05DZ
M(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U3
M25I%.B`Q
'!T)SXF(S$V
#L\+V9O;G0^(`@(`T*(`@(`@(`@(#PO=&0^
M(`-B`@(`@(`@(`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^
M(`@#0H@(`@(`@(`@(`\9F]N=!S='EL93TS1=$25-03$%9.B!I;FQI

M

M(`@(`@(`\+V1I=CX@(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@(`@
M(`@(`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
24^(`@#0H@(`@

05DZ(&EN;&EN93L@1D].5U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXE/]F;VYT
M/B`@(`-B`@(`@(`@(`@(`@/]D:78^(`-B`@(`@(`@(`@(#PO
M9&EV/B`@(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT9!V
M86QI9VX]
T1B;W1T;VT@=VED=&@]

M;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@(`@(`@(`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$
24^(`@#0H@(`@(`@(`@(`\9F]N=!S

Q-C`[/]F;VYT/B`@(`-


05DZ(&)L;V-K.R!-05)'24XM
M3$5&5#H@

M(`@/&1I=B!S='EL93TS1=415A4+4E.1$5.5#H@
'!T.R!$25-03$%9.B!B


M
T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O

M(`@(`\+V1I=CX@(`T*(`@(`@(`@(`@/]D:78^(`@(`-B`@(`@
M(`@(`\+W1D/B`@#0H@(`@(`@(`@/'1D('9A;&EG;CTS1&)O='1O;2!W

T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&

38P.SPO9F]N=#X@(`@#0H@(`@(`@(`@



05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
'!T.R!-05)'24XM

M15A4+4E.1$5.5#H@
'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z
'!E8W1E9!T97)M(AY96%R<RD\+V9O;G0^(`@(`T*(`@(`@(`@
M(`@(`\+V1I=CX@(`T*(`@(`@(`@(`@/]D:78^(`@(`-B`@(`@

T1B;W1T;VT@=VED=&@]
M

3$E

M(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU

M3BU224=(5#H@


3PO9F]N=#X@(`@#0H@(`@(`@(`@(`@(#PO9&EV/B`@#0H@
M(`@(`@(`@(`\+V1I=CX@(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@
M(`@(`@(`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

M)B
Q-C`[/]F;VYT/B`@(`-B`@(`@(`@(`\+W1D/B`@#0H@(`@(`@

T1B;W1T;VT@=VED=&@]

M('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@(`@(`@(`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$

M($U!4D=)3BU



M(`T*(`@(`@(`@(#PO=&0^(`-B`@(`@(`@(`\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$
24^(`@#0H@(`@(`@(`@(`\9F]N=!S='EL




05DZ(&EN;&EN93L@
M1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T


M3E0M4TE:13H@


T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&3TY4+5-)


1494

'!T)R!A;&EG;CTS1')I9VAT/B`@(`T*

M(`@(`@(`@(`\+V1I=CX@(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@
M(`@(`@(`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^(`@#0H@

M4U!
05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
'!T.R!-05)'24XM4DE'2%0Z

M1$5.5#H@
'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@

M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q,'!T)SXE/]F
M;VYT/B`@(`-B`@(`@(`@(`@(`@/]D:78^(`-B`@(`@(`@(`@
M(#PO9&EV/B`@(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT
M9!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`-B`@(`@(`@(`@

05DZ(&EN;&EN93L@1D].5U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V
#L\+V9O
M;G0^(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@(`@(`@(`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^(`@#0H@(`@(`@(`@(`\9F]N
M=!S='EL93TS1=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE


M(`-B`@(`@(`@(`\+W1D/B`@#0H@(`@(`@(`@/'1D('9A;&EG;CTS




M(`@#0H@(`@(`@(`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#0W


05DZ(&EN;&EN
M93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
M
'!T)SY$:79I9&5N9!Y:65L9#PO9F]N=#X@(`T*(`@(`@(`@(`@(`\
M+V1I=CX@(`T*(`@(`@(`@(`@/]D:78^(`@(`-B`@(`@(`@(`\
M+W1D/B`@#0H@(`@(`@(`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS

T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&3TY4+5-)


05DZ(&EN;&EN
M93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
M
'!T)SXF(S$V
#L\+V9O;G0^(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@
M(`@(`@(`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3$E/B`@(`-



05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
'!T

M(`@(`@(`@(`\9F]N=!S='EL93TS1=$25-03$%9.B!I;FQI;F4[($9/


M(`@(`\+V1I=CX@(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@(`@(`@
M(`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^(`@#0H@(`@(`@

05DZ
M(&)L;V-K.R!-05)'24XM3$5&5#H@

M
'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.

M('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q,'!T)SXE/]F;VYT/B`@
M(`-B`@(`@(`@(`@(`@/]D:78^(`-B`@(`@(`@(`@(#PO9&EV
M/B`@(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT9!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`-B`@(`@(`@(`@(#QF;VYT

05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V



M(`@(`@(`\+W1D/B`@#0H@(`@(`@(`@/'1D('9A;&EG;CTS1&)O='1O





]


C`Q
R!A;F0@
M
C`Q


M(&-E;&QP861D:6YG/3-$

M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@(`@(`@(`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

T0G4$%$1$E.

T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N

#L\


M
C`Q



M14E'2%0Z(&)O;&0G/B8C
38P.SPO9F]N=#X@(`-B`@(`@(`@(`\+W1D
M/B`@#0H@(`@(`@(`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E


05DZ(&EN;&EN93L@1D].5U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T.R!&3TY4+5=%24=(


M9'1H/3-$


M3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU

M($U!4D=)3BU224=(5#H@



T1B;W1T;VT@=VED=&@]
T0Q)2!S

T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&3TY4+5-)

#L\+V9O;G0^(`@
M#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`\+W1R/B`@(`@#0H@(`@





M9VX]
T1B;W1T;VT@=VED=&@]

05DZ
M(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U3
M25I%.B`Q
'!T)SXF(S$V
#L\+V9O;G0^(`@(`T*(`@(`@(`@(#PO=&0^

T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
M63H@=&EM97


T1B;W1T;VT@=VED=&@]
T0Q)2!S='EL93TS




M
T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O

38P.SPO9F]N=#X@(`@#0H@(`@
M(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT9!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!S='EL93TS1=415A4+4%
24=..B!L969T)SX@(`-B`@



24=.

Q-C`[/]F;VYT/B`@(`-B`@(`@(`@(`\
M+W1D/B`@#0H@(`@(`@(#PO='(^(`@(`-B`@(`@(`@/'1R/B`@(`-



M)B
Q-C`[/]F;VYT/B`@(`-B`@(`@(`@(`\+W1D/B`@#0H@(`@(`@

T1B;W1T;VT@
M=VED=&@]
T0Q


M#0H@(`@(`@(`@(`\9F]N=!S='EL93TS1=$25-03$%9.B!I;FQI;F4[

3!P


24=..B!L969T)SX@(`@#0H@(`@

Q
M-C`[/]F;VYT/B`@(`-B`@(`@(`@(`\+W1D/B`@#0H@(`@(`@(`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@(`T*(`@(`@(`@

M86QI9VX]
T1B;W1T;VT@=VED=&@]

M05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5U325I%.B`Q
'!T)SXF(S$V
#L\+V9O;G0^(`@(`T*(`@(`@(`@(#PO


T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E
63H@=&EM97

38P
M.SPO9F]N=#X@(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT


T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@
M=&EM97

38P.SPO9F]N


M4D=)3BU

'!T)R!A;&EG;CTS1&QE

M:6-E/]F;VYT/B`@(`-B`@(`@(`@(`@(`@/]D:78^(`-B`@(`@
M(`@(`@(#PO9&EV/B`@(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@
M(`@(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]

M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@(`@(`@(`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$


Q-C`[/]F;VYT/B`@(`-B`@(`@(`@
M(`\+W1D/B`@#0H@(`@(`@(`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$Q)2!S='EL93TS1=415A4+4%




T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@
M=&EM97

38P.SPO9F]N
M=#X@(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT9!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`-B`@(`@(`@(`@(#QF;VYT

05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V


M



05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXM/]F;VYT/B`@(`@
M#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT9!N;W=R87`]
T1N
M;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

T0G5$58



Q-C`[/]F;VYT/B`@(`-B`@(`@(`@(`\+W1D

M(`@(`@(`@(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]
T0Q)2!S='EL
M93TS1=415A4+4%,24=..B!L969T)SX@(`-B`@(`@(`@(`@(#QF;VYT

05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V

T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&3TY4+5-)



T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P

38P.SPO9F]N=#X@(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@

05DZ(&EN;&EN93L@1D].
M5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF
M(S$V
#L\+V9O;G0^(`@(`T*(`@(`@(`@(#PO=&0^(`-B`@(`@(`@

M86X[($9/3E0M4TE:13H@



05DZ(&EN;&EN93L@
M1D].5U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T
M)SXF(S$V


05DZ(&EN;&EN93L@1D].5U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V
M


M/3-$)T1)4U!
05DZ(&EN;&EN93L@1D].5U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5U325I%.B`Q
'!T)SXF(S$V
#L\9F]N=!S='EL93TS1=$

M($9/3E0M4TE:13H@

M(`@(`@(`@(#QT9!V86QI9VX]
T1B;W1T;VT@=VED=&@]

M(`@(`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$

T0G



T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E
63H@=&EM97


05DZ(&EN;&EN93L@1D].5U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5U325I%.B`Q
'!T)SXR+C`W/]F;VYT
M/CPO9F]N=#X@(`@#0H@(`@(`@(`@/]T9#X@(`T*(`@(`@(`@(#QT
M9!N;W=R87`]
T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
24@


M9VX]
T1B;W1T;VT@=VED=&@]

M(&YE=R!R;VUA;CL@1D].5U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(`@
M(`T*(`@(`@(`@(#PO=&0^(`-B`@(`@(`@(`\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$



Q-C`[/]F;VYT/B`@(`-B`@(`@(`@(`\+W1D/B`@#0H@
M(`@(`@(`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$Q)2!S='EL
M93TS1=415A4+4%


M
T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E
63H@=&EM97
@;F5W(')O

38P.SPO9F]N=#X@(`@#0H@(`@


M
F1C9#
X.&9?9#EA-%\T8F(P7V(V83-?-S4Y-3%D96(T8F(Y#0I#;VYT96YT
M+4QO8V%T:6]N.B!F:6QE.B\O+T
Z+S)D8V0S.#AF7V0Y831?-&)B
%]B-F$S

C$N:'1M;`T*0V]N=&5N



^+RH@


M




B`M(%-534U!
M4ED@3T8@4TE'3DE&24-!3E0@04-#3U5.5$E.1R!03TQ)0TE%4R`H1&5T86EL


]
T1T:#Y$96
N(#
Q+`R,#$S/&)R/CPO=&@^#0H@(`@(`@(#QT:!C

S$L(#(P
3(\8G(^/]T:#X-B`@(`@(`@/'1H
M(&-L87-S/3-$=&@^1&5C+B`S
2P@
C`Q





24-)15
@*$1E=&%I;'
I(%M
:6YE

]
T1T



]


]






]
T1N=6UP


;V-A=&EO;CH@9FEL93HO+R]#.B\R9&-D
S@X9E]D.6$T7S1B8C!?
M8C9A
U\W-3DU

T1#;VYT

]
T13:&]W+FIS



@+2!'



]
T1T:#Y$96
N(#

S$L(#(P








]






]
T1N=6T^*#$S+#$R
2PW

3`L




]

M;CX\+W-P86X^/]T9#X-B`@(`@(#PO='(^#0H@(`@/]T86)L93X-B`@

M7V0Y831?-&)B







]

T1)1#!%4D1!0SX-






]





]
T1N=6UP/C
T

]




C`S



;V-A=&EO;CH@
M9FEL93HO+R]#.B\R9&-D
S@X9E]D.6$T7S1B8C!?8C9A
U\W-3DU
61E8C1B



]







]







]



]
T1N=6T^*#





]
T1R


2PP.3DL
C@R*3QS

M-C
U+#`U





S4L
#4S

]



S@X9E]D.6$T7S1B8C!?8C9A
M
U\W-3DU



^#0H@(`@(`\='(^#0H@


@

]
M
T1T:#Y$96
N(#
Q+`R,#$S/&)R/CPO=&@^#0H@(`@(`@(#QT:!C;&%S

S$L(#(P





]






M=&EO;G

]
T1N=6UP/C`\



]
T1N=6UP/C$L
S@T+#


3





]
T1N=6UP/B0@


F1C9#
X.&9?9#EA-%\T8F(P
M7V(V83-?-S4Y-3%D96(T8F(Y#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O
M+T
Z+S)D8V0S.#AF7V0Y831?-&)B



M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-B`@/&AE860^#0H@(`@


^+RH@1&\@3F]T(%)E;6]V92!4:&ES

$5$2$%%/@T*(`@(`@/'1R


M/3-$



#$S/&)R/CPO=&@^#0H@(`@(`@


]

M345.5%
@04Y$($-/3E1)3D=%3D-)15
@*$1E=&%I;'
I(%M
:6YE($ET96US

]






]


]


M4&%Y;65N='


M9VX]

M;65N='



M($UI;FEM=6T@4&%Y;65N='







T1T

@



]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P








\+W1D/@T*




]
T1T97AT/B=3=6)S97%U

3
L('1H92!#;VUP86YY(')E;G1E9!I=',@;V9F
M:6-E('-P86-E(&]N(&$@;6]N=&@@=&\@;6]N=&@@8F%S:7,N/'-P86X^/]S

F1C9#
X.&9?9#EA
M-%\T8F(P7V(V83-?-S4Y-3%D96(T8F(Y#0I#;VYT96YT+4QO8V%T:6]N.B!F
M:6QE.B\O+T
Z+S)D8V0S.#AF7V0Y831?-&)B




^+RH@1&\@3F]T(%)E;6]V



2!R





]
T1T:#Y$96
N(#

S$L(#(P



]






]
T1N=6UP/C$Y




M






]
T1N=6UP/B0@






]






]


M;&]C871E9!3:&%R92UB87-E9!#;VUP96YS871I;VX@17AP96YS92`H:6X@


]


]





M9VX]

G($5154E4











T1T;W`^4V5R:65S($$@



]
T1P


]



]






]
T1R



]
T1R93X-B`@(`@

I(%M
:6YE($ET96US

]



]
T1N=6UP/C(L
#4P+#`P
M


]



M3$1%4E



T1T;W`^0V]M;6]N('-T



]





]

]
T1N
M=6UP/C$L


]


]





@6TUE;6)E





\+W1D/@T*(`@(`@





]


\+W1D/@T*





M9VX]

M:7!T:6]N/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^

@



C4P+#`P



M;B!A;F0@4V%L97

M97










I


M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]
T1T97AT/B=S:7@@;6]N=&AS(&9R;VT@=&AE

]




M:6


@86YD(%!U8FQI8R!A;F0@
M26YV97-T;W(@4F5L871I;VX@4V5R=FEC97






T1T

]



#`L


]






M.#`L


]

]


M/DY/5$4@-B`M(%-43T-+2$]

]
T1T








\+W1D




M

G($5154E462`H






F1C9#
X.&9?9#EA-%\T8F(P7V(V83-?
M-S4Y-3%D96(T8F(Y#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T
Z+S)D
M8V0S.#AF7V0Y831?-&)B

M+U-H965T

M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-B`@/&AE860^#0H@(`@/$U%5$$@


^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE



CX\


T0R/C$R($UO

#$S/&)R/CPO=&@^#0H@


]

]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P







M+#0U
RPU








]
T1N=6T^*#@X+#

M(`@(`@/'1D(&-L87-S/3-$;G5M/B@Q
#`L



]
T1P;!V86QI9VX],T1T;W`^1F]R9F5I=&5D/]T

]




]


]



]
T1T




]




]




T1T;W`^56YV97-T

MB`@(`\+W1A8FQE/@T*(`\+V)O9'D^#0H\+VAT;6P^#0H-BTM+2TM+3U?

F1C9#
X.&9?9#EA-%\T8F(P7V(V83-?-S4Y-3%D96(T8F(Y
M#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T
Z+S)D8V0S.#AF7V0Y831?
M-&)B

CDN:'1M








M-R`M(%-43T-+($]05$E/3E
@*$1E=&%I;'





]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^


]
M



T1T;W`^16UP;&]Y964@4W1O8VL@
M3W!T:6]N(%M-96UB97)=/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X


]






]
T1N=6UP/C(Q



M=&EO;G


]
T1T






]



]
M



]





L($-O;7!E;G-A=&EO;B!.

\+W1D/@T*(`@(`@

]





@;V8@



]
T1R;SX-B`@(`@

]
T1N=6UP/B0@
#QS





]


M


#$S/&)R





]
T1R93X-B`@(`@

#$R/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$



3`L



]


3`L




]
T1P


]






2P@
C`Q


]

]
T1N=6UP/B`R



2P@
C`Q
SPO=&0^#0H@


]
T1R;SX-B`@(`@

#$S/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$


]


]





2P@
C`Q


F1C9#
X.&9?9#EA

O4VAE970S
2YH


M87-C
M:6DB#0H-CQH=&UL/@T*(`\:&5A9#X-B`@(`\345402!H='1P+65Q=6EV






T0Q(')O=W-P86X]


M871I;VX@07-S=6UP=&EO;G






]


]



]


M


M9VX]





]
T1R93X-B`@(`@

]
T1N=6UP/C`N
#`E/'-P


S@X
M9E]D.6$T7S1B8C!?8C9A
U\W-3DU

M;G1E;G0]



]



]
T1T:#Y$96
N(#




]

M+2!38VAE9'5L92!O9B!3:&%R92UB87-E9!087EM96YT($%W87)D+!3=&]C








M8V5S(&EN(%)E;&%T960@=&\@36%R:V5T(%!R:6-E(%M
:6YE($ET96US73PO

]


M97)C:7-E('!R:6-E/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG




]


T1T




F1C9#
X.&9?
M9#EA-%\T8F(P7V(V83-?-S4Y-3%D96(T8F(Y#0I#;VYT96YT+4QO8V%T:6]N
M.B!F:6QE.B\O+T
Z+S)D8V0S.#AF7V0Y831?-&)B


S


^+RH@1&\@3F]T(%)E


$5054%%/@T*

M


]


]
T1T:#Y$96
N(#

M/DY/5$4@.`M(%-%4DE%4R!!($-/3E9%4E1)0DQ%(%!2149%4E)%1!35$]#




M+C`P

]




]







]
T1P;!V86QI9VX],T1T;W`^1&5B=!#







]
M




]

]


]
T1R




]

M97


]
M



]

M1&YU;7`^




]





F1C9#
X.&9?

O4VAE970S









M8RX@
S$L(#(P
3
\8G(^/]T:#X-B`@(`@(`@/'1H(&-L87-S/3-$=&@^
M1&5C+B`S
2P@
C`Q

]




]


]
T1N=6UP/B0@
3@W+#4P



]

]
M




]


]
T1N=6UP/C0R


]


3`P+#8Y



]






T1T





M-2PS




]



@
M*$1E=&%I;'
I(%M


]













T1T;W`^/'-T




T1T;W`^1&5B=!#;VYV97)S:6]N+!#;VYV97)T960@




@86YD


]


M4D%.4T%#5$E/3E
@*$1E=&%I;'
I(%M


]






]
T1N=6UP/C$X-RPU








]



]

M87AI;75M/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^

3`N
#`E



M(`@/'1D(&-L87-S/3-$=&5X=#Y397`@,34L#0H)3(P
3








]
M





]

M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^








]




]




;V-A=&EO;CH@9FEL93HO+R]#.B\R9&-D
S@X9E]D.6$T7S1B
M8C!?8C9A
U\W-3DU

U+FAT;6P-


M@T*/&AT;6P^#0H@(#QH96%D/@T*(`@(#Q-151!(&AT='`M97%U:78]
T1#

]
T13:&]W


M(T@4U54T51545.5!%5D5.5%,@*$1E=&%I;',I(A54T0@)D\8G(^/]S

M1#$^
3(@36]N=&AS($5N9&5D/]T:#X-B`@(`@(`@/'1H(&-L87-S/3-$

2!-;VYT:'

3XQ
B!-;VYT:'
@16YD960\+W1H

M/3-$=&@^1&5C+B`S
2P@
C`Q



C`Q
B!



#$T/&)R/E-U8G-E


S$L(#(P


]
T1T:#Y-87(N(#

M=&EO;G

M=&@^1&5C+B`S
2P@
C`Q


]

@*$1E=&%I;'
I(%M
:6YE

]
T1T




]



]
T1P


]





M


S4L

M




M9VX]


]



M.3$W+#4X


]







]





]





]



]




]



]


M+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^

]
T1N=6UP
M/B0@

]
M







]











]





]
T1N=6UP/C$X
RPT


M;7`^
3



]

]




]

C
L



]

M;CX\+W-P86X^/]T9#X-B`@(`@(`@/'1D(&-L87-S/3-$=&5X=#XG/'-P


]
M
T1N=6UP/C(U


]



]




T1T;W`^4VAA






]








]


]



]



F1C
M9#
X.&9?9#EA-%\T8F(P7V(V83-?-S4Y-3%D96(T8F(Y#0I#;VYT96YT+4QO
M8V%T:6]N.B!F:6QE.B\O+T
Z+S)D8V0S.#AF7V0Y831?-&)B



M;&YS.F\]
T0B=7)N.G-C:&5M87


T0B4VAE970P
2YH=&UL(B\^#0H@/&\Z1FEL
M92!(4F5F/3-$(E-H965T
#(N:'1M;(O/@T*(#QO.D9I;&4@2%)E9CTS1)3
M:&5E=#`S+FAT;6PB+SX-B`\;SI&:6QE($A2968],T0B4VAE970P-YH=&UL
M(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T
#4N:'1M;(O/@T*(#QO.D9I
M;&4@2%)E9CTS1)3:&5E=#`V+FAT;6PB+SX-B`\;SI&:6QE($A2968],T0B
M4VAE970P-RYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,#@N:'1M
M;(O/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E=#`Y+FAT;6PB+SX-B`\;SI&
M:6QE($A2968]
T0B4VAE970Q
YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$
M(E-H965T,3$N:'1M;(O/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E=#$R+FAT
M;6PB+SX-B`\;SI&:6QE($A2968]
T0B4VAE970Q
RYH=&UL(B\^#0H@/&\Z
M1FEL92!(4F5F/3-$(E-H965T

M.D9I;&4@2%)E9CTS1)3:&5E=#$X+FAT;6PB+SX-B`\;SI&:6QE($A2968]
M
T0B4VAE970Q.2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T
C`N
M:'1M;(O/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E=#(Q+FAT;6PB+SX-B`\
M;SI&:6QE($A2968],T0B4VAE970R,BYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F
M/3-$(E-H965T,C,N:'1M;(O/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E=#(T
M+FAT;6PB+SX-B`\;SI&:6QE($A2968]
T0B4VAE970R-2YH=&UL(B\^#0H@
M/&\Z1FEL92!(4F5F/3-$(E-H965T
C8N:'1M;(O/@T*(#QO.D9I;&4@2%)E
M9CTS1)3:&5E=#(W+FAT;6PB+SX-B`\;SI&:6QE($A2968],T0B4VAE970R
M.YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T
CDN:'1M;(O/@T*
M(#QO.D9I;&4@2%)E9CTS1)3:&5E=#
P+FAT;6PB+SX-B`\;SI&:6QE($A2
M968],T0B4VAE970S,2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T
M,S(N:'1M;(O/@T*(#QO.D9I;&4@2%)E9CTS1)3:&5E=#,S+FAT;6PB+SX-
MB`\;SI&:6QE($A2968]

 'defref_mojo_NOTE7STOCKOPTIONSDetailsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensation'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_NOTE7STOCKOPTIONSDetailsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestDate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensation'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_NOTE6STOCKHOLDERSEQUITYDetailsScheduleofSharebasedCompensationRestrictedStockActivityLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_NOTE6STOCKHOLDERSEQUITYDetailsScheduleofSharebasedCompensationRestrictedStockActivityLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_NOTE7STOCKOPTIONSDetailsScheduleofSharebasedCompensationStockOptionsActivityLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_NOTE7STOCKOPTIONSDetailsScheduleofSharebasedCompensationStockOptionsActivityLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_NOTE7STOCKOPTIONSDetailsScheduleofSharebasedCompensationStockOptionsActivityLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AccountingPoliciesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SignificantAccountingPoliciesTextBlock'

              <font style=DISPLAY: inline; FONT-FAMILY: symbol

              <font style=DISPLAY: inline; FONT-FAMILY: symbol

              <font style=DISPLAY: inline; FONT-FAMILY: symbol

begin 644 0001185185-14-001008-xbrl.zip
M4$L#!!0````(`/$D$17O-1W<``)QJ!P`1`!P`;6]J;RTR
#$S
3(S
2YX


YG9+RD



7+I8F%GWP[-$!LX\G6-Z]C8#?

[



MUV_O9#U/)M=TUQ_\-/W![NU2R;7+&P?
@.
`(QZ$#LSTBA6?Q6/1J/$(%*Y6

MKCS4WXKGX_ITN]VUKW$)K[Q'/EVFL

.#
M'G1$&%O=.YKEXK



MI8







M3

:8G$



0A],:^U$XA/:ZOQVYWTP-=WF
M3]YU/GDT0UPI?ZZL\^4]Z(-W8A-28B6M\_<]WFLB);=Y=7Z[\SZ8FF[SZ1=
M+I:FO0(@$
\]V@[\+S^6@9P(@:#3Q*ZYZN8PT=J=ZP/

PBOLCY)<(N7W0`#&!D&<Q/;RQYLCGR;0IR_B'2SESVVUQV$ET*#J-V

MUQT?X!(MFK




MQVB







M%@+.X'1+)=G6JZRWO)7(YE4J5GG0AN;(F^B:V2Q5O#K]
R2S?WNJD3V;H/
*HO<EG*

#VBHA3A)[4M1CWHS!E*FMB?(X_)R$SZ
M?76?A(?:7!OG.4HJ*.66;)+#%!4::&I$,U(T**[13PWB?A,CD16O2'4M[XR





628DFQI'(TO)9B





9I+6$01+3K!


BJ3TXSQB;UZ*3X+:
3GU!J.J+];I=C-B

(
NJ1N9R&C'-\7XCMV(@WG&E%I)2+F58DJ9AP/)@;!L2S^)IY@_+-
ML76A+:&GF0T8%UA1Y+AHZ

S(85Z

MHS2@!ZP2BEO.:Z2
M#@#E(%
G*!YF!.%K
R]
-`==($



9[((E7[8HH0



5_`J\5





MRUO$OBQQA+-0

B)

/:B81+J:U`#S_RN4LX)7\




===:]C
M`]P;!T'IC@/0CQ&AX
^QE2Y?1L7`8^7:2*BFZDW0UJOMT)S%*@F]IHE'+O
MOJ@J4A'*#V*\$@%FH





MH



D&,*G)MPAA3OZ@A;Z+?68KPJBPI4G-1G4T^?W
M*






MM


6W7=\`]0GAN

MO\S1NU``^#\











M@%#+G



-(/8#J&P5LX4
MM/$+'IP5JO1/OHMAOTJF?VB!`=!3FQC`@L@QR'3T+Q_MA@MC@G/\@B;6:\


O/!
&:4%4X\
]]7
M$R0$2&8Y]AB


?BXTB)26(HZZFI

M


+8?OJ?8G6!;A:G)\
M!W7H3V?\.J4AN-JXTILN]XHC%T\BPK4H?&HEHN`#'6L$/A#\NY@::.R4



M1^84!`-



MIKB3$!L#+KJN4%M@
;ECL;
)]@L@QE8(WAN891V.O^,:LG-(N]?AV1#!

M46?









Y?/AB






[

=EXOZ






U'GR*

M;)N#O2WWJ7NNR74:_T7)OAD&C(@F^8BK?@LZ=%'

X)K&2Y%



MXZ/4J67--`
A+AH5@`0^`N;:7K^EU?3\;!
TP0$#S.266(!Q['`QOPP%UT



F3P
R2M4
M&



@(\)P
M#L#MX=T%?H03^H0T4:!E_FVQ(W4;KMD(R=^0/?;NG35
@ZMQ'MO+W;5%NZ5P
MA?F]E

M

M7




MU:'

MYO^2^;]V-
&_Y<V<]@/;(5LDB(,'





R@V%=#:3DWX/


\2]*@Y.8(`Y+N)7ZO*:;21L&VYGA%?E1/HQ$9*(C;WBOFKY


MDM\*G_.;=OPVB6.7W+@K;&ZM2W@2B3@2H0R]6.9T;XJ!4-!/`M:1CY/P.H&
MR?0[W6]/WMT`2./8M'E$#/






M-]MN=[JGK2I

MRH

M+[CX5*+0#IM:6Y


/+;I8B1TXO;8G
M6($:VR_-3K8V(]](B:V`N0U@-(E?$K\D?DG\:ABCE1CCXO$Z&4;WD
$H/;P=
MWWP/


M-7/6#S


3=_67I+I9`\U500;=2)3IV4






B5!JJ.C:4G$




MR27T`FS`?
L3Y(RV/JFBX;`#@M&8#!L)BY2S5:B

R46$QN
Z`9%C1/W


-4

(?GQ[']M?POL-H#$18GBBDD7NWK79X-ZG*\TVQ2
MVSL)V!*PWPP]YO;20+V\IQQ$IGK+T
2;%8DE`2;FH%-6X)-0V1HB76X?AA.


$GV?=5JKT3Z)D
A2`202`2`#9/8!L[

M(`PEK/FJB$&462,!O;IPED:VE$2IUB-0A&7KT3L^62,_1:Y#J6$;B(21




MJ9
2D64(#[`

N@%BR\=,E+F$9G+)=1!=0JEO($N/5\S?FN,<8-
M.+<JJRZX'6@P!4

*RU(56../T@M





MIO^Y^?(TG7[\G^_
\:_.]#\_WOWQZR=W_
O+G?;WS/SU^?/@\75B_Z'^]^R_
B\<[


MO
7U&VEE[GCYGB::2T^&&J
&/Y*D-A/WU


;.
M.2).V1X3RV&



S$VZP_#OH1NE$'PC
MDBZDJ#1\V^?@4:F!R:VGNAP(RK'?7^FH)9(S*,EUFW#*%85=9XGG#8SS9X3
MGE$&MDYQ#-)LYH9`((,^J^X'^UL4LI4I`UHE^G&DZY0\T`E]/

M&.^$$1IF)B:7

3'UCSL8D11$1A@U'H3S4L

@:D^(1)HKTZ)(




$3'


M0RHE9$VH*W705=K=5J'^N2CN)52B7S@'.CX#*;,OB6PXR;OS\Y5OI(PJJX
MS2OMLU[XH


/O[!&:!P@7\3JX!/8.RW<<&TXR(R'LR;F)BKCJO0Z\)T

.F6[M25DWY4IEMRT;C[R?!&2(`





M=4[O(C;Q0\5MB?2G3S
+C


M/ZI9PM






1MU?R1;F!#




M]R@+&'/)4B5
EG


M@%EX4:]-J8;H\NQ$_)'OIFYQJW-)]SXX/6FS:DIL?IPG'N=1.P+P$
=LB%

GL_`=8!:^





MBMJIB^.RS0Y=)B0Z-`4=VJ=J_6W)AH)#39VYTL24T;7U!TZI0IJB0CX
!DJG
M=2X-3!E;*U%!HH(3.BF[


M4M

4;D6QZT-R0DL3`C&QU59A:%_X)&\@Q+WU\
MEJWD&S)3

A6_-0M6
M@@NZQI@)@I`KIPTB^.JX?XKB\R!3V@PY`P5Q*@2+7&:JX0;@`@@4=II#([C

Q<A6/(I=_ST2VQF;&-+)GTF2$:N2

T*'.GFK)JC%KQ+BSE8J'T]F8MD#5ET



M8N/P4@:=CAJ;KE?5`P6BWNDM

MV\0RJ8_MZ1J;%/







1]0L5PE?VZ7K

FR]40!5









ML=H^ZVQCXV?FIT^HX?-S#?QDF
6#+._:1N;)SS!C=HEQX@`*S^BIB
X$5SXB
MNR3




N:/OGK[LH3$6H

M@=#KK\2M&!M;@Y0MUM3'=&%V.G9\`NY1I?W
M)\UT=^?2JRN


M3';MN4NF
))P)5
829BJIP0N


-@H'1:

ME'9.5]5.5=7L/&VO5JV











4R7ZI[C

*?3BC%*?


JWL?E'3F6Y;QRVO$U9?YTJKGFW]!$:H6T(/`#S!(#

TW/_Y*
]^GWB@)^U@K$


M^?2'*B`F-Q1L?C6C;0(







8?$1SG+9LVR
M
7`F'42EOTGFKWWLF/04O84I658.6(J:U*92FTIM6OB;9'XYRP-Q#LG@IY+?
M=L`7$OHE]$M0E+-L_PED$D@.R3F7^81JL[)(R\(UM41M.28+9@?4UE[S##

M$JOA;:/O#1XBQK9.^SV)L35U%\H`LB

M=W3


MYLS2MHA0FWWRC'R+`KIV-]SH8.+\KQ%\?2/-
RO7FQ1ZE
'G=U3+14*`M'
M5V-ID]
LG&;VX._(I/[-[QD

RTY=BO<=-(^F

M%UH-AY1


M03H/)6Q*V-R


`T:QPHQ(\AA%.'9OP

U;_(4R[QI'60&1?O*M.6:JZ/[C

MB@07F9%&C5/W!82C^*
:M3I053.OA:
M$.D\1:3VRD3:#X$**+2Z$=9.KW_.ONIEYQ;/]MTVTE3---MZ[2_:K?ZA!J^

5^1%#6I3:4V


K:F[4`:0'9'Y'!0T





M8DP6A(VL4C&P-)JDV]\H_JLY#IEJR%15E%S=B92N/'RV%HW:9\T*W:YY!=(D
M$X,_=O*&2NEHIQ(R^+^)9+3);5X(\)DPL#/4:2]H'9$D:-0)-/+EIB5H
MU


M5=&V3M5Z9+*49S%UU!#R+*8F.'DDTY3J0.Z[#E(0Y%G
82O*:_/%-*AMD+E)


M:S]2BX_MV?FBN7]2CS_?(C

YZ

MNX;O8O*[5+XZ`O




M3\_W5__.Z`LQ^F0X?X]=*-L'F]4[)+JL;]W-L$6
G7W#E1VPI/?*+PM@H
M)9H])_P6,36PT(]#-)MHH/7038#943GD(9U1!G5?=?T3.ATYKOZ!
2
:&.7
M\CPS9.2XO$EG!.S-/V2:A?\DIL?($W7Q.U@QQWZAKF=BZI1(%`B7!87





8U(W/H_
'PVA?&(9@R*!66!'0TR
MG!



8L8C

M8!P?_D6-
7!.BB.4A#3SEV`^0!8'6-NE?_DF_'=HC@!]N&(OE`:@*0!31#
C





MD=[
/P26$FY\\&7$H/O1@S##'BQ-YV;FC]RJ2HX_NV7KE&Y$5YQ`Z]T%&&I@
MIP6;T34&EDG9F[!UTYTF2?+SS+&O8CT43:W21;F]^_3N0DTLR@9#R^=M+FT$



M05_I@6D`&U/N/(
WYG@F=TIN8X=HWAD*VV\*&VZ#.T(-PT11A6U5
&5N4/1:
M2JO5*G

\
M%IUY
M8O+HC
&1%F_%I4\MXU



MFV
C!AUZ20][L`



)?:?!3B+#M_PM`4!G96YA!(^

ZN-+

M-?AXY(-V`XWRB0[=T%[JKGF*%^^9UM@(97VS=XBE#\*`2S0#$[JR-
;
D4F-

;DVIOCL$8^'OIBV


M*FPX\T


]008^:JKMM?%K.JF
M-2A=D






M0(OQV*7C('S]O:H


M8.2Z/%?[2F_0*3OQ0/E^WSH]5^.[1?Q9(@+[?3#DPH%]@G=I?&DGO$T5B)K)
MHK$J\0Q380GF=`H4@


UJ#29$/
MH!FUV0P
&)32;S.13J$FQJP(Q0$(Z0-6/7&U&7[0_]3&H;#8]!40`;IR\(`P
M)FOAV75PU7
T


MD462CKSX2@&4X;^#MM)5!XML!\UX
?DM:4;=%\S)4LJ#T3BQCRQ8K0)0\FYB
MW

^56_#!N(C:RL9(
M)4R1M(9,&S`<R-J\C/BP)H(VQ

M6S3FUQ

G(TN\21

<I+%[Z<BO!?%E[:W.V\P&+MI7SD*XWW8J4YBI.!@DD6
M'V1TUI[GKZ8W^56HK%6GS(\XSM5^;]!9.N?
^/
G!%O=(1Z$5ZUV



7C*7K#U1F*GP$A=HS-?NX[PX#2G_










G)?=







M7_QX_-8(LVZ[;O\J2/8#;#W32WRX=.^]T5TH);;EVZ&(M!#NU2=#B)D:HUX%




:&0P(



B5.:'


;X0




M!%18`!P1^;W[NJ@$2P+S!(^$`W'N27TP-
D40G;%(P5HWW;;P`1T*427/2J.







ME+&IJP=

MXCFJI.W279SI`JH@4D93_3PM%@(3S5;YO3MA=T:S.(J73KHS6+8WB+:L7`




B#=-
G9_ER`74XDC8LZKOWK;B:6O3(^O;-UK



M
3
Q
C
Q7V1E9BYX;6Q55`D``X/J3E.#ZDY3=7@+``$$)0X```0Y`0``[%U;

A(U`E;





M'XG[\


M8U(_8]\[2QKI[)\-(9;JL&D-'Y*`^WH6'.0*`-DO@V5#$%Y0G9NJ8:1!+C







D


M%5\K^-3&_\T

0`\X5TD61)8G(:H14R'00RGVW'#C
H60YAETM\M=DA

M`B`XOVE+S

M(.\E+_SN.1E$;


#T5LXVXDIQ:(6E]1OK\B9)HKJC7
T=]
A-KIB3
M(=&_K*P[G/2V<)59*GFB;A?[AZ7O5JK!4G9-NZUBO*9^&3O/E.QQ46XE.`S

T(])MAD!'2$5.%S\:#?O



MQZ%]'J(T5+5I_[6`N#,$TVHA.4\FY['X)-:XBX'+C\0
[_(0*5MH883'CJ


M:=;
@^/'DF
+H4H5W?MWZ!T+O

8X&W/$=[QY




M.5;
2D_
)]18`H3S16R6Q.R05%P

;N6'0=3Z0\1UBVO$&!B*8NE8:T1(EWS
M3D?.8






M)3E!%;K$&T(L80*U



P-=U`E#*C.;'H'^P-[BF=

(*R374[NQ=7
MV)]P2..UR2ZEI%_^M5Z&^SF:1A-67MB?

M(\Y:CE5#Q6NN%37KF*_*?

^!'U203?I5C'









MXDCQ7H`N$//8U+DB-NM!!/,!,8O;\W+H9[AH6(%F`E@;5`$_6%A4-08@F3

!U`PO0'6)]3_@WVM##1






M!R5FVX2T(K09E!%LWM*:

%&+LB:^(F7FK;FD7;RO02QF%;9:#ZX1C






6'3I%R$2ZV(SR8Q

MKX&GEXX!QV&3?)5`A;AW




MZ

E^&94VKI4`)
M?%8@8BQ%I9)$)WLS(Y;;[879=Q8A[JU(,PNS1#E(R)B%_.N;;)*PYMM6R_O


MC:RUX-ZE*M'UCAUDJ[I!!-FYV[]!*?F**%@6Q#JV@S#EB:DT3#SR@%.U:A@1
M)EV


MHK_$FO.(3NE3BBX=MBC=)G95B\2891_)&)9L==!/
(SQ\!+MK:R.QT&N(U


20PPN
]XM0)&O#:#CGY$^?Z)




M%WQPE[=ZK@)[O'NKP*]_.SUM_/MS[^'M?_[]15LZ+U_-=]?3GQ]6\Z]K\[[C


M9JVF^O4OV/Z]=?%T0=5B\:?2&R\6K5_.]/EG:_'G;?_[YQL\?UCUU9]+_?/D








6)59:3NXR.I1_;#78


*L_)N;@[?P:+^-

WJY:

L*3ZM=%L$\_

=A06X

MTX=5LF0DQ



M[B4'X*C5NW5+%[-[NLH;A:









2IR9
LH
=IAOW^C/

M4TIR_#_^N519#_PIEO8[;E'7_%G+:,^0$VXG_XN**@3%?+Z6RS?-]NNZV%



MR!1A('7XEK*!$.3@O:(O7,HF].GN,49.T328'V*SJ-\!G%[329KQ1A9[

[
M'!!+@41OPS


MHY\7

M':;A^*U=O?;NTVK03ND
!I+LKFV-!PR03.!BJ\;UK#E:8:C\O.W--'UZPCDO

M8I:PJ@6KPQV*




M((SY/NZ/_DHV0?1;]M=.CWE:$`!;O@\[TDV'




I'
MM[OVTHT3)#/1P@R-:RXM**$R#GGV\I;^(=3%5E/`





MA?5TKEHWC`@GL/F]+0PFI$K

/4=0J&#6&!^.(@0:OIH8


M+F`V*
L)9AT\^(()L.J24-#@MGZ.2]K)A,+$08[NT$$HVRRIJ9#A(;524N


ML


M



05
[
M:3'P2YGG
J=IDM$])4Z.#N^1]
O!J+:F4
L?VSN#_7VM4]\%7+9@@%D9*B4&
M9EU:4I9


-



7_LF!`K`Y]G##X5S)D2K9KZ/9OJ<JK?!9#<U:S






MM2:XR
[AGO21`/4==1DC-LA5]`K-_#/#G..+N4%_2*A.A=E;6K6&F#[&4K

PA!E461D*]*.J%=NX.WX
MKWR.ZKJBW+&L2?J&3_(:!DA_?*87F@-#!7L:G)]B*J=?^'/N5IO%ZNEET9V
MH@%;D&GK8*I'Z=2J3C2T79%.^0@!FM$9X=THRZD`($R[N9^R'*?6#;L5XAQ





S.:SS69VRQ_:!U?!5(@]?\%^Y$Z<!E-Q=CP'NU$#<!^<
#(1#$-!8J20[`+?)C)M-'7MX1DZ-';IZ.ELP6M7
MSVM7SVM7SVL/I?'W4/H<$9P666T&Q%95\57?#PJX?+WZMME2/KO_KCR59M=





MVR)'/^MJ


\%#(+%8^;G\D$*+=B]8%,^;40J:S`U3RL

LN5R7)ELER9+&!ORI7Q



MXD
3P9SN;)UP]CUEO/






MW`]@*B&*)OD5#@TQ5$VZMVE5

M\$Z+4%Q\B:AA$+#
W+5!4)!!!]::MBT0L%6Q5%@_!!\5'U_MLQH;@9/RI3*!



M.BS1]UM
T(Y^T\)$5@

M

MA.9=NMSCZJ&!RG!2
23H)
7^Q(AM\?,S9N971%?_]JC`UR%A





M


M#@``!#D!``#MO?USY+:1
/S[6_7^#WAR;Z7L.JUW92?^2NZJ9J711HE64J19
M;_RZKJXH#D9B3)%CDB/M^*]_\$4..
0W28`C^ZHNUDI$H]'=:#2Z&]U__3^O
M7H%W
(-%5



J[+^
MS2O\FU=OCAE[_D

M\_8D+ZNK%0

M':^2*0TN



GP7&6[WUW452W?E+?
M'D

MZ

MMY

FDP7=1``GN



6;U5P:

^LJC9UKJH*)8[D
:8/44)




MN35N.$K$_&TCN[74/C/P2/`)?)1;!/LY9^/%



M;[%Y.0ZR9/`/-S?SRP68W=[.%[??!Q((/=$Q^S6+\^/952


M\_EVB:F0D4A8/03LQH25+1

M[)/`
-/QHS!?5<KUX+718BS&#M5#FN4#4+K/
MHY_K`JZC9


B4V*:D*


M#L#A$CYQ7&S@DIO
0PS69/I0(5D#

K

M=7)


M?W\.GWE7^Y
K[(/Z[2L2H.\L)0@-^?+HZZ^.C_[T[9^)??'MT9__?'STY==_

^_9'AYY]G$?+)7G:%:774;(\
MSTZB=8*


MU]+0MP$SMLJE34@(YX11[IKJ4_N93.M9W`Q0

1`D8JA2K?1JXRQ97




D@Q1?)O')+A:W4!DZ29Q


`NY`3]P&S@2WYUV0&VQ#%4YC`
M%B_1AC;AEN3-[$MD7;]&U@0
M#@O?57.L

JDT1_)F9NVAT;$I[


MD


M9J.[F:*\+W=FS'OK(C7@X:7151TI\53HHUTC]X$4TE3$V$@B='*LI^HHA0;T


M53Q;_GM3TA*LBUQ2V8K





M?FK9




+.:)N)^$=+.

M`]IPFK]I&U.DA[.X.\=Y]H3

P

M9

*2:`N)R+#-J)B=NW0

M!.Q5)+6AD5-LB



M2@4JJ'&E0
S(N%K5XR=I7!EP4'12ZX@2Q+C2(*4WKH2LFIQQ-0[+^AA774_$

MU%XN


Y)+OQQ4V
M]FK



6;6:?_C*HCIAM4%/(:X)%Z`E


Z;(W1O#8EHD0_5[`


3=8'KM_Z1`X:R





J'-P328DIM*UTY5\44O&2
YZ!_5HN&%Q^D!
M$KUG@)Y%_79.N:-0#6=[_]%!-Y71\T`J`AK=OL9-P_!JP4QGLE!.@=_??D
MRE'.%^06H,+(3K8F8_&;,%4C7'VM^R:-,G]\3&BS-%I='5\A8(8O$'YTF!T


Z-G7:O&1I5HP0;]
M

23D
5



M=&F



O#%2



#

5XWR_I%+A(


74.2N-KUW][[



MY-N:ACX;C;BCJ=.:YF&/\)6.IL%XM_8F3=ZQR6S5&5S@G9\V^!G:*V/1TE:
M'P`MOP5Q!L!8ZM+Y!.Y@!E=)!:(*K@(4-8P0('&AJZ9


58`0\+7RJ?%P1/68P-4]1I(PV^UC2^3A32[:!6&39/=7:Z3)R`W6WWX1
MZ^
MI<=K@!O!L`@&:N(V!.[J1VF<;80O^U+`O@



3@1`:3/655]4#+
:PCOJB


MV#45X;&AFTZ:L5
I8H+5]W=






N0&@#SHH)]'@!ZEOM^(WJKC%3;7E
MOB2`-'B(6+%J



^NR9XXK.-P#W?_
MC=1\+4URGI&/X#)L=43/DNEG8PO(/WQCN.$1?6'FKNWB0A0LG\KB#57$BS
-

M&]$79B#8+NY%&0B6BS?5$B]91TS
/'#AX/3
@[.\6




YO#=0=QL














3H[
MP;O6N-@OT.7B&Q):.2(DS+P]YN&=XLN\YC4MB9S]ENL9*,M'B`]9Y8$[E'

(Z\NV8#COFS8EC'/*W2Q&5ZD-
;BKS0K')PC6Z-'(\#)5.V%B/BE6UKI[RCWGQ
M
ZX\$*V3*DJ-K

\0
MQJ=)B593)=D&+J^0?B6JUNS.9@//?[*@!78&AWE*0`#




M-'R4!A6*V;S?X.2XR(K6U0


MI!@;3-0)K`XAAQ?A$GQML!M


M(90T]N#X[FF

H`@WO76!/ESAAB$^!6!-7O'!'+$,9S[EZ?[]%_LGN`_O8E5VLN*)
MLIQD8J`?-XC)U4-4M4;#[#ZZ)X=+E.U`H7\6N%@-`](:]04`N(1*`R3)GG)T


M@W4%AI%R^RNZ
&?[
=\@(4!R^\@.B8*=(NOZL%A2\P;S*L

.
ML

\33'+EKC*PV7TZ+VJ?4\\
MI]4WTV$%LM9\OVSPW9*,$[T&F%(E^F%$S:JWDNA^[3%''^'A)1M(ZG$'P'\


MC?YCM
[+OP`*1/7F*-K(T,6MEYTF)#'^9&;'/B%];LB$UA^G[898#2(=%T(
MZW).3,(Z##64L@M%M4T_2:'7)!A30%JQ?[\ED.P.V8RB718$_9B&[3JA0D-


\I##
M9-H0


OT?2X




M5N2C#^L\.X$%[G7P/DG1;_/





D.R6X?`?S[-*WV^QR0=+7!D<'BI'
23*N&*

=Q.X




MU:6P.;VV-)

02

M'=W#^2=8Q$D)24&!/J)9NLMFC1)@.($:*5K!(6PM''_4=Y+EH9GO/S6/7
2O









MN)E=WLY.W



S!%@PP-G

WX6K[
MDJ^A0;\;V\X$.\\0/V!9W:`I;BLR#T0

M@V%S
!N#XCO.QJP#V]CM6J[\;@*#S4QG@?59LB04?12
6/%+-Y-Y#EN)@*





7&X?0R56(X(KT=/^:WHXT*03MG$G




MV_D_/\PO%_


M/6AQDDE6T\Q3WL:]#&A9&7.LT]Y338D`5585]MTE?9_D??1TYO&`;]0%*$

$]Q+`WWD@#R$=[K^PM147VC!)_

'

]Y`7N*O
A




$8V/X@AP(R;T\D+'Q)8N4ZZ]ER[C
M.EB-J+CV9O%M$751
*LS
17K6

*0RS'DA#A/)[5

CNW\T84GW@59(!-FPR%S(CEK8NZ%HZ]*FO+GA[.-J%33*5=W^W&`^[

[J3

M:1KUA%XUC1(5B=@T'P+JE)Z`66/$0EZ].ONHV7VDY;'-'.$,_G5-V(DI)8.
M35!OOIZ*YE$SK6WL2-?KJH-PK@9N7C26RFG!]RP=W-0RF4#_8BVHIFSB)C1
MXO_^BERYSLK
CQCZ;DW@/?3-SRX+?=-O)G/A$;*D%?KN+*I'Z+M]Q1XQ/5HX

P'6B2'^6+K5':NO;39ED$-DG

MB=#47P/N\ZE$C#3


MZ--4ZD'@:@+YX.:L:4H5Z)?OO?JB%B51


4-@GQ*1:TNB
MW53C_3BG=&B8W@CK

:C$1*T)@5!\V+-X.?^5J5J
%(


DH*
M3LJ!-N?%:PVDX(3(2!6<FO*'1_50DZ(C%3!\50_<#$?2
&Q+/%%?EL5Z(?[

^6

MW3M$$J2#?5J?8A342A(WXE:&$T))@Y0/^Y(@7G``.U..C4(Q:NE_H`P(9E;*
M45(H0QT7#I
'_5ZN1NDB?Q\5/\.*-#6U4(;2P?Z4H0P%^1O6*

M?]?3L8%_Y=?KW==J,)&\J`5D;_2D?]`Z1](%:I0DKQN-6)"'4X!_ZJ
-/
M


X25N`B5HB']#Y8!(?*&




((9G60V

M\DYS3)6_R)]AL7B(


MH7E3H\8H2;3J;CRH`8`:PN0*Z%ASLY$O.S+Y5L%6V(DTLBL77RH'PZAO*Q1%
MVMR






X?/%]7(O@_PQJ1X^1D416=WTS:%YB_
;HV2O=#$(P&!
6*:DK-2*EYA&


-1(^(;6\^SUL
;0\$_0

[6'

Y7;C6!5U-!*@H8.





M4S@$3;;J





-96!0_`3X.)?B&G


ATTFB;C.:L)T9ZY;CF^UWI\'_D^)_^@&/CU08^Y%'/S8&]6P2XC;V;P
MC-Q/;'+!IIU`-,N+F,KWYN!\].VC'WM!9G;&T;YH'@ED,VHD,G*2S4D<%(<M
MGF'B&&.ORLQH\2.COTMH7UXZQGQ^B(HDWY1D8KB\CHHJL;)65.,]QED4:$CL
M!#8L&`C9E`HIH!2QK!TJW;?PA!@Y'H8#1FQ4'S(H![7(.1Z`0\.)%[`9'
MUR]+[BS/RW(#EXM\MEHE:8)FN%I=PN?3I(`Q&FFA


![/!RTRLE.!


M:3AM_`Z?`J=([Y]%2?%#E&YZJ&0IK&!Z68:1J7(FXP$&`#`$0$!

W\#%*LB2[/\FSJHCB

;ZZ;-7Y&5KPE

9G1&


L5;GFVJ30'?HYO.
MX^:Q_N7I!LY6%2S.T+0_PJB0
L

M



MY2%%I[;-U]!0*'Z\28NWC.!_(%
4`!VR?8HMK#!]2BFM=KYW61QQ`NRS.T

0Q75R.N13?6DHH7=C?9;6I]EXX3&-#8:3

M24KJQD@DDB=L(&;L/)-6LL2@7MUA6(`'=@0H.%;+F`$$!*@(,%/[+_XK`3D
ML`Q3]Z$'67@V]Z:NKW.M1A1ADC_1?0)6Y-I7B(%T3);1/RF8P`:!':CP$\B


M*R66--OEE



KE4WA7[73@;YK
M%%5+

MUR]BLR
10]_/9(^W\7%&3]&RW#S2W_6[J^T93'N7M68^P$VHO+E-YNKF3D+3

ME[%17
JL8B9=[VB]:['MVRKNH$S;U=RK2LW%JM$0%!WEU4E2QG:J5Z;A&.!T
M*1J:_[XM4_Q6E+UN6[[=?BCQ/8UEMF3WS
.5T!=.
J
4@P`U#R(GV$P2,8^
M!PTDL`,56J+,%RTQ1*U(YI6?%TETEZ1D=B[`+.(;]R4R,+MQ]Q
Z6(O8H!L




M:SC#&UX];*??)WRMTZQ1:*&:D


MX


M0A

M:VBY)\]*(?M
F94A(4F499\#^CW``P`:`0*61#-A4IT2JURM5_VY;P:=9^=(
M6#
D@XH
`X&EB--7N)&A5:QR6:(];$`'SC8TWK5U?RW*Z;K*5[PI^V];.6@O
M`J1$0==*C6U;=O$@0T+FM&NY5.];]8(]G]%-!!GG7Y]$1;%=Y05Y1JF/D^
A









O6
MX$&O?L:C0#V
RE81
1GQ+AVJ1K5XOUO?U9#A5I#-Q#?AR&]+*]3^;64'_K'
M:)V7?V'6ZQ%@,%BA@)E`CGQZF5*=[T)=3R7)VC7N;C;/Z!ND
F*CI.*N3QF

3_:
M5P7!^GI=


MHFXZ



MUEO--:TA3P`Y6Y!!)NVS]NKZ-$4@9(UN@B1R]:.0

MV[?TV.JL8;1+DDSK87U[I2*&VE')+P==GH
GV8A/[BGP`WQR3Q$7VXC]:.S[
MD5DG)92$G6CDP2%5ED87Z?#@ET/5VLSR8SO$\%K$4ER0G\:#G+H3T*'!TZ/4

M(!%+]`3P[K2XJW9RTK2MVECH^U#3K0=F*-=1X_6.2?=4*%.,/.5RTXM6]KY
M?PN_9R!SUO$EE&XZH4,*?3\M!U1[+4;.)]'R^\6V3QCBR@]SY;PTS_@8.'.





M(:IO]F_N2OC+!FF6^9-1=OMN`*`CQ#LT/MD:Q&R2+UPO_&IKAW!U$1Y`V.8
M/.%T$DO3J@8`=A!WYE


M(V3*?I.9[@I]IFO
']=IOH60/=



K8S`9V

7!]Z+1+42[#$.7\K<



M/![`TWH_#-`LPGL9E@+)TDV^C5).TZ.;]25:D_H896-!


!)FS0JI#*%&)-56#DXY:.NQ#
H+_\E`O



M^
O






_Y-E$JW'5?\G`#`X9:

M&6!_G@8)!KHT5/HYP-\#

D
GAW+_-R2
M[=A\Q)JTA8Z^B!C2]@MW%N62]M\!=Y%D\!S]J-#(`TC!;A;OV=


C`Q
S$R

#HY.3W(_+??__7

/W?O1AW[.M`'HN!5]'A=\@
M_SK9?.V$?'1R_NKDXOSG1W]Z_'N
W-'1K\ASP`C

X


=RR'@#^^!Z`*MYEA3G^7


M




AF?;
MV!]$(+2:;7NA&T!W/L1;J@V!WUE'/ZT962T92)COD%TH)]:=`UB]L]PA1.^\


`W?$N^!&4`(3#%5S?=!X%ONM`^M.TPXP
95;694@TN8

MOLP)%]
1N(GD
3&TUB2SH#U8:)IFXI/EA!%G6/'1?R9J(FSTQ08A#/PHS\
M9$

=DEWJN
8-E@;[LQ#
MB\AG8.2U=*BMS[5$P
??BC[N8]8R3(/'`+A3


R0=


MEM/?RH9+
N:2%/9!=ZX_DH0N\&4ZWL7$&K




7@#A-5'LM12Y00$A'I=T!Y[K9==UB4993*PU
L6<K$GX`\!BLIY(\;P9M^#3AALBX-$BOX0
MR19D0PZBMA%LQ;

MDY
M)RAY\-(
MUA)SL%1TN2N-7JH`&U\%R*)X]6!+P6!+P6!+P6!39A
?06!W1`1KN+VUOP]
MJZ!W(?\OFV&/N8Y/P53Y*R-V#P!Y*_\L_QX[6.1_)6YLAR2AM2KH70&GM@

MN9


IP%P



^$J


BSO!'N7AI)0A&/URP*C8

U3:8HQY`F]@*/8X9(GOX
X!B8Q81!M'NPR8BN50U
M`5BGX=*0;8=DJ0`447A?5;QUV&H9N59<K5&*EXA$DR@Y&KX?UB3#A%1+-M%
MI(14]8L27^KNAEIDF*;75D%F
./O!-B39NVII6@ZF739!(_XRD


!7YK

M_U]U+5M^O*3HDJ




`J-JSN*?

M@

^/)OR%NYR
MV=
M5O6C=RNF)(FMK4WRN?ALY



MFCZ\4MAV&U-?&B*5-$3NW4'4;!/OVJ(?`HCKC`G)H[0+?(2FX:7_17'[&T


_
MD/G=^F!JN%5-4!0M)8?R/&(6!J[JF[IZ`%.UH;0VC\SXBKPGP9:0-O
L?`JL
M/)
UKZ=QIZ13ZUG)]DWCI)7$YWH]V:SYO^2'Z44YE+1UG97BU1#VA!%W$C

Z



2==



:U6P'CJ6&^`UAC3[+
E79%@M`W5%5LNFUIF[



MH\L2R_.
V^!+(+E@XG]41%BQ$QX(^`&YK5A.])X:7]%27$&!LU%Z&BJ%K2-Q



EB
X+M1P3\]O)%HKI1








HJ46&Y2
MF8JPXM8=-ME28JGV

F


M*\_G+B2(UB#VPT251]QL`J=`D;\S4HB5ZQ9R\61(8W:4RJY!RH=(MF#MID9/

E

M+I)M[Y]$3:`CW(HUG!'+3594Z6XPJIA]2\D.?B'VV08K&&U9Z9AY9YT^P8








/M$-WPSN`9)A9U59:H`]
BI#
M]HF$B@(1\FA1S;J4?Q1&



MX+P_5.4X4BAE9%2YDQ5]VSLU]I\!G-]CGK45CD_FX!I9;M##SN53ZRR#.&C'
M4K




9\S&X#%<C_^/DRPUVPA[ZZP^7'_[X]L9XL[Q;V;W';WWM




K_]PQ^T7YU9$Y%<%))%N,F9Z)8R:=.8]1^)'W1









KV0*CS+L2D'G5T5K
'7-6;M_&[%B0
WQ/H*/:Q'!7L9\#5B+:(#NA]L-:8;@NSQU%,V
M$4`0!:3;+1.P=J6KVAUS
#]953.3S^U8\J.!Q5=2\P%:9#KWVW?O+K/9D
M$::$

7@9V9'?TG(,0N6_M%*H'
M)A/3@RM
MI.J&ED(8+9);


M+Y`2E



MN@A/3)M





R#Y

CNPX=7/
Y/\

-/1Q&3;*EJV4OH





[:R\IX&KT=C2?R<_8^SMOA
M#8B*9$F3.0G3P$N2]3$736M5![F38?H@&II3@!KGJ:PB5TC
BB)L2J/5LC85

I
MU:%IE!E3Q7L9A2=VA[4(]Y1*_X44-CV;@R+W2:F2J

*`_

TA2_G_ZZ(4A0RX9Y<-'NV5PPL(X^3G]5:5)




!Q6N\)7IGAZ2\3+3
M.JCI=$KI

M'7SLG_S0]BGDR?60N@7&\SNG]1%9DM`?=@QDX*

MA5\HZ4\

[LD
ZJ@EJQ'ZR
]



MW`I$1JQS(X(*1

M;T$I2



_QSC5](RSZ3@Z3%Q)[)S)[


[3C=T_)_[V78QNY]


MR1$*LR.ZSUI[LMX041YD
[9^]:CIF26587VEFMJB[R-W+E*75



E*I/6KK`E5N8D272VE?\0
U7$@-


GB$7!-+;W4VQY


M:MP5$!


MX];&'W$(2
C2.DC(]?A*8F:OK
Y<
M6@4LN5BH/7_H&0:6M)8\ZY.W'$_US#X9*N_3^C@&41&N3DJS:Y]%:7Z;M6!


OLM\]
SFX+B]DDA

O'2O1BD?7-S]]


L'48T!@#*)


M5M;5PGZVV




IP3O.9.%$UH`.%@+`8/C^L9+R&$:/;&$[@O*
7MKR9R)F_/[
9@]2[H5)Z?V<_-$O8J=D0Y@$.V


7P2Q08NB6$/2LQ1KHV&8F3J@%O'H/'`

FBRQT9397KH


Z
BQ

-7HKM9168R;
M#S=E2=U1#*9BZH

M))G)2^U


SOHV`DW/9V]M'\TA

(;J1+(







JT2_GIH4:82Z
(I]/P&)M

V



!$'`#EA#_Q!_M56W5PC&6EB0_,BC+_MPL?-E*U.H%!7@$
M.C/N^U@U^DMI71!(C

E)

[
90%)
M=Z34]S:_^KA
P(7N[6M.E;4[@WKYZK;?;-?[_4J[=E7I-_N=1K=7[]?;@\J@


MB

DY3V;Q#*V\^\O`H[$]W7Z?*H;G.J
MI=]FS*UCJ8K.8A6!2

MALJR:V2H\42J1AZ
A))!!21D@Z7P4


M+)(Q!]_*U^9'8MD6BP*AK+T]S:FMBFWCP/.1-^YB%]D(TJN%^&F1TIBF6&:2

_E.6I]UK
7
4-K*$+J68M%Q7(2(:5Y6F2]'(.
MO`F%[3\I/&




MA1@2(0[`@(`$DOVHV
WG+Y7ISU





JB5
D
Y]RD['V#U)TAL1&&7.7'(Q/2@
MRX\W^/C&(E^A+QX_;\#E;R$CF#F1IUY?8O3%F$$(&B`/1+!CT$(/'RW-WH[

M:55=




M(6
RLEPJI1+.?3]^-0SOF6`4X1#YV_-3`2ZE;%N:9.*[*G







UP#X4(S=8W41C7
M.2_
4KNL7[:=YXB1.49M2]R:)?Q2X



9\/*

[-@DS4


LO;
(&X-^H;U9T=C!L&C@@?Y^^6;'1
M?RG+)Z\R\B'Y.W70&B%E)C;Z^ZC$8HM!F[=MSKI.!4T?V*@__Q@9SF7!W?YK





M)8!6OT!]_\U\;^%^CSS5ECC\]'DSU_`19:KQ%
AY!T1GU(YFS9UB5XCOBI
MRC1UY/EP#


&L=E$5HC-<L=\G^%E

M

0-

MM_`C)`/FVHTT(1ITFF$8EJ`3-&MZ/B0L5.D&Q)Y8B5W+YE#
#U9WX(FM$J/:
M5]#BJ]



3
Q
C

3
Q
C


```)(`P`5`!@`


 'defref_mojo_NOTE7STOCKOPTIONSDetailsScheduleofSharebasedPaymentAwardStockOptionsExercisePricesinRelatedtoMarketPriceLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_ShareBasedCompensationOptionsExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_NOTE7STOCKOPTIONSDetailsScheduleofSharebasedPaymentAwardStockOptionsExercisePricesinRelatedtoMarketPriceLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_ShareBasedCompensationOptionsExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_NOTE7STOCKOPTIONSDetailsScheduleofSharebasedPaymentAwardStockOptionsExercisePricesinRelatedtoMarketPriceLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_ShareBasedCompensationOptionsExercisePrice'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Revenues'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CostOfRevenue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_GrossProfit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingExpensesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_GeneralAndAdministrativeExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingExpenses'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingIncomeLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherExpensesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InterestExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DerivativeGainLossOnDerivativeNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NonoperatingIncomeExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxExpenseBenefit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetIncomeLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DividendsPreferredStock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EarningsPerShareBasicAndDiluted'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_CashFlowsFromOperatingActivitiesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetIncomeLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Depreciation'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensation'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AllocatedShareBasedCompensationExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_ShareBasedCompensationToEmployeesInLieuOfSalary'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_ShareBasedCompensationAdvisorsAndConsultants'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DerivativeGainLossOnDerivativeNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_ChangesInAssetsAndLiabilitiesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncreaseDecreaseInInventories'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncreaseDecreaseInOtherDeposits'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncreaseDecreaseInSecurityDeposits'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_NetCashFromInvestingActivitiesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_NetCashFromFinancingActivitiesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncreaseDecreaseInNotesPayableRelatedPartiesCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_SupplementalDisclosureOfCashFlowInformationAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InterestPaid'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxesPaid'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_NonCashInvestingAndFinancingActivitiesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtConversionOriginalDebtAmount1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_NonCashInvestingAndFinancingActivitiesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_NonCashInvestingAndFinancingActivitiesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_NOTE10SUBSEQUENTEVENTSDetailsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_NumberOfPrivatePlacementOfferings'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharesIssuedPricePerShare'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_ClassOfWarrantOrRightTerm'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_ClassOfWarrantOrRightGranted'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_StockIssuedDuringPeriodSharesToEmployeesInLieuofCash'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_NumberOfServiceProviders'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_GoingConcernTextBlockAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetIncomeLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_WorkingCapital'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RetainedEarningsAccumulatedDeficit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_AccumulatedLossesFromDiscontinuedOperations'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_ScheduleOfEffectiveIncomeTaxRateReconciliationAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxExpenseBenefit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DisclosureTextBlockAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_CurrentAssetsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AccountsReceivableNetCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InventoryNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_SupplierDepositsCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PrepaidExpenseCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AssetsCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentNet'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OtherAssetsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SecurityDeposit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_Assets'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_CurrentLiabilitiesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LiabilitiesCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommitmentsAndContingencies'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_StockholdersDeficitAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PreferredStockValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommonStockValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AdditionalPaidInCapital'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RetainedEarningsAccumulatedDeficit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquity'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_LiabilitiesAndStockholdersEquity'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AccountingPoliciesAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_UseOfEstimates'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InventoryPolicyTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_SupplierDepositsPolicyTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RevenueRecognitionPolicyTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EarningsPerSharePolicyTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_StartUpCostsPolicyTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxPolicyTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy'

              <font style=DISPLAY: inline; FONT-FAMILY: symbol

              <font style=DISPLAY: inline; FONT-FAMILY: symbol

              <font style=DISPLAY: inline; FONT-FAMILY: symbol
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_DocumentAndEntityInformationAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityRegistrantName'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_DocumentType'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_CurrentFiscalYearEndDate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityCommonStockSharesOutstanding'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityPublicFloat'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_AmendmentFlag'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityCentralIndexKey'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityCurrentReportingStatus'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityVoluntaryFilers'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityFilerCategory'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_EntityWellKnownSeasonedIssuer'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_DocumentPeriodEndDate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_DocumentFiscalYearFocus'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_dei_DocumentFiscalPeriodFocus'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PreferredStockParOrStatedValuePerShare'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PreferredStockSharesAuthorized'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommonStockParOrStatedValuePerShare'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommonStockSharesAuthorized'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommonStockSharesIssued'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommonStockSharesOutstanding'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquityNoteAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingLossCarryforwards'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingLossCarryforwardsExpirationDate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquityNoteAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DisclosureTextBlockSupplementAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PreferredStockTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SubsequentEventsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SubsequentEventsTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_NOTE9RELATEDPARTYTRANSACTIONSDetailsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtConversionOriginalDebtAmount1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InterestPaid'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_StockIssuedDuringPeriodSharesToEmployeesInLieuofCash'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_StockIssuedDuringPeriodValueToEmployeesInLieuOfCash'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_NOTE9RELATEDPARTYTRANSACTIONSDetailsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtConversionOriginalDebtAmount1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_NOTE9RELATEDPARTYTRANSACTIONSDetailsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtConversionOriginalDebtAmount1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_NOTE9RELATEDPARTYTRANSACTIONSDetailsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_NOTE9RELATEDPARTYTRANSACTIONSDetailsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProceedsFromRelatedPartyDebt'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentageRateRangeMinimum'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentageRateRangeMaximum'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentMaturityDate'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtInstrumentConvertibleTermsOfConversionFeature'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtConversionOriginalDebtAmount1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InterestPaid'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_InterestExpenseRelatedParty'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_NOTE9RELATEDPARTYTRANSACTIONSDetailsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProceedsFromRelatedPartyDebt'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_NOTE2SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_NOTE5COMMITMENTSANDCONTINGENCIESDetailsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_LicenseAgreementTerms'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_RoyaltyPaymentsFutureMinimumPaymentsDueCurrent'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_RoyaltyPaymentsFutureMinimumPaymentsDueInTwoYears'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_RoyaltyPaymentsFutureMinimumPaymentsDueInThreeYears'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_RoyaltyPaymentsFutureMinimumPaymentsDueInFourYears'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_RoyaltyPaymentsFutureMinimumPaymentsDueAfterFourYears'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_NOTE5COMMITMENTSANDCONTINGENCIESDetailsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_TermOfLease'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_OperatingLeasesRentExpenseMinimumRentals'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DescriptionOfLesseeLeasingArrangementsOperatingLeases'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquity'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharesOutstanding'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquityOther'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquityOtherShares'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetIncomeLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquity'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharesOutstanding'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_StockIssuedDuringPeriodValueToEmployeesInLieuOfCash'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_StockIssuedDuringPeriodSharesToEmployeesInLieuofCash'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodValueOther'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesOther'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_NetIncomeLoss'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquity'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SharesOutstanding'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxDisclosureAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_IncomeTaxDisclosureTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_NOTE6STOCKHOLDERSEQUITYDetailsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PreferredStockSharesAuthorized'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommonStockSharesAuthorized'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PreferredStockParOrStatedValuePerShare'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_CommonStockParOrStatedValuePerShare'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockholdersEquityReverseStockSplit'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtConversionOriginalDebtAmount1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AllocatedShareBasedCompensationExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_NOTE6STOCKHOLDERSEQUITYDetailsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSharesWhichVestBasedUponCertainMilestones'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_AllocatedShareBasedCompensationExpense'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_NOTE6STOCKHOLDERSEQUITYDetailsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PreferredStockSharesAuthorized'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_PreferredStockParOrStatedValuePerShare'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_NOTE6STOCKHOLDERSEQUITYDetailsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_NOTE6STOCKHOLDERSEQUITYDetailsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_CommonStockAuthorizedToBeIssuedInAPrivatePlacementOfferingShares'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_SaleOfStockPricePerShare'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DebtConversionOriginalDebtAmount1'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_NOTE6STOCKHOLDERSEQUITYDetailsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_AdvisorAgreementTerms'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_AdvisorAgreementTerminationDescription'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_NOTE6STOCKHOLDERSEQUITYDetailsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_ShareBasedCompensationCostNotYetRecognized'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_NOTE6STOCKHOLDERSEQUITYDetailsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_NOTE6STOCKHOLDERSEQUITYDetailsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_NumberOfServiceProviders'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_NOTE6STOCKHOLDERSEQUITYDetailsLineItems'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock'
<a class=a href=javascript:void(0); onclick=top.Show.showAR( this
 'defref_mojo_ScheduleOfShareBasedPaymentAwardStockOptionsExercisePricesInRelationToMarketPriceTableTextBlock'

